Relationships between psychological factors and immune dysregulation in context: a life-course approach by Hammond, Catherine Campbell
  
Relationships between psychological factors and immune 
dysregulation in context: A life-course approach 
 
Catherine Campbell Hammond 
 
 
A thesis submitted for the degree of Doctor of Philosophy in Health Research 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Institute of Social and Economic Research 
 
University of Essex 
 
 
 
Date of submission for examination: March 2018
ii 
 
 
 
Contents 
Acknowledgements ................................................................................................................................. xi 
Summary xii 
 
Chapter 1: Introduction ........................................................................................................................... 1 
1. Rationale ..................................................................................................................................... 1 
2. The life-course approach ............................................................................................................ 7 
3. Relationships between psychological factors and health in context .......................................... 8 
3.1 Adversities ................................................................................................................................. 9 
3.2 Resources ................................................................................................................................ 13 
3.3 Confounding and mediating factors ........................................................................................ 13 
3.4 Moderators .............................................................................................................................. 15 
4. Psychological stress and immune dysregulation....................................................................... 15 
5. The inflammatory theory of depression ................................................................................... 18 
6. Research aims ........................................................................................................................... 21 
7. Empirical chapters in more detail ............................................................................................. 24 
7.1 Chapter 2: Does adversity predict onset of asthma during mid-adulthood? Do psychosocial 
pathways play a role? .................................................................................................................... 24 
7.2 Chapter 3: Does adversity predict onset of rheumatoid arthritis? Do psychosocial pathways 
play a role? .................................................................................................................................... 25 
7.3 Chapter 4: Prospective associations between low-grade inflammation and depressive 
symptoms and the factors that confound and mediate them. ..................................................... 26 
7.4 Methods and data ................................................................................................................... 26 
8. Final remarks ............................................................................................................................. 28 
 
Chapter 2: Does adversity predict onset of asthma during mid-adulthood?  Do psychosocial 
pathways play a role? ............................................................................................................................ 30 
1. Introduction .............................................................................................................................. 30 
1.1 Rationale .................................................................................................................................. 30 
1.2 Asthma ..................................................................................................................................... 31 
1.3 A model of adversities over the life-course and the development of adult onset asthma ..... 33 
1.4 Summary of existing evidence about factors that predict adult onset asthma ...................... 37 
1.5 Research questions .................................................................................................................. 45 
2. Data and measures ................................................................................................................... 46 
2.1 Onset of asthma during mid-adulthood .................................................................................. 46 
2.2 Adversities ............................................................................................................................... 47 
2.3 Moderating variables ............................................................................................................... 53 
2.4 Confounding variables ............................................................................................................. 53 
2.5 Mediating variables ................................................................................................................. 55 
3. Analyses .................................................................................................................................... 56 
RQ1: Life-course adversities as predictors of asthma onset during mid-adulthood? ................... 57 
RQ2: What confounding and mediating factors explain the association between childhood 
adversity and adult onset asthma? ............................................................................................... 59 
iii 
 
 
 
RQ3: What combination of factors best predict asthma onset during mid-adulthood? ............... 60 
Sensitivity analyses ........................................................................................................................ 60 
4. Results ....................................................................................................................................... 61 
Summary statistics......................................................................................................................... 61 
RQ1. Life-course adversities as predictors of asthma onset during mid-adulthood? ................... 67 
RQ2: What confounding and mediating factors explain the association between childhood 
adversity and adult onset asthma? ............................................................................................... 73 
RQ3: What combination of factors best predict asthma onset during mid-adulthood? ............... 75 
Sensitivity analyses ........................................................................................................................ 76 
5. Discussion .................................................................................................................................. 78 
5.1 Discussion of findings .............................................................................................................. 78 
5.2 Strengths and limitations ........................................................................................................ 87 
5.3 Conclusions and implications .................................................................................................. 88 
 
Chapter 3: Does adversity predict onset of rheumatoid arthritis?  Do psychosocial pathways play a 
role?  ..................................................................................................................................... 91 
1. Introduction .............................................................................................................................. 91 
1.1 Rheumatoid arthritis ............................................................................................................... 92 
1.2 Epidemiology of rheumatoid arthritis ..................................................................................... 93 
1.3 Model of how adversity may contribute to the onset of RA .................................................102 
1.4 Research questions ................................................................................................................105 
2. Data and measures .................................................................................................................107 
2.1 The dataset ............................................................................................................................107 
2.2 Onset of RA ............................................................................................................................108 
2.3 Adversities .............................................................................................................................109 
2.4 Resources ..............................................................................................................................111 
2.5 Factors to condition upon .....................................................................................................112 
2.6 Health behaviours .................................................................................................................113 
2.7 Variables used in sensitivity analyses ....................................................................................113 
3. Analyses ..................................................................................................................................114 
RQ1. Do adversities predict RA onset? ........................................................................................119 
RQ2: How do adversities combine over the life-course to predict RA onset? ............................122 
RQ3: Do material, psychosocial and behavioural factors independently predict RA onset? ......124 
RQ4: Are some types of social adversity more salient predictors of RA onset than others? ......126 
Sensitivity analyses ......................................................................................................................126 
4. Results .....................................................................................................................................128 
Descriptive statistics ....................................................................................................................128 
RQ1: Do adversities predict RA onset? ........................................................................................134 
RQ2: How do adversities combine over the life-course to predict RA onset? ............................137 
RQ3: Do material, psychosocial and behavioural factors independently predict RA onset? ......140 
RQ4: Are some types of social adversity more salient predictors of RA onset than others? ......143 
Sensitivity analyses ......................................................................................................................147 
5. Discussion ................................................................................................................................148 
iv 
 
 
 
5.1 Discussion of findings ............................................................................................................148 
5.2. Limitations ............................................................................................................................155 
5.3 Main conclusions and their implications ........................................................................160 
 
Chapter 4: Prospective associations between low-grade inflammation and depressive symptoms, 
and the factors that confound and mediate them .............................................................................163 
1. Introduction ............................................................................................................................163 
1.1 Rationale ................................................................................................................................164 
1.2 Inflammation .........................................................................................................................165 
1.3 Relationships between inflammation and depressive symptoms .........................................166 
1.4 Direct effects of inflammation on depression: The inflammatory theory of depression ......167 
1.5 Direct effects of depressive symptoms on inflammation ......................................................169 
1.6 Epidemiological evidence about prospective associations between inflammation and 
depressive symptoms ..................................................................................................................170 
1.7 Research Questions ...............................................................................................................181 
2. Methods ..................................................................................................................................182 
2.1 Data .......................................................................................................................................182 
2.2 Measures ...............................................................................................................................184 
3. Analyses ..................................................................................................................................194 
RQ1. What are the prospective relationships between inflammation and depressive symptoms?
 .....................................................................................................................................................195 
a. Does inflammation at time t-1 predict depressive symptoms at time t? ................................195 
b. Do depressive symptoms at time t-1 predict inflammation at time t? ...................................195 
RQ2. Are prospective associations between inflammation and depressive symptoms confounded 
or.mediated by other factors? ....................................................................................................197 
4. Results .....................................................................................................................................203 
RQ1. What are the prospective relationships between inflammation and depressive symptoms?
 .....................................................................................................................................................203 
a. Does inflammation at time t-1 predict depressive symptoms at time t? ................................203 
b. Do depressive symptoms at time t-1 predict inflammation at time t? ...................................203 
RQ2. Are prospective associations between inflammation and depressive symptoms confounded 
or mediated by other factors? .....................................................................................................210 
RQ3. Moderation by gender, age and health status ...................................................................222 
5. Discussion ................................................................................................................................226 
5.1 Discussion of findings ............................................................................................................226 
5.2 Strengths and limitations ......................................................................................................236 
5.3 Conclusions, policy implications, and future research ..........................................................240 
 
Chapter 5: Chapter 5: Discussion ................................................................................................243 
1. Strengths and limitations ........................................................................................................243 
2. Main conclusions and implications for policy, practice and research.....................................246 
2.1 Psychosocial factors predict onsets of asthma and RA .........................................................246 
2.2 Additional evidence about adversities as predictors asthma and RA onsets during adulthood
 .....................................................................................................................................................250 
v 
 
 
 
2.3 Additional evidence about behavioural and biological predictors of asthma and RA onsets 
during adulthood .........................................................................................................................253 
2.4 Prospective associations between chronic inflammation and depressive symptoms ..........254 
2.5 Psychological stress and immune dysregulation ...................................................................257 
 
References………………………………………………………………………………………………………………………………………264 
 
Appendices to Chapter 2 
Appendix 1: Evidence of associations between adversities and negative health outcomes…… 325 
Appendix 2: Measurement of quality of relationship with partner …………………………………………328 
Appendix 3: Factor analyses of responses to items of Rutter scale …………………………………………330 
Appendix 4: The Malaise Inventory  ……………………………………………………………………………………….331 
Appendix 5: How multiple imputed datasets were created …………………………………………332 
Appendix 6: Correlations between adversities …………………………………………………………………….337 
Appendix 7: Analyses using the observed sample. ………………………………………………………338 
Appendix 8: Sensitivity analyses using a measure of asthma onset that disregards symptoms up 
to age 7 ………………………………………………………………………………………………………………………………………….340 
Appendix 9: Sensitivity analyses using an index of childhood adversity that excludes residential 
moves ………………………………………………………………………………………………………………………………………….344 
 
Appendices to Chapter 3 
Appendix 10: Additional information about data and measures …………………………………………347 
Appendix 11: Choice of model for survival analyses ………………………………………………………373 
Appendix 12: How multiple imputed datasets were created …………………………………………374 
Appendix 13: Descriptive statistics ………………………………………………………………………………….382 
Appendix 14: Do adversities predict RA onset? Additional results. …………………………………………396 
Appendix 15: How do adversities over the life course combine to predict RA onset?  …….……….398 
Appendix 16: Do material, psychosocial and behavioural factors independently predict RA onset?              
 ………………………….………………………………………………………………………………………………………………400 
Appendix 17: Are some types of social adversity more salient predictors of RA onset than others?
 ………………………………………………………………………………………………………………………………………….406 
Appendix 18: Sensitivity analyses excluding those who reported pain or depression, or performed 
poorly on a memory test at the time of LIFE ………………………………………………………………………………….414 
Appendix 19: Sensitivity analyses using alternative multiple imputed datasets  ……………………….423 
 
Appendices to Chapter 4 
Appendix 20: Detailed information about data and measures  ………………………………………………. 430 
Appendix 21: Additional information about analyses  ………………………………………………………………445 
Appendix 22: Additional results  ………………………………………………………………………………………………446 
Appendix 23:  Discussion of relationships between obesity, inflammation and depressive 
symptoms                 ……………………………….. ………………………………………………………………………………………461 
 
 
 
vi 
 
 
 
List of Tables 
Chapter 2 
Table 2.1:   Questions used to code asthma or asthma and/or wheezy bronchitis ............................... 47 
Table 2.2:    Questions asked about childhood adversity ....................................................................... 49 
Table 2.3: Exposures to adversities during transition and early adulthood ........................................... 51 
Table 2.4:   Summary statistics for asthma onset .................................................................................. 61 
Table 2.5:   Summary statistics for adversities for cohort members without asthma before age 33
1
 ... 64 
Table 2.6: Summary statistics for hypothesised modifiers, confounders, and mediators of adversities-
adult onset associations. ........................................................................................................................ 66 
Table 2.7:   Odds ratios for asthma onset between 34 and 42 predicted by life-course adversity ........ 67 
Table 2.8: Comparison of alternative life-course models of adversities as predictors of adult onset 
asthma .................................................................................................................................................... 71 
Table 2.9: Odds ratios for asthma onset contingent upon adversity in various domains, with mutual 
adjustment ............................................................................................................................................. 72 
Table 2.10: Evidence of attenuation of association between childhood adversity and asthma onset 
during mid-adulthood ............................................................................................................................ 74 
Table 2.11:   Predictors of asthma onset ................................................................................................ 75 
Table 2.12:   Comparison of different models estimated to predict asthma onset during mid-
adulthood ............................................................................................................................................... 77 
 
Chapter 3 
Table 3.1:   Waves of data collection in ELSA .......................................................................................107 
Table 3.2:   Exposures to adversity and indices of exposure ................................................................111 
Table 3.3:   Details of models used to address RQ1 .............................................................................120 
Table 3.4:   Details of models used to address RQ2 .............................................................................123 
Table 3.5:   Details of models used to address RQ3a and b. ................................................................125 
Table 3.6:   Numbers of LIFE participants who reported RA onset during each life stage ...................128 
Table 3.7:   Summary statistics .............................................................................................................132 
Table 3.8: Associations between total exposure to adversity and risk of RA onset .............................135 
Table 3.9:   Associations between cumulative exposure to adversity and risk of RA onset ................137 
Table 3.10: Associations between RA onset and adversity during each life stage, with mutual 
adjustment ...........................................................................................................................................138 
Table 3.11: HRs for RA onset contingent upon material and social adversities ...................................141 
Table 3.12: HRs for RA onset contingent upon relationship-related and traumatic adversities .........144 
Table 3.13: HRs for RA onset contingent upon chronic and acute adversities ....................................145 
Table 3.14:   Summary of conclusions ..................................................................................................150 
 
Chapter 4 
Table 4.1: Waves of data collection in ELSA .........................................................................................184 
Table 4.2: Summary statistics for variables in each wave ....................................................................204 
vii 
 
 
 
Table 4.3: Summary statistics of variables pooled across waves for the whole sample and for the sub-
sample used to address RQ1 ................................................................................................................205 
Table 4.4:   Associations between inflammation and depressive symptoms four years later by gender, 
age category and health status. ...........................................................................................................208 
Table 4.5: Associations between depressive symptoms and Ln(CRP) four years later by gender, age 
category and health status. ..................................................................................................................209 
Table 4.6: Summary statistics of variables pooled across waves for the whole sample and for the sub-
sample used to address RQ2 ................................................................................................................212 
Table 4.7: Associations between each hypothesised explanatory variable and (1) Ln(CRP), (2) 
depressive symptoms, and estimated associations between Ln(CRP) and depressive symptoms as 
each hypothesised explanatory variable is added to the baseline model. ..........................................215 
Table 4.8: Magnitudes of prospective associations between Ln(CRP) and depressive symptoms ......219 
Table 4.9: Delays between main and nurse interviews ........................................................................220 
Table 4.10: Direct and mediated prospective associations between Ln(CRP) and depressive symptoms 
for each sub-sample .............................................................................................................................225 
 
Appendix Tables 
Table A1.1:   Evidence that adversities used in Chapter 2 predict negative health outcomes………… 325 
TableA3.1:   Factor loadings on items of Rutter parent scale  …………………………………………………………330 
Table A5.1:   Numbers of observations and evidence of correlations with missingness and values of 
variable of interest  ………………………………………………………………………………………………………………………..333 
Table A6.1:   ORs for one adversity contingent upon another during childhood  …………………………….337 
Table 6.2:   ORs for adversity in one domain contingent upon adversity in another during youth  ….337 
Table A6.3:   ORs for adversity in one domain contingent upon adversity in another during early 
adulthood  ………………………………………………………………………………………………………………………………………337 
Table A6.4:   Coefficients for levels of adversity at one life stage contingent upon level of exposure in 
another  ………………………………………………………………………………………………………………………………………….337 
Table A8.1:   Summary statistics for asthma onset during mid-adulthood, including respondents with 
asthma symptoms up to age 7  ……………………………………………………………………………………………………….340 
Table A8.2:   Odds ratios for asthma onset 34-42 predicted by life course adversity, including 
respondents with asthma symptoms up to age 7  …………………………………………………………………………..342 
Table A9.1:   Summary statistics for childhood adversity among cohort members without asthma 
before 33   ………………………………………………………………………………………………………………………………………344 
Table A9.2:   Odds ratios for asthma onset between 34 and 42 predicted by life course adversity, 
using index of childhood adversity that excludes residential moves   ……………………………………………..346 
Table A10.1: Questions used to code onset of RA   …………………………………………………………………………348 
Table A10.2: Questions used to measure childhood adversities   ……………………………………………………350 
Table A10.3:   Questions used to measure adversities during adulthood  ……………………………………….352 
Table A10.4: Criteria for poor housing amenities/overcrowding at age 10 for UK residents   ………….356 
Table A10.5: Moving house   
………………………………………………………………………………………………………………………………………………………..357 
Table A10.6: Items used to measure parent-child relationships   ……………………………………………………358 
Table A10.7:   Summary statistics of possible resources   ……………………………………………………………….360 
viii 
 
 
 
Table A10.8: Hazard ratios for RA onset contingent upon hypothesised resources and their 
interactions with adversity   ……………………………………………………………………………………………………………362 
Table A10.9:   Summary statistics for female sex hormone variables   …………………………………………….364 
Table A10.10:   Hazard ratios and p-values from PH tests for RA onset contingent upon female sex 
hormones and education in 2006   …………………………………………………………………………………………………365 
Table A10.11:   Evidence of associations between education at time of LIFE interview and both 
adversity and RA onset   …………………………………………………………………………………………………………………367 
Table A10.12: Questions used to measure smoking history   ………………………………………………………….369 
Table A10.13:   Summary statistics of smoking variables   ………………………………………………………………370 
Table A10.14:   Hazard ratios of RA onset contingent upon smoking behaviours …………………………..371 
Table A10.15:   Items used to measure depressive symptoms ………………………………………………………372 
Table A10.16: Questions used to measure pain   …………………………………………………………………………….373 
Table A11.1: P-values from tests of the proportional hazards assumption for variables included in the 
analyses   ………………………………………………………………………………………………………………………………………..373 
Table A12.1:  Summary statistics using the original and twenty imputed datasets   ……………………….377 
Table A13.1: Lifetime prevalence and incidence rates of RA in weighted and unweighted samples 382 
Table A13.2:   Summary statistics for men and women separately   ……………………………………………….389 
Table A13.3: Summary statistics for exposures to each adversity, using the original dataset   ………..394 
Table A14.1:   Associations between RA onset and single adversities during each life stage with 
mutual adjustment   ……………………………………………………………………………………………………………………….396 
Table A15.1: Associations between adversity during each life stage and RA onset, excluding 
adversities reported using questions about first experiences ………………………………………………………398 
Table A15.2: Cumulative life course adversity and RA onset among men and women   ………………….399 
Table A16.1: HRs for RA onset contingent upon material and social adversities using sets of dummies
 ………………………………………………………………………………………………………………………………………….401 
Table A16.2: HRs for RA onset contingent upon material and social adversities with adjustment for 
smoking   ………………………………………………………………………………………………………………………………………..402 
Table A16.3: HRs for RA onset contingent upon material and social adversities for men and women
 ………………………………………………………………………………………………………………………………………….403 
Table A16.4:   P-values for interaction terms of gender with material and social adversities   ………. 404 
Table A16.5:   HRs for RA onset contingent upon material and social adversities with adjustment for 
smoking for men and women   ……………………………………………………………………………………………………… 405 
Table A17.1:   HRs for RA onset contingent upon relationship-related and traumatic adversities using 
sets of dummies ……………………………………………………………………………………………………………………………407 
Table A17.2:   HRs for RA onset contingent upon chronic and acute adversities using sets of dummies
 ………………………………………………………………………………………………………………………………………….409 
Table A17.3:   Numbers of respondents with one or more adversity who reported RA onset   ……… 410 
Table A17.4:   HRs for RA onset contingent upon relationship-related and traumatic adversities for 
men and women separately   …………………………………………………………………………………………………………411 
Table A17.5:   HRs for RA onset contingent upon chronic and acute adversities for men and women 
separately   …………………………………………………………………………………………………………………………………….413 
Table A18.1: Summary statistics   ……………………………………………………………………………………………………416 
Table A18.2:   Associations between total exposure to adversity and risk of RA onset   ………………….418 
ix 
 
 
 
Table A18.3:   Associations between cumulative exposure to adversity and risk of RA onset   ……….418 
Table A18.4:   Associations between RA onset and adversity during each life stage, with mutual 
adjustment   ……………………………………………………………………………………………………………………………………419 
Table A18.5:   Associations between adversity during each life stage and RA onset, excluding 
adversities reported using questions about first experiences   ……………………………………………………… 419 
Table A18.6: HRs for RA onset contingent upon material and social adversities …………………………..420 
Table A18.7:   HRs for RA onset contingent upon material and social adversities with and without 
smoking ………………………………………………………………………………………………………………………………………….421 
Table A18.8: HRs for RA onset contingent upon relationship-related and traumatic adversities   …. 422 
Table A18.9:   HRs for RA onset contingent upon chronic and acute adversities  …………………………...422 
Table A19.1:   Summary statistics ………………………………………………………………………………………………..424 
Table A19.2:   Associations between total exposure to adversity and risk of RA onset …………….426 
Table A19.3:   Associations between cumulative exposure to adversity and risk of RA onset   ……….426 
Table A19.4:   Associations between RA onset and adversity during each life stage, with mutual 
adjustment ……………………………………………………………………………………………………………………………427 
Table 19.5:   HRs for RA onset contingent upon material and social adversities …………………………..427 
Table 19.6:   HRs for RA onset contingent upon material and social adversities with adjustment for 
smoking ………………………………………………………………………………………………………………………………………….428 
Table A19.7:   HRs for RA onset contingent upon relationship-related and traumatic adversities   .. 428 
Table A19.8: Hazard ratios for RA onset contingent upon chronic and acute adversities …………….429 
Table 20.1:   Items used to measure depressive symptoms ………………………………………………………431 
Table A20.2: Questions asked to elicit information about use of pharmaceutical medication   ………433 
Table A20.3: Classification of physical activity as high, moderate, or low   ……………………………………..434 
Table A20.4: Questions used to measure psychosocial factors   ……………………………………………………. 436 
Table A20.5: Questions used to measure childhood adversities   …………………………..……………………….437 
Table A20.6: Items used to measure stable psychological factors and their factor loadings   ………… 442 
Table A20.7:   Questions used to measure health status   ……………………………………………………………….443 
Table A21.1: Changes in depressive symptoms and inflammation with age   ………………………………….445 
Table A22.1:   Associations between inflammation and depressive symptoms four years later by 
gender, age category  and health status   ……………………………………………………………………………………….447 
Table A22.2:   Associations between depressive symptoms and Ln(CRP) four years later by gender, 
age category and health status   …………………………………………………………………………………………………….448 
Table A22.3:   Pairwise correlations between variables used in the SEM   ………………………………………449 
Table A22.4:   Summary statistics for alternative and additional measures in the SEMs …………….458 
Table A22.5:   Results of SEM for whole sample with MLMV estimation method (n=11,986)   ……….459 
 
List of Figures 
Chapter 1 
Figure 1.1:   Relationships between adversity and health ....................................................................... 8 
Figure 1.2:   Relationships between adversity and health with relevant parts in bold font .................. 15 
x 
 
 
 
Figure 1.3:   Relationships between adversity and health with relevant parts in bold font .................. 18 
 
Chapter 2 
Figure 2.1:   Model of the contribution of the stress process to adult onset asthma ............................ 36 
 
Chapter 3 
Figure 3.1:   Model of how adversity may contribute to onset of RA ..................................................104 
Figure 3.2:   Baseline hazard function for RA onset .............................................................................115 
Figure 3.3:   Hazard function for RA onset, adjusted for birth cohort..................................................129 
Figure 3.4:   Hazard functions for RA onset for different birth cohorts of respondents who participated 
in LIFE ...................................................................................................................................................130 
Figure 3.5:   Hazard functions for RA onset for men and women who participated in LIFE, adjusted for 
birth cohort ..........................................................................................................................................131 
Figure 3.6:   Hazard functions for RA onset for LIFE respondents with different socio-economic 
backgrounds, adjusted for birth cohort ...............................................................................................132 
Figure 3.7:    HRs for RA onset contingent upon chronic and acute adversities ..................................146 
 
Chapter  4 
Figure 4.1:   Model of relationships between depressive symptoms and inflammation .....................167 
Figure 4.2:   SEM specification .............................................................................................................202 
Figure 4.3:   SEM results for the whole sample ....................................................................................218 
Figure 4.4:   SEM results for sub-samples ............................................................................................224 
 
Appendix Figures 
Figure A10.1: Highest level of qualification at time of LIFE interview …………………………………………368 
Figure A13.1: Hazard function for RA onset adjusted for birth cohort using the whole ELSA sample.383 
Figure A13.2:   Hazard function for RA onset adjusted for birth cohort using weighted sample of LIFE 
participants ……………………………………………………………………………………………………………………………384 
Figure A13.3: Hazard functions for RA onset for each birth cohort using weighted sample of LIFE 
participants
 ………………………………………………………………………………………………………………………………………….385 
Figure A13.4:   Hazard functions for RA onset for men and women adjusted for birth cohort, using 
weighted sample of LIFE participants   ……………………………………………………………………………………………386 
Figure A13.5:   Hazard functions for RA onset by socio-economic background, adjusted for birth 
cohort and using weighted sample of LIFE participants   ………………………………………………………………..386 
Figure A13.6: Unadjusted hazard functions with confidence intervals for men and women who 
participated in LIFE   ……………………………………………………………………………………………………………………….387 
Figure A13.7: Unadjusted hazard functions with confidence intervals by socio-economic background 
for LIFE participants   ………………………………………………………………………………………………………………………388 
Figure A22.1:   Building the SEM in stages   …………………………………………………………………………………….450 
Figure A22.2:   Additional robustness checks    ……………………………………………………………………………… 455 
 
 
xi 
 
 
 
 
 
 
 
Acknowledgements 
This thesis was written with the financial support that comes with a PhD Studentship from 
the Economic and Social Research Council. 
I am particularly grateful to my supervisors Cara Booker and Michaela Benzeval, who 
provided invaluable advice and support throughout most of the PhD, and to Maria Iacavou, 
Amanda Sacker and Stephanie McFall, who supervised my work earlier on. I would also like 
to thank staff and students at the Institute of Social and Economic Research, past and 
present, as they have made it an inclusive and stimulating place to work, and have provided 
constructive feedback during seminars. I have benefitted from variables derived by Rebecca 
Ghosh, and from proof-reading provided by kind family and friends; Helen, Suzanne, 
Amanda and Rachel. Last but not least, a big thank you to Fliss Rich for providing me with a 
welcoming, supportive and peaceful home in Wivenhoe.
xii 
 
 
 
Summary 
The thesis provides evidence about relationships between adverse exposures, psychological 
responses to them and immune dysregulation. The approach taken is informed by theories 
about the life-course, the stress process, the stress response and the inflammatory theory of 
depression.  
The first two empirical chapters provide evidence about the contribution of psychosocial 
factors to immune dysregulation. Immune dysregulation is measured by onsets of asthma 
and rheumatoid arthritis during adulthood. Comprehensive life-course data are used to 
provide valuable evidence about the epidemiology of each disease. More specifically, new 
evidence is provided about the psychosocial pathways that lead to disease onset. After 
adjustment for material adversities, social adversities predict onsets of each disease. 
Chronic as opposed to acute adversities are salient for rheumatoid arthritis onset, which is 
consistent with existing theory that chronic stress contributes to immune dysregulation. 
Depressive symptoms mediate an association between childhood adversity and asthma 
onset decades later. A small but consistent association between depressive symptoms and 
asthma onset soon afterwards may reflect psychological consequences of chronic 
inflammation preceding asthma diagnosis. The third empirical chapter tests prospective 
associations between chronic inflammation and depressive symptoms. It finds that chronic 
inflammation predicts depressive symptoms and provides new evidence that these 
associations are mediated by factors associated with sickness behaviours. 
Findings indicate the relevance of psychosocial pathways to the development of immune-
mediated diseases and the potential involvement of immune behaviours in psychological 
symptoms. Practitioners and policy makers working with people who have conditions 
characterised by immune dysregulation should consider the psychological predictors and 
xiii 
 
 
 
consequences of immune dysregulation. More research in this area is needed and this 
would be facilitated by the development and inclusion in surveys of well-validated measures 
of psychological and biological stress and of the psychological and behavioural correlates of 
sickness behaviours thought to be induced by inflammation.  
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Chapter 1: Introduction 
This PhD is motivated by an interest in how social and economic exposures and 
psychological responses to them combine over the life-course to affect health outcomes. Its 
aim is to explore how psychological factors interact with immune dysregulation within a life-
course context. 
This first chapter introduces the research topic, describes the life-course approach and 
presents a model of relationships between negative exposures (adversities) and health 
outcomes. In the model, health impacts of adversities are buffered by resources and 
transmitted through interlinked pathways classified as material, behavioural and 
psychosocial. Psychosocial pathways involve psychological responses to social exposures. 
Two theories are introduced that draw on biological evidence to provide understanding 
about how relationships may develop between psychological factors (specifically, 
psychological stress and depressive symptoms) and immune dysregulation. Finally, the 
research aims and three empirical chapters are summarised. 
1. Rationale 
Recognition of socio-economic inequalities in health (Black 1980, Acheson 1998) focused 
attention on how inequalities develop over the life-course; how life gets under the skin 
(Bartley 2012) or how the social becomes biological (Blane et al. 2013). A theoretical review 
of relevant evidence describes the interlinked processes that link money with health, 
classifying them into three pathways, referred to as material, behavioural and psychosocial 
(Benzeval et al. 2014). The focus here is on the psychosocial pathway, that is, social 
exposures and psychological responses to them, but its relationship with health is 
understood within the context of the other two.    
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The area of physical health examined is dysregulation of the immune system. The immune 
system provides defence against external agents that might cause damage. Dysregulation of 
the immune system can lead to the development of allergic, autoimmune and 
autoinflammatory diseases, chronic low-grade inflammation and immune-deficiency. 
Allergic, autoimmune and autoinflammatory diseases are sometimes referred to as 
immune-mediated diseases. Allergic diseases involve immune responses to substances that 
are not necessarily harmful (Henderson 2015), whilst autoimmune diseases involve “an 
immune response by the body against one of its own tissues, cells, or molecules” (American 
Heritage Medical Dictionary 2007). Autoinflammatory diseases are a relatively new 
classification of (rare) diseases characterised by unprovoked inflammation (McDermott et 
al. 1999) and include Still’s disease and Crohn’s disease. Allergies include asthma and 
autoimmune diseases include rheumatoid arthritis (RA). 
Immune dysregulation is chosen for two reasons. First, immune dysregulation is important 
for public health. This is because conditions involving and arising from immune 
dysregulation are common and costly to individuals and the state. According to 
patient.co.uk, allergies affect about one in four people at some point in their lives 
(Henderson 2015). Although less common than allergies, prevalence and incidence rates of 
autoimmune diseases have risen substantially over the last 30 years, especially in Northern 
and Western countries (Lerner et al. 2015). The British Society for Immunology states that 
eighty autoimmune diseases have been identified, affecting hundreds of thousands of 
individuals in the United Kingdom (UK, Lowry 2016) and prevalence rates have been 
estimated at just under one in ten in Denmark and the United Stated (US) (Cooper et al. 
2009, Shurin & Smolkin 2007, respectively). The National Institutes of Health (NIH 2005) 
estimated that the number of Americans with an autoimmune disease was similar to the 
number with heart disease. In addition, there is growing interest in immune-mediated 
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diseases and especially auto-inflammatory diseases because the physiological mechanisms 
that underlie them may contribute to the chronic inflammation that characterizes better 
known diseases such as artherosclerosis, diabetes and osteoporosis (Ciccarelli et al. 2014). 
Symptoms of immune-mediated diseases are often inadequately controlled by existing 
medications and they are disabling and involve suffering (Lowry 2016). They are chronic 
diseases with lasting impacts, which increases their burdens to the individual and state 
(Lowry 2016). In illustration, the World Health Organisation (WHO) estimates that the 
number of disability adjusted life years lost due to asthma is similar to numbers for 
diabetes, liver cirrhosis and schizophrenia (Bosquet et al. 2005). The quality of life 
associated with RA has been described as one of the poorest among all diseases (Furneri et 
al. 2012) and the (British) National Institute for Health and Care Excellence (NICE) states that 
approximately one third of people with RA stop work within two years of its onset in the UK 
(NICE 2009). Further, autoimmune diseases are a leading cause of death, especially among 
females. Thomas et al. (2010) estimate that among females, autoimmune diseases were the 
sixth or seventh leading cause of death between 1995 and 2003, depending upon age group. 
More evidence is needed about the common determinants of this group of diseases 
(Thomas et al. 2010). They are not currently classified as a group either in the International 
Classification of Diseases or by the WHO, which presents challenges for researchers, 
practitioners and policy makers interested in their common risk factors and causes (Thomas 
et al. 2010). 
As is the case for many health conditions, most immune-mediated conditions are more 
common and their consequences are more severe for those who suffer socio-economic 
disadvantages (Lerner et al. 2015). This adds to the public health importance of these 
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conditions because those affected tend to have fewest resources to manage symptoms and 
their impacts. 
The second reason for the focus on immune dysregulation is that immune-mediated 
diseases appear to have a psychological component as many are exacerbated by 
psychological stress (Straub & Besedovsky 2003, Cutulo & Straub 2007) and many are linked 
to symptoms of depression and anxiety (Chida et al. 2008, Loerbroks et al. 2010, Scott et al. 
2008, Covic et al. 2012). This may be because the immune system is closely integrated with 
the endocrine and nervous systems, which connect with psychological experience. In an 
overview of relationships between behaviour and immunity, Irwin writes: 
The immune system “is sensitive to virtually every hormone, and sympathetic, 
parasympathetic, and sensory nerves innervate the organs of the immune system. 
In turn, the nervous, endocrine, and immune systems communicate bi-directionally 
through common hormones, neuropeptides, and cytokines” (Irwin 2007:450). 
Physiological links between immune behaviours and psychological symptoms do not exist in 
isolation. They are affected by and contribute to psychological and behavioural responses to 
social and economic exposures, within contexts of culture, history, politics and life stage. 
That is why the aim of the PhD is to examine prospective relationships between 
psychological factors and immune dysregulation within a life-course perspective, drawing on 
multiple disciplines. 
2. The immune system and immune dysregulation 
As mentioned above, the immune system provides defence against external agents that 
might cause damage. This involves three stages; (1) recognition of the potentially harmful 
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external agent or pathogen, (2) an acute inflammatory response, and (3) suppression of this 
response once the threat has been resolved.  
Most immune-mediated diseases develop because of errors in the first stage.  As explained 
above, in allergic diseases, the immune system recognises as potentially harmful an external 
agent, such as pollen, referred to as an allergen. The allergen does not stimulate an immune 
response among healthy individuals, but among those with an allergic condition, a specific 
allergen or group of allergens stimulates an acute inflammatory response, which is often 
unpleasant and disabling and can be fatal. In individuals with autoimmune diseases, the 
body recognises as potentially harmful one of its own molecules, cells or tissues. 
The acute inflammatory response involves the production of white blood cells called T-
lymphocytes. There are many different types of T-lymphocytes, and they have been 
classified according to whether they act to defend the body against intracellular or 
extracellular pathogens. T-helper 1 (Th1) cells act against viruses and other intracellular 
pathogens and eliminate cancer cells. Th2 cells act against pathogens external to cells, such 
as parasitic infections. Th1 and Th2 responses involve the production of specific arrays of 
signalling molecules (cytokines) that promote and suppress particular immune pathways, 
and the production of specific white blood cells. For example, the Th2 response is usually 
associated with a white blood cell called immunoglobulin E (IgE) and cytokines called 
interleukins 4, 5, 13 and 10 (Berger 2000).  
Acute allergic responses are associated with a Th2-type immune response as the allergen is 
external to the cells. In contrast, autoimmune responses are mostly associated with a Th1-
type immune response, since the body is responding to its own tissues or cells (Jeong et al. 
2018).  
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As an aside, the immune pathways typically involved in most allergic responses are 
stimulated in response to a group of parasites (worm infections). In countries and 
households with high levels of hygiene, infants and children are rarely exposed to these 
parasites and it has been argued that this lack of exposure is a risk factor for the 
development of allergic conditions. It has been argued that the increase in hygiene is a 
reason why prevalence rates of allergic conditions are increasing in industrialised countries 
(Hellman et al. 2017). 
Allergic conditions cause an inflammatory response that is unpleasant, disabling and can be 
fatal. Autoimmune diseases cause damage for two reasons. First, the immune system 
attempts to destroy the part of the body that it mistakenly recognises as a pathogen. In RA, 
this is connective tissue. Second, a untreated continuining acute inflammatory response 
leads to extreme fatigue, malaise, anaemia, weight loss, and, over time, wasting away and 
death. 
Auto-inflammatory diseases involve an uncontrolled acute inflammatory response for no 
identified reason. The immune pathways stimulated are similar to those involved in 
autoimmune diseases. Untreated, these diseases would lead to wasting away and death. 
Chronic inflammation is a sub-clinical condition that results from incomplete suppression of 
an immune response that is usually stimulated by genuine pathogens. The level of 
inflammation is much lower than in immune-mediated diseases, but it predicts 
cardiovascular disease, type II diabetes, and mortality (Maes et al. 2011, Liu et al. 2016, 
Padayachee et al. 2009, Zhang 2011). 
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The immune system is complex and immune dysregulation takes various forms. I have 
chosen to adopt a comprehensive approach and so I examine relationships between 
psychological factors and an allergic condition (asthma), an autoimmune condition (RA), and 
chronic inflammation. 
3. The life-course approach 
Elder & Johnson (2002) describe life-course ideas as a “focus on the changing contexts of 
lives and their consequences for human development” (p.54). The approach provides a 
conceptual framework that aids understanding of how exposures and experiences during 
earlier years link to outcomes later in life. Human lives are seen in their entirety, which 
directs attention to the causal pathways across the life-course. In addition, individuals are 
placed in their historical context. The life-course approach is necessarily interdisciplinary 
because human lives combine historical, geographical, political, economic, sociological, 
psychological and biological influences. 
The life-course can be divided into life stages constructed on the basis of age-graded 
biological events and social institutions (Elder & Johnson 2002). Familiarly named life stages 
include childhood, youth, transition to adulthood, adulthood, early adulthood, middle age 
and late adulthood.  
Research in social determinants of health and social epidemiology examines (among other 
things) the ways in which biological and psychosocial factors combine throughout the life-
course to affect health in later life. Kuh et al. (2003) describe life-course models that have 
been used to describe these relationships. The model of accumulation of risk posits that life-
course exposures independently predict an outcome. The model of social pathways or 
chains of risk describes, “A sequence of linked exposures that raise disease risk because one 
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bad experience or exposure tends to lead to another and then another” (Kuh et al. 2003: 
779). Effects are not independent or cumulative because earlier exposures only matter 
because they predict later ones, which are more proximal to the outcome. A third model 
refers to sensitive periods, “When an exposure has stronger effects on development and 
subsequent disease risk than it would at other times” (Kuh et al. 2003: 781). Any 
combination of these models can describe the ways in which interlinked factors combine 
over the life-course to predict health outcomes later in life. 
4. Relationships between psychological factors and health in 
context 
Figure 1.1 illustrates relationships between psychological factors and health in the context 
of adversities and the factors that may affect relationships between adversities and health, 
by buffering, confounding, mediating and moderating them. The relationships illustrated in 
Figure 1.1 are repeated over the life-course. 
Figure 1.1:   Relationships between adversity and health  
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4.1 Adversities 
Adversities, on the left-hand side of Figure 1.1, are events and circumstances that are 
usually appraised negatively and that one would expect to have negative consequences.  
4.1.1 Material and social adversities 
Gustafsson et al. (2012) classified adversities as material and social. These authors define 
material adversities are defined as, “exposures to unfavourable circumstances mainly 
related to the immediate physical environment or the financial situation” (p.120) and they 
classify as material adversities low income, unemployment and financial strain. Social 
adversities are defined as, “exposures which hypothetically would impact on health mainly 
by directly threatening salient relationships” (p.119) and include relationship breakdown 
and social isolation.  
4.1.2 Adversities experienced in various domains 
Gallo et al. (2011) classify chronic stress based on the domain in which it is experienced. 
Drawing on this approach, adversities (that may contribute to chronic stress) are classified 
by domain as financial, occupation-related, relationship-related, child loss related and 
traumatic. Broadly speaking, financial and occupation-related adversities would be classified 
as material, and adversities relating to relationships, child loss and trauma would be 
classified as social. 
4.1.3 Chronic and acute adversities 
Pearlin (1989) discusses the distinction between life events and “more enduring or recurrent 
life problems”, which he refers to as chronic strains (p.243). He argues that chronic strains 
are often rooted in institutionalised social roles that involve interpersonal relationships, 
such as being a spouse or parent, and gives as examples difficulties in marriage and 
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parenthood. In contrast to chronic strains, life events are usually discrete and observable 
with a clear onset and offset. However, Pearlin notes that life events are rarely free-
standing; frequently, they are indicators of ongoing conditions. For example, divorce (a life 
event) may be closely associated with the chronic strain of relationship difficulty. More 
contemporary authors continue to classify adversities as chronic stressors and life events, 
whilst noting that the distinction between the two is blurred (Theorell 2012). 
Physiological evidence and evidence from animal studies suggests that chronic and acute 
psychological stress have different impacts on health (McEwen 2004, Eisenmann et al. 
2016). A handful of small-scale epidemiological studies provide evidence about the different 
relationships between chronic and acute adversities and health outcomes (Lepore et al. 
1997, Vreshek-Schallhorn et al. 2015, Bryan et al. 2015), but large-scale epidemiological 
evidence remains scarce.  
4.1.4 Examples of adversities 
Which events and circumstances are appraised negatively depends upon period and culture 
(Seeman et al. 2004, Bolger et al. 2003, Hobfoll 2001). Appraisals also depend on life stage; 
individuals can be exposed to the same event or circumstance at any life stage, but its 
meanings and impacts may differ (Pearlin 2010, Elder & Shanahan 2006). 
With this in mind, exposures are more likely to be appraised negatively, reported as 
stressful and classified as adversities if the event and its consequences are in fact or 
perceived to be out of one’s control (Fairbank & Hough 1979, Averill 1973, Fusilier et al. 
1987, Glass & Singer 1972), unpredicted (Glass & Singer 1972), not normative (Pearlin 2010), 
associated with negative emotional affect (Semmer et al. 2005), or unresolved (Turner & 
Avison 1992, Thoits 1994). 
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Childhood adversities include early parental loss (through death, divorce, or other reasons), 
neglect, psychological, physical and sexual abuse, exposure to violence, conflict and tension 
in the family and living with a household member who is mentally ill, has substance use 
issues, or has been imprisoned, and family poverty (Felitti et al. 1998, Rosenman & Rodgers 
2004).  
Moving house can also be stressful, especially for children, who have little control over 
decisions about moving (Jelleyman & Spencer 2008). Childhood moves are particularly 
difficult if the move involves a change of school (Herbers et al. 2013), as this disrupts the 
child’s social networks and education (Brown et al. 2012, Duncan & Zuberi 2006). 
Furthermore, the circumstances or events that precipitate the move may be difficult for the 
child (Dong et al. 2005).  
During adulthood, material adversities include financial hardship and occupation-related 
adversities such as long term unemployment (Gustafsson et al. 2012, Gerston 1974) and 
involuntary job loss (Wahrendorf et al. 2013). Dohrenwend et al. (1978) included as a 
negative life event failing at school or college, which would be more common during youth 
or the transition to adulthood, and would be classified as an occupation-related adversity. 
Work stress (Siegrist 1996, Karasek et al. 1998) might be classified as social or material. 
Family and relationship-related adversities, classified as social, include relationship 
difficulties (Loving & Slatcher 2013) and broken partnerships (Holmes & Rahe 1967, 
Dohrenwend 1978). Lone parenthood, a role more frequently occupied by women, can 
involve an unshared burden of financial responsibility, work overload, insufficient time for 
rest and sleep, difficulties with social life, isolation and difficult relationships with ex-
partners (Richards 1989, Richards & Schmiege 1993, Sanik & Mauldin 1986, Richards & 
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Schiete 1993). Caring for sick relatives and friends has also been conceptualised as a stressor 
(Pearlin et al. 1997). Cousino & Hazen (2013) report that caring for a child with a 
longstanding illness often involves anxiety for the child’s wellbeing, watching the child 
suffer, managing hospital admissions and treatments, school issues and explaining the 
child’s health problems to strangers. Death of one’s child and stillbirth are ranked as highly 
stressful life events by Dohrenwend and colleagues (1978). Infertility has been described as 
a “chronically stressful” situation (Schmidt et al. 2005). 
Traumatic events are an additional group of adversities that pose a significant risk of death 
or serious injury and evoke fear, helplessness or horror (American Psychological Association 
2000). They include active combat, large scale disasters, serious assault and rape.  
4.1.5 Combinations of adversities 
Adversities tend to cluster, often among the most vulnerable sections of the population 
(Bolte et al. 2009, Evans 2003, Evans et al. 2007), a phenomenon referred to as stress 
proliferation (Pearlin et al. 1997, 2005) and cumulative disadvantage (Sampson & Laub 
1997, Ross & Wu 1996). While single adversities have impacts, individuals are often exposed 
to multiple adversities (Garmezy 1991, Rutter 1981, 2009), and studies have found that 
exposures to multiple adversities incrementally predict poorer health outcomes (Felitti et al. 
1998, Evans 2003, Evans et al. 2007, Larson et al. 2008, Power et al. 2012, Schilling et al. 
2008). For these reasons, researchers create indices of multiple adversities or of adversities 
in multiple domains in order to examine their cumulative impact. A limitation of this type of 
index is that it assumes that different types of adversity are interchangeable and can be 
added together to represent the total load experienced by the individual (Lepore 1995, 
Evans et al. 2007). 
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4.1.6 Bi-directional relationships between adversities and health 
Whilst adversities predict health outcomes, health status also predicts negative exposures 
such as poverty, unemployment and stress in relationships and at work. 
4.2 Resources 
Resources are illustrated in Figure 1.1 as buffers of the impacts of adversity. They include 
money (Benzeval et al. 2014), education (Bartley 2006) and social support (Bartley 2006, 
Ozbay et al. 2007, Wahrendorf et al. 2013). Resources contribute to resilience (Schoon & 
Bartley 2008), and individual differences in access to resources partly explains individual 
differences in the health outcomes associated with a particular adversity, even when 
exposure occurs within the same life stage and context.  
Hobfoll (2001) argues that adversity is sometimes equivalent to a lack or loss of resources. 
For example, poverty (an adversity) is a lack of wealth (a resource). However, this argument 
does not apply to some adversities, for example, work stress. Therefore, the distinction 
between adversities and resources is retained. 
4.3 Confounding and mediating factors 
Factors that confound and mediate associations between adversity and health outcomes 
are, by definition, correlated independently with both. Confounding factors occur earlier 
than both adversity and the health outcome in causal pathways. Mediating factors occur 
after adversity but before the health outcome. Mediation is consistent with but does not 
necessarily imply a causal pathway. 
In Figure 1.1, confounding factors include family medical history. For example, if the health 
outcome were asthma onset, parental experiences of asthma could independently lead to 
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family difficulties that impact on the child, and reflect a genetic vulnerability to asthma and 
related conditions. Another example is difficulties during pregnancy or birth, which could 
affect a child’s early family circumstances and independently have lasting effects on health. 
Mediating factors affect and are affected by health status. They are classified as 
behavioural, material, biological and psychological. Behavioural factors include smoking, 
drinking patterns, physical activity and diet. Material factors include living in poor housing 
conditions and working in occupations that are associated with high risk of exposure to 
toxins. These could be classified as material adversities in the model but are not because of 
where they are hypothesised to occur in causal pathways.  
Biological mediators are specific to the health outcome. They include biological factors, such 
as obesity, which predicts various diseases, and atopic history and early respiratory 
infections, which predict asthma onset. Biological mediators also include sub-clinical 
changes, such as the development of low-grade chronic inflammation, which might predict 
onsets of asthma and RA.. 
Psychological factors include psychological stress and related psychological factors such as 
distress, low self-efficacy and isolation. Physiological evidence suggests that psychological 
stress can lead to immune dysregulation. 
Sections 4 and 5 describe two hypotheses about links between psychological factors and 
immune dysregulation. Each hypothesis applies to part but not all of the model illustrated in 
Figure 1.1. The first hypothesis is that psychological stress, which is a response to adversity, 
leads to immune dysregulation. The second hypothesis is that immune dysregulation leads 
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to chronic inflammation, which has psychological and behavioural correlates that lead to the 
development of depressive symptoms.  
4.4 Moderators 
All relationships in Figure 1.1 may differ by factors referred to as moderators, such as 
gender, age and health status. 
5. Psychological stress and immune dysregulation 
Figure 1.2 presents the same model as the one illustrated in Figure 1.1, but the parts of the 
model that this section relates to are in bold font. 
Figure 1.2:   Relationships between adversity and health with relevant parts in bold font 
 
Confounding factors 
e.g. family medical 
history 
   
      
  
  
 
Adversities: 
   Material, social 
   By domain    
   Chronic, acute 
   
 Health 
outcomes: 
immune 
dysregulation 
  
 
  
  
 
All relationships may differ by moderating factors such as gender, age and health status 
 
Psychological experiences of stress are believed to evoke and reflect a set of common 
physiological responses (Selye 1956). These responses appear to vary little between 
mammals (Brunner & Marmot 2006).  
  
Mediating factors: 
    Psychological: 
         stress     
    Behavioural 
    Material 
    Biological 
 
Chapter 1: Introduction     16 
 
 
 
The physiological response is a form of crisis management in which the ‘fight or flight’ 
response is prepared for whilst other systems are put on hold. This is achieved through the 
activation of two separate but inter-related systems; the sympathoadrenal medullary (SAM) 
and the hypothalamic-pituitary-adrenal (HPA) axis. When the SAM is stimulated, it activates 
the fight or flight response by increasing the heart rate and blood supply to the skeletal 
muscles, the brain and other parts of the body that are involved in the response. This 
happens within milliseconds, lasts for only a few minutes, and is experienced as a ‘rush’. The 
HPA axis response, on the other hand, takes minutes to become activated and continues for 
hours. It involves a chain of reactions, resulting in elevated levels of cortisol in the blood. 
High levels of cortisol act together with other signalling molecules (called catecholamines) 
to change the balance of activity in distinct but inter-related physiological systems. For 
example, the cardiovascular and respiratory systems are upregulated and stores of energy 
are mobilized in preparation for fight or flight, while other functions that use energy but are 
not necessary during a crisis are inhibited, for example, digestion, reproduction and immune 
activity. 
These responses are important for saving life and they cause the body no harm if the threat 
is acute with a well-defined ending, especially when exercise is part of the response. On the 
other hand, if the stimulus is chronic, a continued stress response can lead to adverse 
physiological changes (Sapolsky 1993), such as wear and tear on systems that are 
continuously activated and dysregulation of systems that are chronically activated or 
suppressed. 
An important physiological consequence of prolonged stress responses is dysregulation of 
the stress response itself. For example, adults who experienced traumatic events as children 
appear to have chronically elevated cortisol levels (Luecken and Appelhaus 2006) and 
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unusually large cortisol responses to acute stress (Luecken 1998). It is argued that early 
experiences of intense or prolonged stress can lead to increased responsiveness to stressful 
events and circumstances for many years afterwards, on both psychological and 
physiological levels.  
The stress response inhibits immune activity, indicated by associations between chronic 
stress responses and raised levels of a latent virus (Chida & Mao 2009) and slower wound 
healing (Kiecolt-Glaser et al. 1995). In addition, chronic stress responses can lead to 
dysregulation of the immune system resulting in increased levels of inflammation. More 
specifically, elevated levels of cortisol, associated with the stress response, act on proteins 
called cytokines that regulate inflammatory activities. Continued exposure to cortisol 
resulting from chronic stress results in these cytokines becoming less sensitive to cortisol, a 
phenomenon referred to as glucocorticoid resistance (Miller et al. 2002, Chrousos et al. 
1996). Glucocorticoid resistance is associated with higher levels of pro-inflammatory 
cytokines in the blood leading to inflammation. Some of these pro-inflammatory cytokines 
are associated with specific autoimmune diseases, such as RA (Noack & Miossec 2017) and 
asthma (Wright et al. 1998). In addition, prolonged stress responses, especially during early 
life, has been linked to increased levels of IgE (Wright et al. 2005), which is often raised in 
allergic conditions. 
In order to test whether stress is involved in psychosocial pathways linking adversity with 
immune dysregulation, it is necessary to consider how best to define and measure stress. 
Stress involves psychological and biological responses to events and circumstances. It is a 
construct that has been described as a model (Selye 1956), a process (Pearlin 1981, 1999) 
and a transaction between individuals and situations (Lazarus 1966). Cohen (1997) describes 
stress as,  
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“A process in which environmental demands tax or exceed the adaptive capacity of 
an organism, resulting in psychological and biological changes that may place 
persons at risk of disease” (p.3).  
Stress is measured in various ways. Cortisol, sometimes referred to as a stress hormone, is 
used as a physiological marker of stress (Ryan et al. 2016, Chen et al. 2015, Hostinar et al. 
2015, Wosu et al. 2013). Psychological stress is measured using self-report. Well-developed 
theories and measures of work stress involve the balance between perceived effort and 
reward (Siegrist 1996), and a combination of perceived demands, control, social support, 
and job insecurity at work (Karasek et al. 1998). Instruments have also been developed to 
measure relationship stress and distress (Locke & Wallace 1959, Schuster et al. 1990), 
loneliness (Hughes et al. 2004), and community stress (Stafford et al. 2003). However, it is 
the combination of pressures that act on the individual to make them feel stressed, and 
there is no well tested or validated measure of global stress that combines perceived stress 
in multiple domains.  
Adversities can also be used to indicate stress (Holmes & Rahe 1967, Pearlin et al. 2005) 
because they are likely to be experienced as stressful. They are a step removed from 
psychological and physiological experiences of stress as these experiences arise not only 
from exposure to adversity but also how the individual responds to it (Lazarus 1966).  
6. The inflammatory theory of depression 
Figure 1.3 presents the same model as the one illustrated in Figure 1.1, but the parts of the 
model that this section relates to are in bold font. 
Figure 1.3   Relationships between adversity and health with relevant parts in bold font 
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As explained above, the healthy immune system responds to injuries or infection in a 
process that involves three stages; (1) recognition of the potentially harmful external agent 
or pathogen, (2) a series of inter-related responses that stimulate a cascade of defensive 
behaviours, referred to as the acute inflammatory response, and (3) suppression of this 
response once the threat has been resolved. In healthy individuals, suppression is complete. 
When it is not complete, this is manifested as chronic low-grade inflammation, a 
phenomenon that reflects immune dysregulation and predicts cardiovascular disease, type II 
diabetes, and mortality (Maes et al. 2011, Liu et al. 2016, Padayachee et al. 2009, Zhang 
2011).  
Symptoms of acute inflammation are familiar and unpleasant. They include redness, 
swelling, heat, pain (Calder et al. 2013), and also sickness behaviours that have 
psychological features, such as fatigue, social withdrawal, negative mood, loss of appetite, 
sleep disturbance, arousal and anxiety (Miller & Raison 2016, Dantzer & Kelly 2007). 
Sickness behaviours may have been selected for in the past because they promote 
withdrawal into a place of safety during periods of sickness and convalescence, away from 
predators (Miller & Raison 2016), as well as conservation of energy to fight infections. The 
inflammatory theory of depression (Smith 1991) is that these sickness behaviours contribute 
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to the development of depression as well as to other psychiatric disorders including anxiety 
and schizophrenia.  
Sickness behaviours resemble symptoms of depression (Byrne et al. 2016, Capuron & Miller 
2011). For example, the 8 item version of the Centre for Epidemiologic Studies Depression 
Scale (CESD) includes items relating to motivation and fatigue; “Much of the time during the 
last week, you could not get going” and, “Much of the time during the last week, everything 
you did was an effort”. A cross-sectional study found that these items and two others, 
referring to sleep disturbance and feeling depressed, were associated with chronic 
inflammation (White et al. 2017). 
Evidence from various research perspectives is consistent with the inflammatory theory of 
depression. Substantial progress is being made in understanding the physiological 
mechanisms that link inflammatory processes with the psychological changes that 
characterise sickness behaviours and heightened arousal (Byrne et al. 2016, Miller & Raison 
2016). In addition, injecting pro-inflammatory cytokines induces both an acute inflammatory 
response and depressive-like behaviours in animals and depressive symptoms in humans 
(Byrne et al. 2016, Dantzer & Kelly 2007), and some studies report that anti-inflammatory 
drugs reduce depressive symptoms (Kohler et al. 2014, Kohler et al. 2016).  
Dantzer et al. (2011) discuss the relative timings of the acute inflammatory response, 
sickness behaviours and the development of depressive symptoms. They cite evidence that 
whilst sickness behaviours are concurrent with the acute inflammatory response, there is a 
delay before these develop into depressive symptoms. Clinical studies found that among 
cancer patients treated with high doses of cytokines, most reported fatigue, pain, decreased 
appetite and sleep disturbance immediately after administration of the cytokines, and 
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during subsequent weeks, some reported depressed mood and feelings of worthlessness 
and guilt (Capuron et al. 2000). Equivalent studies conducted in mice report that cytokine 
administration provokes immediate sickness behaviours such as reduced activity and 
decreased food intake that last for a few hours, followed 24 hours later by depressive-like 
behaviours (Frenois et al. 2007, O’Connor et al. 2009). This evidence is consistent with 
hypotheses that (1) prolonged periods of inflammation lead to greater increases in 
depressive symptoms, and (2) other factors are involved in the development of depressive 
symptoms. 
Prospective epidemiological studies provide evidence about relationships between chronic 
inflammation and depressive symptoms years later. These studies make an implicit 
assumption that symptoms of chronic inflammation include the same sickness behaviours as 
those that are associated with acute inflammation, albeit to a lesser degree. Most studies 
report prospective associations between chronic low-grade inflammation and subsequent 
depression or depressive symptoms (Valkanova et al. 2013). Inconsistent results  may reflect 
differences between samples and in the timing between measures of inflammation and 
depressive symptoms. 
7. Research aims 
The broad research aim is to explore how psychological factors interact with immune 
dysregulation within the context of the life-course. Each empirical chapter addresses a 
different type of immune dysregulation. 
In Chapters 2 and 3, immune dysregulation is measured using onsets of immune-mediated 
diseases; adult onset asthma in Chapter 2 and RA in Chapter 3. Probably because incidence 
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rates of these conditions are low, there is a lack of epidemiological evidence about the 
psychosocial factors that contribute to them. 
In relation to adult onset asthma, I have found three large-scale epidemiological studies that 
examine relationships between adversities and asthma onset during adulthood. Two 
examine adversities shortly before asthma diagnosis (Lietzen et al. 2011, Loerbroks et al. 
2009, Loerbroks et al. 2010) and the other uses retrospective information about childhood 
adversities (Scott et al. 2008), but no study provides comprehensive life-course evidence 
about adversity as a predictor of asthma onset.  
While there is clear evidence that symptoms of anxiety and depression are associated with 
asthma activity, and some evidence that depressive symptoms predict asthma onset, 
evidence from prospective studies remains sparse (Chida et al. 2008, Loerborks et al. 2010), 
and none examine when during the life-course depressive symptoms are salient for asthma 
onset. Neither am I aware of any studies that examine whether psychological factors 
mediate associations between adversity and asthma onset, as illustrated in Figure 1.1.  
In relation to RA, a recent study states that evidence about psychosocial predictors of RA is 
sparse and inconclusive (Wesley et al. 2014). Large scale epidemiological studies include 
Wesley’s, which measures a wide range of adversities shortly before RA onset and others 
that examine the contributions of job stress and child death to RA onset (Bengtsson et al. 
2009, Li et al. 2005, respectively). A small study examines life-course adversities as 
predictors of RA onset but numbers are low, with just 55 respondents reporting RA onset 
(Carette & Surtees 2000).  
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The aims of chapters 2 and 3 are to provide evidence about the contributions of a wide 
range of adversities over the life-course to onsets of asthma and RA in the context of the 
framework set out in Figure 1.1. They will compare the importance for disease onset of 
social adversities of different types, after adjustment for material adversities. Further 
objectives are to estimate the extent to which associations between adversity and disease 
onset are mediated by behavioural and psychological factors, and when during the life-
course psychosocial factors are particularly salient for disease onset. This approach will 
provide more comprehensive evidence than presently exists about the psychosocial factors 
that contribute to onsets of each immune-mediated condition. 
Because adult onset asthma and RA have importance for public health, subsidiary aims of 
chapters 2 and 3 are to provide evidence about additional factors that predict them. 
In chapter 4, immune dysregulation is measured using a biomarker; C-reactive protein (CRP). 
Biomarkers are relatively new to longitudinal surveys and there is potential for novel 
research using them. One aim of this chapter is to contribute to existing evidence about 
prospective associations between chronic low-grade inflammation and depressive 
symptoms. Another aim is to provide new evidence about the biological, behavioural and 
psychological factors that mediate any prospective association found, and to test whether 
associations are moderated by gender, age group or health condition. 
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8. Empirical chapters in more detail 
Chapter 2: Does adversity predict onset of asthma during mid-adulthood? Do 
psychosocial pathways play a role? 
Asthma is disabling, frightening, costly to the nation, and is the most common chronic 
disease among children (WHO 2011). Asthma develops during all life stages and compared 
against childhood asthma, relatively little is known about the determinants of adult onset 
asthma. Chapter 2 provides evidence that contributes to this area with a focus on 
psychosocial factors.  
The importance of life-course adversity for adult onset asthma is estimated. As mentioned 
above, evidence about life-course adversity is lacking and chapter 2 contributes by including 
more comprehensive measures of life-course adversities than in previous studies, and 
examining relationships within the context of a model similar to that set out in Figure 1.1. It 
provides new evidence about whether associations differ by gender, atopic history and 
childhood temperament, how adversities during different life stages combine to predict 
asthma onset, and the relative importance for asthma onset of different types of adversity, 
including social and material adversities. 
Associations between social adversities and adult onset asthma after adjustment for 
material adversities suggest the importance of psychosocial pathways in the development of 
asthma during adulthood. This hypothesis is further tested by examining whether 
depressive symptoms mediate associations between childhood adversity and asthma onset 
decades later. 
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Epidemiological studies provide evidence about other factors that predict asthma. The 
chapter tests whether these factors predict asthma onset during mid-adulthood, as much of 
the existing evidence relates to asthma with onsets during other life stages. Using a novel 
approach, life-course adversity is included in models as a summary measure of social and 
material exposures so that the specific contributions of psychological and behavioural 
factors can be assessed. These factors are measured in multiple life stages so that 
comparisons can be made between their salience at different life stages for asthma onset 
later.  
Chapter 3: Does adversity predict onset of rheumatoid arthritis? Do psychosocial 
pathways play a role? 
This chapter addresses the importance of psychosocial pathways in the development of RA. 
RA is a relatively common chronic inflammatory disorder that is a concern for public health 
because it is associated with very poor quality of life (Furneri et al. 2012) and is costly to the 
state (NICE 2009). It is also thought to be exacerbated by psychological stress (National 
Rheumatoid Arthritis Society 2017), although evidence about whether adversities that are 
likely to be stressful predict RA onset is sparse and inconsistent (Wesley et al. 2014).  
The chapter addresses this gap in the literature by estimating associations between 
adversity and RA onset, including a range of adversities measured over the life-course that is 
much more comprehensive than measures used in previous studies. New evidence is 
provided about whether relationships between life-course adversity and RA onset vary by 
gender. Further, comparisons are made between different types of adversity. Adjustment 
for material adversity and health behaviours means that new evidence is provided about the 
importance for RA onset of social adversities likely to affect health through psychological 
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pathways. Finally, a new research question is addressed that concerns the relative 
importance for RA onset of acute and chronic social adversity. 
Chapter 4: Prospective associations between low-grade inflammation and 
depressive symptoms and the factors that confound and mediate them. 
A growing body of epidemiological evidence suggests that chronic low-grade inflammation 
predicts depressive symptoms several years later (Valkanova et al. 2013). Epidemiological 
evidence about prospective associations between depressive symptoms and subsequent 
inflammation is less consistent (Das 2016, Engler et al. 2016).  
This chapter contributes to existing evidence by estimating prospective associations in both 
directions using a large-scale dataset with measures of CRP and depressive symptoms on 
multiple occasions. This provides useful evidence because few studies include multiple 
measures of CRP as it has not yet been measured on more than two occasions in many 
longitudinal surveys. In addition, new evidence is provided about the factors that mediate 
prospective associations, and differences by gender, age group and health status. Three 
health statuses are included; at least one longstanding health condition and two immune-
mediated conditions, asthma and RA.  
Methods and data 
The thesis uses exclusively quantitative methods. This approach was chosen because 
quantitative methods allow the generalisability of findings to be tested. In addition, 
individuals have limited insight into the causes of disease onset, low-grade inflammation 
and depressive symptoms, and so in-depth interviews and focus groups would not have 
yielded much useful information.  
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It was not necessary to collect quantitative data as large-scale longitudinal datasets are 
publicly available for researchers and these contain comprehensive information collected to 
the highest standards. Data are analysed using sophisticated software and statistical 
methods. 
Chapter 2 uses data from the National Child Development Study (NCDS). This was originally 
a perinatal mortality survey of all babies born during one week in mainland Britain in March 
1958. The original sample of over 17,400 babies has been followed up on multiple occasions 
with collections of comprehensive information. Data are used from every wave up to 2000, 
when the sample was aged 42. Asthma onset is measured during mid-adulthood and using 
prospective data, a wide range of material and social adversities are measured throughout 
the life-course, as well as other factors thought to predict adult onset asthma. 
Chapters 3 and 4 use data from the English Longitudinal Study of Ageing (ELSA), a 
representative sample of over 10,000 adults living in private households in England, mostly 
aged 50 and over. Comprehensive data have been collected every two years since 2001-
2002. 
This dataset is appropriate for Chapter 3 because good measures of RA are available and RA 
onset typically occurs between ages 40 and 60, so the ageing sample maximizes numbers 
reporting the condition. Life-course adversities are measured using retrospective 
information collected during an interview in which a temporal referencing system was used 
to aid full and accurate recall (Berney & Blane 1997, Means et al. 1991). RA was measured 
using contemporaneous information and a wide range of adversities were measured using 
the retrospective data. 
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ELSA was appropriate for chapter 4 because depressive symptoms were measured during all 
waves and biomarkers of inflammation were measured during three nurse interviews. 
Comprehensive contemporaneous information is also available so that it was possible to 
test whether a range of factors mediated prospective associations between inflammation 
and depressive symptoms. Furthermore, because of its age, the sample includes relatively 
high levels of baseline inflammation, as well as high proportions with longstanding illness, 
asthma and RA. 
9. Final remarks 
The PhD combines evidence and theory from Sociology, Psychology and Biology to 
investigate links between psychological factors and immune dysregulation using a life-
course approach. Evidence and theory inform the choice of research questions and 
interpretation of findings. 
The approach taken is to examine the psychosocial factors that predict onsets of two 
immune-mediated diseases, adult onset asthma and RA, about which existing evidence is 
sparse. In addition, prospective associations are estimated between chronic low-grade 
inflammation and depressive symptoms, and new evidence is provided about the factors 
that moderate and mediate these associations. New findings raise questions about 
generalisability and should be tested in other datasets. They also contribute to the 
development of hypotheses to explain links between psychological factors and immune 
dysregulation in the context of the life-course.  
This PhD and the papers published from it will direct attention to the links between 
psychological factors and immune dysregulation within a real life (life-course) context 
because understanding about these links may be integral to understanding the psychosocial 
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pathways through which health inequalities develop over the life-course. I hope that the 
findings prompt further research about these links and greater consideration of them by 
policy makers and practitioners. 
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Chapter 2: Does adversity predict onset of asthma 
during mid-adulthood?  Do psychosocial pathways play 
a role? 
The aim of this chapter is to investigate the psychosocial factors that contribute to asthma 
onset during mid-adulthood. It does so by examining the contributions of life-course 
adversities of various types to asthma onset during mid-adulthood, and the factors that 
moderate, confound and mediate associations that are identified.  
1. Introduction 
1.1 Rationale  
Asthma onset is the health outcome examined in this chapter because it is a major concern 
for public health. Furthermore, while the disease is diagnosed by physical symptoms such as 
respiratory problems, it appears to be closely linked to psychological symptoms. For 
example, asthma prevalence, severity, and progression are associated with psychological 
stress (Chida et al. 2008, Wainwright et al. 2007, Kilpelainen et al. 2002) and its prevalence 
is correlated with symptoms of anxiety and depression (Loerbroks et al. 2010).  
Asthma with adult onset is of particular interest for several reasons. One is that while an 
interaction between genetic and environmental factors contributes to asthma onset during 
all life stages, environmental factors are probably more important contributors to asthma 
with onset later in life. Adult onset asthma has received scant attention from researchers 
compared with childhood asthma and adult asthma with no specified age of onset, and 
many key questions have hardly been addressed. For example, it is not clear that adult 
onset asthma reflects the same pattern of aetiologies as asthma with childhood onset, or 
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why onset is delayed until adulthood for some individuals. Indeed, it may be that asthma 
with onsets during different stages of adulthood has different determinants.  
Asthma onset is therefore measured during a relatively short period of adult life; mid-
adulthood. This is late enough to be distinct from childhood and early enough to precede 
decades of working life. Findings will contribute to understanding about the causes of adult 
onset asthma generally, but with a focus on psychosocial pathways. This understanding will 
inform public health decision-making about preventive strategies to reduce risk of adult 
onset asthma. Findings about the psychosocial predictors of adult onset asthma may also be 
relevant to childhood asthma, and to other immune-mediated conditions with adult onset, 
for example, late onset hay fever, urticaria and many autoimmune diseases. 
1.2 Asthma 
Asthma is a major concern for public health. The WHO (2011) estimates that 235 million 
people worldwide suffer from asthma, and that it is the most common chronic disease 
among children. Prevalence rates of asthma are almost as high among adults as they are 
among children. Asthma UK (2013) reported that 5.4 million people in the UK were currently 
receiving treatment for asthma, and of these, 1.1 million were children (1 in 11) and 4.3 
million were adults (one in twelve). The Centers for Disease Control and Prevention (CDC 
2012) reports similar rates of asthma prevalence in the US.  
Rates of asthma vary widely between countries, and according to the Department of Health 
(DoH 2012), the UK has the highest prevalence in the world, with rates estimated between 
11% and 17% (Simpson & Shiekh 2010, Hall & Mindell 2011). Although asthma is more 
common in higher income countries, it is the low income and minority groups within them 
that experience the highest levels of morbidity and mortality associated with it (NIH 2002, 
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Basagana et al. 2004). Specifically, Simpson & Sheikh (2010) report a graded relationship 
between socio-economic deprivation and risk of asthma onset in England. 
Although asthma onset is most common during childhood, substantial numbers develop 
asthma for the first time during adulthood. In a large study using English medical records, 
Simpson & Shiekh (2010) estimated that of the 50 million individuals living in England in 
2005, 0.45% (5,459) persons aged 15 to 44 and 0.38% (2,892) aged 45 to 64 developed 
asthma during that year. In addition, whilst incident rates of asthma between 2001 and 
2005 had fallen by around one third among children, declines in incidence during adulthood 
were more modest (by around one sixth for the 15-44 age group, and by one fifth for those 
aged 45-64). 
In a report published by the WHO, Bosquet et al. (2005) state that prevalence rates of 
asthma are rising in countries where prevalence is relatively low, and suggest that this 
occurs as communities adopt modern lifestyles and become more urbanised. In contrast, 
prevalence rates have plateaued in countries where rates were already high (Bosquet et al. 
2005), and may even be decreasing (Simpson & Shiekh 2010). Simpson & Shiekh suggest 
that changes in incidence rates of asthma may reflect real changes in asthma incidence 
and/or changes in diagnosis. 
Asthma is frightening and disabling and can result in death. For example, in 2010, there 
were 1,143 recorded deaths from asthma in the UK, almost all of them among adults 
(Asthma UK, 2013). Adult asthma is also costly to the state. The WHO estimates that the 
number of disability adjusted life years (DALYs) lost due to asthma are similar to numbers 
for diabetes, liver cirrhosis, and schizophrenia (Bousquet et al. 2005). Although some of 
these DALYs are lost due to care of children with asthma, others may result from asthma 
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among adults. In the UK, the DoH recently reported that asthma costs the National Health 
Service (NHS) around one billion pounds each year (DoH 2012), and a substantial proportion 
of this money is spent on adult asthma. 
Asthma is a chronic condition that affects the airways in the lungs (DoH 2012). Unlike 
chronic obstructive pulmonary disease, obstruction of the airways is periodic or variable 
(Hall & Mindell 2011). Attacks can be triggered by allergens, exercise, occupational 
exposures, tobacco smoke, air pollution, and airway infections (CDC 2012). During attacks, 
airways become inflamed, making it hard to breathe (CDC 2012). Because the process of 
inflammation is a symptom critical to the diagnosis of asthma, it is classified as an immune 
as well as a respiratory disorder (Newson 2015). However, the causes of asthma are not well 
understood; it is a syndrome diagnosed on the basis of symptoms, triggered by a variety of 
circumstances.  
A high proportion of individuals with asthma have other atopic conditions such as eczema 
and hay fever and/or raised levels of the immunoglobulins (total and specific IgEs) 
associated with atopy (Pearce et al. 1999). Preliminary evidence suggests that individuals 
with asthma are at increased risk of some autoimmune conditions (Hemminki et al. 2010) 
and at reduced risk of others (Tirosh et al. 2006). These comorbidities suggest that the 
development of asthma and other immune-mediated conditions may share common 
pathways (Rottem & Shoenfeld 2003, Lee et al. 2014). 
1.3 A model of adversities over the life-course and the development of adult onset 
asthma 
The model illustrated in Figure 2.1 illustrates how adversities experienced during the life-
course may contribute to onset of asthma during mid-adulthood.  It is similar to the model 
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set out in Figure 1.1 in Chapter 1. As with the model illustrated in Chapter 1, relationships 
may differ by gender and other characteristics. For asthma onset, these include atopic 
vulnerability and internalising temperament. 
As explained in Chapter 1, adversities are events and circumstances that are usually 
appraised negatively and that one would expect to have negative consequences. They are 
exposures, conceptually distinct from responses and appraisals, and include life events and 
stressors. Evidence of associations between a range of adversities and negative health 
outcomes is summarised in Appendix 1. 
In Figure 2.1, adversities are classified by domain, but it is the combination of adversities 
that act on an individual and it is relatively rare that a single risk factor is associated with 
serious consequences (Garmezy 1991, Rutter 2009).  
Figure 2.1 includes mediating factors, classified as material, behavioural, psychological and 
biological. It also includes confounding factors, such as very early experiences and 
temperament. No direct effects of adversities on health are included. Some material 
mediating factors could be (but are not) classified as adversities. For example, occupational 
exposures to airborne pollutants are negative exposures but they are classified as a 
hypothesised mediator because they are a risk factor specific to asthma and may not be 
involved in the development of other health conditions, or other negative outcomes.  
The arrow at the bottom of Figure 1 includes four life stages; childhood, transition to 
adulthood (referred to as transition), early and mid-adulthood. Adversity is measured during 
the first three life stages and asthma onset during the fourth. As explained in Chapter 1, 
theories of cumulative disadvantage (Ross & Wu 1996) and stress proliferation (Pearlin et al. 
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1997) suggest that exposure to adversity during earlier life stages predicts adversity during 
later life stages.  
Adversities over the life-course combine in various ways to predict an outcome (Kuh et al. 
2003). Models of cumulative exposure refer to the cumulative impact of exposures 
regardless of life stage. ‘Chains of risk’ refers to earlier exposures that have relevance for an 
outcome only because they predict later exposures that are more proximal to it. In contrast, 
exposures during critical or sensitive periods are not proximal to the outcome and have 
particular relevance for the outcome, regardless of subsequent exposures.  
In relation to the sensitive period, Martinez (2009) argues that early life is a “developmental 
window of susceptibility”, during which functional and structural characteristics of the 
respiratory system are established that affect asthma risk subsequently. For example, early 
respiratory infections are associated with the development of childhood asthma, probably 
through damage to the airways combined with over-stimulation of specific pathways in the 
developing immune system that are associated with atopy (Busse 1990).  
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Figure 2.1   Model of the contribution of the stress process to adult onset asthma 
 
 
 
 
 
 
 
All relationships may differ by moderating factors such as gender, atopic history and temperament 
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1.4 Summary of existing evidence about factors that predict adult onset asthma 
1.4.1 Adversity 
A few studies provide evidence consistent with prospective associations between adversity 
and asthma onset among adults. None examine how adversities combine over the life-
course to predict asthma onset. 
A large prospective study in Finland found that cumulative exposure to negative life events 
during a five year period predicted asthma onset during the following two years among 
adults aged 20-54 at baseline (Lietzen et al. 2011). Life events included death and severe 
illness of a family member, divorce or separation, marital problems, severe conflicts with a 
supervisor, and emotional, sexual, or physical violence. One hundred and ninety-two 
respondents developed asthma, and those who reported high as opposed to low levels of 
exposure had twice the risk of incident asthma, an association not explained by age, gender, 
education, marital status, pets, smoking status, and baseline allergic rhinitis.  
Loerbroks and colleagues (2009) used data from over 4,000 German residents aged 40-65 at 
baseline, who were followed up for eight and a half years, with 63 developing asthma. 
Exposure to three specific adversities during the five years prior to baseline was reported 
retrospectively. Breaking a relationship with a partner or parent predicted asthma onset for 
women, but job loss and death of a partner, family member, or friend did not. The 
association found with breaking a partnership among women was not explained by age, 
education, family history of asthma, smoking status, alcohol consumption, body mass index, 
or physical activity. Using the same dataset, an association was found between work stress 
and asthma onset during the following 8.5 years, with slightly fewer (41) participants 
reporting new diagnoses of asthma (Loerbroks et al. 2010).  
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Using data from national cross-sectional surveys in ten countries worldwide, Scott and 
colleagues (2008) report a graded relationship between childhood adversities reported 
retrospectively and asthma with onset after age 20. Compared to adults exposed to no 
childhood adversities, those exposed to two and three adversities had increased odds of 
adult onset asthma by 49% and 71%, respectively. This study included almost 650 
respondents with adult onset asthma. 
Two smaller scale clinical studies used retrospective data collected from asthma patients, 
who were more likely than non-asthmatic control groups to report divorce, marital 
separation or family illness prior to onset (Teiramaa 1979, Salminen 1985).  
This evidence is limited because it provides no information about how adversities combine 
over the life-course to predict asthma onset, and little insight into the types of adversity that 
matter most. 
1.4.2 Moderators 
As mentioned above, the relationships illustrated in Figure 2.1 may differ by gender and 
other variables. These variables would moderate relationships, because the magnitudes and 
consistencies of the associations would depend upon them. Factors that I consider as 
moderators of the association between adversity and asthma onset are gender, atopic 
history, and internalising temperament during childhood. 
More boys than girls develop childhood asthma (Peckham & Butler 1978), and it has been 
suggested that this is because boys up to age 10 have narrower airways and increased 
airway tone than girls, which may predispose them to asthma (NIH 2002). In contrast, adult 
onset asthma is more common among women than men (Simpson & Shiekh 2010). This may 
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reflect gender differences in exposure to adversities and responses to them, in terms of self-
reported stress (Gersten 2008, Gustafsson et al. 2012), and behavioural and physiological 
responses (Gersten 2008, Stroud et al. 2002). Moderation by gender is suggested by 
Loerbroks’ finding that breaking a life partnership predicted asthma onset for women but 
not men (Loerbroks et al. 2009). However, other studies found no evidence of moderation 
by gender, although this may reflect power as numbers developing asthma (especially of 
men) were low (Lietzen et al. 2011, Rod et al. 2012).  
Asthma is sometimes classified as atopic and non-atopic. Atopic asthma is identified by 
raised levels of specific IgEs and a history of atopic conditions other than asthma. If atopy 
reflects a genetic vulnerability, then one would predict adversity to be more strongly 
associated with non-atopic than atopic asthma.  In order to examine the relative importance 
of adversity for atopic and non-atopic individuals, Lietzen and colleagues (2011) identified 
asthmatics with and without allergic rhinitis. They found no evidence that associations 
between adversity and subsequent asthma onset differed by atopic status.  
Temperament refers to “consistencies in emotional and motivational responses” that begin 
to stabilize during childhood (Friedman 2011, p.220). It could affect responses to adversities 
in systematic ways. However, styles of appraisal and coping are not stable over time and 
context (Watson et al. 1999), and authors emphasise the specificity of coping responses to 
each stressor (or adversity) and context (Lazarus 1991, Eckenrode 1991). 
1.4.3 Confounding factors 
A factor confounds an association between two variables if it predicts both variables 
independently and if adjustment for the factor attenuates the association. In addition, a 
confounding factor occurs in causal pathways earlier than each variable. The association 
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here is between childhood adversity and asthma onset decades later, and factors 
considered as confounders are conditions during pregnancy, low birthweight, breastfeeding, 
and temperament. Temperament is also hypothesised as a moderator.   
Conditions during pregnancy include maternal smoking and complications such as bleeding. 
Studies provide evidence that maternal smoking during pregnancy predicts life-course 
adversities (Jarvis & Wardle 2006, Phung et al. 2003), and childhood asthma (NIH 2002, 
Burke et al. 2012). I am aware of no direct evidence that complications during pregnancy 
predict life-course adversities, but Norbeen & Tilden (1983) report that earlier adversities 
predict complications during pregnancy. Based on theories of stress proliferation (Pearlin et 
al. 1997) and cumulative disadvantage (Ross & Wu 1996), complications during pregnancy 
should predict subsequent adversities because they are markers of earlier adversity. A large 
scale study using the NCDS found that bleeding during pregnancy predicted childhood 
asthma and protein in the urine during pregnancy (albuminaria) predicted adult onset 
asthma (Strachan et al. 1996). 
Low birth weight predicts life-course adversity (Roland et al. 2014, Lechtig et al. 1975) and 
childhood asthma (Jaakkola & Gissler 2004).  
A large population study in Gateshead, UK, concludes that affluent women are particularly 
likely to breastfeed their babies (Wright et al. 2006). Assuming that compared against 
women who are less affluent, more affluent women live in families with fewer 
circumstances that are classified as childhood adversities, it follows that breastfed babies 
tend to come from backgrounds with little adversity. Evidence that breastfeeding is 
negatively associated with childhood asthma is marginal (Gdalevich et al. 2001, Schmitz et 
al. 2012), possibly because associations between breastfeeding and asthma depend upon 
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atopic characteristics of the child and mother. I am aware of no evidence about associations 
between breastfeeding and adult onset asthma. 
Temperament has been conceptualised as a moderator, but could also confound 
associations between adversity and asthma onset. The idea that temperament predicts ill 
health dates back to Hippocrates, and in 1950, Alexander suggested that asthma is 
associated with separation anxiety (Alexander 1950). Friedman & Booth-Kewley (1987) 
found evidence of associations with trait anxiety. It also appears that asthma is associated 
with internalising behaviours, which encompass level of mal-adaption, but also response 
type. Temperament is of particular interest in this chapter because it is likely to be 
associated with psychological factors that predict asthma onset. 
Internalising behaviours during childhood encompass anxiety, fearfulness, withdrawal, and 
depression (Fanti and Henrich 2010). Consistently high levels during childhood predict 
outcomes during adolescence and adulthood that include depressive symptoms 
(Toumbourou et al. 2011, Dingle et al. 2011, Gander & Buchheim 2013) and anxiety (Dingle 
et al. 2011, Gander & Buchheim 2013). With few exceptions, studies consistently find 
positive cross-sectional correlations between internalising behaviours and childhood asthma 
(Annesi-Maesano et al. 2013). One large prospective study found that asthma at age 5 
predicted high levels of internalizing behaviour at 14, but high levels of internalizing 
behaviour at age 5 did not predict onset of asthma between ages 5 and 14 (Alati et al. 2005).  
1.4.4 Mediating factors 
Mediating factors are predicted by adversity and predict asthma onset. They are classified as 
material, behavioural, biological, and psychological. 
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The material mediating factors referred to in Figure 2.1 are exposures to airborne pollutants 
and toxins that result from area of residence and occupation.  
Material adversities, such as low income, predict exposures to airborne pollutants. In a 
recent study of socio-economic differentials in exposure to air pollution in England, 
Malojevic et al. (2017:2) state that there is a “significant body of evidence” from developed 
countries including the UK demonstrating that individuals on low incomes tend to be 
exposed to higher levels of air pollution. High prevalence of childhood asthma is associated 
with living in urban as opposed to rural areas, where air pollution is relatively high (Schmitz 
et al. 2012). Further, emergency admissions for asthma among adults and children have 
been linked to air pollution in European cities including London (Sunyer et al. 1997). 
In addition, those working in poorly (as opposed to well) paid occupations are relatively 
likely to be exposed to pollutants and toxins at work. Kennedy et al. (2000) developed a job 
exposure matrix specific to asthma, and found that high risk occupations tended to fall into 
skilled and unskilled manual categories associated with low rates of pay. Adult asthma onset 
and prevalence are predicted by occupational exposures (Lillienberg et al. 2013, Ghosh et al. 
2013, respectively). 
Smoking is a behavioural mediator. Those who smoke tend to be exposed to more as 
opposed to less adversity (Kouvonon et al. 2005, Jarvis & Wardle 2006), and the NIH (2002) 
reports that smoking contributes to the progression of asthma, although it may not 
contribute to its onset. It has been suggested that smoking may increase the risk of asthma 
onset because smokers have elevated levels of serum IgE, which is raised in atopic 
conditions (Gerrard et al. 1980, Tsukioka et al. 2010), as well as increased bronchiole hyper-
responsivity (Nadel & Comroe 1961).  
Chapter 2: Psychosocial predictors of asthma onset             43 
 
 
Biological mediators include early respiratory infections, growing up in a family with older 
siblings, exposure to parental smoking, obesity, and the development of other atopic 
conditions. Referring back to the model described in Chapter 1, these are biological factors 
as opposed to the sub-clinical changes. 
Children exposed to adversity are more likely to develop respiratory infections early in life 
(Cohen 2005, Trueba & Ritz 2013). Large scale studies report evidence of associations 
between early respiratory infections and asthma onset and prevalence (Montgomery et al. 
2013, Strachan et al. 1996). Wright et al. (1998) suggest that early respiratory infections lead 
to asthma onset through damage to epithelium cells that line the airways, causing local 
inflammation. 
Evidence from the NCDS led to the development of the hygiene hypothesis (Strachan 1989). 
Childhood asthma was less common among children who grew up in households with older 
children, and Strachan suggested that these children were exposed to more immune 
challenges from bacteria and viruses than children without older siblings, which protected 
them from the development of allergic conditions. 
There is a socio-economic gradient in smoking among parents of young children (Kuntz et al. 
2016). Tobacco smoke appears to increase risk of asthma onset during childhood, and also 
to exacerbate existing asthma (Karimi et al. 2015), although I am aware of no evidence 
about parental smoking and subsequent asthma onset during adulthood. 
Whilst there is insufficient evidence to draw conclusions about whether or not childhood 
adversity predicts obesity (Tamayo et al. 2010), obesity predicts asthma with onsets during 
childhood, youth, and old age (Chen et al. 2013, Leone et al. 2012). 
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Eczema and hay fever predict asthma onset (Burgess et al. 2008, Dharmage et al. 2014), a 
phenomenon sometimes described as the atopic march (Zheng et al. 2011, Han et al. 2017). 
Bosquet et al. (2008) suggest that hay fever predicts asthma onset because it is 
characterised by hyper-reactivity of the upper respiratory airways (Cirillo et al. 2009), which 
may lead to more widespread bronchial hyper-reactivity and asthma. Childhood adversity 
may predict the development of allergic conditions other than asthma, such as eczema and 
hay fever, through a similar group of factors to those described in this section. 
The hypothesised psychological mediator of an association between childhood adversity and 
asthma onset decades later is symptoms of depression. Depressive symptoms are predicted 
by childhood adversity (Felitti et al. 1998), and by stressful life events (Cohen et al. 2007), 
and they predict asthma onset (Chida et al. 2008, Loerbroks et al. 2010, Scott et al. 2008). 
The mechanisms underlying associations between asthma and depressive symptoms (and 
internalising behaviours among children) are unclear. One possibility is that immune 
dysregulation associated with not-yet-diagnosed asthma has psychological symptoms that 
resemble and lead to the development of depressive symptoms (Smith 1991, Miller & 
Raison 2016). Another is that psychological stress leads to (1) the development and 
recurrence of depressive symptoms (Hammen 2005, Leggett et al. 2016) and (2) lasting 
changes in the immune and respiratory systems. Wright and colleagues (2005) discuss the 
physiological mechanisms through which psychological stress may lead to biological 
hypersensitivity to environmental stimuli, and the development of asthma and other atopic 
conditions. In relation to respiration, the immediate physiological response to stress that is 
co-ordinated by the sympathoadrenal medullary results in narrowing of the airways. 
Frequent and prolonged activation, especially during infancy, may lead to lasting changes in 
the structure and functioning of these airways (Martinez 2009, Chen et al. 2006, Joachim et 
al. 2003, Hasler et al. 2005, Rietveld et al. 2000). 
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1.5 Research questions 
The research questions (RQs) are designed to elicit information that will contribute to 
limited existing evidence about the psychosocial pathways that contribute to the 
development of asthma during mid-adulthood. They ask about the importance for adult 
onset asthma of adversities over the whole life-course, which is a question that has not 
been addressed before. Questions are also asked about the factors that moderate 
associations between adversities and asthma onset, as very little evidence exists about 
gender differences or differences by atopic history, and the question has never before been 
asked before in relation to temperament. Other studies have compared the importance for 
asthma onset of different types of adversity, but they have not classified them as social and 
material or by domain, or examined the factors that mediate associations between adversity 
and asthma onset. These questions are addressed to provide evidence about psychosocial 
pathways. The final RQ, which addresses the life-course factors that predict asthma onset, 
will provide new evidence because salient psychological and biological factors will be 
identified after adjustment for a comprehensive range of social and material adversities 
measured over the life-course. 
The RQs are set out below. 
1. Do life-course adversities predict asthma onset during mid-adulthood? 
a. Does total life-course adversity predict asthma onset?  
b. Do associations between adversity and adult onset asthma vary by gender, 
atopic history or temperament? 
c. Do adversities at any particular life stage matter, and if so, which life stage 
matters most? 
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d. Do social adversities predict asthma onset after adjustment for material and 
occupation-related adversities? 
2. What confounding and mediating factors explain the association between childhood 
adversity and adult onset asthma? Are psychological factors important? 
3. What combination of factors best predicts asthma onset during mid-adulthood?  
2. Data and measures 
The dataset used is from the National Child Development Study (NCDS), a perinatal 
mortality survey of every baby born in England, Scotland and Wales during a week in March 
1958 with over 17,400 babies. Follow-up occurred at ages 7, 11, 16, 23, 33, 42, 46, 50, and 
55, and data are used from all the sweeps up to and including age 42. During cohort 
members’ childhoods, information was collected by health visitors from parents and 
children through educational and medical assessments. Teachers also supplied information. 
Since adulthood, data have been collected directly from cohort members using structured 
interviews. Power & Elliott (2006) provide a full description of the study. 
2.1 Onset of asthma during mid-adulthood 
Onset of asthma is measured for all cohort members with no history of asthma at age 33. 
The variable takes a value of one if the cohort member reports asthma onset between ages 
33 and 42. Questions used to code asthma onset are presented in Table 2.1. 
Measures for asthma onset up to age 23 include wheezy bronchitis. This is partly because at 
ages 16 and 23 questions did not discriminate between the two outcomes. In addition, until 
the 1980s when cohort members were in their twenties, asthma and wheezy bronchitis 
were often used interchangeably as diagnoses (Koopman et al. 2001), and authors argue 
that conditions diagnosed as asthma and wheezy bronchitis were clinically and 
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pathologically equivalent (Williams & McNicol 1969, Sibbald et al. 1980). For these reasons, 
other studies using the same dataset have combined asthma with wheezy bronchitis during 
childhood and up to age 23 (Power & Manor 1995, Butland & Strachan 2007). I do the same. 
For many cohort members, reports of asthma history are inconsistent, with history reported 
in earlier sweeps combined with later reports of never having had asthma. In these cases, I 
assume that information provided earlier is correct. At age 42, cohort members who 
reported ever having had asthma were asked about age of onset. This information was used 
only if information about asthma was not available in earlier sweeps.  
Table 2.1:   Questions used to code asthma or asthma and/or wheezy bronchitis 
Age 7 “Has the child ever had attacks of asthma?”                  (parental and medical questionnaires) 
“Has the child ever had bronchitis with wheezing?”     (parental and medical questionnaires) 
Age 11 “Has the child ever had attacks of: asthma, wheezy bronchitis, both, neither?”  
                                                                                                                         (parental questionnaire) 
“Has the child ever had wheezy bronchitis or asthma (other than mild attacks in infancy)?”  
                                                                                                                           (medical questionnaire) 
Age 16 “Has the child ever had an attack of asthma or wheezy bronchitis?” (parental questionnaire) 
Age 23 “Since your sixteenth birthday have you had an attack of asthma or wheezy bronchitis?” 
Age 33 “Have you ever been told that you have asthma?” 
Age 42 “Have you ever had or been told you had:  
…..“migraine or severe headaches associated with vomiting or dizziness 
…..“hay fever 
…..“bronchitis 
…..“asthma 
…..“allergic rhinitis (persistent runny nose when you haven’t got a cold) 
…..“none of these?” 
“How old were you when you first became aware that you had this condition?” 
 
2.2 Adversities 
Adversities at each life stage are listed in Tables 2.2 and 2.3 with the domain in which they 
are classified and the questions used to measure them. Childhood is birth to 16, transition is 
17-23, early adulthood is 24-33, and mid-adulthood is 34-42. Each measure of adversity 
takes two values to indicate exposure or no exposure. 
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The measure for cumulative exposure during childhood is the total number of adversities 
reported. Measures of cumulative exposure during transition and early adulthood were 
created in two stages. First, variables were created to indicate whether the cohort member 
was exposed to any adversities within each domain. Second, these were summed to create 
variables taking values between 0 and 4 domains in which adversity was reported during 
transition, and 0 and 5 domains in which adversity was reported during early young 
adulthood.  
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Table 2.2:    Questions asked about childhood adversity 
Variable Age Questions used 
Early 
parental loss 
(up to 16) 
0 Mother’s marital status at birth (only used if other information is missing) 
7 Health visitor reports family difficulties due to death of mother, death of 
father, divorce, separation or desertion. 
“Please ascertain, or state to your knowledge, whether the child is normally 
cared for by his/her: …”  
“Please ascertain, or state to your knowledge, whether the child’s father is 
his/her : …” 
Parental situation of illegitimate children  
 11 “The actual relationship to the Study child of the persons acting as the child’s 
parents is: (Please ring as appropriate):”   
 16 “The relationship to the study child of the person acting as the child’s mother 
is:…” 
“The relationship to the study child of the person acting as the child’s father 
is:…” 
 33 Cohort member’s parents ever permanently separated or divorced, and if so, 
age when parents last lived together (only used to code a positive value and 
if other information is missing) 
 50 Age of cohort member when mother died, age of cohort member when 
father died (only used to code a positive value and if otherwise missing) 
Any time in 
care 
7 “Has the child been in the care of the local authority?”  
11 “Has the child ever been in the care of a Local Authority Children’s 
Committee?” 
“Has the child ever been in the care of a Voluntary Society?” 
16 “Has this child ever been in the care of a Local Authority?”  
“Has this child ever been in the care of a Voluntary Society?” 
 23 “Were you ever, to your knowledge, “in care” as a child?” 
“Note: “in care” of a local authority social services / children’s department or 
voluntary children’s society. Children can be “in care” but live at home or 
with relatives.” 
Neglect at 
either age 
7 Teacher rating of child’s appearance as “looks underfed”/“scruffy and dirty” 
11 Teacher rating of child’s appearance as “looks underfed”/“scruffy and dirty” 
Parental 
mental 
illness 
reported at 
any age 
7 Health visitor reports family difficulties “due to mental illness or neurosis” 
11 “Since the child’s 7th birthday has either parent (or parent substitute) 
suffered from chronic or serious disability or ill-health, including any hospital 
in-patient admission of two weeks or longer?” 
“What is/was the condition?.../psychiatric/…” 
16 “Chronic ill health or disability in the household. In answering this question: 
“Include conditions which have been present since the study child’s 11th 
birthday, irrespective of when they commenced 
“Include only the most severe condition if more than one is affecting the 
same person 
“Include parent substitute under mother or father 
“Has the study child since his/her 11th birthday lived in the same household 
as anyone suffering from chronic physical or mental ill health or disability?” 
Diagnosis for mother and father: “…psychiatric…” 
Residential 
and school 
moves:  
at least one 
move of 
home and 
school 
between 5 
and 16 
7 “Number of times family has moved since child’s birth (applicable only where 
the child has been with this family since birth). Please state number of 
moves” 
“Since the age of five, how many schools has the child attended? (Count the 
present school as one)”  
11 “How many times has the family moved home since the child was born. State 
number of moves, e.g. 6 moves=6. If 9 or more, enter 9. If the answer is not 
straight-forward give brief details” 
“How many schools has the child attended since the age of 5 years, not 
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counting moves from one department to another of the same school.” 
16 “How many schools has the study child attended since his/her 11th 
birthday?” 
“How many times has the family moved since the study child was born?” 
Poverty: 
Free school 
meals at 11 
and/or 16 
11 “Does any child of the family receive free school meals at present?” 
“Is the child at present receiving free school meals?” 
16 “Does any child of the family receive free school meals at present?” 
Con-current information about parental loss up to age 16 was provided by 12,052 cohort members, 
and this was supplemented by retrospective information provided by 2,540 cohort members at age 
33 and by 20 cohort members at age 50. Con-current information about whether the cohort member 
had spent time in care up to age 16 was provided by 9,280 cohort members, and this was 
supplemented by retrospective information provided by 4,885 cohort members at age 23. The 
variable used to measure neglect was also used by Kelly-Irving et al. (2013a,b). 
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Table 2.3: Exposures to adversities during transition and early adulthood 
Variable Age Questions asked 
Material adversities   
Financial hardship 
Currently on means 
tested benefits
1
 and 
savings of no more 
than £1,000. 
 
23 
 
“I now want to talk to you about income from sources other than 
work. At present are you (or your husband/wife/partner) receiving 
any of the state benefits or payments shown on this card?” 
“Which of these are (or your husband/wife/partner) receiving?” 
“Do you get any rebates on your rent or rates?” 
“Do you (or your husband/wife/partner) get a rent allowance or a 
rate rebate from the local council?” 
“At the moment do you (or your husband/wife/partner) have any 
money saved in any of the places mentioned on this card? At the 
present time, how much do you (or your husband/wife/partner) 
have saved in...” 
Currently on means 
tested benefits
2
 and 
not a part or full owner 
occupier. 
33 “I now want to talk about income from sources other than work. At 
present, are you (or your husband/wife/partner) receiving any of the 
state benefits or payment shown on this card?” 
Details of benefits received, period covered, and whether it was 
respondent or spouse who received it. 
Household tenure at age 33. 
Ever been homeless   
Time spent homeless 
or in a refuge. 
23 “Have you ever had to move out of a place and had nowhere to go?” 
33 “Have you ever over the last 10 years become homeless, I mean 
having to move out of a place and having nowhere permanent to 
live? (NOTE: LIVING WITH PARENTS = ‘NO’)” 
Normal address hostel for homeless/women’s refuge/night shelter. 
Occupation-related adversities 
Unemployment   
Ever unemployed for 
at least 12 months
3
. 
23 Activity histories with start and end dates for each period of activity. 
One of the activities is unemployment. 
Unemployed for at 
least 12 months since 
age 24. 
33 Activity histories with start and end dates for each period of activity. 
One of the activities is unemployment. 
Involuntary job loss   
Involuntary job loss, 
ever 
23 “I would like to ask you how your first job came to an end. Did it 
come to an end because: it was a temporary job, the firm closed 
down, you were made redundant, you were sacked, or did you leave 
of your own accord?” Also asked about last job. 
Involuntary job loss 
since age 24 
33 “If not currently in paid work: (About most recent job) “What was 
the main reason you left this job? Please show me on this card. It 
was a fixed term or temporary job / you were made redundant / you 
were dismissed / you were pregnant / for other health reasons / you 
decided to leave yourself / other”. Asked about most recent job, and 
two previous jobs since March 1981. 
Failed a course   
No qualifications from 
year+ full-time 
accredited  
23 “Did you pass all the qualifications you were studying for on this 
course?” 
“Which of these types of course was it? Full-time course / …” 
Relationship adversities 
Caring for sick child   
Current care of 
biological child 
23 “Does any child born to you have any longstanding illness, disability 
or infirmity?” 
“Does the child normally live with you?” 
Poor quality relationship  
With current partner 33 Items from the Locke-Wallace Marital Adjustment Test. See 
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Appendix 2. 
Overcrowded housing   
Overcrowded housing
4 
33 “(Apart from the bathroom and kitchen) how many rooms does this 
accommodation have? Include shared rooms. Exclude kitchen, 
bathroom, toilets, halls, garages, etc.” 
Household composition from household grid. 
Broken partnerships   
One+ broken 
partnerships since 16 
23 “Apart from anyone you subsequently married, how many people 
have you lived with as married for six months or more? (Include 
current partner if lived with for 6 months or more)” 
“When did you first start living together?” 
“Are you living with someone as married at present?” 
Age 33 information used only if age 23 information was missing. 
 ……………...… since 24 33 Couple separated or partner died (with dates). 
Lone parenthood   
Spent any time as a 
lone parent since 16 
23 “Now I want to ask you about lone parenthood – I mean having to 
bring up a child on your own because a relationship with a 
husband/wife or partner has broken down or ended. Have you ever 
been a lone parent for a continuous period of one month or more?” 
Spent any time as a 
lone parent since 24 
33 “Could you tell me when each of these periods of lone parenthood 
started and ended? If 4 or more take first three and most recent” 
Separation from child   
Current separation 23 “Is the child living with you now”, asked of up to four biological 
children. 
Currently not living 
with biological child 
under 16
5 
33 Age of child 
“Child is: living with respondent/living elsewhere/not living or not 
born” 
“Who is this child living with now?” Options include special school, 
boarding school 
Loss of child   
Death of child, stillbirth  
Death of own child 
Stillbirth 
23 “Is the child still alive?” 
“How old was the child when he/she died?” Options include stillborn. 
Age 33 information used only if age 23 information was missing. 
Death of own child 33 “Please give details of each child by answering questions (a) – (e) 
opposite. You should start with your first child. If you have had any 
more than four children continue on pages 10 and 11. If you had 
twins, or a multiple birth, please fill in a separate column for each 
child” 
“Where is the child now? Living with you/living elsewhere/stillborn 
/died (please give date below)” 
Stillbirth since age 24 33 “I would like to ask about any pregnancies you may have conceived / 
fathered, whether or not the pregnancy was carried to full term. Can 
I first check, have you ever conceived / fathered a pregnancy?” 
“It is important to know in what order things have happened, so I 
would like to ask a few questions about each pregnancy in turn. Let’s 
start with the first pregnancy. Did this pregnancy end in a live birth, 
or a miscarriage, or a still birth, or what? Live birth, single / twins 
identical / twins fraternal / twins, no sure / multiple / still birth / 
miscarriage / abortion / still pregnant” 
Infertility   
Infertility 23 “Can we talk about the future now.  As far as you know, are you 
personally able to have (more) children of your own?” 
Age 33 information used only if age 23 information was missing. 
Infertility 33 “As well as pregnancy, we are interested in any problems couples 
may have in getting pregnant when they want to. Has there ever 
been a time of six months or more when you and your partner were 
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having sex regularly without using any method of birth control? Yes / 
no / never use birth control” 
“When was this? Approximate duration” 
“Do any of these apply to you or your partner? You have been 
sterilized or had a vasectomy or hysterectomy / you have been told 
by a doctor that you are unable to have children / you have been 
told by a doctor that you should not have children for health reasons 
/ none of these” 
Traumatic events   
Assault or rape 33 “Which of the things on this card best describes why you had to go to 
hospital? Road accident as pedestrian / road accident as driver or 
passenger / accident at work / accident at home / sports accident / 
another kind of accident / a violent assault or mugging / rape” 
1. Means tested benefits at 23 were supplementary benefit, unemployment and supplementary 
benefit combined in one payment, sickness benefit, family income supplement, and rent and rates 
rebates, claimed by cohort member or their partner.  
2. Means tested benefits at 33 are supplementary benefit or income support and family credit 
(Blundell & Walker 2000). 
3. Long term unemployment is defined as periods of continuous unemployment lasting for 12 months 
or more (Begum 2004). 
4. For the purposes of calculating Local Housing Allowance, households are assessed as needing a 
bedroom each for a couple, a person aged 21+, two same sex people aged 10-20, two children both 
under 10 (Shelter website, downloaded Jan 2018). When the household has insufficient bedrooms 
according to these guidelines, the variable for overcrowded housing is assigned a positive value. 
Overcrowding applies during early adulthood and may reflect economic circumstances, but is 
included because it is associated with family stress. Values of total family and relationship adversity 
during early adulthood were identical when overcrowded housing was excluded, as every cohort 
member who reported overcrowding reported additional family or relationship adversities. 
5. Child separation takes a negative value if the child is at boarding school. 
 
2.3 Moderating variables 
Gender was measured during all sweeps. Respondents reporting different genders over time 
were assigned a missing value. Internalising childhood temperament is classified also as a 
confounding variable and atopic history is classified also as a mediating variable, and their 
measurements are described below. 
2.4 Confounding variables 
The perinatal survey, conducted soon after the births of cohort members, provided 
information to measure maternal smoking after the fourth month of pregnancy, bleeding 
during pregnancy, albuminaria and birthweight below the tenth centile, adjusted for sex and 
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gestation period. When cohort members were 7, parents were asked whether they had 
been breastfed for at least one month.  
Childhood internalising temperament was indicated using measures of internalising 
behaviours. These were assessed by parents when cohort members were 7, 11, and 16. 
Parents were asked about the frequency of behaviours described in the Rutter scale (Rutter 
et al. 1970). Separate factor analyses were conducted at each age, with rotations allowing 
factors to correlate. Three factors were identified, reflecting internalising, externalising and 
hyperactive behaviours, and factor scores were used to measure each type of behaviour. 
Details are presented in Appendix 3. 
Other authors report that the Rutter scale, completed by parents and teachers, identifies 
three factors, similarly interpreted (Kumpulainen et al. 1999a, McGee et al. 1985, Pereira et 
al. 2008). 
Internalising temperament has not been measured before using maladaption scores, so far 
as I am aware. Cohort members were classified at each age by comparing their internalising 
and externalising scores. Based on distributions of each type of behaviour, they were 
classified as having relatively high internalising behaviours if their internalising score fell into 
a centile that was at least one decile higher than the centile into which their externalising 
behaviour fell. The indicator for internalising type took a yes value if the cohort member 
was classified as having relatively high internalising behaviours at 7, 11, and 16, or in two 
sweeps if information was missing in one. 
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2.5 Mediating variables 
Data specially provided by the Centre for Longitudinal Studies, which manages the NCDS, 
were used to create variables indicating residence in an urban industrialised area at age 23, 
and occupational exposures likely to predict asthma onset. The latter variable was derived 
by Rebecca Ghosh (Ghosh et al. 2013). 
Early respiratory infections were indicated if the cohort member’s parent reported that they 
had had pneumonia by age 7. Household information provided when cohort members were 
aged 11 indicated the number of children (under 21) who lived in the household and were 
older than the cohort member. Parental smoking was indicated if at least one parent 
smoked when the cohort member was 16.  
Smoking was measured at ages 16, 23, and 33. At age 16, a value of one was assigned if the 
cohort member reported currently smoking at least 10 cigarettes a week. At ages 23 and 33, 
they were assigned a positive value if they reported currently smoking at least one cigarette 
a day or a history of smoking at least one cigarette a day for a 12 month period since the last 
sweep. 
Obesity was defined as having a body mass index (BMI) of 30 Kg/m2 or more (Public Health 
England 2013), measured at ages 23 and 33. Atopic vulnerability was indicated by reported 
eczema or hay fever by age 33.  
Depressive symptoms were measured at ages 23 and 33 using the Malaise Inventory (Rutter 
et al. 1970). See Appendix 4. 
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3. Analyses 
To increase numbers and reduce bias, missing values were imputed in multiple datasets 
using as a base the whole sample except for three cohort members with missing data about 
gender. Details of the process are given in Appendix 5. Analyses were conducted on 20 
multiple imputed datasets and the results pooled using the combination rules suggested by 
Rubin (1987). 
Missing values were imputed for each childhood adversity and for indicators of one or more 
adversity in each domain during transition and early adulthood. After multiple imputation, 
these measures were used to create additional indices of adversity.  
Using the original or observed dataset, summary statistics for each adversity during 
transition and early adulthood were calculated. In addition, bi-variate correlations were 
estimated between each childhood adversity, and between adversities in each domain 
during transition and early adulthood. 
Summary statistics were calculated for asthma onsets during childhood, transition, early and 
mid-adulthood using the whole observed dataset and the twenty imputed datasets, for men 
and women combined and for men and women separately. 
Based on the sample used in the analyses, that is, all cohort members who had not reported 
asthma symptoms by age 33, descriptive statistics for all other variables were calculated 
using the observed sample and multiple datasets with imputed values. Comparisons of 
values of variables in the observed sample and in the imputed datasets provides information 
about the likely characteristics of cohort members who provided incomplete information. 
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Using imputed datasets, summary statistics were calculated for men and women separately, 
and bi-variate logistic regressions were estimated to test gender differences.  
In order to address the RQs, logistic regressions were estimated with asthma onset between 
ages 33 and 42 as the outcome using the imputed datasets and results were pooled. 
Analyses conditioned on gender because there are known gender differences in asthma 
onset and exposures to adversity. 
RQ1: Do life-course adversities predict asthma onset during mid-adulthood? 
RQ1a: Does total life-course adversity predict asthma onset?  
Asthma onset during mid-adulthood was regressed onto adversity, conditioning on gender. 
Separate models were estimated for measures of total adversity during childhood, 
transition, early adulthood and between birth and the beginning of mid-adulthood.  
In order to examine the nature of any correlations between adversity and asthma onset, 
total levels of adversity were measured using sets of dummies. This uses all available 
information and makes no assumptions about how increasing levels of exposure are 
associated with asthma onset. More parsimonious measures of exposure were also used; a 
continuous measure, and an indicator of exposure to two or more adversities during 
childhood or in two or more domains thereafter. Fits of models using these measures were 
compared using F-statistics. The continuous measure assumes a linear relationship between 
levels of adversity and asthma onset. This assumption was tested by comparing the fits of 
two models, one using the set of dummies, and the other using a measure of exposure 
calculated by multiplying the coefficient for one adversity by the number of adversities 
reported. 
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RQ1b: Do associations between adversity and adult onset asthma vary by gender, 
atopic history, or temperament? 
Three sets of models were estimated in which asthma onset was regressed onto total 
adversity during each life stage, conditioning on gender and (1) its interaction with 
adversity, (2) atopic history and its interaction with adversity, (3) internalising temperament 
and its interaction with adversity.  
RQ1c: Do adversities at any particular life stage matter, and which life stage matters 
most? 
An analogous research question was addressed using a structured modelling approach 
developed by Mishra and colleagues (2009), which was used in subsequent research 
(Murray et al. 2011, Robertson et al. 2014). Using this approach, a saturated model was 
estimated that included as predictors of asthma onset cumulative adversity measured 
during all three life stages plus all possible interactions between them. Additional 
specifications that dropped predictors from the saturated model in various combinations 
were also estimated. Wald tests were used to assess each specification’s parsimony and 
accuracy. The specifications are presented in Table 2.8. 
RQ1d: Do social adversities predict asthma onset after adjustment for material and 
occupation-related adversities? 
Asthma onset was regressed onto adversities in each domain, with mutual adjustment. This 
specification was estimated for men and women together, and for men and women 
separately, during transition and early adulthood.  
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RQ2: What confounding and mediating factors explain the association between 
childhood adversity and adult onset asthma? 
For each hypothesised confounding and mediating variable, associations were tested with 
(1) childhood adversity, and (2) asthma onset during mid-adulthood. 
To test for attenuation, models were estimated in which asthma onset was regressed onto 
childhood adversity conditioning on gender, first without adjustment (the baseline model), 
and then adjusting for each hypothesised explanatory variable that was associated with 
both childhood adversity and asthma onset. The baseline (unadjusted) association was 
compared with adjusted associations. 
The Karlson Holm Breen (KHB) method (Karlson et al. 2012, Breen et al. 2013) was used to 
test for attenuation of the association between childhood adversity and asthma onset. 
Direct comparisons between nested models are not feasible when the dependent variable is 
binary because the baseline for each odds ratio (OR) estimated depends upon the other 
variables in the model. Consequently, changes in ORs when a hypothesised confounder or 
mediator is added to a model reflect not only attenuation by this variable but also changes 
resulting from rescaling. The KHB method addresses this complication by decomposing the 
change in a coefficient across nested logit models into an attenuating component and a 
rescaling component. 
Two factors apart from adversity during subsequent life stages predicted both childhood 
adversity and asthma onset and attenuated the association between them. KHB tests were 
performed to examine whether each factor attenuate new baseline associations that 
included adjustment for adversity and the other factor.  
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RQ3: What combination of factors best predict asthma onset during mid-adulthood?  
Variables that are correlated with asthma onset were identified in analyses conducted to 
address RQs1 and 2. These were included in a single model with asthma onset as the 
outcome. Variables were dropped from this model, F-statistics compared, and Wald tests 
used to identify which variables had coefficients that differed from zero after mutual 
adjustment. 
Sensitivity analyses 
Three sets of sensitivity analyses were conducted. The first repeated all the analyses using 
the observed dataset. 
The second used a measure of asthma onset that disregarded history of asthma and wheezy 
bronchitis reported at age 7. It is not uncommon that individuals report asthmatic 
symptoms during the first years of life but not thereafter. This is reflected in the NCDS; 
parents of 1,439 cohort members reported that they had a history of asthma or wheezy 
bronchitis at age 7, but no history was reported in subsequent sweeps up to and including at 
age 33. These 1,439 cohort members are excluded from the main analyses but included in 
the sensitivity analyses. 
The third used a measure of childhood adversity that excludes residential mobility. 
Residential mobility was the most commonly reported adversity during childhood and it is 
not conventionally included in measures of childhood adversity. I wanted to check whether 
the results depended upon its inclusion.  
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4. Results 
Summary statistics 
Summary statistics for asthma incidences are presented in Table 2.4. Incidence rates are 
consistently higher in the multiple imputed datasets than in the observed NCDS sample, 
indicating that at each life stage, cohort members with missing information about asthma 
onset and other variables of interest were at higher risk of having developed the condition 
than cohort members who provided complete information. 
Table 2.4:   Summary statistics for asthma onset 
  NCDS sample Multiple imputed datasets 
Life stage
 
Missing Obs %=yes No.=yes %=yes 95% CI 
       
Men and women       
Childhood 6,176 12397 28.6% 3546 33.9% 33.0% - 34.9% 
Transition 11,406 7170 5.8% 416 6.5% 5.3% - 7.8% 
Early adulthood  11,284 7288 3.3% 241 4.5% 3.5% - 5.4% 
Mid-adulthood 11,414 7140 3.7% 264 4.6% 3.6% - 5.6% 
       
Men       
Childhood 3,175 6431 31.7% 2039 37.0% 35.8% - 38.3% 
Transition 6,147 3457 4.2% 145 4.9% 3.6% - 6.3% 
Early adulthood  6,138 3467 2.5% 87 3.5% 2.4% - 4.5% 
Mid-adulthood 6,172 3424 2.6% 90 3.4% 2.2% - 4.6% 
       
Women       
Childhood 3,001 5966 25.2% 1503 30.7% 29.4% - 31.9% 
Transition 5,259 3713 7.3% 271 8.3% 7.0% - 9.6% 
Early adulthood  5,146 3821 4.2% 160 5.5% 4.4% - 6.7% 
Mid-adulthood 5,242 3716 4.7% 174 5.8% 4.7% - 6.8% 
  
   
  
Gender difference p=0.000 for every life stage P<=0.001 for every life stage 
      
Onset of asthma is coded for cohort members with no history of asthma at baseline. During 
childhood and transition, asthma includes wheezy bronchitis. Childhood is 0-16, transition 17-23, 
early adulthood 24-33, and mid-adulthood 34-42. Multiple imputed datasets have 18,554 
observations; 9,596 men, 8,958 women. Obs is the number of respondents for whom the variable has 
a non-missing value. %=yes and N=yes indicate the percentages and numbers, respectively, of 
respondents who reported asthma onset. 
 
Percentages of respondents reporting asthma onset vary between life stages partly because 
they cover different numbers of years. Based on the imputed datasets, mean incidence rates 
per 1,000 persons per year for asthma are 16.8 (i.e. 286/17) during childhood, 9.7 during 
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transition, 3.3 during early adulthood, and 4.1 during mid-adulthood.  Although incidence 
rates are not uniform during each life stage, these percentages suggest that incidence rates 
are greatest during childhood, decline through transition into early adulthood, and begin to 
rise during mid-adulthood.  
Gender differences in asthma onset depend upon life stage. More boys than girls developed 
asthma during childhood, and thereafter, more women than men developed the condition. 
In both the observed and multiple datasets with imputed values, these gender differences 
are statistically significant with very low p-values. 
Summary statistics for other variables are presented in Tables 2.5 and 2.6. They are based 
on cohort members who reported no history of asthma by age 33. The first columns use the 
observed NCDS sample, and the others use the twenty imputed datasets. Cohort members 
with missing information were exposed to more adversities during each life stage, with the 
exceptions of adversities involving child loss and trauma during early adulthood. In addition, 
higher proportions manifested internalising type behaviours during childhood, had 
pneumonia by age 7, grew up with older children,  lived in urban industrialised areas at age 
23, were exposed to toxins or pollutants through their occupations and were obese at age 
33. They also smoked and had more depressive symptoms at 23 and 33. 
The final column in Tables 2.5 and 2.6 give p-values of gender coefficients estimated from 
bivariate regressions with each variable included in the analyses. During childhood, there is 
no evidence of gender differences in exposure to any adversity, except that teachers 
described more boys than girls as underfed, scruffy or dirty. This could reflect gender bias in 
teachers’ assessments as well as any gender difference in neglect. During both transition 
and early adulthood, more women reported material adversity and adversities involving 
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child loss and more men reported occupation-related adversities and trauma. During 
transition but not early adulthood, women reported more family and relationship 
adversities than men. More women than men had a history of eczema and/or hay fever by 
age 33, and they reported more depressive symptoms. Men reported higher levels of 
occupational exposures, and were more likely to have smoked at ages 23 and 33.  
Evidence for associations between adversities is presented in Appendix 6. Those exposed to 
one childhood adversity were at relatively high risk of being exposed to another. Later in 
life, those exposed to adversities in one domain were more likely to be exposed to adversity 
in another. Those exposed to adversities during one life stage were at relatively high risk of 
being exposed during other life stages. 
 
  
Chapter 2: Psychosocial predictors of asthma onset             64 
 
 
Table 2.5:   Summary statistics for adversities for cohort members without asthma before age 331 
 Observed Multiple datasts with imputed values (n=14,109)
2
 
 Men&women Men&women Men (n=7,241) Women (n=6,868) Diff. 
Adversities Obs % %  95%CI %=Y  95%CI %=Y  95%CI p-val
3
  
 
Childhood adversity (0-16) 
Early parental loss 7807 28.9 36.0 35.0-37.0 35.9 34.5-372 36.1 34.4-37.7 0.845 
Spent time in care 10359 5.6 8.2 7.5-8.9 8.6 7.7-9.4 7.8 6.9-8.6 0.154 
Neglect at 7 or 11 5124 8.9 12.2 11.0-13.4 14.6 12.9-16.3 9.8 8.5-11.1 0.000 
Parent mentally ill 8079 7.4 10.4 9.5-11.2 10.4 9.3-11.5 10.4 9.3-11.4 0.928 
High mobility
4
 7509 47.2 55.0 53.9-56.0 54.1 52.7-55.5 55.9 54.4-57.4 0.078 
Free school meals
5
 7680 22.0 30.2 28.9-31.4 30.1 28.3-31.9 30.2 28.8-31.6 0.910 
Total adversity
6 
 
0 9281 32.5 28.2 27.2-29.2 28.2 26.9-29.5 28.1 26.8-29.5 0.916 
1 9281 45.6 30.8 29.7-31.9 30.4 28.8-32.0 31.2 29.8-32.7 0.420 
2 9281 15.1 17.0 16.1-17.8 16.9 15.8-18.1 17.0 15.5-18.4 0.953 
3 9281 5.1 13.7 12.8-14.6 13.4 12.2-14.6 14.0 12.7-15.3 0.540 
4 9281 1.5 6.6 5.9-7.3 7.0 6.1-7.8 6.2 5.4-7.0 0.135 
5-6 9281 0.2 3.7 3.3-4.2 4.0 3.4-4.6 3.4 2.8-4.1 0.154 
          
Adversities during transition (17-23) 
Material 7032 18.4 24.6 23.4-25.8 21.7 20.3-23.1 27.7 26.0-29.4 0.000 
Occupation-related 9091 20.2 24.2 23.0-25.4 28.2 26.5-30.0 20.0 18.7-21.2 0.000 
Family & relationships 9142 12.9 16.2 15.4-17.1 11.7 10.7-12.7 21.0 19.6-22.4 0.000 
Child loss 9124 2.2 3.5 2.9-4.1 2.2 1.5-2.8 4.9 3.9-5.9 0.000 
Number of domains in which adversities were reported 
0 7747 58.9 55.6 54.4-56.7 56.9 55.4-28.5 54.1 52.5-55.8 0.012 
1 7747 29.4 26.2 25.3-27.2 26.8 25.4-28.1 25.7 24.4-26.9 0.250 
2 7747 9.7 13.0 12.1-13.8 12.3 11.2-13.4 13.6 12.6-14.7 0.062 
3-4 7747 2.0 5.3 4.7-5.8 4.0 3.4-4.7 6.5 5.6-7.5 0.000 
          
Adversities during early adulthood (24-33) 
Material 8117 10.5 14.1 12.9-15.3 11.7 10.3-13.1 16.5 15.1-18.0 0.000 
Occupation-related 8293 23.0 26.8 25.3-28.4 34.3 32.2-36.4 19.0 17.5-20.5 0.000 
Family & relationships 7503 24.4 30.0 28.5-31.5 30.9 29.0-32.9 29.0 27.3-30.7 0.088 
Child loss 8039 20.5 21.4 19.7-23.1 19.8 17.9-21.7 23.1 21.2-25.0 0.001 
Trauma 8243 2.7 3.5 2.7-4.3 4.8 3.7-6.0 2.1 1.5-2.7 0.000 
Number of domains in which adversities were reported 
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0 7692 41.8 38.6 37.4-39.8 35.4 33.8-37.0 42.0 40.5-43.5 0.000 
1 7692 39.1 36.4 35.3-37.5 37.7 36.2-39.2 35.0 33.6-36.4 0.008 
2 7692 14.7 17.3 16.4-18.2 18.8 17.5-20.0 15.8 14.6-16.9 0.000 
3-5 7692 4.4 7.7 6.8-8.6 8.2 7.0-9.3 7.2 6.3-8.2 0.125 
 
Adversities over the early life-course (0-33) 
0 4309 14.6 10.1 9.5-10.8 9.5 8.7-10.3 10.8 9.9-11.8 0.024 
1 4309 28.3 19.1 18.3-19.9 18.7 17.5-19.9 19.5 18.5-20.6 0.312 
2 4309 22.0 18.3 17.6-19.1 18.5 17.3-19.7 18.2 17.0-19.4 0.762 
3 4309 16.0 15.6 14.8-16.4 15.9 14.9-17.0 15.2 14.2-16.3 0.333 
4 4309 9.7 11.8 11.1-12.5 12.1 11.1-13.1 11.5 10.5-12.6 0.441 
5 4309 4.9 8.6 8.0-9.2 8.9 8.1-9.8 8.2 7.4-9.0 0.219 
6 4309 3.0 6.0 5.5-6.6 6.1 5.3-6.9 6.0 5.2-6.7 0.784 
7-15 4309 1.5 10.3 9.7-11.0 10.2 9.4-11.0 10.5 9.5-11.5 0.664 
Single adversities in  
observed dataset 
Transition Early adulthood Summary statistics exclude cohort members who reported asthma symptoms by 33. 
Obs is the number of respondents for whom the variable has a non-missing value. % 
refers to binary variables and is the percentage of respondents with a yes value for the 
variable. %=Y if the percentage of men or women with a yes value. Cumulative 
exposures using the observed sample were coded to maximise variation. Childhood 
adversities were summed only if information was available for three or more 
adversities. If information was available for fewer adversities, it was only used if this 
indicated at least one exposure. Cumulative measures based on incomplete 
information were not scaled up. Similar approaches were used to code cumulative 
exposures during the other two life stages. Different distributions of variables in the 
observed and multiple imputed datasets and between genders are in bold font. 
1. No history of asthma or wheezy bronchitis 0-23, no history of asthma 24-33. 
2. 20 datasets with missing values imputed. Summary statistics reported for cohort 
members with no history of asthma/wheezy bronchitis 0-23, asthma 24-33. 
3. P-values refer to logit regression analyses of female gender on each variable. 
4. Residential mobility is one+ move of home and school during same period 5-16. 
5. Any family member on free school meals at ages 11 or 16 or both. 
6. Value in imputed datasets is sum of childhood adversities after imputations. 
7. On means tested benefits and savings <=£1,000 (transition), not owner occupier 
(early adulthood). 
8. Continuous period of unemployment lasting 12 months +. 
9. Full-time accredited courses only. 
10. Partnerships defined as romantic relationships including marriage that involved 
cohabitation for at least six months. 
11. Cohort member’s biological children living in same household. 
12. Only identified if assault or rape led to hospital care. 
Obs %=Y Obs %=Y 
     
Material adversities     
On means-tested benefits
7 
6918 12.4 8116 7.5 
Homeless 9087 5.9 8264 3.8 
   
Occupation-related adversities   
Unemployment
8 
10682 6.1 10649 6.7 
Redundant/sacked 9066 10.6 8268 17.1 
Failed a course
9 
9096 5.4   
   
Family & relationship adversities   
Broken partnership
10 
9332 9.3 8173 8.0 
Lone parenthood 9094 4.0 8174 5.3 
Child has chronic illness
11 
8967 1.1   
Separation from child
12 
9095 1.5 7676 6.0 
Poor relationship
10 
  7833 2.9 
Overcrowded home   8292 5.4 
     
Child loss adversities     
Death of child 10234 0.6 7993 1.0 
Stillbirth 10299 0.5 8269 0.8 
Infertility 9110 1.0 8299 18.6 
     
Trauma     
Assault or rape
13
   8243 2.7 
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Table 2.6: Summary statistics for hypothesised modifiers, confounders, and mediators of adversities-adult onset associations. 
 Observed sample Multiple datasets with imputed values (n=14,109) 
 Men & women Men & women Men (n=7,241) Women (n=6,868) Difference 
 
Obs. %=Y %=Y 95%CI %=Y 95%CI %=Y 95%CI p-val
1
 
Modifiers
2 
            
Female 14109 48.7 48.7 47.9-49.5    
    Atopic history
3 
9685 12.8 13.0 12.3-13.7 9.6 8.8-10.5 16.5 15.4-17.5 0.000
Internalising type
4 
9812 33.8 40.9 39.8-42.0 40.2 38.7-41.7 41.6 40.2-43.0 0.139 
Confounders             
Bleeding < 28th week
5 
12779 3.4 3.5 3.2-3.8 3.3 2.9-3.7 3.7 3.2-4.2 0.222 
Bleeding > 28th week 12779 24.0 24.1 23.4-24.8 24.1 23.0-25.1 24.1 23.1-25.2 0.916 
Albuminaria
6 
12512 8.1 8.2 7.7-8.6 8.4 7.8-9.1 7.9 7.2-8.6 0.266 
Maternal smoking
7 
12986 32.8 33.0 32.1-33.8 33.0 31.8-34.1 33.0 31.8-34.1 0.998 
Low birthweight
8 
11188 9.7 10.1 9.5-10.6 9.9 9.1-10.7 10.3 9.5-11.1 0.525 
Breastfed
 
for at least one month 10475 43.7 42.6 41.5-43.6 41.7 40.4-43.0 43.5 42.0-45.0 0.066 
Mediators             
Pneumonia by age 7 10498 2.9 3.4 3.0-3.8 3.4 2.9-4.0 3.3 2.8-3.8 0.757 
Parental smoking
9 
8349 71.3 71.0 69.5-72.5 70.4 68.6-72.1 71.6 69.8-73.4 0.187 
Older children
10 
10034 0.952 0.976 0.954-0.998 0.987 0.958-1.017 0.965 0.934-0.996 0.272 
Urban residence at 23
11 
8566 20.7 23.1 22.0-24.1 22.6 21.1-24.0 23.6 22.0-25.1 0.344 
Occupational exposures
12 
8338 1.077 1.105 1.081-1.129 1.190 1.160-1.221 1.016 0.990-1.041 0.000 
Smoker at 23
13 
9163 47.6 51.2 50.0-52.4 53.0 51.5-54.5 49.2 47.7-50.8 0.000 
Smoker at 33 8161 43.0 45.7 44.2-47.1 47.5 45.7-49.3 43.8 42.1-45.4 0.000 
Obesity at 23
14 
8922 2.5 2.8 2.3-3.3 2.5 2.0-3.0 3.1 2.4-3.8 0.083 
Obesity at 33 8020 11.2 12.7 11.4-14.0 12.4 10.8-14.1 13.0 11.6-14.3 0.448 
Depressive symptoms 23
15 
9057 2.528 2.749 2.678-2.820 2.140 2.056-2.224 3.391 3.293-3.489 0.000 
Depressive symptoms 33 8241 2.267 2.580 2.491-2.670 2.234 2.130-2.337 2.945 2.827-3.063 0.000 
1. From logits of gender on each variable. 
2. Variables may moderate, confound and mediate associations. 
3. History of eczema and/or hay fever by age 33. 
4. Measurement of internalising type is described in text. 
5. Bleeding before and after 28
th
 week of pregnancy. 
6. Albuminaria is protein in mother’s urine during pregnancy. 
7.   Maternal smoking after fourth month of pregnancy. 
8.   Below 10th centile, adjusted for gestation period and sex.9.   At 
least one parent smoked when cohort member 16. 
10. No. older children under 21 in same household at 11. Means. 
11. Urban industrialized residence at age 23. 
12. Likely to increase asthma risk, by 33, range 1-3. Means. 
13. Smoking at least 10 per week at 16, and/or 
smoking one or more cigarette per day 17-33. 
14. Obesity defined as BMI of 30 and over. 
15. Continuous malaise scores at 23 and 33, 
ranges 0-16 and 0-21, respectively. Means 
here but standardised values used in analyses. 
Summary statistics for cohort members without asthma by 33. Bold font indicates differences that are statistically significant at p<0.05.    Obs is the number of respondents for 
whom the variable has a value. % refers to binary variables and is the % of respondents with a yes value for the variable. %=Y is the percentage of men or women with a yes value. 
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RQ1. Do life-course adversities predictor asthma onset during mid-adulthood? 
RQ1a: Does total life-course adversity predict asthma onset?  
Table 2.7 presents results indicating that risk of asthma onset increases with total adversity 
from birth to 33, and with levels of adversity during each life stage. 
Comparisons of F-statistics for specifications that measure adversity using sets of dummies, 
binary indicators, and continuous measures indicate that relationships with asthma onset 
are described most accurately and parsimoniously using continuous measures. Additional 
tests indicate that relationships with adversity during each life stage are linear. 
 
After conditioning on gender, the odds of asthma onset during mid-adulthood increase with 
each additional adversity during childhood (OR=1.263, 95% confidence interval 
95%CI=1.112-1.434, p=0.001, maximum value of 5 or more), and with exposures in each 
additional domain during transition (OR=1.559, 95%CI=1.351-1.799, p=0.000, maximum 
value of 3 or more) and early adulthood (OR=1.430, 95%CI=1.221-1.675, p=0.000, maximum 
value of 3 or more).   
After adjustment for adversity during each life stage, asthma onset during mid-adulthood 
was more common among women than men. 
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Table 2.7:   Odds ratios for asthma onset between 34 and 42 predicted by life-course adversity, unadjusted, for men and women together. 
 
Set of dummies Continuous measure Indicator of two or more adversities 
  
OR 95%CI p-val OR 95%CI p-val V OR 95%CI p-val 
            
Life-course (0-33) adversities 
           Female 
 
1.748 1.310-2.333 0.000 1.756 1.318-2,340 0.000 
 
1.752 1.320-2.326 0.000 
Adversities 0 
  
 
 
1.232 1.140-1.332 0.000 0-1 Reference   
 
1 1.062 0.647-1.742 0.813 
    
2+ 1.860 1.302-2.659 0.001 
 
2 1.214 0.699-2.108 0.492 
         
 
3 1.432 0.833-2.460 0.197 
         
 
4 1.513 0.818-2.798 0.192 
         
 
5 2.167 1.204-3.900 0.012 
         
 
6 2.514 1.310-4.822 0.007 
         7-15 4.027 2.089-7.762 0.000 
         Wald test   F=8.630,p=0.000     
F-stat. model fit F=9.362   F=21.967               F=12.880   
Test of linearity     p=0.654        
               Childhood adversities (0-16) 
           Female 
 
1.761 1.325-2.341 0.000 1.753 1.321-2.326 0.000 
 
1.739 1.307-2.313 0.000 
Adversities 0 
    
1.263 1.112-1.434 0.001 0-1 Reference   
 
1 1.158 0.796-1.684 0.445 
    
2+ 1.723 1.242-2.390 0.003 
 
2 1.531 1.047-2.238 0.031 
         
 
3 1.555 0.928-2.605 0.102 
         
 
4 2.366 1.333-4.197 0.005 
         
 
5-6 3.770 1.918-7.413 0.001 
         Wald test   F=6.017, p=0.000  
   F-stat. model fit F=7.317   F=13.206    F=11.996 
  Test of linearity     p=0.561     
              
Adversities during transition (17-23)           
Female 
 
1.639 1.216-2.210 0.002 1.645 1.222-2.214 0.002 
 
1.662 1.239-2.231 0.002 
Adversities 0 
  
 
 
1.559 1.351-1.799 0.000 0-1 Reference   
 
1 1.432 1.089-1.883 0.012 
    
2+ 2.422 1.818-3.225 0.000 
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2 2.280 1.659-3.134 0.000 
         
 
3-4 3.943 2.428-6.403 0.000 
         Wald test  
 
F=18.676, p=0.000 
         F-stat. model fit F=17.184 
  
F=25.872 F=24.616 
  Test of linearity  
   
P=0.718     
               
Adversities during early adulthood (24-33) 
 
 
         Female 
 
1.799 1.350-2.397 0.000 1.808 1.359-2.405 0.000 
 
1.784 1.341-2.374 0.000 
Adversities 0 
  
 
 
1.430 1.221-1.675 0.000 0-1 Reference   
 
1 1.287 0.993-1.668 0.058    
 
2+ 1.895 1.436-2.501 0.000 
 
2 1.718 1.247-2.366 0.001  
         
 
3-5 3.156 1.891-5.268 0.000  
         Wald test   F=12.132, p=0.000  
   F-stat. model fit F=12.571   F=17.138    F=16.863 
  Test of linearity     p=0.279     
   Results of 12 models with no other covariates. Within life stage, models were estimated for each measure of adversity using 20 datasets with imputed values, N=14,109 and 
includes all cohort members with no history of asthma symptoms by 33.  
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RQ1b: Do associations between adversity and adult onset asthma vary by gender, 
atopic history or temperament? 
There is no evidence that associations between asthma onset and adversity varied by 
gender, atopic history, or temperament. In models that included interaction terms, after 
adjusting for gender and adversity during the appropriate life stage, ORs for asthma onset 
contingent upon the interaction between female gender and adversities during childhood, 
transition and early adulthood were 1.027 (95%CI=0.889-1.185, p=0.716), 1.046 
(95CI%0.856-1.278, p=0.655) and 1.126 (95%CI=0.899-1.412, p=0.293), respectively. After 
adjustment for gender, atopic history, and adversity during the appropriate life stage, ORs 
for asthma onset contingent upon interactions between atopic history and adversities were 
1.018 (95%CI=0.869-1.192, p=0.823), 1.050 (95%CI=0.862-1.280, p=0.622), and 1.020 
(95%CI=0.877-1.187) p=0.795 for the life stages in the same order. Odds ratios for 
interactions between internalising temperament and adversities during childhood, 
transition and early adulthood were 0.905 (95%CI=0.622-1.238, p=0.526), 1.112 
(95%CI=0.821-1.505, p=0.488), and 0.986 (95%CI=0.748-1.300, p=0.921), respectively. 
RQ1c: Do adversities at any particular life stage matter, and if so, which life stage 
matters most? 
Table 2.8 presents information about the accuracy and parsimony of various specifications 
that constrain the ways in which adversities combine over the life-course to predict asthma 
onset. F-statistics indicate parsimony and accuracy (how well values predicted by the model 
match the data given its complexity), and these are highest for the model that includes 
adversity during transition as a sensitive period and the strict accumulation model. Wald 
tests report probabilities that coefficients of variables dropped from the saturated model 
are zero. This indicates that coefficients excluded to create the strict accumulation model 
did not differ from zero, but that the coefficients excluded to create the model with 
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transition as a sensitive period did. Therefore, the strict accumulation model was selected. 
According to this model, each additional adversity during childhood, and adversity in each 
additional domain during transition and early adulthood is associated with an OR for asthma 
onset during mid-adulthood of 1.232, 95%CI=1.140-1.332, p=0.000 (Table 2.7). Reporting 
maximum life-course adversities as opposed to none is associated with increased odds of 
asthma onset during mid-adulthood by 4.26 (1.237). 
Table 2.8: Comparison of alternative life-course models of adversities as predictors of 
adult onset asthma, each adjusted for gender, for men and women together. 
Model Specification F-stat. p-val 
Saturated = α + β1AC + β2AY + β3AEA + β4ACAT + β5AYAEA + 
β6ACAEA  + β7ACAYAEA 9.22  
Accumulation:   strict = α + β1(AC + AY + AEA) 21.97 0.396 
..                           relaxed = α + β1AC + β2AY + β3AEA 13.68 0.396 
Sensitive periods = α + β1AC 13.21 0.000 
 = α + β1AY  25.87 0.018 
Accumulation over sensitive periods = α + β1AC + β2AY  16.23 0.147 
Chain of risk = α + β1AEA 17.14 0.000 
Accumulation within chains of risk = α + β1AY + β2AEA 18.93 0.072 
Sensitive period with chain of risk = α + β1AC + β2AEA 13.29 0.001 
Ac, AY, AEA represent total adversity during childhood, transition, and early adulthood, respectively. 
All models are estimated for 14,109 respondents and are conditioned on gender.   
High values of the F-statistic indicate models’ parsimony and accuracy. 
p-values are from Wald tests and indicate probabilities that coefficients of parameters dropped from 
the saturated model equal zero. 
 
 
RQ1d: Do social adversities predict asthma onset after adjustment for material and 
occupation-related adversities? 
Table 2.9 indicates that after adjustment for material and occupation-related adversities, 
adversities associated with child loss during transition and adversities associated with family 
and relationships and trauma during early adulthood each predict asthma onset during mid-
adulthood. Evidence for these associations appears to be stronger among women than men. 
After adjustment for adversities in other domains, material adversities during transition and 
early adulthood each predict asthma onset. Associations with occupation-related adversities 
Chapter 2: Psychosocial predictors of asthma onset             72 
 
 
are only statistically significant for men during transition, but trends are consistently 
positive. 
Overall, evidence of associations is slightly stronger for women than men. This is expected, 
as a higher proportion of women than men reported asthma onset during mid-adulthood. 
Table 2.9: Odds ratios for asthma onset contingent upon adversity in various domains, 
with mutual adjustment and adjustment for gender, for men and women together and 
separately 
 Models 
 Men & women (n=14,109) Men (n=7,241) Women (n=6,868) 
Variable Transition 
Early 
adulthood Transition 
Early 
adulthood Transition 
Early 
adulthood 
           
Female 1.610 1.818     
 1.174-2.208 1.351-2.447     
 0.004 0.000     
             
Material 1.791 1.531 1.708 1.739 1.816 1.398 
 
1.274-2.517 1.058-2.216 1.019-2.856 1.017-2.974 1.249-2.642 0.905-2.160 
 
0.002 0.029 0.048 0.048 0.003 0.138 
            
Occupation-
related 
1.368 1.201 1.552 1.342 1.252 1.087 
0.987-1.896 0.862-1.675 1.029-2.341 0.866-2.079 0.842-1.860 0.720-1.641 
 
0.067 0.286 0.039 0.194 0.272 0.695 
            
Family and 
relationships 
1.202 1.492 1.095 1.368 1.247 1.565 
0.880-1.642 1.104-2.015 0.589-2.034 0.885-2.114 0.871-1.785 1.109-2.208 
 
0.252 0.012 0.776 0.164 0.232 0.013 
            
Child loss 2.420 1.101 2.540 0.807 2.374 1.283 
 
1.276-4.588 0.782-1.550 1.006-6.416 0.475-1.370 1.183-4.767 0.898-1.833 
 
0.011 0.583 0.054 0.430 0.021 0.176 
            
Trauma  2.333  1.981   2.792 
 
 1.390-3.916  0.976-4.018   1.463-5.328 
 
 0.002  0.064   0.003 
These are results from six models with asthma onset as the outcome, predicted by adversity in each 
domain with mutual adjustment and gender, as appropriate. Binary variables are used to indicate 
exposure to one or more adversity in each domain. ORs of asthma onset are presented, with 95% 
confidence intervals below, and p-values below these. Results in bold font are statistically significant 
with p-values<0.05. 
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RQ2: What confounding and mediating factors explain the association between 
childhood adversity and adult onset asthma? 
Results of bi-variate analyses presented in Table 2.10 found that both childhood adversity 
and asthma onset were associated with internalising temperament, occupational exposures 
up to age 33, smoking at 23 and 33, depressive symptoms at 23 and 33 and with adversity 
during transition and early adulthood. Maternal bleeding after 28 weeks of pregnancy, 
maternal smoking during pregnancy, low birthweight and not having been breastfed each 
predicted childhood adversity but not asthma onset. Childhood adversity was associated 
with early respiratory infections, parental smoking, more older children in the household 
during childhood and urban industrialised residence at age 33, but these factors did not 
predict asthma onset. 
Of the variables associated with both childhood adversity and asthma onset, there was 
evidence from KHB tests of attenuation of the association between childhood adversity and 
asthma onset by adversities and depressive symptoms during transition and early 
adulthood.  
KHB tests report changes in ORs for asthma onset contingent on childhood adversity 
attributable to dropping variables. After adjustment for gender, subsequent adversity and 
depressive symptoms during the other life stage, KHB tests find that changes in ORs of 
asthma onset contingent on childhood adversity attributable to dropping depressive 
symptoms at ages 23 and 33 are 1.002 (95%CI=-0.994-1.012) p=0.534, 1.012 (95%CI=-1.004–
1.021) p=0.004, respectively. This indicates that depressive symptoms at age 33 as opposed 
to age 23 are the more salient mediator of associations between childhood adversity and 
asthma onset, after adjustment for adversity after childhood.  
Chapter 2: Psychosocial predictors of asthma onset             74 
 
 
Table 2.10: Attenuation of association between childhood adversity and asthma onset during mid-adulthood for men and women together 
 
Estimated associations between each hypothesised attenuator 
and: 
Estimated associations between childhood adversity and 
asthma onset 
 Asthma onset Childhood adversity As each variable added 
Change in OR due to 
attenuation 
Hypothesised attenuators OR 95% ci p-val OR 95% ci p-val OR 95% ci p-val OR 95% ci p-val 
None (baseline)         1.263 1.112-1.434 0.001     
Hypothesised confounders                 
Internalising temperament 1.506 1.050-2.160 0.031 0.880 0.808-0.959 0.004 1.269 1.117-1.443 0.001 0.997 0.994-1.001 0.109 
Bleeding < 28 weeks 0.860 0.394-1.880 0.708 0.946 0.811-1.102 0.477         
Bleeding > 28 weeks 1.108 0.821-1.496 0.504 1.144 1.072-1.221 0.000         
Albuminaria 1.212 0.806-1.822 0.359 1.107 0.991-1.237 0.075         
Maternal smoking pregnancy 1.298 0.991-1.702 0.064 1.406 1.325-1.491 0.000         
Low birthweight 1.427 0.853-2.387 0.185 1.475 1.307-1.665 0.000         
Breastfed 0.895 0.703-1.141 0.374 0.770 0.716-0.829 0.000         
Hypothesised mediators                 
Atopic history 1.875 1.438-2.445 0.000 1.053 0.984-1.127 0.141         
Pneumonia by age 7 1.533 0.772-3.044 0.229 1.475 1.249-1.742 0.000         
Parental smoking 1.298 0.991-1.702 0.064 1.406 1.325-1.491 0.000         
Older children in household 0.948 0.836-1.075 0.410 1.200 1.163-1.238 0.000         
Urban residence at 23 1.300 0.911-1.855 0.158 1.398 1.257-1.554 0.000         
Occupational exposures 1.217 1.010-1.465 0.045 1.279 1.232-1.329 0.000 1.246 1.097-1.416 0.002 1.013 1.000-1.027 0.065 
Smoking at 23 1.263 1.010-1.580 0.044 1.625 1.502-1.758 0.000 1.252 1.098-1.428 0.002 1.008 0.993-1.024 0.287 
Smoking at 33 1.300 1.031-1.638 0.030 1.658 1.554-1.768 0.000 1.250 1.092-1.430 0.003 1.010 0.993-1.028 0.242 
Obesity at 23 1.251 0.574-2.726 0.576 1.360 1.050-1.761 0.025         
Obesity at 33 1.193 0.808-1.761 0.380 1.067 0.962-1.184 0.223         
Depressive symptoms at 23 1.134 1.093-1.177 0.000 1.106 1.094-1.118 0.000 1.190 1.037-1.366 0.020 1.047 1.024-1.070 0.000 
Depressive symptoms at 33 1.156 1.119-1.195 0.000 1.094 1.081-1.108 0.000 1.168 1.026-1.331 0.026 1.059 1.041-1.077 0.000 
Adversities during transition 1.583 1.373-1.826 0.000 1.620 1.560-1.681 0.000 1.158 1.014-1.323 0.039 1.076 1.045-1.107 0.000 
Adversities early adulthood 1.405 1.199-1.647 0.000 1.439 1.383-1.498 0.000 1.200 1.057-1.362 0.009 1.047 1.020-1.075 0.001 
These are results from 51 models, estimated for 14,109 respondents; 21 estimating bi-variate associations between each hypothesised attenuator and asthma onset (ORs refer 
asthma onset contingent upon each hypothesized attenuator); 21 more with childhood adversity (ORs refer to childhood adversity contingent upon each hypothesized attenuator). 
Nine models estimated associations between childhood adversity and asthma onset adjusted for gender (ORs of asthma onset contingent upon childhood adversity), the first as a 
baseline model, with eight additional models each including one hypothesised attenuating variable. Changes in ORs as hypothesised attenuators are added are estimated using the 
KHB method, described in the text. Evidence statistically significant at 95% level is in bold font.
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RQ3: What combination of factors best predict asthma onset during mid-adulthood?  
The first set of columns in Table 2.10 indicate that asthma onset is predicted by internalising 
temperament during childhood, atopic history, urban industrialised residence, occupational 
exposures, and depressive symptoms at 23 and 33. Table 2.7 indicates that gender and 
adversity over the life-course and during each life stage predict asthma onset. Adversities 
over the life-course are used as a single predictor of subsequent asthma onset because 
results relating to RQ1c indicate that this measure is a parsimonious and accurate predictor 
of asthma onset.  
Table 2.11 presents results when these variables are included in a single model as predictors 
of asthma onset. After mutual adjustment, asthma onset during mid-adulthood is predicted 
by female gender, life-course adversity, atopic history, internalising temperament and 
depressive symptoms at age 33. 
Table 2.11:   ORs for asthma onset contingent upon predictors in a single model with 
mutual adjustment using the whole sample 
Variables OR 95% ci p-value 
The model was 
estimated using 20 
datasets with 
imputed values and 
14,109 observations. 
 
Female 1.519 1.146 2.014 0.005 
Life-course adversity (0-33) 1.139 1.043 1.244 0.007 
Urban industrialised residence at 23 1.181 0.814 1.713 0.386 
Occupational exposures 1.115 0.931 1.334 0.243 
Atopic history 1.709 1.300 2.248 0.000 
Internalising type 1.513 1.035 2.213 0.038 
Depressive symptoms at 23 1.020 0.970 1.072 0.448 
Depressive symptoms at 33 1.105 1.063 1.149 0.000 
F-statistic 13.381    
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Table 2.12 presents F-statistics and the results of Wald tests as variables were dropped from 
this model. The first model in the table, the full model, is the same as the model presented 
in Table 2.11. Subsequent models (specifications 1-8 in the top row of Table 2.12) drop one 
variable at a time. The model selected as the most accurate and parsimonious on the basis 
of high F-statistic and high p-value from the Wald test drops urban industrialised residence 
at age 23. This specification is the new ‘full’ model from which additional variables are 
dropped. The following ‘full’ model excludes depressive symptoms at age 23, and the third 
excludes occupational exposures. All remaining variables independently predicted asthma 
onset and were retained in the final model. This specification includes female gender, life-
course adversity, atopic history, internalising temperament during childhood and depressive 
symptoms at age 33 as predictors of asthma onset during mid-adulthood. These are the 
variables that predict asthma onset in the original model presented in Table 2.11. 
9.1.2 Sensitivity analyses 
Sensitivity analyses produced similar results. Details are presented in Appendices 7-9. 
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Table 2.12:   Comparison of different models estimated to predict asthma onset during mid-adulthood, estimated for men and women together 
  Eight models with one variable dropped      
Specifications Full 1 2 3 4 5 6 7 8 
    Female + - + + + + + + + 
    Life-course adversity (0-33) + + - + + + + + + 
    Urban industrialised at 23 + + + - + + + + + 
    Occupational exposures + + + + - + + + + 
    Atopic history + + + + + - + + + 
    Internalising type + + + + + + - + + 
    Depressive symptoms at 23 + + + + + + + - + 
    Depressive symptoms at 33 + + + + + + + + - 
    F-statistic 13.38 14.17 14.83 15.66 14.72 13.40 14.58 15.17 11.97 
    Wald test p-value  0.005 0.007 0.386 0.243 0.000 0.038 0.448 0.000 
    
    
Seven models with two variables dropped Six models with three variables dropped   
Specifications 1 2 3 4 5 6 7 1 2 3 4 5 6 
Female - + + + + + + - + + + + + 
Life-course adversity (0-33) + - + + + + + + - + + + + 
Urban industrialised at 23 - - - - - - - - - - - - - 
Occupational exposures + + - + + + + + + - + + + 
Atopic history + + + - + + + + + + - + + 
Internalising type + + + + - + + + + + + - + 
Depressive symptoms at 23 + + + + + - + - - - - - - 
Depressive symptoms at 33 + + + + + + - + + + + + - 
F-statistic 16.93 17.87 17.66 16.05 17.45 18.24 14.25 20.23 20.83 21.03 19.16 20.86 14.62 
Wald test p-value 0.005 0.005 0.269 0.000 0.039 0.448 0.000 0.005 0.002 0.264 0.000 0.039 0.000 
                Five models with four variables dropped 
Specifications 1 2 5 6 8 + indicates that the variable is included in each model  
and – indicates that the variable is dropped from the model. 
High F-statistics indicate accuracy of fit between the data 
and the specification given the number of parameters, 
and p-values from Wald tests indicate the probability that 
asthma onset is predicted equally well by the reduced 
model compared against the full model that includes all 
variables. All models are estimated using 20 imputed datasets  
with 14,109 respondents. 
Female - + + + + 
Life-course adversity (0-33) + - + + + 
Urban industrialised at 23 - - - - - 
Occupational exposures - - - - - 
Atopic history + + - + + 
Internalising type + + + - + 
Depressive symptoms at 23 - - - - - 
Depressive symptoms at 33 + + + + - 
F-statistic 24.41 24.84 22.75 24.81 17.20 
Wald test p-value 0.008 0.001 0.000 0.047 0.000 
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5. Discussion 
As set out in the introduction, this chapter provides evidence about the psychosocial 
pathways through which asthma develops during mid-adulthood within the context of the 
model set out in Figure 2.1. It uses large-scale prospective life-course data that include a 
broad range of adversities and contextualising factors as well as substantial numbers 
reporting asthma onset. The evidence provided is comprehensive and detailed and many 
findings are new. 
5.1 Discussion of findings 
Main findings 
For respondents with no history of asthma by age 33, adversities during childhood, 
transition and early adulthood are associated with substantial increases in the risk of 
developing asthma during mid-adulthood, that is, between ages 33 and 42. These 
associations do not differ by gender, atopic history, or internalising temperament. 
Adversities over the life-course combine cumulatively with an OR of 1.232, 95%CI=1.140-
1.332, p=0.000 for each additional adversity during childhood and adversity within each 
domain during transition and early adulthood. The maximum value of seven or more is 
associated with a very substantial increase in the risk of asthma onset during mid-
adulthood; the OR of asthma onset contingent upon maximum exposure as opposed to 
none is 4.26. 
New evidence is provided through comparison of the importance for asthma onset of 
different types of adversity. After mutual adjustment for material, occupation-related, 
relationship-related and child loss adversities, adversities that predict asthma onset during 
transition are material adversities and adversities associated with child loss. After mutual 
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adjustment, adversities that predict asthma onset during early adulthood are those 
associated with material pathways, relationship difficulties and trauma. The importance of 
non-material adversities as predictors of asthma onset after mutual adjustment indicates 
the relevance of psychosocial pathways in the development of asthma. They appear to be 
more salient predictors of asthma for women than for men. 
Mediation of associations between childhood adversity and adult onset asthma has not, to 
my knowledge, been examined before. The findings suggest that the association between 
childhood adversity and asthma onset decades later is mediated by adversities after 
childhood and depressive symptoms. Mediation by depressive symptoms suggests a 
psychosocial pathway, most simply explained by adversity leading to the development of 
depressive symptoms, which in turn increase risk of asthma onset.  
When all predictors of asthma onset are included in a single model, the salient predictors of 
asthma onset are female gender, internalising temperament during childhood, life-course 
adversity, history of eczema or hay fever, and depressive symptoms shortly before asthma 
onset. 
RQ1: Do life-course adversities predict onset of asthma during mid-adulthood? 
Findings that adversity during each life stage predicts asthma onset during mid-adulthood 
are consistent with existing evidence, and the magnitudes of associations are comparable. 
Lietzen et al. (2011) reported roughly doubled odds for asthma onset during adulthood 
contingent upon high as opposed to low levels of adversity during the previous five years, 
which is consistent with my findings that exposures in each additional domain (up to five) 
during early adulthood were associated with increased odds by 43%. Scott et al. (2008) 
reported that exposure to two as opposed to no childhood adversities was associated with 
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an OR for asthma onset of 1.49, which is consistent with my finding that each additional 
childhood adversity is associated with an OR for asthma onset of 1.21, or 1.42 for two 
adversities. My results add to the small evidence base that exposures to life-course 
adversities are associated with substantial increases in the risk of developing asthma during 
adulthood, and suggest that the association is graded as opposed to a threshold effect. 
The very substantial association between total life-course adversity and asthma onset 
during mid-adulthood is an indication of the importance of environmental factors in the 
development of asthma during adulthood. The magnitude of the association is greater than 
magnitudes reported in previous studies, presumably because in this study, measures of 
adversity are comprehensive and encompass the whole life-course. 
This chapter provides no evidence that associations between adversity and asthma onset 
are modified by gender, history of other atopic conditions or internalising temperament 
during childhood. Other studies report no evidence of gender differences in associations 
between adversity and asthma onset (Lietzen et al. 2011, Rod et al. 2012), and no evidence 
of differences by history of hay fever (Lietzen et al. 2011). No studies that I am aware of 
have examined the importance of internalising temperament as a moderator of the 
association between adversity and asthma onset.  
I am not aware of studies that have examined the relative contributions to adult onset 
asthma of adversity during different life stages. The approach taken in this chapter was to 
compare how well different life-course models described the data, assuming that adversities 
were equivalent during each life stage. This assumption is questionable because the 
comprehensiveness of adversities differed between life stages as trauma was measured 
during early adulthood but not during transition. In addition, the same adversity may have 
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different meanings depending upon the life stage when it is experienced. For example, 
partnership breakdown may be experienced differently during transition and early 
adulthood. These differences complicate interpretation of results. In illustration, the strict 
accumulation model was selected in the chapter. If adversities were measured more 
comprehensively during early adulthood than during transition, then a different model 
might better describe how adversities that are truly equivalent to one another combine over 
the life-course to predict asthma onset. This could be the relaxed accumulation with a 
higher coefficient for adversities during transition than for adversities during early 
adulthood.  
Findings that adversity during each life stage independently contributes to asthma onset 
during mid-adulthood may be less affected by differences between life stages in the 
meanings and measurement of adversities than if a different life-course specification had 
been selected. For example, interpretation would have been more problematic if the results 
had indicated that adversities during one life stages mattered more than others. 
The life-course model selected suggests that adversities during each life stage contribute to 
the risk of adult onset asthma and that this risk is cumulative. The finding resonates with 
evidence that adversities and low socio-economic position (SEP) combine over the life-
course in a cumulative way to predict dysregulation across multiple physiological systems, 
including the immune system (Singer & Ryff 1999, Hale 2004, Gustafsson et al. 2011, 
Gruenewald et al. 2012).  
As with comparisons between adversities during different life stages, comparisons between 
domains of adversity are complicated because measures differ in terms of 
comprehensiveness and the severity of adversities included. For example, during transition 
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there are only two measures of material adversity but four measures of adversities 
associated with relationships and family.  
Not forgetting this caveat, there is evidence that after adjustment for material and 
occupation-related adversities, social adversities (family and relationship-related, child loss-
related and traumatic) predict asthma onset during mid-adulthood. This is consistent with 
the argument that intense and/or chronic psychological stress has physiological correlates 
that increase the risk of immune dysregulation resulting in biological hypersensitivity to 
environmental stimuli and the development of asthma (Wright et al. 2005). 
Material adversities during both transition and early adulthood were also salient predictors 
of adult onset asthma. This is consistent with evidence that asthma onset and prevalence 
during adulthood are inversely correlated with SEP (Basagna et al. 2004, Simpson & Sheikh 
2010).  
During early adulthood, adversities associated with family and relationships and traumatic 
events predicted asthma onset. In contrast, it is during transition that child loss is salient for 
asthma onset during mid-adulthood.  The greater importance of child loss during transition 
than during early adulthood may reflect differences in the prevalence of child loss during 
each life stage, and the availability of resources to cope effectively. Based on multiple 
datasets with imputed values, 3% (494) respondents during transition reported child loss 
compared to 21% during early adulthood.  
Although gender did not moderate associations between total adversity and asthma onset, 
there is an indication of gender differences in the types of adversities that are most salient. 
After mutual adjustment, material adversities predicted asthma onset for both men and 
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women, but occupational adversities appeared more salient for men. In contrast, family and 
relationship-related adversities during early adulthood predicted asthma onset among 
women but not men. The importance of family and relationship-related adversity for 
women is consistent with evidence that breaking a life partnership during the previous eight 
years predicted asthma onset for women but not men (Loerboks et al. 2009). It is also 
consistent with evidence that women suffer more psychological distress than men following 
multiple partnership transitions (Willits et al. 2004).  
RQ2: What confounding and mediating factors explain the association between 
childhood adversity and adult onset asthma? 
In order to identify the factors that confounded or mediated the association between 
childhood adversity and adult onset asthma, bi-variate associations were estimated 
between hypothesised variables and both childhood adversity and adult onset asthma. 
Nineteen variables were considered and 38 associations tested. Given that the level of 
statistical significance was <0.05, two of the associations would be statistically significant by 
chance. The use of KHB tests of attenuation for the seven variables that were correlated 
with childhood adversity and asthma onset adds credibility to the findings. 
The association between childhood adversity and asthma onset during mid-adulthood was 
explained by subsequent adversity and depressive symptoms. These are new findings, 
consistent with evidence that depressive symptoms predict adult onset asthma (Chida et al. 
2008, Loerbroks et al. 2010, Scott et al. 2008).  
Evidence that depressive symptoms mediated associations between childhood adversity and 
asthma onset decades later indicates the importance of psychosocial pathways in the 
development of asthma during adulthood. It suggests that depressive symptoms are a 
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marker of processes that contribute to the development of asthma during youth and 
adulthood. Authors suggest that depression affects inflammation via pathways similar to 
those involved in the stress response, involving the hypothalamic-pituitary-adrenal axis and 
the autonomic nervous system (Martinac et al. 2014, Penninx et al. 2013). This could result 
in hypersensitivity to environmental stimuli and the development of asthma (Wright et al. 
2005). 
I found no evidence that associations between childhood adversity and asthma onset were 
attenuated by many hypothesised variables, and those that mediated the association only 
did so partially. Other studies similarly report that associations between adversity and adult 
onset asthma are not fully explained by similar variables (Lietzen et al. 2011, Loerbroks et al. 
2009). Lack of attenuation may reflect measurement error in the hypothesised attenuating 
variables tested. For example, lifetime exposure to environmental pollution was measured 
imprecisely by residence in an urban industrialised area at one point in cohort members’ 
lives. Moreover, many factors that plausibly explain the association were not included, for 
example, parental history of asthma.  
RQ3: What combination of factors best predict asthma onset during mid-adulthood?  
After mutual adjustment for a wide range of factors, salient predictors of adult onset 
asthma were female gender, atopic history, internalising temperament, life-course 
adversity, and depressive symptoms shortly before onset. This highlights the importance of 
social and psychological factors in the development of asthma during adulthood. 
Other evidence suggests that exposures to adversity (Lietzen et al. 2011, Loerbroks et al. 
2009, Loerbroks et al. 2010, Scott et al. 2008), and depressive symptoms (Chida et al. 2008, 
Loerbroks et al. 2010, Scott et al. 2008) predict adult onset asthma. These results add to this 
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evidence. Further, they indicate that adversity over the life-course and depressive 
symptoms shortly before asthma onset are particularly salient predictors, even after mutual 
adjustment, and adjustment for a comprehensive range of co-variates. 
Depressive symptoms at age 33 were also the most salient mediator of the association 
between childhood adversity and asthma onset shortly afterwards. The findings are new 
and very intriguing. They may reflect associations between depressive symptoms and 
inflammation that precedes asthma diagnosis. This is consistent with the inflammatory 
theory of depression (Smith 1991, Miller & Raison 2016) and with epidemiological evidence 
of small associations between depressive symptoms and chronic low-grade inflammation 
(Howren et al. 2009). 
Another new and intriguing finding is that internalising temperament during childhood 
predicts asthma onset during adulthood, after adjustment for a range of other factors 
including atopic history and depressive symptoms. Possible explanations for the association 
are (1) that internalising temperament reflects atopic vulnerability, and (2) that internalising 
temperament predicts depressive symptoms, which increase risk of asthma onset. However, 
the association is robust to adjustment for both atopic history and life-course depressive 
symptoms. A third explanation is that internalising temperament predicts anxiety (Dingle et 
al. 2011, Gander & Buchheim 2013) and anxiety is associated with asthma onset (Scott et al. 
2008 report trends that were not statistically significant). It may be that internalising 
temperament is a more accurate predictor than depressive symptoms of the types of 
anxiety that contribute to asthma onset during adulthood.  
Regardless of the explanations, this finding is not backed up by other studies (since they do 
not exist) and could be specific to this dataset. Existing evidence uses measures of 
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internalising behaviours, which combine internalising type response with level of mal-
adaption. Studies report cross-sectional correlations between internalising behaviours and 
childhood asthma (Annesi-Maesano et al. 2013), but no evidence that internalising 
behaviours predict subsequent asthma onset (Alati et al. 2005). 
Female gender and atopic history predicted asthma onset. This was expected as there is 
consistent evidence that adult onset asthma is more common among women than men 
(Simpson & Shiekh 2010) and among adults who have a history of other atopic conditions 
(Han et al. 2017, Dharmage et al. 2014, Zheng et al. 2011). 
Assessing the relative salience of variables as predictors of asthma onset using a single 
model with mutual adjustment, such as the model presented in Table 2.11 is complicated by 
differences between variables in the accuracy and comprehensiveness of their 
measurement, and by correlations between predictors. For example, neither urban 
industrialised residence nor occupational exposures predicted asthma onset after mutual 
adjustment, and this probably reflects correlations between these two factors and life-
course adversity. This difficulty is partly addressed by the analyses presented in Table 2.12, 
in which variables are dropped one at a time from the full model. The results using this 
method were the same. Given evidence that exposure to air pollutants contributes to the 
development of asthma (Schmitz et al. 2012, Lillienberg et al. 2013, Ghosh et al. 2013), my 
interpretation of the final model is that life-course adversities proxy for these exposures as 
well as measuring other factors such as stress-inducing adversities that are important 
predictors of adult onset asthma. 
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5.2 Strengths and limitations 
Strengths of this study are that it uses prospective life-course data, and consequently 
provides evidence relevant to causality. The sample is large, and multiple imputation 
increases its power and reduces bias. Rates of asthma incidence (4.3 per 1,000 per year) are 
equivalent to those reported in a study using a large sample of English medical records 
(Simpson & Sheikh 2010). Simpson & Sheikh (2010) reported incidence rates of 5.3 per 1,000 
per year, which is slightly higher, but reflects a younger age range (15-44 as opposed to 33-
42) as incidence rates of asthma are higher during transition. A comprehensive range of 
adversities and other predictors are included. The results are robust to sensitivity analyses 
that use alternative measures of asthma onset and childhood adversity, and the observed 
dataset. 
The study is also subject to limitations. Firstly, findings relate to individuals born in mainland 
Britain in 1958, and I cannot be sure to what extent they apply to other populations. 
Second, long gaps between data collection mean that much information depends upon 
recall, which could be biased by factors relating to asthma onset, such as emotional and 
physical wellbeing. Third, comprehensive information was not available for many measures. 
In particular, I was unable to measure parenting quality, which is critical for assessment of 
the impacts of childhood adversities (Shonkoff et al. 2012). Neither was information 
available about several variables thought to predict asthma onset; family history of atopic 
conditions (Viegi et al. 2003, National health Service 2014), maternal stress during 
pregnancy (De Marco et al. 2012, Khashan et al. 2012), and living in damp housing (Schmitz 
et al. 2012). Fourth, the measures of cumulative exposure to adversity assume that each 
adversity, or adversities in each domain, has equal importance. This is unlikely to be true, 
although reviews of evidence about the value of combining life events using differential 
weightings suggest that these do not add to their accuracy in predicting outcomes 
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(Zimmerman 1983, Turner & Wheaton 1995). Fifth, comparisons are made between 
adversities by life stage and type, and results may be affected by differences in the 
comprehensiveness, precision and accuracy of measures. 
A final caveat is that many correlations were tested using the conventional but arbitrary cut 
point for statistical significance of 0.05%. If no correlations existed, the results of one in 
twenty tests would, on average, attain this level of statistical significance. This should be 
borne in mind when interpreting findings as some of the correlations, especially those not 
backed up by other evidence, may reflect patterns specific to the sample used. I have more 
confidence in findings that are consistent with existing evidence. 
5.3 Conclusions and implications 
This chapter provides evidence that suggests the importance of psychosocial pathways for 
asthma onset during mid-adulthood. It is a very comprehensive study and includes good 
measures of asthma onset, a wide range of adversities and a well-validated measure of 
depressive symptoms, with measures on multiple occasions throughout the life-course. 
Evidence about the importance for adult onset asthma of adversities is very limited and this 
chapter makes an important contribution. It adds new evidence about how adversities 
during different life stages combine to predict asthma onset, about the relative importance 
for adult onset asthma of different types of adversity, and about the factors that mediate 
the association between childhood adversity and asthma onset decades later. Evidence that 
depressive symptoms predict adult onset asthma is not new, but the chapter adds new 
evidence about when in the life-course depressive symptoms are most salient for asthma 
onset. 
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Adversities combine cumulatively over the life-course to predict risk of asthma onset during 
mid-adulthood. The magnitude of the association is substantial; maximum as opposed to no 
adversity is associated with a more than four-fold increase in the odds of asthma onset.  This 
indicates the importance of environmental factors in the development of asthma during 
adulthood. 
Psychosocial pathways involve psychological responses to social exposures. The importance 
for adult onset asthma of social adversities is indicated by new evidence that associations 
between asthma onset and social adversities relating to relationship difficulties, child loss 
and trauma are robust to adjustment for material and occupation-related adversities. 
Moreover, the correlation between childhood adversity and asthma onset decades later is 
partially mediated by depressive symptoms, suggesting a psychosocial pathway. Finally, 
after adjustment for a wide range of carefully chosen factors, life-course adversity (which 
includes social exposures) and depressive symptoms (psychological response) each predict 
asthma onset. 
Whilst previous studies have found that depressive symptoms predict asthma onset, 
evidence presented here indicates for the first time that it is shortly before onset that 
depressive symptoms are salient. This small but consistent association may reflect changes 
in immunological activity that precede asthma diagnosis and have implications for affective 
states.  In addition, and consistent with evidence that depressive symptoms mediate 
associations between exposures to childhood adversity and asthma onset, depressive 
symptoms may reflect psychological experiences of stress (in response to social adversities) 
that influence immunological function in ways that contribute to asthma risk. The 
association between depressive symptoms and asthma onset shortly afterwards, if 
replicated, could be used to facilitate early diagnosis and treatment of asthma.  
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These findings beg questions about how social conditions and affective states are involved 
in the development of asthma, and whether there may be a role for psychological as well as 
pharmacological interventions in its prevention and treatment. They highlight the 
importance of psychosocial pathways in the development of asthma during adulthood, and 
the need for more research in this area. 
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Chapter 3: Does adversity predict onset of rheumatoid 
arthritis? Do psychosocial pathways play a role? 
1. Introduction 
This chapter examines relationships between adversities during childhood, transition to 
adulthood and adulthood and subsequent onset of rheumatoid arthritis (RA).  
In this context, I provide new evidence about whether psychosocial mechanisms contribute 
to the development of RA. As mentioned before, psychosocial mechanisms involve 
psychological responses to social exposures. I hypothesise that three interlinked pathways 
contribute over the life-course to the development of rheumatoid arthritis; material, 
behavioural and psychosocial. The importance for RA onset of social adversities is tested 
with adjustment for adversities such as financial hardship that are likely to be associated 
with material pathways. If correlations exist after further adjustment for smoking, this is 
consistent with the hypothesis that psychological factors mediate associations between 
social adversities and asthma onset, reflecting a psychosocial pathway. Additional analyses 
examine whether some types of social adversity are more salient for RA onset than others; 
family-related adversities and traumas, and chronic and acute adversities. 
The introduction describes RA and its importance for public health, and summarises what is 
known about its epidemiology, with a focus on psychosocial factors. A model is presented 
that describes how adversities over the life-course might contribute to RA onset. The 
research questions are set out at the end of the introduction. 
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1.1 Rheumatoid arthritis 
1.1.1 Why is it important to understand the causes of rheumatoid arthritis? 
RA is a relatively common chronic inflammatory disease that is classified as autoimmune 
(Aletaha et al. 2010). Like most diseases of this type, its causes are not understood. Its 
impacts include the direct costs of health care and associated services (Maravic 2010), 
indirect costs to the economy including lost productivity (Filipovic et al. 2011), early 
mortality (John 2012), and the impacts of RA and its complications on people with the 
condition and their families. RA has been described as one of the diseases associated with 
poorest quality of life (Furneri et al. 2012). NICE (2009) states that in the UK approximately 
one third of people with RA stop work within two years of its onset. They add that the total 
annual cost of RA in the UK, including indirect costs, is estimated to lie between £3.80 and 
£4.75 billion. This chapter provides evidence that contributes to understanding about why 
RA develops. The findings indicate whether further research about the social and 
psychological determinants of RA onset – and possibly onsets of other immune-mediated 
conditions – will be fruitful. Robust and detailed evidence can be used to inform public 
health policies aimed at prevention of RA and to facilitate its early diagnosis. This is 
important because early and effective treatment affects the subsequent course of the 
disease (Aletaha et al. 2010, Niu & Chen 2014).  
1.1.2 Description of rheumatoid arthritis 
RA is a disease that is driven primarily by dysregulation of the immune system. This 
dysregulation leads to chronic inflammation and damage of connective tissues in the joints. 
RA is chronic and relapsing, that is, it is a condition that people do not recover from but one 
that is characterised by periods of remission. Damage to the joints caused by RA activity is 
irreversible and progressive. The most common symptom of RA is pain and stiffness in 
Chapter 3: Adversities and onset of rheumatoid arthritis             93 
 
 
 
affected joints, often in the hands and feet. Other symptoms include inflammation around 
the tendons, muscle pain, anaemia, fatigue, poor sleep, fever, malaise, weight loss and the 
development of small, painless, harmless nodules on the skin. The disease is systemic; it can 
affect any part of the body, including internal organs and tissues such as the lungs, heart, 
blood vessels and eyes. RA may develop very fast and so, as mentioned above, early 
diagnosis coupled with effective treatment is important for prognosis in terms of quality of 
life, joint damage, disability, and systemic complications. However, there is no definitive test 
for RA and it is difficult to diagnose in its early stages. 
Most people with RA have a protein in their blood called rheumatoid factor. Individuals with 
serum rheumatoid factor are referred to as seropositive, and those without it are referred 
to as seronegative. Between 50 and 70% people with RA are seropositive, whilst among 
healthy individuals, 2-10% are seropositive (Del Puente et al. 1988, Aletaha et al. 2010). 
Whilst rheumatoid factor is not specific enough to be particularly useful for diagnosis of RA, 
its presence or absence may indicate two types of RA (Sverdrup et al. 2005).  
1.2 Epidemiology of rheumatoid arthritis 
1.2.1 Prevalence and incidence rates of rheumatoid arthritis 
Reviews suggest that prevalence and incidence rates differ markedly between populations, 
with prevalence rates ranging from 0.2-0.3% in Japan and China to 6.8% among the 
Chippewa Indians, native to the US (Silman & Pearson 2002, Tobon et al. 2010). In 2009 in 
the UK, NICE (2009) reported that about 400,000 people have RA, with 12,000 developing it 
each year. The National Rheumatoid Arthritis Society (Panayi 2014) report a higher number 
of people with RA; 580,000 in England alone. These numbers are in line with estimated 
prevalence rates in the US, Canada and Western Europe of around 1% (Tidy 2015, Widdifield 
Chapter 3: Adversities and onset of rheumatoid arthritis             94 
 
 
 
et al. 2014, Tobon et al. 2010, AbdelNasser et al. 1997, Silman & Pearson 2002). Incidence 
rates in the US and Western Europe are estimated to lie between 0.25 and 0.60 per 1,000 
per year (Widdifield et al. 2014, Tobon et al. 2010, Aho et al. 1998, AbdelNasser et al. 1997). 
Tidy (2015) reports incidence rates in the UK of 0.15 per 1,000 annually for men and 0.36 
per 1,000 annually for women. 
There is mixed evidence concerning changes over time in prevalence and incidence rates of 
RA. Some studies and reviews suggest that in the US and Western Europe, incidence rates 
rose until the 1970s but fell subsequently, possibly due to increasing use of oral 
contraception and post-menopausal hormone therapies, which are thought to confer 
protection against progression and possibly onset (Linos et al. 1980, Hochberg & Spector 
1990). There is little evidence of changes in incidence rates since the 1990s in Western 
Europe or the US. For example, a recent large scale study using Canadian medical records 
reports that incidence rates hardly changed between 1996 (0.62 per 1,000 annually) and 
2010 (0.54 per 1,000 annually, Widdifield et al. 2014).  
1.2.2 Co-morbidity of rheumatoid arthritis with other health conditions 
Progression of RA is associated with increased susceptibility to a range of other serious 
conditions. These include artherosclerosis and cardiovascular disease (Ross 1999, Solomon 
et al. 2003), Felty’s Syndrome (Panayi 2013), lymphomas and lung cancer (John 2012), 
interstitial lung disease and pneumonia (Kelly 2011), osteoporosis (Litwic & Dennison 2011), 
vasculitis (Scott 2008), Sjogren’s Syndrome (or dry eyes) and other inflammatory eye 
disorders (Madgula & Jones 2010). Increased susceptibility to these conditions may reflect 
both shared disease processes and side effects of the drugs used to treat RA. Co-morbidities 
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with RA of several of these conditions, in particular cardiovascular diseases and cancers are 
associated with reduced life expectancy. 
Prevalence rates of additional conditions are associated with RA prevalence but not its 
progression, so it is less clear to what extent they are consequences or predictors of RA, or 
whether they share common vulnerabilites1. For example, type 1 diabetes and Hashimoto’s 
thyroiditis, which are autoimmune diseases (Somers et al. 2006), anxiety and depression 
(Covic et al. 2012), and periodontal disease (Smolik et al. 2009) are associated with 
increased rates of RA, whilst negative associations have been reported between RA and 
multiple sclerosis (Somers et al. 2006) and schizophrenia (Hochberg & Spector 1990).  
1.2.3 Demographic distribution of rheumatoid arthritis 
RA is more common among women than men. In the UK, the estimated ratio is between 
two and four to one (Tidy 2015). The gender difference may not be the same in all 
populations. For example, a recent study reports a four to one ratio of women to men with 
RA in Pakistan (Alam et al. 2011). 
Mean age of RA onset probably differs between populations, genders, and over time. 
However, onset appears to be most common among all populations during mid or late 
adulthood. The National Rheumatoid Arthritis Society reports that in the UK, RA onset is 
most common between 40 and 60 (Panayi 2014), although NICE (2009) report that peak 
incidence in the UK is during one’s 70s. A large study of white Caucasian women in the US 
estimated mean age of RA onset to be 55.2 years (Karlson et al. 2010), whilst in Pakistan, 
                                                          
1
 Co-morbidity of RA with other conditions may reflect common predictors, as well as RA being a 
cause or consequence of other conditions. It is likely that most co-morbidities reflect all three 
mechanisms. However, greater relative importance of RA as a cause of another condition is implied if 
the second condition is associated with RA progression. 
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mean age of onset was younger and differed by gender (38.5 for women, 44.8 for men, 
Alam et al. 2011). Finnish administrative data indicate that mean age of RA onset increased 
by 7.6 years from 50.2 years to 57.8 years between 1975 and 1990 (Aho et al. 1998). 
Evidence suggests that those who are socio-economically disadvantaged are at increased 
risk of developing RA. Large scale studies using Swedish administrative data report that 
adults with manual occupations, and adults with qualifications below degree level were at 
relatively high risks of developing RA (Bergstrom et al. 2011, Bergstrom et al. 2013, 
respectively). An earlier large population based case-control study of women in the US 
similarly found that those without a college education were more likely than those with one 
to develop RA (Voigt et al. 1994).  
1.2.4 Biological factors that predict onset of rheumatoid arthritis 
Epidemiological evidence suggests that there is a strong genetic component to RA onset. An 
early review of twin studies reported RA concordance levels between monozygous twins of 
12.3% in Finland and 11.1% in England, and concluded that while genetic factors predict RA 
onset, environmental factors are also of great importance (Hochberg & Spector 1990). 
Recent reviews estimate that genetic factors explain up to 60% of the risk of RA onset and 
identify specific genes that are associated with the condition (Oliver et al. 2006, Tobon et al. 
2010, Malysheva et al. 2010, Suzuki & Yamamoto 2015).  
There is some evidence that the gender bias in RA reflects (in part, at least) the involvement 
of sex hormones in the development and progression of RA. A systematic review concludes 
that sex hormones are associated with both progression and onset of RA (Malysheva et al. 
2010). For example, studies have found RA onset to be positively associated with early age 
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of menarche (before 13, Avila et al. 1990), late menarche (Deighton et al. 1993), and early 
menopause (by age 45, Pikwer et al. 2012). Reviews report that the risk of developing RA is 
reduced during pregnancy and increases immediately after giving birth, when levels of 
female sex hormones are changing rapidly (Lahiri et al. 2012, Silman & Pearson 2002). 
Associations with breastfeeding appear complex (Hoovestol & Mikuls 2011). Despite earlier 
suggestions that use of oral contraceptives and post-menopausal hormone replacement 
therapy reduce the risk of RA onset (Silman & Pearson 2002, D’Elia et al. 2003), more recent 
evidence suggests that use of oral contraceptives confers protection only against 
progression of the disease (Chen et al. 2014), and that use of post-menopausal hormone 
replacement therapy confers no protection at all (Lahiri et al. 2012). 
Reviews suggest that infections with particular viruses (Epstein-Barr virus and parovirus) and 
bacteria (proteus and mycoplasma) are associated with the development of RA (Malysheva 
et al. 2010, Silman & Pearson 2002). More recent studies provide additional evidence 
consistent with the involvement of bacterial infections in RA onset; in relation to proteus 
(Ebringer & Rashid 2014), which typically causes urinary tract infections and infections of 
wounds, mycoplasma (Ataee et al. 2015, Golmohammadi et al. 2014), which are a group of 
bacteria sometimes associated with pneumonia and sexually transmitted diseases, and 
porphymonas gingivalis, which is associated with periodontal disease (Smolik et al. 2009). 
However, a recent systematic review and meta-analysis found no evidence of an association 
between a history of infections with the Epstein-Barr virus and RA (Ball et al. 2015). 
1.2.5 Behavioural, material and psychosocial factors that predict RA onset 
Building on a conceptual framework used to explain socio-economic inequalities in health 
(Benzeval et al. 2014), I classify environmental factors that might contribute to the 
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development of RA as behavioural, material and psychosocial. While the importance of each 
group of factors for RA onset is examined, the focus of this chapter – and section –  is on 
psychosocial factors.  
Behavioural factors include smoking, drinking patterns, diet, and exercise. Evidence that 
smoking predicts RA onset seems consistent (Tobon et al. 2010, Lahiri et al. 2012). 
Systematic reviews also conclude that risk of RA onset is positively associated with obesity 
and high levels of coffee consumption, whilst moderate levels of alcohol consumption and a 
diet with plenty of antioxidants, fruit, vegetables and oily fish may be protective (Lahiri et al. 
2012, Hoovestol & Mikuls 2011, Tobon et al. 2010). 
Material factors that predict health outcomes have been classified as household factors, 
including housing quality and amenities, occupational factors, including unemployment and 
exposures to toxins at work, and neighbourhood factors, including exposure to air pollution 
and poor access to recreational areas (Benzeval et al. 2014). Few studies have examined the 
material factors that contribute to RA onset, although some studies report that risk of RA 
onset is higher among individuals living close to traffic, even after adjusting for economic 
deprivation (Hart et al. 2009, De Roos et al. 2014). These findings suggest that exposure to 
airborne traffic-related pollutants contributes to the development of RA, but there is no 
clear evidence about which pollutants are involved (Gan et al. 2013, Hart et al. 2013). There 
is also evidence that exposure to mineral oils, which are used in the motor industry and in 
manufacturing, predicts RA (Sverdrup et al. 2005). 
Psychosocial factors involve psychological responses to social exposures. Social exposures 
are circumstances and events that occur in the social world. These, in the context of the 
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psychosocial pathways that contribute to the development of RA onset, are the focus of this 
chapter. 
Psychological responses to social exposures may contribute to the development of RA 
through experiences of psychological stress, which is associated with physiological changes 
that could influence the onset and progression of RA (Huyser & Parker 1998, Li et al. 2005, 
Affleck et al. 1997, Zautra et al. 1997). As explained in Chapter 1, psychological feelings of 
stress are believed to evoke and reflect a set of common physiological responses (Selye 
1956). Chronic, repeated, and intense experiences of stress can result in lasting changes in 
the regulation and activity of multiple systems (McEwen & Seeman 1999) including 
uncontrolled inflammatory behaviours that contribute to the development of RA. 
Testing the importance of stress for poor health generally and RA in particular is less straight 
forward than testing the importance of material and behavioural factors. Material factors 
such as exposure to silica and behavioural factors such as smoking may not be easy to 
measure, but they are at least simple to conceptualise. In contrast, stress is a construct and 
it has been measured in various ways; using cortisol as a physiological marker of stress, 
perceived stress as an indicator of psychological stress, and life events and stressors as 
exposures likely to be experienced as stressful.  
I refer to life events and stressors as adversities, and use them to indicate stress. Adversities 
provide a measure of stress that has limited accuracy because stress arises not from adverse 
exposure alone but from the exposure in combination with the coping response to it. On the 
other hand, understanding relationships between adverse exposures and RA onset may be 
useful for policy makers and practitioners who are interested in preventing RA, especially if 
they can modify risk of exposure to adversity.  
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Early reviews of stress and RA reported that while some studies found evidence of 
associations between stressful exposures such as life events and RA onset, others did not 
(Koehler 1985, Huyser & Parker 1998). Subsequent studies using life events provide 
inconclusive evidence, and a recent study states that evidence about psychosocial factors as 
predictors of RA onset is both sparse and inconclusive (Wesley et al. 2014).  
A large Swedish population-based study (Wesley et al. 2014) included 2,774 adults with 
newly diagnosed RA, matched on sex, age, and area of residence with 3,911 controls. It 
found that slightly more adults with RA than controls (ORs 1.1-1.2) reported at least one life 
event during the previous five years. The association was statistically significant for men and 
women together and for women, but not for men. Life events that were particularly salient 
for RA onset were conflict at work, increased responsibility at work, change of work place, 
change of residence, and (during the three to five years before RA diagnosis) death of a child 
or spouse. Divorce, marriage, conflict with spouse, conflict with relative, disease or accident 
of a close relative or friend, death of a relative or friend, decreased responsibility at work, 
unemployment and impaired finances were not salient predictors of RA onset. 
Bengtsson and colleagues (2009) examined whether psychological stress at work is 
associated with increased risk of developing RA. They used data from a population-based 
case-control study of individuals aged 18-65 living in Sweden, with 1,221 incident cases of 
rheumatologist-diagnosed RA, and 1,454 controls, matched for age, sex, and area of 
residence. Job stress, defined as high demands combined with low decision latitude, was 
not associated with onset of RA. However, low decision latitude was positively associated 
with RA incidence, and there was some evidence that high levels of psychological work 
demands were associated with lower risk of RA onset.  
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An earlier, very large Danish study of 21,062 parents whose child had died before the age of 
18 between 1980 and 1996, matched on family structure with almost 300,000 controls 
found no difference in RA risk between bereaved and non-bereaved parents (Li et al. 2005). 
In the light of the evidence reported by Wesley and colleagues, this finding is rather 
surprising. It is possible that physiological responses to extremely traumatic adversities 
differ from responses to other types of adversity.  
A much smaller case-control study using retrospective data found no evidence that adverse 
exposures over the life-course predicted RA onset, although trends were in the expected 
direction (Carette & Surtees 2000). It included 55 adults with RA who were participants in a 
larger community-based study in the UK. Each was matched by age and gender with three 
controls. A wide range of adversities throughout the life-course were measured using 
retrospective data. The authors suggest that their results “hinted at possible relationships 
that for the most part fell short of statistical significance” (p.2128).  
In line with the earlier reviews (Koehler 1985, Huyser & Parker 1998), these studies provide 
evidence that RA onset is predicted by some but not all types of adversity. Huyser & Parker 
(1998) suggest that associations with adversities may depend on the chronicity and intensity 
of exposures, as well as perceived control over and affective responses to them.  
While this suggestion is both interesting and plausible, little evidence exists to test it. There 
is virtually no evidence about the relative importance for RA onset of chronic as opposed to 
acute adversities, social or material adversities or adversities experienced in different 
domains. Neither is there evidence about the relative importance for RA onset of adversities 
during different life stages. One aim of this chapter is to provide evidence to fill these gaps. 
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1.3 Model of how adversity may contribute to the onset of RA 
Figure 3.1 presents a model illustrating how exposures to adversities over the life-course 
might contribute to the development of RA. It is similar to that set out in Chapter 1. 
Adversities are classified as material and social. Material adversities include financial 
hardship and unemployment, and affect health through pathways involving material factors. 
For example, financial hardship may be associated with living in an area or working in an 
occupation that involves exposure to airborne pollutants, and these exposures may 
contribute to biological changes that increase risk of RA onset. Social adversities include 
relationship-related adversities, such as partnership breakdown or long-term caring for a 
relative, and traumatic adversities, such as being a victim of sexual assault or witnessing a 
death. These adversities affect health through psychological pathways involving stress. They 
may also affect self-efficacy, which is associated with the adoption of health-related 
behaviours and lifestyles (Ogden  2012).  
Social adversities may have material consequences, for example, relationship breakdown is 
associated with loss of income, especially among women (Jarvis & Jenkins 1997, Fisher & 
Low 2012). Conversely, material adversity is stressful and may contribute to RA onset for 
this reason.  
The combination of psychological stress, material factors and health-related behaviours 
contribute to sub-clinical biological changes that increase the risk of RA onset. 
As explained in Chapter 1, exposures to adversity occur during all life stages. People are 
exposed to different types and levels of adversity during each life stage, and the meanings 
and consequences of the same exposure may differ depending upon the life stage during 
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which it is experienced. Adversities earlier in the life-course predict subsequent adversity 
(Sampson & Laub 1997, Pearlin et al. 1997).  
Kuh et al. (2003) propose three life-course models that describe how exposures at different 
life stages combine to influence subsequent outcomes. The model of sensitive or critical 
periods applies when adversity during earlier life stages is particularly pertinent for RA with 
onset not immediately afterwards. For example, childhood adversity may have salience for 
the development of RA later in life because the immune system develops quickly during 
early life and so may be at its most sensitive to environmental exposures. If exposures to 
adversity during childhood have lasting impacts on the immune system, these could 
increase vulnerability to immune-mediated conditions such as RA, which might not develop 
until much later in the life-course. The chains of risk model describes outcomes that are 
predicted by exposures shortly before the outcome occurs. According to this model, RA with 
onset during mid-adulthood would be predicted by adversities experienced during early 
adulthood, but earlier exposures would not be directly (or independently) predictive. The 
third life-course model is the cumulative model, in which exposures during every life stage 
have an independent and cumulative impact on the outcome. This model would apply to RA 
onset if adversities experienced during childhood, youth, and early adulthood independently 
and cumulatively contributed to the dysregulations that ultimately result in RA onset during 
mid- and late adulthood. The models are not mutually exclusive and may apply in any 
combination. 
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Figure 3.1:   Model of how adversity may contribute to onset of RA 
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Personal, social and economic resources buffer the negative impacts of adversity. Personal 
resources include self-efficacy (Rutter 1987), optimism (Hobfoll, Semmer et al. 2005), 
problem solving skills (Rutter 1987, Semmer et al. 2005), and a trusting attitude (Semmer et 
al. 2005). Social and economic resources include social support (Pearlin 1999), social 
integration (Myers et al. 1975), education, income and assets, housing, and occupational 
status. In relation to childhood adversities, Shonkoff et al. (2012) argue that having available 
a supportive adult renders potentially toxic adversities tolerable. The role of resources as 
buffers of the negative impacts of adversity is central to theories of resilience (Rutter 1987, 
Schoon & Bynner 2003, Bartley 2006), coping (Lazarus 1966), and the stress process (Pearlin 
1999).  
The relationships described above may differ between men and women. Further, although 
not included in the model, factors such as gender, cohort of birth, viral exposures and 
female sex hormones may confound associations between adversity and RA onset. 
This research does not test every part of the model illustrated in Figure 3.1. It focuses on 
relationships between adversity and RA onset. 
1.4 Research questions 
Evidence about the importance of adversities for RA onset is sparse and inconclusive 
(Wesley 2014), and there is no evidence about how adversities combine over the life-course 
to predict RA onset. While it is likely that relationships between adversities and RA onset 
differ depending upon characteristics of the adversity (Huyser & Parker 1998), few studies 
have examined this hypothesis. Furthermore, very little evidence is available about how 
relationships between adversities and RA onset differ by gender. 
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Evidence about associations between RA onset and social adversities after adjustment for 
material adversities is relevant to whether psychosocial pathways contribute to RA onset. 
Additional adjustment for behavioural factors as mediators of these associations provides 
further evidence relevant to psychosocial pathways because if associations are fully 
mediated by behavioural factors, it is less likely that psychological factors play a mediating 
role. However, no studies that I am aware of have examined the factors that mediate 
associations between adversity and RA onset. 
As evidence in these areas would inform understanding about the importance of 
psychosocial pathways in the development of RA, the following RQs are addressed:  
1. Do adversities predict RA onset? 
a. Does the answer to this question vary by gender? 
2. How do adversities combine over the life-course to predict RA onset? 
a. Does the length of exposure matter? For example, does adversity that 
continues from childhood, through youth, early and mid-adulthood predict 
RA onset more strongly than the same adversity experienced during just 
one life stage? 
b. Does the life stage during which one is exposed matter? More specifically, 
what is the relative importance for RA onset of adversities during childhood, 
transition to adulthood, early and mid-adulthood? 
c. How do the answers to these questions vary by gender? 
3. Do material, psychosocial and behavioural factors independently predict RA onset? 
a. Do material and social adversities independently predict RA onset? 
b. Are any associations found explained by health behaviours? 
c. How do the answers to these questions vary by gender? 
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4. Are some types of social adversity more salient predictors of RA onset than others? 
a. Comparison of adversities in different life domains: relationship-related and 
traumatic adversities. 
b. Comparison of chronic and acute adversities. 
c. How do these comparisons differ between men and women? 
2. Data and measures 
2.1 The dataset 
Data from the English Longitudinal Survey of Ageing (ELSA) are used. This study is designed 
to represent people aged 50 and over living in private households in England. The sample 
was originally constructed from people aged 50 and over in March 2002, who had 
participated in one of three cross sectional waves of the Health Survey for England (HSE) 
conducted in 1998, 1999 and 2001. This sample is referred to as wave 0 and contains 
common variables from the three HSE studies. Members of wave 0 have been interviewed 
seven times subsequently, with responses from between just over 9,000 and 12,000 
participants (see Table 3.1). They exit from the sample when they die or move away from 
mainland Britain. See Appendix 10 for more details. 
Table 3.1:   Waves of data collection in ELSA 
Wave Years Number of observations 
0 1998, 1999, 2001 19,834 with common variables 
1 2002-2003 12,099 
2 2004-2005  9,432 
3 2006-2007  9,711 
3 Life history 2006-2007  7,833 
4 2008-2009 11,050 
5 2010-2011 10,274 
6 2012-2013 10,601 
7 2014-2015  9,666 
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Waves 1 to 7 contain comprehensive social, psychological, health and financial data. Wave 3 
included a separate interview in which retrospective life history data were collected. This 
interview is referred to as LIFE, and participants were those who had taken part in the wave 
3 main interview and consented to provide information about their lives so far in an 
additional interview. The exception is that participants who did not provide a wave 3 
interview were invited to participate in LIFE if their cohabiting partner had agreed to provide 
life history data. Those whose wave 3 main interview was conducted late (after April 19th, 
2007) were excluded. 
A temporal referencing system or life-grid approach was used to collect the information, as 
this is thought to help full and accurate recall (Berney & Blane 1997; Means et al. 1991). 
Biases due to sample selection, incomplete reporting, and measurement error are likely to 
differ systematically between the retrospective and contemporaneous data. For example, 
cognitive function (more specifically, scores on tests of delayed recall) appears to be 
associated with accuracy of recall (Brown 2013), but it may not be associated with the 
reporting of contemporaneous information. 
2.2 Onset of RA 
Wave 0 does not identify individuals with RA. In wave 1, respondents were asked whether a 
doctor had ever told them that they had or had ever had arthritis. If they answered yes, they 
were asked to identify which type or types of arthritis they had; rheumatoid arthritis, 
osteoarthritis, or some other kind of arthritis. They were also asked their age when they 
were first told by a doctor that they had arthritis. In subsequent waves, those who had 
reported arthritis were asked to confirm that they had or had had the condition. In waves 2 
to 7, all respondents were also asked questions about new diagnoses of arthritis and RA.  
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RA onset is identified if it was reported in any wave. Missing values are assigned to 
respondents who report RA and subsequently report having another type of arthritis but not 
RA, or who report RA and subsequently report that the condition was never diagnosed. 
Some respondents who initially report RA, subsequently dispute that they ever had RA, and 
after this report having RA. For these respondents, it is assumed that they do have RA and 
age of onset is assigned using the age given when RA was first reported. 
For all respondents, age of onset is identified using information provided the first time that 
RA was reported. Age of onset is coded as missing if multiple types of arthritis were 
reported when RA was first reported. 
Appendix 10 provides details about measurements of RA onset and other variables included 
in the analyses. 
2.3 Adversities 
Adversities are measured using retrospective information that in most instances includes 
the years when circumstances changed or events occurred. This contrasts with the 
information used in Chapter 2, in which prospective information was collected when cohort 
members were particular ages. These ages determined the age ranges for life stages in 
Chapter 2.  In contrast, in this chapter age ranges are chosen and include four life stages 
that each encompass 15 years. Childhood is birth to 15, transition to adulthood, referred to 
as transition, is 16-29, early adulthood is 30-44 and mid-adulthood is 45-59. 
Information about adversity was collected in three ways. First, during the face-to-face life 
history interview, respondents provided fertility, partnership, housing, employment and 
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health histories. This information is used to code adversities relating to family and 
partnerships and periods of unemployment, and the variables are referred to as histories. 
Second, respondents were asked in self-completion questionnaires whether they had been 
exposed to a series of adversities during childhood. These variables are referred to as 
childhood adversities. Third, in the self-completion questionnaire, respondents provided 
information about life events. If they reported a life event, they were then asked when they 
first experienced it. These variables are referred to as events.  
The adverse exposures measured are listed in Table A3.2. 
Adversities were summed to create indices of total adversity during childhood, transition, 
early and mid-adulthood, and of different types of adversity; material, social, family-related, 
traumatic, chronic, and acute.  
Exposures to adversity were also summed over life stages to create indices of total life-
course and cumulative life-course adversity. Indices of total life-course adversity were 
created by summing total levels of exposure at each life stage. Indices of cumulative 
exposure measure the number of life stages during which at least one adversity was 
reported.  
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Table 3.2:   Exposures to adversity and indices of exposure 
Adversity Question type Index 
 
   
 
 
 
   
 
 
Adversities experienced during childhood    
 
 
Poor housing amenities and/or crowding at 10* History Total Material Material  
Severe financial hardship Event Total Material Material  
Parental unemployment 6m+ 
Childhood 
adversity Total 
Material Material 
 
Early parental loss 
Childhood 
adversity Total 
Social 
Family  
Separation from mother for 6m+ 
Childhood 
adversity Total 
Social 
Family  
Parents argue often 
Childhood 
adversity Total 
Social 
Family  
Parent drank, took drugs, mental health problems 
Childhood 
adversity Total 
Social 
Family  
Parent physically abused respondent 
Childhood 
adversity Total 
Social 
Family  
Sexual assault Event Total Social Trauma  
Major natural disaster Event Total Social Trauma  
Had life threatening illness or injury Event Total Social Trauma  
Severe physical attack Event Total Social Trauma  
Witness death or serious injury Event Total Social Trauma  
Lost close relative or friend Event Total Social Trauma  
 
   
 
 
Adversities experienced during adulthood    
 
 
Severe financial hardship  Event Total Material Material  
Unemployed and searching for work History Total Material Material  
Involuntary job loss History Total    
Main occupation carer  History Total
 Social Family Chronic 
Provided long-term care for relative or friend  Event     
Partner or child addicted to a substance Event Total Social Family Chronic 
Breakdown of cohabiting partnership  History Total Social Family Chronic 
House moves  History Total Social Family  
Death of cohabiting partner History Total Social Family  
Death of child History Total Social Family  
Stillbirth, miscarriage or abortion History Total Social Family  
Death of close friend/relative Event     
Victim of sexual assault  Event Total Social Trauma Acute 
Victim of serious physical attack  Event Total Social Trauma Acute 
Life threatening illness or accident  Event Total Social Trauma  
Active combat  Event Total Social Trauma  
Witnessed serious injury or death  Event Total
 
Social Trauma Acute 
Natural disaster  Event Total Social Trauma Acute 
*And living in the UK. For indices of total, family and chronic adversity, caring is identified if the respondent 
reports that their main occupation was a carer or if they report providing long-term care for a relative or friend. 
 
 
2.4 Resources 
A range of factors were considered as resources, relating to parenting, cultural capital 
during childhood and education at the time of LIFE. In analyses described in Appendix 10, 
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there was no evidence that any of the variables tested buffered impacts of adversity on RA 
onset and so they are not included as resources in the analyses. 
2.5 Factors to condition upon 
All models condition on cohort of birth because it is likely that patterns of RA and its 
diagnosis differ between cohorts. In addition, levels of adversity and the meanings 
attributed to them may vary between cohorts. 
Models condition on gender for similar reasons. Risk of RA onset differs by gender, as do 
exposures to adversities and the meanings attributed to them. 
As RA prevalence rates vary between ethnic groups, I considered conditioning upon whether 
the respondent described themselves as white. However, only seven non-white respondents 
who participated in LIFE reported having RA with onset after age 16. 
As explained in the introduction, there are socio-economic inequalities in RA prevalence and 
onset. Various measures of socio-economic class are available in the dataset. Education was 
used because occupational class is conceptually closer to material adversity and is probably 
more highly correlated with it. Education at the time of the LIFE interview was associated 
with both RA onset and exposure to adversity. Education is not classified as a resource 
because whilst higher levels of qualification are associated with a lower risk of RA onset, 
they are associated with a higher risk of total adversity during transition and early 
adulthood. Models therefore condition on education level at the time of the LIFE interview. 
A binary indicator of qualifications at Level 2 or above is used. 
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LIFE includes comprehensive fertility histories and information about use of hormonal 
contraceptives, ages of menarche and menopause, and removal of ovaries and 
hysterectomies. As mentioned in the introduction, female sex hormones appear to be 
involved in the development of RA, and so they were considered as conditioning factors. 
However, analyses described in Appendix 10 found no evidence that any of them predict RA 
onset in this sample, and so they are not included in the models. 
2.6 Health behaviours 
Smoking is the only health behaviour measured in LIFE. Smoking is measured using 
continuous measures of the numbers of years smoked during early and late adulthood. 
2.7 Variables used in sensitivity analyses 
Sensitivity analyses were conducted that excluded respondents with low scores on a 
memory recall test at the time of LIFE, as Brown (2013) reports that poor recall scores in the 
NCDS were associated with inaccurate retrospective accounts of childhood circumstances. 
Respondents reporting pain and depressive symptoms at the time of LIFE were also 
excluded because these are symptoms of RA that could bias recall of childhood adversities 
(Raphael et al. 2001, Widom & Morris 1997). 
Memory function, depressive symptoms, and pain were measured during the main wave 3 
interview, shortly before the LIFE interviews took place. 
Memory function was measured using a delayed word recall test. Depressive symptoms 
were measured using the 8 item Centre for Epidemiology depression scale (CESD). Pain was 
measured using answers to simple questions about perceived pain. 
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3. Analyses 
I use survival analysis to estimate associations between adversity and RA onset. Survival 
analysis is a set of methods that are used when the outcome variable is the time until the 
occurrence of an event (Despa 2015), which in this chapter is RA onset. Time to the event is 
referred to as survival time. The issue that complicates the modelling of survival time is that 
some people provide incomplete information about it. For example, some ELSA respondents 
did not report RA onset by the last wave of data collection, and we do not know whether 
they subsequently developed RA. This type of missing data is referred to as right censoring. 
In survival analysis, the dependent variable is composed of two parts; time to the event (RA 
onset) or to right censoring, and whether the event occurred or not. 
Figure 3.2 illustrates the outcome function that was modelled using survival analysis 
techniques. It represents the changing risk of developing RA with age, or the number of 
respondents who developed RA at each age divided by the number of respondents who had 
not yet developed it when they were one year younger. It is unadjusted and referred to as 
the baseline hazard function.  
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Figure 3.2: Baseline hazard function for RA onset 
 
Note: The figure uses data from 6,626 respondents who participated in the LIFE interview and provided 
information about RA onset. Of these, 261 respondents reported RA onset. 
 
Hazard functions are usually plotted against time. I use age because conceptually, age is 
more relevant to the lives of respondents and to the research questions. However, because 
evidence exists (albeit inconsistent) that the outcome variable (the changing risk of RA onset 
with age) differs between birth cohorts, all models used in the analyses adjust for birth 
cohort. If RA onset were plotted against time, it would be adjusted for age. Once these 
adjustments are made, the results of analyses depend little upon whether the hazard 
function is plotted against age or time (Pencina et al. 2007).  
Most survival analysis techniques assume that time of right censoring is unrelated to the 
outcome of interest, after conditioning on covariates. In this study, time is measured using 
age, and many respondents are right censored because they left the sample in 2014, when 
the last wave of data collection occurred. Their age in 2014 is directly related to their birth 
cohort, which, as mentioned above, may be associated with the outcome of interest. This is 
another reason why I condition on cohort of birth. 
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Various survival analysis models are available, and the choice of which to use is determined 
by how accurately each can be manipulated to describe the outcome function. The outcome 
function for this set of analyses is illustrated in Figure 3.2, and the technique of Cox’s 
Proportional Hazards regression was selected to model it, as this specification makes no 
assumptions about the form of the hazard function.  
Cox regression assumes that time to the event (RA onset) is continuous, and that each event 
occurs at a unique point in time. The measure of time used is age in years, which is discrete, 
and for many ages, two or more respondents report RA onset. These are referred to as ties. 
In the sample of respondents who participated in LIFE and provided information about RA 
onset, 261 reported RA onset between six and 87, with a maximum of 13 respondents 
reporting RA onset at any one age. The Breslow method is used to handle ties, by assuming 
(almost always incorrectly) that when each tied observation was taken from the pool of 
respondents without RA and who have not dropped out of the sample, none of the 
observations that were tied had yet been extracted. This matters little because even for the 
age with maximum ties, the proportion reporting RA onset hardly varies between the first 
and last respondent drawn from the pool. Thirteen respondents reported RA onset at age 
60, when 5,820 respondents were in the pool. So, the proportions reporting RA onset at this 
age varied between 1/5820 (0.0001718) – before any respondents had been drawn – and 
1/5808 (0.0001722) – after twelve had been drawn.  
While Cox regression makes no assumptions about the form of the baseline hazard function, 
it does assume that associations between the outcome function and each predictor variable 
are the same regardless of when RA onset occurs. For example, if a period of unemployment 
during one’s twenties is associated with risk of RA onset, then the assumption is that the 
magnitude and consistency of this association is the same regardless of whether RA onset 
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occurs during one’s thirties or one’s eighties. The assumption is referred to as the 
proportional hazards (PH) assumption. 
The PH assumption was tested for the main predictor variables used in the analyses using 
the observed dataset with complete cases and RA with onsets from ages 16, 45, and 60. The 
results, which are presented in Table A11.1 in Appendix 11, provide no evidence that the PH 
assumption is violated by any of these variables. 
To increase numbers and reduce bias, missing values were imputed in multiple datasets 
based on the sample that participated in at least one sweep of ELSA. Missing values were 
imputed for all variables used in the analyses except for RA status and age of onset. RA 
onset was not imputed because the software used (Stata 14, StataCorp. 2015) does not 
support survival analysis using outcome variables for which missing values have been 
imputed using multiple imputation. However, variables indicating RA status and age of onset 
or censoring were used to impute missing values for the other variables of interest.  Missing 
values were imputed for indices of adversity as opposed to single adversities, since indices 
are used in most of the analyses. Further details about the multiple imputation methods are 
presented in Appendix 12. 
Analyses were conducted in 20 imputed datasets and results pooled using the combination 
rules suggested by Rubin (1987). The sample used in the analyses excluded sample members 
who did not participate in LIFE or had missing values for RA onset, gender or date of birth. 
Incidence and prevalence rates for RA were estimated for respondents who participated in 
LIFE and for the whole ELSA sample. In order to illustrate the changing risk of RA onset with 
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age, the hazard functions of RA onset were estimated with adjustment for birth cohort for 
the sample who participated in LIFE, and for the whole ELSA sample.  
For respondents who participated in LIFE, who are included in the rest of the analyses, 
hazard functions were plotted separately for five birth cohorts, for men and women 
separately, and for those who did and did not have fathers with manual or routine 
occupations when respondents were aged 14. Cox regression models were conducted to 
estimate the statistical significance of differences in RA onset between cohorts, men and 
women and between groups with different socio-economic backgrounds. 
Because of biases in the observed sample and attrition, the samples used in ELSA and LIFE 
are not representative of adults aged 50 and over living in the community in England. 
NatCen used information from earlier ELSA sweeps to compare the characteristics of ELSA 
participants who did and did not complete the LIFE interview. Based on this information, 
they constructed weights designed to compensate for biases resulting from attrition and 
improve the representativeness of the sample. In order to provide indications of the 
distribution of RA onset that are more representative of older adults living in private 
households in England, additional hazard functions for RA onset were estimated using the 
weighted LIFE data. 
Descriptive statistics for other variables used in the analyses were calculated without 
weights for respondents who participated in the LIFE interview and provided information 
about RA onset, gender, and date of birth, using the observed and multiple imputed 
datasets. Using the multiple imputed datasets, summary statistics were calculated for men 
and women separately. The statistical significance of gender differences was indicated by 
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lack of overlap between confidence intervals for mean values estimated for men and 
women.  
Analyses were conducted to address each research question. Unless stated otherwise, these 
use the unweighted imputed datasets. 
RQ1. Do adversities predict RA onset? 
Details of models used to address RQ1 are summarised in Table 3.3, at the end of this 
section. 
Three sets of Cox regression analyses were estimated of risk of RA onset on level of 
adversity. For RA onset from age 16, associations were estimated with total level of 
adversity up to age 15. For RA with onset from age 45, associations were estimated with 
total level of adversity up to age 44. For RA with onset from age 60, associations were 
estimated with total level of adversity up to age 59.  
Each set of regressions was initially conducted using measures of adversity in terciles. Wald 
tests were used to test whether including these measures of adversity improved the fit of 
models of RA onset risk. Based on the results of analyses using these measures, summary 
measures of exposure were created to reflect the nature of any likely associations with RA 
onset, as either graded or threshold effects. For childhood adversity, a binary indicator of 
exposure to one or more adversities was created. For the longer periods between birth and 
ages 44 and 59, continuous measures were created. These summary measures of life-course 
adversity were used to test associations with RA onset. 
Chapter 3: Adversities and onset of rheumatoid arthritis             120 
 
 
 
All models were adjusted for birth cohort and level of education at the time of LIFE. Models 
estimated using the whole sample were also adjusted for gender.  
To examine whether associations between adversity during each life stage and RA onset 
were driven by specific adversities, associations were estimated between RA onset and 
single adversities during each life stage with mutual adjustment. As missing values are not 
imputed for single adversities, the observed dataset was used. Separate models were 
estimated for single adversities at each life stage, with mutual adjustment and adjustment 
for total levels of adversity during other life stages, gender, birth cohort and qualifications.  
RQ1a: How does the answer to this question vary by gender? 
The analyses were conducted for men and women separately. Interaction terms of gender 
with total levels of adversity up to ages 15, 44, and 59 were included in models to test 
whether gender differences in the associations between adversity and RA onset were 
statistically significant. 
 
Table 3.3:   Details of models used to address RQ1 
Outcome Exposures Controls Interaction Sample Imputed? N Method 
RQ1: Results in Table 3.9      
RA onset 
from 16 
 
Adversities 
0-15: terciles 
Birth cohort, 
education, gender 
No 
In LIFE 
Yes 
 
6,623 
Cox PH, 
Wald 
test 
 
Birth cohort, 
education 
Men in LIFE 2,997 
Birth cohort, 
education 
Women in 
LIFE 
3,626 
Adversities 
0-15: binary 
Birth cohort, 
education, gender 
In LIFE 6,623 
Cox PH 
Birth cohort, 
education 
Men in LIFE 2,997 
Birth cohort, 
education 
Women in 
LIFE 
3,626 
RA onset 
from 45  
Adversities 
0-44: terciles 
Birth cohort, 
education, gender 
No 
In LIFE 
Yes 
 
6,560 Cox PH, 
Wald 
test 
 
Birth cohort, 
education 
Men in LIFE 2,975 
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Birth cohort, 
education 
Women in 
LIFE 
3,585 
Adversities 
0-44: 
continuous 
Birth cohort, 
education, gender 
In LIFE 6,560 
Cox PH 
Birth cohort, 
education 
Men in LIFE 2,975 
Birth cohort, 
education 
Women in 
LIFE 
3,585 
RA onset 
from 60 
 
Adversities 
0-59: terciles 
Birth cohort, 
education, gender 
No 
In LIFE 
Yes 
 
5,525 
Cox PH, 
Wald 
test 
 
Birth cohort, 
education 
Men in LIFE 2,593 
Birth cohort, 
education 
Women in 
LIFE 
2,932 
Adversities 
0-59: 
continuous 
Birth cohort, 
education, gender 
In LIFE 5,525 
Cox PH 
Birth cohort, 
education 
Men in LIFE 2,593 
Birth cohort, 
education 
Women in 
LIFE 
2,932 
RQ1. Results in Table A14.1 in Appendix 14.      
RA onset 
from 45  
 
14 childhood 
adversities 
Indices of 
adversity during 
other life stages, 
birth cohort, 
gender, L2+ 
qualifications 
No 
In LIFE with 
complete 
information 
about 
gender and 
birth 
No 
3,256 
Cox PH 
16 transition 
adversities  
3,239 
16 early 
adulthood 
adversities 
3,319 
RA onset 
from 60  
14 childhood 
adversities 
Indices of 
adversity during 
other life stages, 
birth cohort, 
gender, L2+ 
qualifications 
No 
In LIFE with 
complete 
information 
about 
gender and 
birth 
No 
2,586 
Cox PH 
16 transition 
adversities  
2,570 
16 early 
adulthood 
adversities 
3,319 
16 mid-
adulthood 
adversities  
2,743 
RQ1a: Results in text       
Outcome Exposures Controls Interaction Sample Imputed? N Method 
RA onset 
from 16 
Adversities 
0-15: binary 
Birth cohort, 
education, gender 
Adv 0-15 
*gender 
In LIFE 
Yes 
 
6,623 
Cox PH 
RA onset 
from 45 
Adversities 
0-44: binary 
Birth cohort, 
education, gender 
Adv 0-44 
*gender 
In LIFE 6560 
RA onset 
from 60 
Adversities 
0-59: binary 
Birth cohort, 
education, gender 
Adv 0-59 
*gender 
In LIFE 6560 
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RQ2: How do adversities combine over the life-course to predict RA onset? 
Various specifications were used to address RQs 2a, 2b and 2c. They each include 
adjustment for birth cohort, education level in 2006 and, if not stratified by gender, gender. 
Details are summarised in Table 3.4, which is presented at the end of the section. 
RQ2a: Does the length of exposure matter?  
Cox regression analyses were conducted to estimate associations between the risk of RA 
onset from age 45 and cumulative adversity during childhood, transition and early 
adulthood using an indicator of the number of life stages during which at least one adversity 
was reported. Associations were also estimated between risk of RA onset from age 60 and 
cumulative adversity during childhood, transition, early and mid-adulthood.  
RQ2b: Does the life stage during which one is exposed matter?  
Cox regression analyses were used to estimate associations between adversities during each 
life stage with mutual adjustment for RA with onsets from 45 and 60. While RQ1 was 
addressed using a binary indicator of childhood adversity and continuous measures of 
adversity during subsequent life stages, I thought that it would be a fairer comparison to use 
the same type of measure of adversity in all life stages when comparing their salience for RA 
onset. Binary indicators of one or more adversity were used. 
Sensitivity analyses were conducted using indices of adversity that excluded life events, as 
information was available only about the first time that the respondent experienced the 
event and this could affect the results.  
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RQ2c: How do the answers to these questions vary by gender? 
The analyses were conducted for men and women separately and tests conducted with the 
whole sample using models that included interaction terms between adversity and gender. 
Table 3.4:   Details of models used to address RQ2 
Outcome Exposures Controls Interaction Sample N Method 
RQ2a. Results in Table 3.10 
RA onset 
from 45  
No.life stages to 44 
when adversity 
reported: dummies 
Birth cohort, 
gender, 
education 
 
No In LIFE 
6,560 
 
Cox PH, 
Wald 
 
continuous Cox PH 
RA onset 
from 60  
No. life stages to 59 
when adversity 
reported: dummies 
Birth cohort, 
gender, 
education 
 
No 
In LIFE 5,525 
Cox PH, 
Wald 
 
 
continuous Cox PH 
RQ2b. Results in Table 3.11 
RA onset 
from 45  
Summary measures 
of childhood, 
transition early 
adulthood adversity 
Birth cohort, 
gender, 
education 
 
No 
 
In LIFE 
 
6,560 
Cox PH 
 RA onset 
from 60  
Summary measures 
childhood, transition 
early and mid-
adulthood adversity 
Birth cohort, 
gender, 
education 
 
No In LIFE 5,525 
RQ2c. Results in Table A15.2 
RA onset 
from 45  
No. life stages 44 adv. 
reported: dums Birth cohort, 
education 
No 
Men in LIFE 2,975 
Cox PH, 
Wald  
test  
Women in LIFE 3,585 
Continuous Men in LIFE 2,975 
Women in LIFE 3,585 
RA onset 
from 60  
No. life stages 59 adv. 
reported:  dums Birth cohort, 
education 
No 
Men in LIFE 2,593 
Cox PH 
Women  in LIFE 2,932 
continuous Men in LIFE 2,593 
Women  in LIFE 2,932 
RQ2c. Results in text 
RA onset  
45  
No. life stages to 44 
adversity reported: 
continuous 
Birth cohort, 
gender, 
education 
Adv* gender In LIFE 6,560 Cox PH 
RA onset  
60  
No. life stages to 59 
adversity reported: 
continuous 
Birth cohort, 
gender, 
education 
Adv* gender In LIFE 5,525 Cox PH 
RQ2c. Results in Table A15.3, Appendix 15. 
RA onset 
45  
Childhood, transition 
early adulthood 
adversity 
Birth cohort, 
education No 
Men in LIFE 2,975 
Cox PH 
 
Women in LIFE 3,585 
RA onset 
60  
Childhood, transition 
early, mid-adulthood 
adversity 
Birth cohort, 
education No 
Men in LIFE 2,593 
Cox PH Women in LIFE 2,932 
RQ2c. Results in text 
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RA onset 
45  
Childhood, transition 
early adulthood 
adversity 
Birth cohort, 
gender, 
education 
Adv* gender In LIFE 6,560 Cox PH 
 
RA onset 
60  
Childhood, transition 
early, mid-adulthood 
adversity 
Birth cohort, 
gender, 
education 
Adv* gender In LIFE 5,525 Cox PH 
All models estimated using twenty imputed datasets. A15.2 and A15.3 refer to tables in Appendix 15. 
 
 
RQ3: Do material, psychosocial and behavioural factors independently predict RA 
onset? 
Details of models used to address RQ3a and RQ3b are summarised in Table 3.5, presented 
at the end of the section. 
RQ3a: Do material and social adversities independently predict RA onset? 
Three sets of Cox regression analyses were conducted of RA with onsets from ages 16, 45 
and 60 on material and social adversity, with mutual adjustment for each type of adversity 
and adjustment for birth cohort, gender and education. Total material and social adversities 
were measured from birth to ages 15, 44, and 59. Models were estimated using sets of 
dummies and then, depending upon the pattern of relationship indicated by the results, 
more parsimonious binary or continuous measures.  
RQ3b: Are any associations found explained by smoking behaviour? 
Models were estimated of material and social adversities up to age 29 (childhood and 
transition) as predictors of RA onset from ages 45 and 60, adjusting for the factors in 
previous models and also for smoking.  
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RQ3c: How do the answers to these questions vary by gender? 
The models estimated to address RQs 3a and 3b were conducted for men and women 
separately. Tests using interaction terms between gender and each type of adversity were 
conducted to see whether or not gender differences were statistically significant. 
Table 3.5:   Details of models used to address RQ3a and b. 
Outcome Exposures Controls N 
RQ3a. Table A16.1, Appendix 16 
RA from 16 
 
Material adversities 0-16 
(dummies) 
Social adversities 0-16 (cont.), birth 
cohort, gender, education 
6,623 
Social adversities 0-16 (dummies) Material adversities 0-16 (cont.), birth 
cohort, gender, education 
RA from 45 Material adversities  0-16 
(dummies) 
Social adversities 0-16 (cont.), total 
adversity 17-29 and 30-44, birth cohort, 
gender, education 
6,560 
Social adversities  0-16 (dummies) Material adversities 0-16 (cont.), total 
adversity 17-29 and 30-44, birth cohort, 
gender, education 
Material adversities  0-44 
(dummies) 
Social adversities 0-44 (cont.), birth 
cohort, gender, education 
Social adversities  0-44 (dummies) Material adversities 0-44 (cont.), birth 
cohort, gender, education 
RA from 60 Material adversities  0-16 
(dummies) 
Social adversities 0-16 (cont.), total 
adversity 17-29, 30-44, 45-59, birth 
cohort, gender, education 
5,525 
Social adversities  0-16 (dummies) Material adversities 0-44 (cont.), total 
adversity 17-29, 30-44, 45-59, birth 
cohort, gender, education 
Material adversities  0-44 
(dummies) 
Social adversities 0-44 (cont.), total 
adversity 45-59, birth cohort, gender, 
education 
Social adversities  0-44 (dummies) Material adversities 0-44 (cont.), total 
adversity 17-29, 30-44, 45-59, birth 
cohort, gender, education 
Material adversities  0-59 
(dummies) 
Social adversities 0-59 (cont.), birth 
cohort, gender, education 
Social adversities  0-59 (dummies) Material adversities 0-59 (cont.), birth 
cohort, gender, education 
RQ3a. Table 3.12   
RA onset 
from 16 
Material adversities (binary), social 
adversities (cont.) 0-16 
Birth cohort, gender, education 6,623 
RA onset 
from 45 
Material adversities (binary), social 
adversities (cont.) 0-16 
Birth cohort, gender, education, total 
adversity 17-29, 30-44 
6,560 
Material adversities (binary), social 
adversities (cont.) 0-44 
Birth cohort, gender, education 
RA onset 
from 60 
Material adversities (binary), social 
adversities (cont.) 0-16 
Birth cohort, gender, education, total 
adversity 17-29, 30-44, 45-59 
5,525 
Chapter 3: Adversities and onset of rheumatoid arthritis             126 
 
 
 
Material adversities (binary), social 
adversities (cont.) 0-44 
Birth cohort, gender, education, total 
adversity 45-59 
Material adversities (binary), social 
adversities (cont.) 0-59 
Birth cohort, gender, education 
RQ3b. 
Table A16.2 
RA onset 
from 45 
Material adversities (binary), social 
adversity (cont.) 0-29 
Birth cohort, gender, education 6,560 
Material adversities (binary), social 
adversity (cont.) 0-29, years 
smoked 30-44 
Birth cohort, gender, education 
RA onset 
from 60 
Material adversities (binary), social 
adversity (cont.) 0-29 
Birth cohort, gender, education 5,525 
Material adversities (binary), social 
adversity (cont.) 0-29, years 
smoked 30-44, 45-59 
Birth cohort, gender, education 
All models are estimated using Cox PH regressions and twenty datasets with information from LIFE 
participants with imputed values. All models adjust for birth cohort, gender and education and there 
are no interaction terms. 
 
RQ4: Are some types of social adversity more salient predictors of RA onset than 
others? 
Models used to address RQ4 are equivalent to those used to address RQ3, but instead of 
comparisons between material and social adversities, the comparisons are between (1) 
family/relationship and trauma, and (2) chronic and acute adversities. 
Sensitivity analyses 
As mentioned above, sensitivity analyses were conducted in relation to RQ2b using 
alternative indices of adversity that excluded life events. Two additional sets of sensitivity 
analyses were conducted for all the results, each using different samples. The first sample 
excluded respondents who in Wave 3 of data collection reported pain or depression or 
scored poorly on a memory recall test.  
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Respondents with low recall scores were excluded because a study using data from the 
NCDS found that recall by 50 year old cohort members of childhood circumstances such as 
household composition was less accurate among respondents who did not perform well on 
a memory test of delayed recall (Brown 2014).  
Respondents reporting pain and depressive symptoms were excluded because these are 
symptoms of RA that could bias recall of childhood adversities. If recall was affected by 
symptoms of RA, the bias could contribute to associations between adversity and RA onset, 
and one would not know to what extent the relationship was prospective. Chronic pain is a 
symptom of RA, and studies have found pain in adulthood (at the time of recall) to be 
associated with retrospective reports of childhood adversity (sexual and physical abuse and 
neglect) but not with formal documentation of abuse and neglect that was recorded at the 
time it took place (Raphael et al. 2001). Evidence of a similar type suggests that diagnosed 
depression is associated with over-reporting of sexual abuse (Widom & Morris 1997), which 
is relevant to this study because individuals with RA are at elevated risk of having depression 
(Covic et al. 2012) and sexual abuse is one of the adversities measured in childhood. 
The second set of sensitivity analyses uses imputed datasets derived from alternative 
indices of adversity in the observed data. For the main analyses, indices were created in the 
observed data for respondents who provided complete information about adversity and 
values were imputed during multiple imputation for all other respondents. For the 
sensitivity analyses, indices of adversity were created in the observed dataset that assigned 
values to indices for respondents who provided partial information about adversities as well 
as for those who provided complete information.  
Details of sensitivity analyses are given in Appendices 18 and 19. 
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4. Results 
Descriptive statistics 
Numbers of respondents who participated in LIFE and reported RA at each life stage are 
presented in Table 3.6.  
Table 3.6:   Numbers of LIFE participants who reported RA onset during each life stage 
Life stage All Men Women 
Childhood (0-15) 1 1 0 
Transition (16-29) 10 2 8 
Early adulthood (30-44) 29 12 17 
Mid-adulthood (45-59) 84 33 51 
Late adulthood (60+) 137 67 70 
All stages 261 115 146 
 
Two hundred and sixty of 6,624 (3.94%) LIFE interview participants who provided 
information about RA onset, gender, and date of birth reported RA with onset after age 16. 
Gender differences in lifetime prevalence rates among LIFE participants are 1.28:1.00 
(women:men). Incidence rates of RA for LIFE participants are 0.57 (95%CI=0.50-0.64) per 
1,000 per year. 
The baseline hazard function for RA onset is presented in Figure 3.2. Figure 3.3 presents the 
equivalent hazard function after adjustment for cohort of birth. Relationships between risk 
of RA onset and age are similar in the two figures, and show that risk of RA onset increases 
until the late seventies, when risk levels off and may even decline. 
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Figure 3.3:   Hazard function for RA onset, adjusted for birth cohort 
 
Note: The figure uses data from 6,626 respondents who participated in the LIFE interview and provided 
information about RA onset and date of birth. 261 respondents reported RA onset. 
 
Hazard functions for RA onset for LIFE respondents born in different decades, of different 
genders, and with different socio-economic backgrounds are presented in Figures 3.4, 3.5 
and 3.6. These illustrate differences in RA onset over the life-course for respondents 
included in the analysis. Equivalent hazard functions are presented in Appendix 13 that 
include weights designed to address sample bias so that results are more likely to be 
representative of adults aged 50 and over living in England. The results using weights are 
very similar to those presented here. 
Figure 3.4 indicates that RA onset has been diagnosed earlier in life for younger cohorts. The 
mean age of RA onset is 47 for those born after 1950, 54 for those born between 1941 and 
1950, 62 for those born between 1931 and 1940, 68 for those born between 1921 and 1930, 
and 77 for those born before 1921. The proportion of respondents reporting RA onset is 
higher for the oldest cohort, probably because some of those with other health conditions 
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have died, or are no longer eligible (if they live in an institution) or able to participate in 
ELSA surveys.  
 
Figure 3.4:   Hazard functions for RA onset for different birth cohorts of respondents who 
participated in LIFE 
 
Note: The figure uses data from 6,626 respondents who participated in the LIFE interview and provided 
information about RA onset and date of birth. 247 of these were born before 1921, 854 between 1921 and 1930, 
1,581 between 1931 and 1940, 2,297 between 1941 and 1950, 1,647 born after 1950. 261 reported RA onset.  
Figure 3.5 indicates that more women than men reported RA, and that onset tended to 
occur earlier in their lives. However, a test conducted using a Cox regression model of RA 
onset on gender with adjustment for birth cohort finds that the gender difference is not 
statistically significant; the hazard ratio (HR) for women as opposed to men developing RA is 
1.061, (95%CI=0.831-1.356, p=0.634, N=6,624). 
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Figure 3.5:   Hazard functions for RA onset for men and women who participated in LIFE, 
adjusted for birth cohort 
 
Note: The figure uses data from 6,624 respondents who participated in the LIFE interview and provided 
information about RA onset, date of birth and gender. 2,998 of these were men and 3,626 were women. 261 
reported RA onset.  
Figure 3.6 indicates that respondents who, at age 14, had a main carer who worked in a 
routine or manual occupation are at increased risk of developing RA, and that they tend to 
develop it earlier in their lives. After adjusting for birth cohort, the HR is 1.690, 
(95%CI=1.203-2.227, p=0.000, N=5,386). 
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Figure 3.6:   Hazard functions for RA onset for LIFE respondents with different socio-
economic backgrounds, adjusted for birth cohort 
 
Note: Note: The figure uses data from 5,386 respondents who participated in the LIFE interview and provided 
information about RA onset, date of birth and socio-economic background, measured by whether the 
respondent reported that their father had a manual or routine occupation when they were 14 years old. 1,726 
respondents reported their father’s occupation as manual or routine and 3,660 reported other occupation, 
classified as reflecting a higher occupational status. 261 respondents reported RA onset. 
 
Summary statistics from the 20 imputed datasets for all variables used in the main analyses 
are presented in Table 3.7.  
Table 3.7:   Summary statistics 
Variable Measure Values Mean/ % 95% ci  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Childhood adversity terciles 0 43.9 41.9-45.9 
  
1 29.6 27.9-31.4 
  
2+ 26.4 24.9-28.0 
 
binary 1+ 56.1 54.1-58.1 
Adversity 0-44 terciles 0-1 36.4 35.0-37.8 
  
2-3 37.5 36.1-38.9 
  
4+ 26.1 24.8-27.5 
 
continuous 0-6+ 2.4 2.3-2.5 
Adversity 0-59 terciles 0-1 27.3 26.0-28.6 
  
2-3 36.2 34.8-37.5 
  
4+ 36.6 35.2-37.9 
 
continuous 0-7+ 3.0 2.9-3.0 
Cumulative adversity 0-44 dummies 0 15.1 14.1-16.1 
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1 34.4 33.0-35.9  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes: The summary 
statistics are from 20 
imputed datasets that 
include 6,623 respondents 
who participated in LIFE and 
provided information about 
RA onset, gender, and date 
of birth, excluding one 
participant, who reported 
RA with onset before age 
16. Childhood is 0-15, 
transition 15-29, early 
adulthood 30-44, mid-
adulthood 45-59. Mean is 
for continuous variables. % 
is for binary variables and 
indicates the percentage of 
respondents for whom the 
variable has a yes value. 
1. Social adversity between 
birth and 44 is a continuous 
variable with values of zero, 
one or two, three to five, 
and six or more adversities.  
2. These continuous 
variables have values of 
zero, one or two, and three 
or more.  
3. Family adversity from 
birth to age 59 has values of 
zero, one to three, and four 
or more adversities. 
  
2 34.0 32.7-35.3 
  
3 16.4 15.3-17.6 
 
continuous 0-3 1.5 1.5-1.5 
Cumulative adversity 0-59 dummies 0 9.9 9.1-10.8 
  
1 26.7 25.5-27.9 
  
2 33.4 32.1-34.8 
  
3 22.5 21.3-23.6 
  
4 7.5 6.6-8.3 
 
continuous 0-4 1.9 1.9-1.9 
Transition adversity binary 1+ 51.0 49.7-52.2 
Early adulthood adversity binary 1+ 44.8 43.4-46.1 
Mid-adulthood adversity binary 1+ 39.0 37.7-40.4 
Material adversity 0-15 binary 1+ 16.7 15.6-17.9 
Material adversity 0-29 binary 1+ 19.5 18.3-20.7 
Material adversity 0-44 binary 1+ 22.1 20.8-23.3 
Material adversity 0-59 binary 1+ 25.0 23.7-26.3 
Social adversity 0-15 continuous 0-3+ 0.7 0.7-0.7 
Social adversity 0-29 continuous 0-3+ 1.3 1.2-1.3 
Social adversity 0-44
1 
continuous 0-6+
 
1.1 1.1-1.1 
Social adversity 0-59
2 
continuous 0-3+
 
1.2 1.2-1.3 
Family adversity 0-15 binary 1+ 35.8 34.5-37.1 
Family adversity 0-29
2 
continuous 0-3+
 
0.6 0.6-0.7 
Family adversity 0-44
2 
continuous 0-3+
 
0.8 0.8-0.8 
Family adversity 0-59
3 
continuous 0-4+
 
0.8 0.8-0.8 
Traumatic adversity 0-15 continuous 0-2+ 0.3 0.3-0.3 
Traumatic adversity 0-29 binary 1+ 39.6 38.2-41.0 
Traumatic adversity 0-44 binary 1+ 43.4 42.0-44.8 
Traumatic adversity 0-59 binary 1+ 48.1 46.6-49.5 
Chronic adversity 16-29 binary 1+ 13.1 12.2-14.0 
Chronic adversity 16-44 binary 1+ 28.0 26.8-29.2 
Chronic adversity 16-59 binary 1+ 39.2 37.9-40.5 
Acute adversity 16-29 binary 1+ 11.2 10.4-12.1 
Acute adversity 16-44 binary 1+ 15.1 14.1-16.1 
Acute adversity 16-59 binary 1+ 18.0 16.9-19.0 
Female gender binary 
 
54.7 53.5-55.9 
Level 2+ quals in 2006 binary 
 
67.7 66.5-68.9 
Born by 1920 binary 
 
3.7 3.3-4.2 
Born 1921-1930 binary 
 
12.9 12.1-13.7 
Born 1931-1940 binary 
 
23.8 22.8-24.9 
Born 1941-1950 binary 
 
34.7 33.5-35.8 
Born 1951 or after binary 
 
24.9 23.8-25.9 
Years smoked 30-44 continuous 5.6 5.4-5.7 
Years smoked 45-59 continuous  3.4 3.2-3.5 
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Appendix 12 presents comparisons between summary statistics using the observed dataset 
with complete information and the multiple datasets with imputed values. These 
comparisons suggest that respondents who provided complete information report slightly 
fewer adversities than those for whom missing values are imputed.  
Appendix 13 presents summary statistics for men and women separately using the multiple 
datasets with imputed values. Women reported more adversities than men, especially 
social, family-related and chronic adversities. Men reported more material, traumatic and 
acute adversities. Men smoked for more years than women and were more likely to have 
Level 2 or higher qualifications in 2006. Women are over-represented among the cohorts 
born before 1921 and after 1950 (aged 85+ and below 56 in 2006). 
RQ1: Do adversities predict RA onset? 
Table 3.8 presents results of Cox regressions of RA onset on adversity over the life-course 
with adjustment for birth cohort, gender and education level at the time of LIFE. For the 
whole sample (men and women together), there is evidence that adversity earlier in the life-
course predicts RA with onsets from 16, 45, and 60. 
For RA onset from age 16, the HRs associated with each tercile of exposure to childhood 
adversity suggests a threshold effect. Exposure to one or more childhood adversities is 
associated with a hazard ratio of 1.645 (95%CI=1.165-2.323, p=0.005). For RA onset later in 
life, HRs associated with each tercile of adversity suggests graded relationships. Using 
continuous measures of adversity, the HRs for each additional adversity (maximum of 6 or 
more) from birth to age 44 is 1.152 (95%CI=1.054-1.260, p=0.002), and from birth to age 59 
(maximum of 7 or more) is 1.142 (95%=1.042-1.251, p=0.004).  
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Table 3.8: Adjusted associations between total exposure to adversity and risk of RA onset for men and women together and separately 
RA onset from 16 
Adversity 0-15 Men and women (n=6,623) Men (n=2,997) Women (n=3,626) 
Measure Adv. HR 95%CI p-val HR 95%CI p-val HR 95%CI p-val 
Terciles 0 Reference 
 
Reference 
 
Reference 
   1 1.603 1.133-2.269 0.008 1.436 0.838-2.460 0.188 1.753 1.093-2.812 0.020 
  2+ 1.688 1.106-2.577 0.015 1.540 0.840-2.824 0.163 1.811 1.049-3.126 0.033 
 
 
Wald test       0.037 
Binary 1+ 1.645 1.165-2.323 0.005 1.487 0.902-2.452 0.120 1.785 1.134-2.809 0.012 
            
RA onset from 45 
Adversity 0-44 Men and women (n=6,560) Men (n=2,975) Women (n=3,585) 
Measure Adv. HR 95%CI p-val HR 95%CI p-val HR 95%CI p-val 
Terciles 0-1 Reference 
 
Reference 
 
Reference 
   2-3 1.542 1.066-2.229 0.021 1.601 0.919-2.788 0.096 1.475 0.876-2.483 0.144 
  4-11 1.939 1.264-2.974 0.002 2.108 1.170-3.797 0.013 1.785 0.972-3.279 0.062 
  Wald test 0.006   0.048   0.137 
Continuous 1.152 1.054-1.260 0.002 1.177 1.041-1.332 0.010 1.129 0.997-1.279 0.057 
           
RA onset from 60 
Adversity 0-59 Men and women (n=5,525) Men (n=2,593) Women (n=2,932) 
Measure Adv. HR 95%CI p-val HR 95%CI p-val HR 95%CI p-val 
Terciles 0-1 Reference 
 
Reference 
 
Reference 
   2-3 1.729 1.009-2.962 0.046 2.298 0.956-5.523 0.063 1.407 0.707-2.803 0.331 
  4-12 2.130 1.257-3.610 0.005 3.219 1.404-7.384 0.006 1.504 0.725-3.120 0.273 
 
 
Wald test 0.023   0.002   0.515 
Continuous 1.142 1.042-1.251 0.004 1.202 1.057-1.368 0.005 1.086 0.951-1.240 0.222 
HR refers to hazard ratios of RA onset contingent upon adversity. For men and women together, two models are estimated for RA onset from each age. One includes adversity 
measured in terciles, and the other includes either a binary or continuous measure of adversity. The same applies to the separate samples of men and women. Models are adjusted 
for birth cohort and Level 2+ qualifications at time of LIFE and gender, as appropriate. Continuous measures have maximum values of 6 for adversities 0-44, of 7 for adversities 0-59.  
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Additional analyses presented in Appendix 14 suggest that during childhood, poor housing 
amenities is a particularly important predictor of RA onset. During transition, a high number 
of house moves is protective against RA onset. Partnership breakdown and a life-
threatening illness or injury during transition are particularly important predictors of RA 
onset from age 60. Otherwise, there is no evidence that associations between RA onset and 
indices of adversity are driven by specific adversities. 
RQ1a:  How do the answers to this question vary by gender? 
Table 3.8 presents results for men and women separately. HRs for RA onset contingent upon 
adversity are greater than one for RA onset at all life stages for men and women. However, 
the magnitude and consistency of associations differ slightly by gender, with stronger 
associations for women than men between childhood adversity and RA onset from age 16, 
and stronger associations for men between adversity up to age 59 and subsequent RA 
onset. Additional analyses using the same models as those presented in the first columns of 
Table 3.8 but also including interaction terms between adversity and gender provide no 
evidence of gender differences. HRs for the interactions between female gender and 
adversity during childhood, 0-44, and 0-59 are 1.552 (95%CI=0.946-2.541) p=0.081 N=6,623, 
0.959 (95%CI=0.803-1.146) p=0.644 N=6,560, and 0.948 (95%CI=0.785-1.146) p=0.579 
N=5,525, respectively. 
Sensitivity analyses described in Appendices 18 and 19 provide similar results. 
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RQ2: How do adversities combine over the life-course to predict RA onset? 
RQ2a:  Does the length of exposure matter?  
Table 3.9 presents the results of Cox regression analyses of RA onset on the number of life 
stages in which at least one adversity was reported. Two measures of cumulative adversity 
are used; a set of dummies and a continuous measure. The latter assumes that any 
association with RA onset is linear. Results for both measures are consistent with a 
cumulative model of life-course exposure.  
Table 3.9:   Adjusted associations between cumulative exposure to adversity and risk of 
RA onset for men and women together 
Number of life stages 
exposed to adversity RA onset from age 45 (n=6,560) RA onset from age 60 (n=5,525) 
 
Values HR 95%CI p-value HR 95%CI p-value 
Dummies 0 
        
 
1 1.802 0.909  3.572 0.092 2.237 0.771  6.489 0.138 
 
2 2.603 1.353  5.009 0.004 3.484 1.304  9.305 0.013 
 
3 2.611 1.282  5.315 0.008 3.849 1.429  10.370 0.008 
 
4     3.688 1.070  12.712 0.039 
 
Wald test 0.010    0.067 
  
        
Continuous measure 1.339 1.134  1.582 0.001 1.310 1.107  1.551 0.002 
Notes: Models are adjusted for birth cohort, gender, and education level at the time of LIFE. HR is hazard ratio, 
95% ci is 95% confidence interval. 
 
 
 
The magnitudes of HRs for the sets of dummies suggest graded relationships with RA onset 
from ages 45 and 60, except for the final life stage added. This suggests that the impact (for 
RA onset) of adversity accumulates over the life-course during most (but not all) life stages. 
Using the continuous measure, the mean HR for each additional life stage during which 
adversity is reported is 1.339 (95%CI=1.134-1.582, p=0.001) for RA with onset from 45, and 
1.310 (95%CI=1.107-1.551, p=0.002) for RA with onset from 60. 
Sensitivity analyses described in Appendices 15, 18 and 19 provide very similar results. 
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RQ2b: Does the life stage at which one is exposed matter?  
RQ1 was addressed using a binary indicator of childhood adversity and continuous measures 
of adversity during subsequent life stages. In order to compare the salience of adversities 
during different life stages, the binary measure was used to measure adversity during each 
life stage.  
Table 3.10 presents the results of Cox regression analyses of RA onset on adversity during 
each life stage with mutual adjustment.  The results suggest that adversity during childhood 
and transition is particularly salient for RA onset from ages 45 and 60. After adjustment for 
adversity during childhood and transition, adversity during early and mid-adulthood does 
not increase the risk of RA onset. After mutual adjustment for exposures at each life stage, 
birth cohort, gender and education at the time of LIFE, HRs for exposure to at least one 
childhood adversity are 1.579 (95%CI=1.095-2.277) p=0.015 for RA with onset from 45, and 
1.685 (95%CI=1.116-2.544) p=0.013 for RA with onset from 60. The equivalent HRs for at 
least one adversity during transition are 1.574 (95%CI=1.164-2.130) p=0.003 for RA with 
onset from 45, and 1.890 (95%CI=1.278-2.796) p=0.001 for RA with onset from 60. 
Table 3.10: Associations between RA onset and adversity during each life stage, with 
mutual adjustment and adjustment for demographic variables, for men and women 
together 
Adversity 
during each life 
stage 
RA onset from age 45 (n=6,560) RA onset from age 60 (n=5,525) 
HR 95%CI 
 
p-value HR 95%CI 
 
p-value 
Childhood 1.579 1.095 2.277 0.015 1.685 1.116 2.544 0.013 
Transition 1.574 1.164 2.130 0.003 1.890 1.278 2.796 0.001 
Early adulthood 0.985 0.721 1.346 0.926 0.834 0.550 1.263 0.391 
Mid-adulthood     1.163 0.795 1.702 0.436 
These are results from two models, each adjusted for birth cohort, gender, and Level 2+ qualifications at the 
time of LIFE. HR is of RA onset contingent upon adversity, and 95%CI is 95% confidence interval. Childhood is 
ages 0-15, transition 16-29, early adulthood 30-44, mid-adulthood 45-59. Measures of adversity at each life stage 
are binary indicators of exposure to one or more adversities. 
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Sensitivity analyses were conducted using indices of adversity that exclude life events, which 
were measured using questions about first time of exposure. Associations between RA 
onset and adversity during childhood and transition have slightly reduced magnitude and 
consistency, especially for childhood adversity. There is no longer evidence that childhood 
adversity predicts RA onset from age 60 (HR=1.326, 95%CI=0.914-1.922, p=0.137). See 
Appendix 15, Table A15.1. Very similar results to those reported in Table 3.10 are reported 
in Table A19.4 Appendix 19, which uses datasets imputed from indices of adversity created 
in the observed data that include partial information. 
In contrast, the sensitivity analyses, described in Appendix 18, provide inconsistent 
evidence. These sensitivity analyses use a smaller sample that excludes respondents who, in 
wave 3, reported depression, pain or who performed poorly on a memory recall test. Using 
this sample, although all HRs are greater than one, there is evidence only that childhood 
adversity predicts RA onset; the association with transition adversity is no longer statistically 
significant. Still using this sample, when indices of adversity are used that exclude life 
events, HRs for adversity during each life stage are all greater than one (except for mid-
adulthood), but it is adversity during early adulthood that appears particularly salient. 
RQ2c:  How do the answers to these questions vary by gender? 
Results of analyses conducted separately for men and women are presented in Appendix 15. 
There is no evidence for gender differences in associations between cumulative adversity 
over the life-course.  
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RQ3: Do material, psychosocial and behavioural factors independently predict RA 
onset? 
RQ3a:  Do material and social adversities independently predict RA onset? 
In order to examine whether any relationships between material and social adversities and 
RA onset are graded or reflect threshold effects, associations were tested using sets of 
dummies for each level of exposure. The results, which are presented in Appendix 16, 
suggest that relationships between RA onset and material adversities are likely to be 
threshold effects of one or more material adversities, and that relationships with social 
adversities are likely to be graded. Consequently, binary indicators of material adversity and 
continuous measures of social adversity were used in the models.  
Six Cox regression models were estimated of material and social adversity during different 
life stages on RA with onsets from ages 16, 45 and 60. The results are presented in Table 
3.11. 
All HRs for RA onset contingent upon material and social adversities are greater than one. 
Evidence that material adversities predict RA onset from ages 16 and 45 is not statistically 
significant. However, respondents who reported at least one material adversity between 
birth and age 59 had a hazard of RA onset from age 60 that was 1.491 (95%CI=1.025-2.168, 
p=0.037) times greater than that for respondents reporting no material adversities, after 
adjustment for birth cohort, gender, qualifications and social adversities.  
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Table 3.11: HRs for RA onset contingent upon material and social adversities, adjusted for demographics, for men and women together 
 
Life stage and type 
RA onset from age 16 (n=6,623) RA onset from age 45 (n=6,560) RA onset from age 60 (n=5,525) 
HR 95%CI  p-val HR 95%CI p-val HR 95%CI p-val 
Childhood             
 Material (0,1+) 1.324 0.920-1.905 0.131 1.288 0.877-1.891 0.197 1.488 0.937-2.361 0.092 
 Social (0,1,2,3+) 1.183 1.003-1.394 0.046 1.206 1.010-1.440 0.038 1.104 0.881-1.385 0.390 
Birth to age 44 
    
    
    
 
Material (0,1+) 
    
1.243 0.902-1.713 0.184 1.455 0.973-2.176 0.068 
 Social(0,1-2,3-5,6+) 
   
1.374 1.144-1.651 0.001 1.302 1.019-1.662 0.035 
Birth to age 59 
    
    
     Material (0,1+) 
        
1.491 1.025-2.168 0.037 
 Social (0,1-2,3+) 
       
1.359 1.029-1.795 0.031 
These are results of six models with mutual adjustment for material and social adversities and total adversity during other life stages, birth cohort, gender and 
Level 2+ qualifications at time of LIFE. HR is for RA onset contingent upon each type of adversity. Material adversity is measured using an indicator of one or more 
adversity. Social adversities are measured using continuous variables with values indicated in the table. 
 
After adjustment for the same controls and for material adversity, social adversity predicted RA with onsets from ages 16, 45 and 60. For example, 
each additional social adversity during childhood is associated with a HR for RA onset from age 16 of 1.183 (95%CI=1.003-1.394) p=0.046, and a HR 
for maximum social adversity as opposed to none of 1.656 (1.1833). Each additional social adversity between birth and age 44 is associated with a 
HR for RA onset from age 45 of 1.374 (95%CI=1.144-1.651) p=0.001, and the HR for maximum social adversity as opposed to none is 2.594. Each 
additional social adversity up to age 59 is associated with a HR for RA onset from age 60 of 1.359 (95%CI=1.029-1.795) p=0.031, and the HR for 
maximum social adversities is 2.510.  
These results are robust to sensitivity analyses presented in Appendices 18 and 19.
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RQ3b: Are any associations found explained by smoking behaviour? 
Smoking behaviours during early and mid-adulthood (as appropriate) were included in 
models of RA onset on total levels of material and social adversity up to the end of 
transition. The results, which are presented in Appendix 16 , provide little evidence that 
smoking mediates effects of adversity on RA onset. HRs for adversities are reduced, but 
minimally. After adjustment for birth cohort, gender, education and adversity, there is no 
evidence that smoking during early adulthood predicts RA onset from age 45 or 60, and the 
associations between smoking during mid-adulthood and RA onset from age 60 is not quite 
statistically significant. However, adjusting only for gender, smoking does predict RA onset. 
RQ3c: How do the answers to these questions vary by gender? 
Results for men and women separately are presented in Appendix 16. They suggest that for 
RA onset from 45, material adversities matter more for men than women and that social 
adversities matter for both men and women. For RA onset from 60, material and social 
adversities matter for men but not for women. When interaction terms were included in the 
analyses, there was no evidence of gender differences.  
There is no evidence that associations between RA onset and adversities were mediated by 
smoking among men or women.  
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RQ4: Are some types of social adversity more salient predictors of RA onset than 
others? 
RQ4a: Comparison of adversities in different life domains: relationship-related and 
traumatic adversities. 
In order to examine whether associations between relationship-related and traumatic 
adversities and RA onset are likely to reflect threshold or graded effects, associations were 
estimated using sets of dummies. The results, which are presented in Table A17.1 Appendix 
17, suggest that relationships between RA onset and relationship-related adversities 
between birth and ages 44 and 59 are likely to be graded. However, during the relatively 
short period of childhood, the relationship reflects a threshold effect of one or more 
relationship-related adversity. Relationships between RA onset and traumatic adversity 
appear to reflect threshold effects of one or more trauma, except for during childhood, 
when the relationship appears graded.  
Six Cox regression models were estimated of family-related and traumatic adversity during 
different life stages on RA with onsets from ages 16, 45, and 60. The results are presented in 
Table 3.12. 
All hazard ratios for RA onset contingent upon relationship-related and traumatic adversities 
are greater than one.  
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Table 3.12: HRs for RA onset contingent upon relationship-related and traumatic 
adversities after mutual adjustment and adjustment for demographic variables, for men 
and women together 
Life stages and 
type 
RA onset from 16 (n=6,623) RA onset from 45 (n=6,560) RA onset from 60 (n=5,525) 
HR 95%CI p-val HR 95%CI p-val HR 95%CI p-val 
Childhood             
 
Relationship 1.106 0.835-1.465 0.481 1.185 0.874-1.606 0.275 1.053 0.711-1.560 0.795 
 
Trauma 1.288 1.026-1.618 0.029 1.252 0.983-1.595 0.068 1.184 0.848-1.653 0.323 
Birth to age 44             
 
Relationship     1.302 1.055-1.607 0.014 1.252 0.946-1.657 0.116 
 
Trauma     1.298 0.955-1.764 0.095 1.164 0.771-1.757 0.469 
Birth to age 59             
 Relationship         1.327 0.968-1.818 0.079 
 Trauma         1.179 0.784-1.773 0.429 
These are results from six models. HRs are for RA onset, contingent upon each type of adversity. 
Models are adjusted for birth cohort, gender, and Level 2+ qualifications at time of LIFE with mutual 
adjustment for relationship-related and traumatic adversities, material adversity during the life stage 
in which relationship-related and traumatic adversities are included, and total adversity during other 
life stages. Childhood relationship-related adversity is measured using an indicator of 1+ adversities. 
Family adversity during other periods is measured using continuous variables with values for 0-29 of 
0, 1-2, 3+ adversities, for 0-44 of 0, 1-2, 3+ adversities, and for 0-59 of 0, 1-3, 4 adversities. Traumatic 
adversities are measured using indicators of 1+ during all periods except childhood, when the 
variable takes values of 0, 1, 2+. 
 
During childhood, traumatic adversities appear more salient for RA onset, especially with 
onset from age 16. After adjustment for other types of childhood adversity (i.e. family-
related and material adversity), each additional traumatic adversity (maximum value is two 
or more) is associated with a HR for RA onset from age 16 of 1.288 (95%CI=1.026-1.618) 
p=0.029. For RA onsets from ages 45 and 60, relationship-related adversity during the life 
stages after childhood appears more important. For example, after adjustment for other 
types of adversity during transition and total adversity during other life stages, each 
traumatic adversity between birth and age 44 is associated with a HR for RA onset from age 
45 of 1.302 (95%CI=1.055-1.607) p=0.014. 
Sensitivity analyses described in Appendices 18 and 19 provide similar results. 
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RQ4b: Comparison of chronic and acute adversities. 
Results of analyses of RA onset on sets of dummies representing levels of exposure to 
chronic and acute adversities, reported in Appendix 17 Table A17.2, indicate that it is most 
likely that any relationships found reflect threshold effects of one or more adversity. 
Consequently, measures for chronic and acute adversities indicate exposure to one or more 
adversity. Binary indicators of one or more adversity are also used to measure adversities 
not classified as either chronic or acute. Numbers of respondents reporting each type of 
adversity and RA are small, and vary between 72 (those reporting at least one chronic 
adversity between 16 and 44 and RA with onset from age 45) and 19 (those reporting at 
least one acute adversity between 16 and 59 and RA with onset from age 60). See Appendix 
17, Table A17.3. 
Table 3.13 presents results of six models of RA onset on chronic and acute adversities from 
age 16. Figure 3.7 presents a selection of these results in graphical form. It appears that 
chronic but not acute adversities predict RA onset.  
Table 3.13: HRs for RA onset contingent upon chronic and acute adversities, with mutual 
adjustment and adjustment for demographics, for men and women together.  
Life stage 
and type 
RA onset from 30 (n=6,613) RA onset from 45 (n=6,560) RA onset from 60 (n=5,525) 
HR 95%CI p-val HR 95%CI p-val HR 95%CI p-val 
16-29             
 Chronic 1.521 1.045-2.214 0.029 1.685 1.119-2.537 0.013 2.429 1.470-4.014 0.001 
 Acute 0.806 0.494-1.315 0.388 0.821 0.485-1.391 0.463 0.876 0.457-1.678 0.690 
16-44             
 Chronic     1.448 1.060-1.977 0.020 1.653 1.105-2.472 0.014 
 Acute     0.871 0.536-1.416 0.578 0.781 0.415-1.468 0.443 
16-59             
 Chronic     
    
1.374 0.938-2.014 0.103 
 
Acute     
    
0.766 0.438-1.340 0.351 
These are results from six models. HRs are for RA onset contingent upon each type of adversity. Models are 
adjusted for chronic and acute adversities, and adjustment for adversities not classified as chronic or acute, 
childhood adversity measured using an indicator of one or more adversities, birth cohort, gender and Level 2 
qualifications or above at the time of LIFE. Chronic adversities are main occupation as carer and/or reporting 
being a carer, having a partner or child who is addicted to alcohol or drugs and breaking up with a cohabiting 
partner. Acute adversities are being a victim of sexual assault, being a victim of a serious physical attack, 
witnessing a death or serious injury, or a major natural disaster. Measures of chronic and acute adversity and of 
adversities not classified as chronic or acute are indicators of one or more adversity. 
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Figure 3.7: HRs for RA onset contingent upon chronic and acute adversities with full 
adjustment for men and women together 
 
Darker bars represent HRs contingent upon one or more chronic adversity. Lighter bars represent 
hazard ratios contingent upon one or more acute adversity. Bars 1 and 2 refer to adversity between 
ages 16 and 29 and RA onset from age 30. Bars 3 and 4 refer to adversity between ages 16 and 44 and 
RA onset from age 45. Bars 5 and 6 refer to adversity between ages 16 and 59 and RA onset from age 
60. Chronic adversities are caring for a relative or friend, partnership breakdown and having a child or 
partner who abuses alcohol or drugs. Acute adversities are witnessing a death or serious injury, and 
being a victim of a major natural disaster, sexual assault, or serious physical attack. Results are from 
three models, each with mutual adjustment for chronic and acute adversities, other adversities, total 
childhood adversity, birth cohort, gender, and qualifications at Level 2 or above at the time of LIFE. 
Black lines represent 95% confidence intervals. 
 
Appendix 18 reports results of sensitivity analyses that exclude respondents who, in wave 3, 
reported pain, depression or who scored poorly in a memory test. The pattern of results is 
similar, although reduced sample size means that relationships with chronic adversities do 
not reach statistical significance. Sensitivity analyses using alternative multiple imputed 
datasets, reported in Appendix 19, also provide similar results. 
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RQ4c: How do the answers to these questions vary by gender? 
Results of analyses conducted for men and women separately are presented in Appendix 17 
Tables A17.4 and A17.5. The results suggest that, especially for RA onset from age 45, 
traumatic adversities are more important for men and relationship-related adversities are 
more important for women. While there is no evidence that acute adversities predict RA 
onset for either gender, in relation to women, there is an indication that if numbers were 
greater, acute adversities would be negatively associated with RA onset. 
Sensitivity analyses 
Sensitivity analyses were conducted excluding respondents who reported in the wave 
concurrent with LIFE pain or depression, or whose level of cognitive functioning was low. 
Whilst there is a loss of power due to the reduced sample size, the pattern of results is 
generally similar. However, there were a few differences, which are noted above. The most 
important difference is that conclusions drawn about life stages when adversity is 
particularly salient for RA onset are unreliable. See Appendix 18. 
Sensitivity analyses using indices of adversity that included respondents who provided 
partial information about adversity before imputing missing values produced very similar 
results to those presented here. Results of this set of sensitivity analyses are reported in 
Appendix 19. 
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5. Discussion 
5.1 Discussion of findings 
This chapter provides new evidence relevant to the psychosocial pathways that contribute 
to RA onset. It does so by estimating the contribution of social adversities to RA onset after 
adjustment for material adversities and behavioural factors. Further, it examines the 
relative importance of different types of social adversities; relationship-related and 
traumatic social adversities, and chronic and acute social adversities. This evidence is 
contextualised by evidence about how adversities (material and social adversities together) 
combine over the life-course to predict RA onset. 
The evidence is based on information from 6,624 respondents, of whom 261 reported RA 
onset. Retrospective life-course information is used to model the importance for RA onset 
of a wide range of adversities at different life stages. The findings provide an important 
contribution to a rather sparse evidence base concerning the social determinants of RA. 
Main conclusions are presented in Table 3.14. 
Research Question 1: Does adversity predict RA onset? 
This study finds stronger evidence for associations between adversity and RA onset than do 
previous studies. This is probably because it is a large study that includes measures of a wide 
range of adversities over the life-course. In relation to numbers, Carette and Surtees (2000) 
found trends between adversity and RA onset but included just 55 respondents with RA 
onset, whereas this study includes 2602. In relation to the wide range of adversities 
measured from birth through the life-course, this study contrasts with Wesley’s, which 
                                                          
2
 Two hundred and sixty respondents reported RA onset after age 16, and one reported onset before 
age 16. 
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included many more respondents with RA (2,774) but examined adversities reported during 
the previous five years (Wesley et al. 2014). The difference between the results reported 
here and those reported by Wesley and colleagues suggest that adversity earlier in the life-
course is important for RA onset. 
There is no evidence of gender differences in associations between life-course adversity and 
RA onset. However, the findings suggest that small differences may exist that would be 
statistically significant in a larger sample. The association between childhood adversity and 
RA onset from age 16 is statistically significant for women but not men, whereas 
associations between life-course adversity and RA with onsets from ages 45 and 60 are 
statistically significant for men but not women. No explanation comes to mind for the first 
difference. However, a possible explanation for the second is that part of the variation in RA 
onset during adulthood is explained by female sex hormones (Malysheva et al. 2010), which 
would reduce the relative importance of social and material exposures for women but not 
men. 
The indication of a gender difference (it is not statistically significant) reported here 
contrasts with evidence from the larger study (Wesley et al. 2014), which found an 
association between RA onset and life events during the previous five years among women 
but not men. The difference may reflect differences between the adversities measured in 
Wesleys’s study and this one. As mentioned above, I included a wide range of adversities 
from birth, while Wesley’s study included fewer life events and only during the five years 
before diagnosis of RA. As RA onset is often insidious, the association reported by Wesley 
and colleagues may relate to progression as well as onset of the disease. 
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Table 3.14:   Summary of conclusions 
1. Total levels of life-course 
adversity predict RA onset. 
 
Exposure to at least one adversity during childhood is associated with 
increased risk of RA onset from age 16 (HR=1.65, 95%CI=1.17-2.32, 
p=0.005).  
The HR for each additional adversity between birth and age 44 
(maximum value is 6 or more) is 1.15, 95%CI=1.05-1.26, p=0.002.The HR 
for maximum adversity as opposed to none is 2.34. 
The HR for each additional adversity between birth and age 59 
(maximum value is 7 or more) is 1.14, 95%CI=1.04-1.25, p=0.004. The 
HR for maximum adversity is 2.53. 
2a. Adversities during different life 
stages combine cumulatively to 
predict increased risk of RA 
onset.  
Each additional life stage in which at least one adversity is experienced 
is associated with a HR of 1.34 (95%CI=1.13-1.58, p=0.001) for RA onset 
from age 45, and of 1.31 (95%CI=1.11-1.55, p=0.002) for RA with onset 
from age 60.  
2b. Using these data, it is not possible to draw conclusions about the relative salience for RA onset of adversity 
during particular life stages. 
3a. Material and social adversities 
independently predict RA 
onset. 
 
After adjustment for material adversity, associations between RA onset 
and social adversities are statistically significant.  
For example, each additional social adversity during childhood 
(maximum value of 3 or more) is associated increased hazard of RA 
onset from age 16 by 1.18 (95% CI=1.00-1.39) p=0.046. The HR 
associated with maximum social adversity during childhood as opposed 
to none is 1.66. 
For RA with onsets from 45 and 60, the HRs associated with maximum 
life-course social adversity as opposed to none are 3.56 and 2.51, 
respectively. 
Associations with material adversity after adjustment for social 
adversities are positive but most are not statistically significant. 
However, exposure to one or more adversities between birth and age 
59 is associated with increased risk of RA onset from age 60; HR=1.49, 
95%CI=1.03-2.17, p=0.037. 
3b. Associations between RA onset and material and social adversities are not mediated by smoking. This is a 
new finding. 
4a. Both relationship-related and 
traumatic adversities appear to 
contribute to RA onset.  
 
Exposure to one or more traumatic adversity during childhood is 
associated with RA onset from age 16 (HR=1.29, 1.03-1.62, p=0.029).  
Exposure to each additional group of relationship-related adversities 
between birth and age 44 (maximum of three) is associated with an 
increased hazard of RA onset from age 45 by 1.30 (95%ci 1.06-1.61, 
p=0.014). The HR for maximum as opposed to no relationship-related 
adversity is 2.20.  
4b. Chronic adversities predict RA 
onset. Acute adversities do not. 
 
Exposure to one or more chronic adversities between ages 16 and 44 is 
associated with an increased risk of RA onset from age 45; HR=1.45, 
95%CI=1.06-1.98, p=0.020.  
Exposure to one or more chronic adversities between ages 16 and 44 is 
associated with an increased hazard of RA onset from age 60 by 1.65, 
95%CI=1.11-2.47, p=0.014. 
 There is no evidence of gender differences for any of the results 
 These findings are robust to sensitivity analyses that exclude respondents whose recall may have been 
inaccurate or biased by symptoms of RA, and also to sensitivity analyses that used multiple imputation 
based on indices of adversity in the observed datasets that are created for all respondents who provided 
information about most adversities, rather than only for those who provided complete information. 
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Research Question 2: How do adversities combine over the life-course to predict RA 
onset? 
This is the first study that I am aware of which tests how exposures during different life 
stages combine to predict RA onset. The evidence presented here is consistent with a 
cumulative life-course model; the more life stages during which one is exposed to adversity, 
the greater the risk of developing RA later in life. This finding is robust to a range of 
sensitivity analyses. 
The finding resonates with theories about allostatic load, which is conceptualised as a 
marker of physiological wear and tear resulting from stress that accumulates over the life-
course (McEwen & Stellar 1993). Gustafsson and colleagues describe the development of 
physiological disadvantage across multiple inter-related systems as, “an ‘historical index’ of 
physiological toll” (2012,p.118). Several studies provide evidence consistent with the 
accumulation of physiological disadvantage over the life-course (Gustafsson et al. 2012, 
Singer & Ryff 1999, Robertson et al. 2014). The evidence provided here is consistent, but 
applies to a specific form of physiological disadvantage, associated with immune function. 
More detailed tests of how adversities combine over the life-course to predict RA onset 
provided results that were not robust to sensitivity analyses. RA onset was regressed on 
adversity during all life stages with mutual adjustment but sensitivity analyses indicate that 
results depended upon the sample used and the questions used to measure adversities and 
their timings.  
I therefore conclude that retrospective information about timings of adversity is not very 
accurate. This casts doubts on the validity of the evidence used to test the cumulative life-
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course model, and means that no conclusions could be drawn about whether adversity 
during any particular life stage is salient for RA onset.  
Nevertheless, these results indicate that the timing of adversity may be important for RA 
onset. Ideally, prospective data should be used to examine life-course patterns of adversity 
as predictors of RA onset. 
Research Question 3: Do material, psychosocial and behavioural factors 
independently predict onset of rheumatoid arthritis? 
Material and social adversities independently predicted RA onset. These associations were 
not explained by smoking. This is consistent with existing theory that socio-economic 
inequalities in health develop over the life-course through interlinked material and 
psychosocial pathways (Benzeval et al. 2014). Psychosocial pathways are the focus of this 
thesis and additional findings relating to social adversities are discussed below in relation to 
Research Question 4. 
Adversities hypothesised to affect health through material pathways are poor household 
amenities during childhood and self-reported severe financial hardship and unemployment. 
Evans & Kantrowitz (2002) summarise evidence showing that those living on lower incomes 
are more likely to reside in neighbourhoods with higher levels of factory emissions and 
other ambient air pollutants, and Finkelstien et al. (2003) similarly report that in Ontario, 
mean levels of pollutants tended to be higher in lower income neighbourhoods. Thus, it 
seems plausible that respondents who reported material hardship tended to spend periods 
living in areas with relatively high levels of air pollution. As explained in the introduction, 
studies provide evidence consistent with the hypothesis that air pollution leads to RA onset 
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(Hart et al. 2009, De Roos et al. 2014). In addition, respondents reporting severe financial 
hardship and periods of unemployment are more likely than those who did not to have 
worked in occupations associated with exposures to silica (e.g. mining, stone working, 
masonry, glass and ceramics manufacturing, stone drilling, rock crushing), and mineral oils 
(e.g. the motor industry), which have been found to predict onset of RA (Sverdrup et al. 
2005). 
Of course, material hardship has social and psychological consequences. Some of these are 
adjusted for as social adversities were included in the models. As explained in the 
introduction, psychosocial pathways leading to the development of RA are likely to involve 
psychological and physiological stress responses, as discussed in relation to Research 
Question 4 below. 
Adjustment for smoking did not attenuate associations between material or social 
adversities and RA onset. Interestingly, Bergstrom, who found that adults with manual 
occupations were at relatively high risk of developing RA, similarly reports that smoking did 
not mediate the association (Bergstrom et al. 2011). Other behaviours and their 
consequences thought to predict RA, such as diet, BMI, and (low) alcohol consumption 
(Lahiri et al. 2012, Hoovestol & Mikuls 2011, Tobon et al. 2010) were not included in these 
analyses because relevant information was not collected in LIFE. These behaviours may 
mediate associations between adversity and RA onset. 
After adjustment for material and social adversities, birth cohort, education and gender, 
there was no strong evidence of an association between smoking and RA onset. Adjusting 
only for gender, there is stronger evidence that smoking predicts RA onset. This is consistent 
with existing evidence that smoking predicts RA onset (Tobon et al. 2010, Lahiri et al. 2012).  
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Research Question 4: Are some types of social adversity more salient predictors of RA 
onset than others? 
The inclusion of a wide range of social adversities made it possible to compare the 
importance for RA onset of different types of social adversity. The finding that family-related 
and traumatic adversities independently predict RA onset has important policy implications 
as it is an added incentive for policy makers to target interventions that minimise exposure 
to these types of adversity and support those who are nevertheless exposed to them. 
New evidence that chronic but not acute adversities predict RA onset is strong. Even though 
numbers are small, associations with chronic adversities are statistically significant. The 
results are robust to sensitivity analyses. 
The evidence is consistent with theories of allostatic load (McEwen & Seeman 1999), and of 
the impacts of stress on the immune system (Miller et al. 2014, Cohen et al. 2012). As 
explained in the introduction, whilst acute experiences of stress elicit physiological 
responses that are unlikely to have long term harmful effects, chronic stress can result in 
lasting damage and dysregulation of multiple inter-related physiological systems. More 
specifically, continued exposure to cortisol, one of the hormones released during the stress 
response, can result in a type of dysregulation of immune function called glucocorticoid 
resistance, resulting in uncontrolled inflammation. Glucocorticoid resistance is associated 
with RA and other immune-mediated conditions such as asthma and ulcerative colitis (Pace 
et al. 2007, Pariante & Miller 2001). Evidence that exposure to chronic social stressors 
predicts subsequent RA onset suggests a chain of causal relationships in which exposure to 
certain stressors results in chronic experiences of stress, that lead to in the development of 
glucocorticoid resistance, which in turn contributes to the development of RA.  
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As I was unable to measure chronic stress directly, I used as a proxy measure exposure to 
adversities that one would expect to be associated with chronic stress. Adversities that one 
would expect to have acute impacts were similarly used as a proxy for acute stress. Using 
these proxy measures, I found evidence that is consistent with theory. Therefore, the 
findings are of importance, not only substantively, but also because they indicate that 
exposure to particular types of adversity may be useful measures of chronic and acute 
stress. Information about adversities over the life-course is available in longitudinal and 
cohort studies, and is particularly useful for examining impacts of stress over long periods of 
time. Hair cortisol, which is a relatively new and precise measure of stress cannot yet be 
used to examine long term impacts of stress. 
The chronic adversities used were partnership breakdown, living with a partner or child who 
abused drugs or alcohol, and caring for a friend or relative. The acute adversities were 
witnessing a death or serious injury, a major natural disaster, being a victim of a sexual 
assault, and being a victim of a serious physical attack. Other adversities could be added to 
each list. 
The results reported above are robust to sensitivity analyses that create indices of adversity 
in different ways, and that exclude information given by participants whose recall may have 
been inaccurate or biased by symptoms of RA. 
5.2. Limitations 
1. Accuracy of RA measurement 
Three point nine four per cent of the sample used for the analyses (who participated in LIFE 
and provided information about RA onset, date of birth and gender) reported a history of 
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RA. Whilst it is impossible to assess with any certainty the accuracy with which these 
prevalence rates reflect prevalence rates in the English population, they are much higher 
than estimates of around 1% reported in other studies of Western countries.  
Abdel-Nasser and colleagues (1997) discuss the difficulties associated with comparing 
prevalence rates of RA. The severity of RA symptoms fluctuate, and it is more likely to be 
reported when symptoms are severe, which results in under-reporting of the condition. This 
type of under-reporting may apply less to participants in the ELSA study, as they have been 
asked whether they have a history of RA on 7 occasions over 13 years. For example, 
Widdifield et al. 2014 found an increase in prevalence rates in Ontario, Canada between 
1996 (0.49%) and 2010 (0.90%), which they partly attribute to more time in the survey and 
consequently more opportunities to report the existing condition.  
Abdel-Nasser and colleagues also suggest that comparison of prevalence rates is 
complicated by differences in the denominator population. In ELSA, the population is an 
ageing one; prevalence rates of RA are higher among older age groups, and there are high 
rates of attrition due to mortality. Incidence rates, measured in person years from birth, 
side-steps this issue to some degree. Incidence rates among LIFE participants (0.57 per 
1,000 per year) are fairly close to those reported in Ontario by Widdefield et al. (2014) (0.54 
per 1,000 per year). 
However, the gender difference in RA prevalence, whilst in the expected direction, is much 
smaller than the gender difference reported elsewhere. This suggests that women with RA 
are under-represented in this sample. It is possible that among women with RA, those who 
participated differ from those who did not. For example, those with more severe symptoms 
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of RA maybe less likely to participate in the HSE surveys from which the ELSA samples were 
drawn. It is impossible to know how the exclusion of these women affects the results. 
The finding that older birth cohorts tend to report RA onset at older ages than younger birth 
cohorts is consistent with evidence that RA became a more common diagnosis in the UK up 
to the late 1960s (Abdel-Nasser 1997). Similarly, the socio-economic patterning of RA in 
these data is consistent with evidence from other studies, described in the introduction 
(Bergstrom et al. 2011, Bergstrom et al. 2013, Voigt et al. 1994). 
2. Accuracy of retrospective information 
Another limitation is the accuracy with which adversities and health behaviours were 
recalled. In relation to life events, Gorman (1993) reviewed studies that compare 
retrospective accounts of life events using checklists, similar to those used in ELSA, and in-
depth interviews. He concludes that checklists do not distinguish the intensity of events and 
compared against in-depth interviews, over-report life events. In relation to childhood 
adversity, Susser & Widom (2012) summarise evidence that individuals who experienced 
sexual and physical abuse during childhood tend to under-report it as adults. These types of 
measurement error would tend to reduce the consistency and magnitudes of associations 
with RA, lending confidence to any associations found.  
Recall may also be less accurate among respondents with poor recall (Brown 2013). In 
addition, symptoms of RA may bias reporting of childhood adversities (Raphael et al. 2001, 
Widom & Morris 1997). To address this possibility, sensitivity analyses were conducted that 
excluded 3,173 cohort members who scored poorly on a memory recall test or reported 
pain or depression. The general pattern of results was much the same. However, evidence 
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about the relative importance for RA onset of adversity experienced during different life 
stages was unreliable. I conclude that retrospective information about the timings of events 
and circumstances is not sufficiently accurate to make this sort of comparison. 
Consequently, evidence about how adversity during each life stage combines to affect risk 
of RA onset may not be robust. Conclusions about the cumulative impact of adversities 
experienced during different life stages are based on this evidence, and should be tested 
using other datasets.   
3. Representativeness of the sample 
An additional limitation is that we cannot be sure to what extent associations reported here 
reflect patterns common to other populations. Firstly, the sample is drawn from adults living 
in England and the results may not apply to adults living elsewhere. Second, the sample 
used is a sub-sample (those who participated in LIFE and provided information about RA 
onset, gender and date of birth) of a sample (ELSA wave 3 participants) of a sample (drawn 
from HSE). It is therefore unlikely to be representative of people aged 50 and over living in 
private households in England.  
Multiple imputation addresses part of these sample biases because it uses information from 
all waves of ELSA to impute missing values. Thus, one would expect the distribution of 
variables among LIFE participants in multiple imputed datasets to be similar to those who 
participated in any wave of ELSA.  
ELSA documentation (Ward et al. 2009) lists the characteristics of individuals who 
participated in at least one wave of ELSA but did not participate in LIFE. Non-participants are 
more likely than LIFE participants to live in an area of multiple deprivation, have low levels 
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of qualifications and be renting or paying a mortgage as opposed to owning their home 
outright. These characteristics suggest that compared to LIFE participants, non-participants 
are likely to have been exposed to more adversities during their lives. Thus, the additional 
bias in the LIFE sample (over and above the sample bias in ELSA) would tend to reduce mean 
levels of adversity. This is addressed by multiple imputation, as evidenced by mean levels of 
adversity being consistently higher in the imputed datasets than in the observed sample. 
This lends confidence to the validity of the datasets with imputed values. 
To the extent that sampling bias remains after multiple imputation, it probably serves to 
reduce the variation in adversity because those exposed to high levels of adversity were less 
likely to participate. This would result in under-estimations of associations between 
adversity and other variables, including RA onset, which means that we can be more 
confident about the associations found. 
On the other hand, because this is an ageing sample it is subject to survival bias. Lifetime 
prevalence rates are highest for the cohort born before 1921, which probably reflects 
survival bias as respondents with other health conditions die or fail to participate. To the 
extent that non-participation occurs not due to mortality but for age -related reasons, RA 
rates among older ELSA respondents will be higher than they are in the population. This 
would lend power to the analyses but would mean that associations found in the sample 
might not be found in a more representative sample of the population. 
4. Low numbers reported RA, multiple testing and new findings 
A further limitation is that numbers reporting RA are not high. RA is not common and so 
numbers are likely to be low in most population surveys, which is probably partly why so 
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little evidence exists about its social determinants. By using a large study of ageing adults 
combined with multiple imputation, it has been possible to provide relatively robust 
evidence. Findings that are statistically significant despite a lack of power indicate strong 
associations, but some trends are not statistically significant. Furthermore, numerous 
associations were tested and some may be statistically significant by chance, and many 
findings were new and so were unsupported by similar findings from other studies. While 
the originality of the evidence is a strength, findings should now be tested using other 
datasets. 
5. Sub-types of RA not examined 
As mentioned in the introduction, about 70% of people diagnosed with RA are seropositive. 
Various authors suggest that the factors that predict seropositive RA and seronegative RA 
differ (Huyser & Parker 1998). It has not been possible to investigate this possibility, as no 
information was available in the ELSA dataset about the presence or otherwise of serum 
rheumatoid factor. 
5.3 Main conclusions and their implications 
This chapter provides new evidence consistent with the importance of psychosocial 
pathways in the development of RA. After adjustment for a wide range of material 
adversities, social adversities predicted RA onset and this association was not mediated by 
smoking. Additional analyses indicate that family-related and traumatic social adversities 
predicted RA onset after mutual adjustment and adjustment for material adversities. 
Further, chronic as opposed to acute social adversities predicted RA onset, which is 
consistent with physiological evidence about the effects of stress on immune dysregulation. 
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In addition, new evidence suggests that adversities (material and social) combine 
cumulatively over the life-course to predict RA onset. Evidence that adversities predict RA 
onset is stronger than in previous studies, probably reflecting the scope of the data and 
measures used. 
These findings have implications for policy makers, clinicians, and researchers.  
Policy makers should focus on limiting exposure to social adversities likely to cause chronic 
and/or intense stress, especially relating to relationships and trauma, during all life stages 
and on providing support to those individuals who are nevertheless exposed. For example, 
additional support could be extended towards individuals who care for older relatives, and 
the parents and partners of those who are addicted to alcohol or drugs. In relation to 
material pathways, the evidence presented here highlights findings from other studies that 
exposure to airborne pollutants contribute to RA onset. Policy makers should seek ways to 
reduce such exposures.  
The findings have clinical relevance because better understanding of environmental factors 
that predict RA onset will help doctors to diagnose and treat the condition sooner. This is 
important because progression of RA causes irreversible damage, which can be prevented 
by therapeutic interventions.  
The findings provide insights for future research into the social epidemiology of RA and of 
other systemic immune-mediated conditions. In particular, it may be fruitful to examine the 
relative importance of chronic and acute stress, which has been measured here using 
different types of adversity. Further research is needed not only to test the reliability of 
findings presented here, but also to examine in more detail the aspects of adversities (e.g. 
Chapter 3: Adversities and onset of rheumatoid arthritis             162 
 
 
 
chronicity and timing) that are associated with the dysregulations of immune function found 
in RA and other immune-mediated conditions. 
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Chapter 4: Prospective associations between low-grade 
inflammation and depressive symptoms, and the 
factors that moderate and mediate them 
1. Introduction 
Scientific interest in relationships between immune activity and psychological symptoms has 
developed recently and is reflected in the emergence of a discipline called 
psychoneuroimmunology (Ader 2000). Physiological evidence indicates links between 
immune function and psychological symptoms, which can inform studies in social 
epidemiology. This area of social epidemiology is relatively new and under-researched, 
partly because the physiological evidence is relatively new and partly because immune 
function is difficult to measure without the use of biomarkers, and these have only been 
introduced in surveys in the last few years. This chapter provides prospective 
epidemiological evidence about relationships between chronic low-grade inflammation and 
depressive symptoms. 
This section introduces the rationale for this chapter, describes inflammation and 
summarises evidence about relationships between inflammation and depressive symptoms. 
It discusses pathways that might explain the association, and whether these vary by gender, 
age category and health status. Health status includes specific health conditions; 
rheumatoid arthritis (RA) and asthma, as these conditions are driven by immune 
dysregulation and were the subjects of earlier chapters. Research questions are presented 
at the end of the section. 
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1.1 Rationale 
There is a growing literature about the biological pathways that link inflammation with 
depressive symptoms. Epidemiological evidence indicates that inflammation is associated 
with depressive symptoms, but large-scale prospective evidence is limited and results are 
not entirely consistent.  
Evidence about prospective relationships between inflammation and depressive symptoms 
and the factors that mediate them is important because it may inform earlier diagnosis and 
treatment of both depression and disorders involving high levels of inflammation.  
This information can be used to inform the design and targeting of interventions that 
protect individuals from developing depressive symptoms as a consequence of 
inflammation, and inflammation as a consequence of depressive symptoms. A meta-analysis 
of evidence concerning prospective associations between inflammation and depression 
concludes that it is,  
“imperative that prospective studies of both community-based and clinical samples 
be undertaken to test the directionality of the relationship between depression and 
inflammation and to further elucidate mediating and confounding factors. Such 
knowledge will help inform interventions to increase the quality of life in patients 
with pathological inflammatory conditions […] and to decrease the risk of such 
diseases in individuals who are otherwise healthy but suffer from depression” 
(Howren et al. 2009:182).  
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1.2 Inflammation 
Injury and infections provoke an acute inflammatory response, in which levels of 
inflammation increase enormously and then return to baseline levels once the trigger is 
controlled or eliminated. Immune-mediated diseases such as RA and asthma develop when 
acute inflammation does not resolve and chronic high-grade inflammation develops (Calder 
et al. 2013). However, in individuals free of these diseases, full resolution occurs and 
inflammation levels return to baseline.  
Baseline levels of inflammation vary between individuals and under different conditions. For 
example, an elevated baseline level of inflammation, referred to as chronic low-grade 
inflammation, can develop in obesity and with age (Calder et al. 2013). It predicts 
cardiovascular disease, type II diabetes and mortality (Maes et al. 2011, Liu et al. 2016, 
Padayachee et al. 2009, Zhang 2011). 
Symptoms of acute inflammation include redness, swelling, heat and pain (Calder et al. 
2013). Acute inflammation is also accompanied by sickness behaviours, such as fatigue, 
social withdrawal, negative mood, loss of appetite and sleep disturbance, as well as 
increased arousal and anxiety (Miller & Raison 2016, Dantzer & Kelly 2007). 
CRP is routinely used in clinical settings to measure inflammation. In healthy individuals, the 
median plasma concentration is 0.8mg/litre, but levels rise by up to 1,000-fold in response 
to injury or infection (Slaats et al. 2016, Kushner 1982). It has the practical advantages of a 
long half-life, meaning that it is relatively stable in blood samples (Pearson et al. 2003), little 
diurnal variation (Dominguez-Rodriguez et al. 2009), and insensitivity to factors that affect 
plasma levels of many other biomarkers of inflammation, such as feeding state, physical 
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activity and acute psychological stress. Consequently, CRP is a highly sensitive and accurate 
marker of inflammation. 
1.3 Relationships between inflammation and depressive symptoms 
Associations between inflammation and depression were first reported in small-scale clinical 
studies (Maes et al. 1993a, Maes et al. 1993b). Subsequent large-scale studies and meta-
analyses provide convincing evidence of small associations between many inflammatory 
markers and both clinical depression (Jiang et al. 2014, Hiles et al. 2012, Dowlati et al. 2010) 
and symptoms of depression (Howren et al. 2009). Relationships with depressive symptoms 
appear to be dose-dependent (Howren et al. 2009). However, the evidence is not entirely 
consistent; for example, a recent large-scale study in Brazil found no evidence of a cross-
sectional association between clinical depression and chronic low-grade inflammation after 
adjustment for lifestyle and co-morbidities, as well as medication use and socio-
demographic variables (de Menezes et al. 2017). 
Cross-sectional associations between inflammation and depressive symptoms could reflect 
various underlying pathways, which are set out in Figure 4.1. This illustrates auto-
correlations over time for both inflammation and depressive symptoms, cross-sectional and 
prospective correlations between inflammation and depressive symptoms, and prospective 
associations that are mediated and/or confounded by additional factors. These relationships 
may differ by moderating factors such as gender, age, SEP and health status. 
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Figure 4.1:   Model of relationships between depressive symptoms and inflammation 
 
  
 
 
 
 
 
 
 
 
 
 
All relationships may differ by moderating factors, such as gender, age, SEP and health status 
1.4 Direct effects of inflammation on depression: The inflammatory theory of 
depression 
The inflammatory theory of depression (Smith 1991, Miller & Raison 2016) is described in 
Chapter 1. In brief, the theory proposes that sickness behaviours associated with 
inflammation – fatigue, social withdrawal, negative mood, loss of appetite and sleep 
disturbance, increased arousal and anxiety – correspond with, and also contribute to the 
development of, various psychiatric disorders, including schizophrenia, anxiety and 
depression. 
As mentioned in Chapter 1, understanding is developing about the physiological 
mechanisms that link inflammatory processes with psychological changes that characterise 
sickness behaviours (Byrne et al. 2016, Miller & Raison 2016). It is likely that psychological 
stress interacts with these mechanisms as activation of the HPA axis, which is central to the 
physiological stress response, is one of the mechanisms involved (Jiang et al. 2014, Makhija 
& Karunakaran 2013, Capuron & Miller 2011). Further, clinical and animal studies report 
evidence consistent with the theory. These studies involve administration of pro-
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inflammatory cytokines, which have been found to induce depressive symptoms in humans 
and depressive-like behaviours in animals (Byrne et al. 2016, Dantzer & Kelly 2007).  
In addition, some studies report that anti-inflammatory drugs reduce depressive symptoms 
(Kohler et al. 2014, Kohler et al. 2016). These findings have received particular attention 
because they raise questions about whether anti-inflammatories could be used to treat 
some forms of depression (Miller & Raison 2016), especially those that are resistant to 
conventional anti-depressants (Strawbridge et al. 2015, Hughes & Kumari 2017). However, 
the evidence is not consistent, probably reflecting small effect sizes if they exist and 
differences in methodologies and sample characteristics (Eyre et al. 2015).  
As mentioned above, most epidemiological studies using cross-sectional data report that 
inflammatory biomarkers are raised among individuals with depression and depressive 
symptoms. Fewer epidemiological studies use longitudinal data and so conclusions about 
prospective associations between inflammation and subsequent depression or depressive 
symptoms remain tentative.  
Various issues may contribute to differences in findings between epidemiological and 
clinical or animal studies. One issue, discussed by Dantzer et al. (2011) is that depression is 
defined and diagnosed by symptoms and probably encompasses a range of disorders with 
multiple causes. They refer to “inflammation-associated depression” as one type of 
depression that is characterised by elevated plasma levels of pro-inflammatory cytokines, 
and which may be more responsive to anti-inflammatories. This type of depression may be 
identified in clinical and laboratory studies, but in drug tests and epidemiological studies, it 
is not distinguished from other forms of depression that are not affected by inflammation. 
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In addition, laboratory and clinical studies involve the acute inflammatory response, while 
drug treatments are given to patients who mostly have lower levels of inflammation, and 
epidemiological studies measure chronic low-grade inflammation. In illustration, 
epidemiological studies using CRP levels to indicate chronic inflammation often exclude 
measures over 10mg/litre and use a cut-point indicating chronic inflammation of 3mg/litre. 
In contrast, during acute inflammation, CRP levels can reach 800mg/litre (Slaats et al. 2016). 
It is in relation to low-grade inflammation that the evidence is less consistent. Magnitudes 
of associations between chronic low-grade inflammation and depressive symptoms may be 
very small, if they exist at all, and consequently difficult to identify.  
More fundamentally, it is not necessarily the case that chronic low-grade inflammation has 
the same psychological correlates (albeit scaled-down) as an acute inflammatory response. 
Further, the timing of any relationship with depressive symptoms may differ depending 
upon whether an acute inflammatory response or chronic low-grade inflammation is 
measured. As explained in chapter 1, Dantzer et al. (2011) suggest that whilst sickness 
behaviours occur at the same time as the acute inflammatory response, depressive 
symptoms develop over time in response to the sickness behaviours. Little is known about 
the relative timings of any relationships between chronic low-grade inflammation, sickness 
behaviours, and the development of depressive symptoms, and so it is unclear what follow-
up times are appropriate for testing any prospective association. Follow-up times vary 
widely between epidemiological studies, but tend to be measured in years. 
1.5 Direct effects of depressive symptoms on inflammation 
Depression may affect inflammation via pathways similar to those associated with the stress 
response, involving HPA axis hyperactivity, glucocorticoid resistance and dysfunction of the 
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autonomic nervous system (Martinac et al. 2014, Penninx et al. 2013, Kop & Gottdiener 
2005).  
It is more difficult to test direct effects of depressive symptoms on inflammation than vice 
versa because whilst inflammation can be induced artificially, depressive symptoms cannot. 
However, two studies found that people with more depressive symptoms had greater and 
more prolonged inflammatory responses to influenza vaccinations than people with fewer 
depressive symptoms (Glaser et al. 2003, Christian et al. 2010). Also, inflammation following 
birth appears to be greater among mothers with a history of major depression (Maes et al. 
2001).  
In contrast, evidence about the efficacy of anti-depressants on inflammation is inconsistent 
(Alexopoulos & Morimoto 2011, Hamer et al. 2011), and so is evidence from epidemiological 
studies using longitudinal data. 
1.6 Epidemiological evidence about prospective associations between inflammation 
and depressive symptoms  
1.6.1 Evidence of prospective associations 
A systematic review and meta-analyses of evidence about associations between 
inflammatory biomarkers and subsequent depressive symptoms concluded that there is a 
small but statistically significant association, which is robust to adjustment for a wide range 
of factors, although evidence of publication bias cast doubt on this conclusion (Valkanova et 
al. 2013). Three subsequent large-scale studies similarly report prospective associations that 
are robust to age, gender, and other sociodemographic variables (Das 2016, Au et al. 2015, 
Chocano-Bedoya et al. 2014). Das and Au report prospective associations with depressive 
symptoms that were robust to inclusion of additional covariates; health-related behaviours, 
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metabolic factors, health conditions and medication use. The third study (Chocano-Bedoya) 
finds no evidence of an association when additional factors were included, possibly because 
the number of covariates included was higher than in the other studies, the sample 
consisted of women only, and the outcome was incident depression as opposed to 
depressive symptoms. A fourth study (Baune et al. 2012) reports no evidence of a 
prospective association between CRP and depressive symptoms two years later. This may 
reflect lack of power, as the sample is relatively small (about 700), and results are only 
presented for models that adjust for all covariates. 
Evidence about the prospective association between depressive symptoms and subsequent 
inflammation is less consistent. Several epidemiological studies report no evidence that 
depressive symptoms predict CRP (Das 2016, Au et al. 2015, Gimeno et al. 2009). In 
contrast, Stewart et al. (2009) found a prospective association with a biomarker of 
inflammation called IL-6, and Matthews et al. (2010) report an association with CRP that was 
marginally non-significant after adjustment for covariates (baseline CRP, race, education, 
medication use, and health behaviours, p=0.10). It appears that cumulative episodes of 
depression predict subsequent CRP (Copeland et al. 2012, Duivis et al. 2011, Hamer et al. 
2009, Deverts et al. 2010), whilst acute fluctuations in depressive symptoms predict IL-6  
(Rohleder & Miller 2008).  
The lack of strong epidemiological evidence about prospective associations in both 
directions probably reflects associations of very small magnitude if they exist at all. 
Furthermore, levels of inflammation and depressive symptoms change together over time 
and unless they are measured on multiple occasions, it is problematic to draw firm 
conclusions about whether inflammation precedes depressive symptoms or vice versa. 
Because biomarkers of inflammation have only recently been included in large-scale 
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longitudinal surveys, most epidemiological evidence relies on data about inflammation 
measured on just two occasions.  
Inconsistent epidemiological evidence may result from differences between studies in 
biomarkers used to measure inflammation, and in measures of depressive symptoms. 
Various instruments are used to measure depressive symptoms and to identify incident 
depression, including instruments such as the GHQ, which is designed to measure wellbeing, 
not depressive symptoms. Studies also vary in terms of sample size, sample characteristics, 
time to follow-up, and which covariates are included (Das 2016, Engler et al. 2016).  
The research presented here provides valuable epidemiological evidence about prospective 
associations between inflammation and depressive symptoms, especially because it uses 
large-scale data in which inflammation is measured on three occasions. It also provides new 
evidence about the factors that might confound or mediate these associations. 
1.6.2 Evidence of confounders and mediators 
Confounders and mediators predict both inflammation and depressive symptoms. 
Confounders occur earlier in causal pathways than either inflammation or depressive 
symptoms, and mediators occur after either inflammation or depressive symptoms but 
earlier than the predicted outcome. If a variable confounds or mediates an association 
between inflammation and depression, then adjustment for this variable will change 
(usually reduce) the magnitude and consistency of the association.  
It is likely that factors mediate associations between inflammation and depressive 
symptoms found in prospective epidemiological studies because follow-up times are 
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typically measured in years. During these periods, respondents are exposed to 
circumstances and events and engage in activities that could affect predicted outcomes. 
Confounders, mediators and moderators (discussed in 1.6.3) are conceptually distinct but 
some factors occupy more than one role. For example, obesity is classified here as a possible 
mediator, but it could also be classified as a confounder. SEP is classified as a possible 
confounder, but could also be a moderator.  
Little evidence exists about the factors that confound, mediate and moderate prospective 
associations between inflammation and depressive symptoms, although studies include 
similar co-variates. The factors I consider as possible confounders, mediators and 
moderators draw on these studies. I also include factors that are linked to sickness 
behaviours as these may mediate associations between inflammation and subsequent 
depressive symptoms, and health behaviours as these may mediate associations between 
depressive symptoms and subsequent inflammation. 
I classify SEP, personality traits, childhood adversity, functional limitations and medications 
as possible confounders. Factors classified as possible mediators include psychological stress 
and social withdrawal (because each is likely to be associated with sickness behaviours), 
health behaviours, pain, obesity and other metabolic biomarkers. Psychological stress is 
classified as both a confounder and a mediator. 
SEP is likely to confound the association between inflammation and depressive symptoms 
because it predicts not only inflammation and depressive symptoms, but also the factors 
that may confound or mediate the association.  
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Friedman (2008) suggests that personality could be associated with a range of health 
outcomes, including depressive symptoms and inflammation. He describes two mechanisms 
through which personality could affect health. One is that personality affects responses to 
stressful exposures, and the other is that genetic factors and very early experiences shape 
personality and affect health outcomes in ways that are systematically related.  
There is some evidence that baseline levels of CRP are associated with personality traits, for 
example, high harm avoidance and low self-directedness predict high levels of CRP 
(Henningsson et al. 2008). Conscientiousness (one of the Big Five) predicts positive health 
behaviours (Bogg & Roberts 2004), low risk of chronic illness (Goodwin & Friedman 2006), 
and longevity (Friedman 2008), and it is possible that it predicts low inflammation also. In 
addition, certain aspects of personality predict depressive symptoms. Internalising 
behaviours during childhood predict depressive symptoms (Toumbourou et al. 2011, Dingle 
et al. 2011), and neurotic personality trait, another of the Big Five, is thought to involve 
depression (Friedman 2008).  
Childhood adversity predicts a wide range of negative outcomes (Felitti et al. 1998) that 
include in adulthood both depressive symptoms (Nelson et al. 2017, Li et al. 2016) and 
chronic inflammation (Berk et al. 2013, Fagundes et al. 2013, Hansal et al. 2010, Taylor et al. 
2006). A small-scale study of cancer patients reports a prospective association between CRP 
and depressive symptoms 6 and 12 weeks later that is no longer statistically significant after 
adjustment for childhood trauma (Archer et al. 2012). 
Functional limitations are associated with both higher levels of inflammation (Brinkley et al. 
2009) and depressive symptoms (Redmond & Barrett 2015). Van den Biggelaar et al. (2007) 
report a prospective association between baseline CRP levels and depressive symptoms over 
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5 years that was robust to adjustment for numerous covariates, including functional 
limitations.  
As mentioned above, there is some evidence that anti-inflammatory medications reduce 
depressive symptoms and that anti-depressants reduce inflammation, although reviews and 
meta-analyses conclude that the evidence is inconsistent (Eyre et al. 2015, Alexopoulos & 
Morimoto 2011). Most prospective studies adjust for medication use if information is 
available, but just one study examines attenuation by medication alone. Gimeno et al. 
(2009) compared associations between CRP and depressive symptoms almost 12 years later 
adjusting for age, gender, and ethnicity, and for these covariates plus medication use, and 
the magnitude and consistency of the association barely changed. 
Stress may lead to chronic inflammation through the development of glucocorticoid 
resistance. In line with this hypothesis, reviews of studies examining work, unemployment, 
caregiving, interpersonal stress and loneliness conclude that chronic psychological stress 
predicts CRP levels (Johnson et al. 2013, Hansel et al. 2010). In relation to acute stress, a 
review and meta-analysis of 30 studies found that acute stress was followed by increased 
levels of inflammation measured using plasma cytokines (IL-1 and IL-6), although the 
evidence was marginal in relation to CRP (Steptoe et al. 2007). Berk et al. (2013) examined 
the causes of chronic inflammation, and identified psychosocial stress, which involves 
psychological responses to social exposures, as a robust predictor.      
Psychological stress may also mediate associations between inflammation and depressive 
symptoms. Gutman and Nemeroff (2011) state that “no experienced practitioner would 
doubt the fact that stress and depression are inexorably linked” (p.345). Studies report that 
depression and depressive symptoms are predicted by stressful life events (Hammen 2005, 
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Leggett et al. 2016) and that bi-directional relationships exist between depressive symptoms 
and relationship stress (Whisman & Ubelacker 2009). Depressive symptoms may affect 
exposure to stressors, their appraisal, coping responses and inflammatory responses. 
Kiecolt-Glaser et al. (2015) draw on a range of studies to argue that people with a history of 
depression report a relatively high number of stressors but have fewer resources to cope 
effectively with them because they have fewer close family relationships.  
Sickness behaviours associated with inflammation include increased arousal, anxiety and 
negative mood, which are likely to affect appraisals of adversities such that they are 
perceived as more stressful. Consistent with this argument, Das (2016) reports that low-
grade inflammation measured using CRP predicted perceived stress five years later, 
although the association was only statistically significant among women.                                                                                                                                                                                                                                         
Social withdrawal is a sickness behaviour associated with inflammation. It is a feature of 
both inflammation and depressive symptoms (Dantzer et al. 2008). It also relates to stress as 
social withdrawal leads to isolation and this contributes to psychological stress (Cruces et al. 
2014). 
Pain is associated with both inflammation and depressive symptoms (Kiecolt-Glaser et al. 
2015). Pain and depressive symptoms are highly correlated and relationships between them 
appear to be bi-directional (Zis et al. 2017). Recent evidence and reviews suggest that pain 
and depression share numerous neurobiological mechanisms, including neuro-inflammation 
(Sheng et al. 2017, Zis et al. 2017). The increased arousal associated with the inflammatory 
response could heighten sensitivity to pain. Pain also appears to provoke an inflammatory 
response (Griffis et al. 2013). I am not aware that any epidemiological studies of 
associations between inflammation and depressive symptoms include pain as a covariate. 
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Zis et al. (2017) classify sub-types of pain due to seven causes among elderly people. One 
sub-type is chronic primary pain syndrome, which has no known cause and is typically 
experienced as lower back pain. It is possible that relationships between depressive 
symptoms, inflammation and pain differ between this type of pain and other sub-types. Zis 
et al. (2017) report that evidence about chronic pain subtypes and co-morbid depression is 
lacking. 
Health behaviours that may confound or mediate associations between inflammation and 
depressive symptoms include smoking, drinking patterns and physical inactivity. Most 
studies of the association between inflammation and depressive symptoms adjust for health 
behaviours, but few estimate how much they attenuate the association. Gimeno et al. 
(2009) report negligible attenuation of the prospective association between CRP and 
depressive symptoms (already adjusted for age, gender, and ethnicity) by diet, exercise, 
smoking and alcohol consumption, combined.  
Reviews report associations between smoking and depression, probably reflecting effects of 
depression on smoking behaviours (Mathew et al. 2017), and strong evidence that current 
and past smoking are associated with low-grade chronic inflammation (Berk et al. 2013, 
Calder et al. 2013, O’Connor et al. 2009). More specifically, smoking has been reported to 
attenuate associations between cumulative depressive episodes and recurrent depressive 
symptoms and subsequent elevations in CRP (Copeland et al. 2012, Hamer et al. 2009). 
The link between alcoholism and depression is well established (Boden & Fergusson 2011), 
and inflammatory markers are raised among heavy drinkers and abstainers compared 
against moderate drinkers (O’Connor et al. 2009). Hamer et al. (2009) report that alcohol 
use mediated an association between recurrent depressive symptoms and CRP. 
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Relationships between physical inactivity and depressive symptoms appear to be bi-
directional (Mammen & Faulkner 2013, Pereira et al. 2014). Studies suggest that exercise 
has anti-inflammatory effects (Gleeson et al. 2011) and sedentary behaviour predicts 
inflammation (Berk et al. 2013). This may be because people who are physically inactive are 
more likely to be obese, and obesity is the salient predictor of inflammation. Mixed 
evidence about the positive impacts on chronic inflammation of exercise programmes is 
consistent with this explanation (Calder et al. 2013). However, a large-scale study using ELSA 
data that included both physical inactivity and obesity found that the prospective 
association between recurrent depressive symptoms and elevated CRP (the outcome) was 
mediated independently by each factor (Hamer et al. 2009). 
Obesity is associated with both depression (Daly 2013, Capuron et al. 2017, de Wit et al. 
2010, Luppino et al. 2010) and inflammation (Daly 2013, Castanon et al. 2014, Calder et al. 
2013). Some studies report that the inflammation-depression association is attenuated by 
body mass index (Howren et al. 2009, Copeland et al. 2012) and weight gain (Hamer et al. 
2009).  
Metabolic dysregulation appears to be associated with both inflammation (Yudkin et al. 
2000, Brunner et al. 2002, Tamakoshi et al. 2003, Au & Schmitz 2013) and depressive 
symptoms (Penninx et al. 2013). Tully et al. (2013) found that metabolic markers and obesity 
each moderated associations between CRP and depressive symptoms; associations were 
statistically significant only among those not overweight and without metabolic symptoms. 
However, Gimeno et al. (2009) do not report attenuation of the CRP-depressive symptoms 
association by metabolic biomarkers.  
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1.6.3 Evidence about Moderators 
A factor moderates an association if the association differs depending on the value of the 
moderator. For example, if the association between inflammation and subsequent 
depressive symptoms is stronger for men than women, then gender moderates the 
association. Gender, age and chronic illness are classified as potential moderators, although 
they may also confound associations between inflammation and depressive symptoms. 
In their review, Howren and colleagues (2009) report that there is little evidence about 
gender differences in associations between inflammation and depressive symptoms. 
However, associations appear stronger among men than women and associations between 
inflammation and depression is stronger among samples with a higher proportion of men. 
Evidence published after Howren’s review found prospective associations between CRP and 
depression (incident and depressive symptoms) among men but not women (Luukinen 
2010, Vetter et al. 2013, Das et al. 2016). Gimeno et al. (2009) found prospective 
associations between CRP and depressive symptoms that were of greater magnitude among 
men than women. 
In contrast, Derry et al. (2015) argue that women have greater inflammatory responses than 
men to childhood adversity, interpersonal difficulties, obesity and physical inactivity. They 
further argue that among women, inflammation more strongly predicts perceived 
loneliness, which contributes to onset of depression. These arguments suggest that stronger 
associations between inflammation and depressive symptoms exist among women than 
men. 
It is likely that relationships between inflammation and depressive symptoms differ 
between elderly and younger populations. Alexopoulos & Morimoto (2011) review evidence 
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about inflammation and depressive symptoms among older adults and suggest that some of 
the biological processes involved apply to older but not younger populations.   
One of the differences between older and younger populations is the prevalence of chronic 
illness. Stewart et al. (2009) suggest that samples of healthy respondents manifest little 
variation in inflammation or depressive symptoms, and that effects may be more easily 
identified among samples with relatively poor health. Their own empirical study of 263 
respondents with mean age of 61 found no evidence of a prospective association between 
inflammation and subsequent depressive symptoms. The authors cite a study using a 
sample size similar to theirs (267) but of adults aged 85-90, most of whom had chronic 
health conditions, which reports evidence of prospective associations (Van den Biggelaar 
2007).  
More specifically, relationships between inflammation and depressive symptoms may be 
different in populations with immune-mediated diseases, that is, diseases characterised by 
chronic high-grade inflammation resulting from poor resolution of the acute inflammatory 
response (Calder et al. 2013). These are distinct from diseases that are characterised by low-
grade inflammation, which may be a consequence rather than a cause of the disease. Two 
relatively common immune-mediated diseases are asthma and rheumatoid arthritis (RA).  
Both inflammation and depressive symptoms are relatively high in populations with asthma 
and RA. Asthma is characterised by high levels of inflammation (Arif et al. 2007) and 
depressive symptoms (Frieri et al. 2015, Jiang et al. 2014). RA is similarly characterised by 
high levels of inflammation (Pincus & Tuulikki 2009, Dessein et al. 2004) and depressive 
symptoms (Odegard et al. 2007).  
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Few epidemiological studies have examined associations between inflammation and 
depressive symptoms in populations with immune-mediated conditions. However, biological 
evidence suggest that comorbidity of depression and asthma may result directly from 
immune dysregulation; IL-4 is raised in depression and may contribute to allergic responses, 
such as those that characterise asthma (Jiang et al. 2014). RA is characterised by elevated 
levels of pro-inflammatory cytokines IL-1, IL-6, TNF-α, and IFN-ϒ, which in turn are linked to 
the development of major depressive disorder (Malemud & Miller, 2008). Studies have 
found that among populations with RA, there is an association between IL-6 and depression 
(Zautra et al., 2004), and between CRP (levels are regulated by the cytokines mentioned 
above) and depressive symptoms (Dessein et al. 2004, Odegard et al. 2007, Low et al. 2009, 
Kojima et al. 2009). The last two studies (Low, Kojima) report attenuation of the CRP-
depressive symptoms association by pain and functional limitations among populations with 
RA.  
Asthma and RA are also associated with some of the mediators and confounders listed 
above. For example, both conditions are exacerbated by stress (RA: de Brouwer et al. 2010, 
asthma: Chida et al. 2008). RA is painful (Watkins & Maier 2000, Odegard et al. 2007), and 
among adults with RA, depression predicts pain and functional limitations (Katz & Yelin 
1993). In the reverse direction, among adults with RA, functional limitations predict 
depressive symptoms (Odegard et al. 2007). 
1.7 Research Questions 
More epidemiological evidence is needed to address the research topic addressed in this 
chapter. Physiological investigations and clinical and animal studies provide fairly consistent 
evidence about links between inflammation and depressive symptoms. Epidemiological 
evidence is needed to understand these links in real-life social and economic contexts. The 
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RQs ask about prospective relationships between inflammation and depressive symptoms 
because existing evidence is sparce and not all results are consistent. In addition, new RQs 
are asked about factors that mediate, confound and moderate associations found. These 
RQs are open and exploratory, although the ways in which they are addressed and 
interpretations of findings are informed by existing evidence and theory. 
1. What are the prospective relationships between inflammation and depressive 
symptoms? 
a. Does inflammation at time t-1 predict depressive symptoms at time t? 
b. Do depressive symptoms at time t-1 predict inflammation at time t? 
 
2. Which factors confound and mediate prospective associations between 
inflammation and depressive symptoms? 
 
3. How do the answers to the first two RQs differ: 
a. By gender? 
b. By age group? 
c. For populations with a longstanding illness? 
d. For populations with asthma, and RA? 
2. Methods 
2.1 Data 
Information about the sample is taken from the ELSA user guide waves 1-6, and the ELSA 
nurse user guide waves 2, 4 and 6, which were downloaded from the UK Data Service 
website in 2017.  
The sample consists of core members and their cohabiting partners. Original core members 
participated in the Health Survey for England (HSE) in 1998, 1999, or 2001 (ELSA wave 0) 
and in ELSA wave 1, which took place between 2002 and 2003. They were all aged 50 or 
over at the time of wave 1 data collection. Refreshment samples of new core members were 
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added in waves 3, 4, and 6 to maintain numbers and the age distribution as the original core 
members aged. Core members exit from ELSA when they die, move away from mainland 
Britain, or do not participate for any other reason. Core members who move into 
institutions are still eligible for interviews. 
During alternate waves of data collection, nurse interviews were conducted with core 
sample members who had had an interview in person (i.e. not by proxy) during the same 
wave. In addition, partners of core members participating in nurse interviews were given a 
nurse interview if they requested one. 
Nurse interviews took place in respondents’ homes and comprised a face-to-face computer-
assisted interview and the collection of biological measurements and samples. With 
respondents’ consent, if any results were outside the healthy range, letters were sent to 
respondents and their GPs. All nurse interview participants were eligible to have a blood 
sample taken, except for those with bleeding or clotting disorders, taking anti-coagulant 
medications and with a history of convulsions. Blood samples were analysed in external 
laboratories. 
Wave 3 included an additional interview in which retrospective life history data were 
collected using a temporal referencing system or life-grid approach to help full and accurate 
recall (Berney & Blane 1997; Means et al. 1991).  
Dates of data collection and numbers participating are presented in Table 4.1. Nurse 
interviews were conducted about one month after main interviews. Additional information 
about the dataset is provided in Appendix 20.  
Information from all waves was used to code variables.  
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Table 4.1: Waves of data collection in ELSA 
Wave Years Number of observations 
0 1998, 1999, 2001  19,834 with common variables 
1 2002-2003  12,099 
2 2004-2005    9,432 
2 nurse 2004-2005    7,666 
3 2006-2007    9,771 
3 LIFE 2006-2007    7,833 
4 2008-2009  11,050 
4 nurse 2008-2009    8,643 
5 2010-2011  10,274 
6 2012-2013  10,601 
6 nurse 2012-2013    8,054 
Wave 0 numbers obtained from UK Data Archive (2017) ELSA User Guide for Wave 0 
 
2.2 Measures 
Time differences in months between the main and nurse interviews in waves 2, 4 and 6 
were calculated. 
2.2.1 Inflammation and depressive symptoms  
Inflammation was measured using CRP obtained from blood samples taken during the nurse 
interviews. All blood samples were sent for analysis to the Royal Victoria Infirmary in 
Newcastle-upon-Tyne. CRP was analysed using the Behring Nephelometer during waves 2 
and 4, and the Roche Modular system during wave 6. As in other studies (Copeland et al. 
2012), observations with values of CRP over 10mg/litre were excluded, as high levels of CRP 
indicate an acute inflammatory response. Because the distribution of CRP values is skewed, 
values were logged. 
Depressive symptoms were measured during the main interviews using the 8 item CESD. 
The items are set out in Appendix 20 Table A20.1. This version of the CESD is shorter than 
the original, its internal consistency and factor structure are similar to those of earlier 
versions and it predicts clinical outcomes (Turvey et al. 1999). It is used in the Health 
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Retirement Survey (Steffick 2000). Depressive symptoms were measured rather than 
incident depression because the association between CRP and depressive symptoms 
appears to be dose-dependent (Howren et al. 2009). A second measure was constructed for 
use in sensitivity analyses that had three values; no, one and two or more depressive 
symptoms.  
2.2.2 Hypothesised confounders  
Hypothesised confounders are SEP, personality traits, childhood adversity, functional 
limitations and medication use. To facilitate comparisons, these measures and measures of 
hypothesised mediators were scaled to have values between zero and one.  
2.2.2.1 Hypothesised confounder: SEP 
SEP was measured using three variables; childhood SEP, education and accumulated wealth. 
Childhood SEP was measured by the occupational status of the respondent’s main carer at 
age 14; professional or managerial, skilled, semi-skilled, routine or manual, and casual or 
unemployed. Respondents living with an un-partnered mother at age 14 were particularly 
likely to report their main carer’s occupation as casual or unemployed. In other studies, 
measures of childhood SEP are supplemented by maternal education, but this information is 
not available in ELSA.  
Education was measured by an indicator of whether the respondent had qualifications at 
Level 2 or above; Level 2 indicates one GCE ‘O’ level pass or NVQ2. Accumulated wealth was 
assumed to summarise lifetime SEP, and was measured by total assets reported. Values 
were divided into terciles, and reverse coded to give a value of low wealth. All available 
information was used to create variables for education and low wealth, using information as 
Chapter 4: Inflammation and depressive symptoms             186 
 
 
 
close as possible to 2004 (wave 2), as explained in Appendix 1. All three SEP variables are 
time-invariant. 
2.2.2.2 Hypothesised confounder: Stable psychological factors 
Stable psychological factors are five dimensions of personality, referred to as the Big Five, 
measured in wave 5. A version of the Midlife Development Inventory was used, in which 
respondents were asked to rate how well each of 26 adjectives described them. The same 
instrument was used in the US Health and Retirement Survey (HRS) in 2006 and 2008. 
Scores were assigned to each dimension of personality based on unpublished guidelines 
written when the instrument was developed, which are set out on the HRS website 
(Lachman & Weaver 1997). They have been followed in studies that include measurement 
of personality using ELSA data (Gale et al. 2015, Gale et al. 2017). The items used and how 
they were combined are presented in Appendix 1.  
2.2.2.3 Hypothesised confounder: Childhood adversity 
Childhood adversities were poor housing amenities at age ten and up to age 15, severe 
financial hardship, parental unemployment for at least six months, early parental loss 
through divorce, separation, or death, separation from mother for at least six months, 
frequent parental arguments, parental substance abuse or mental health problems, physical 
abuse from a parent, sexual abuse or assault, major natural disaster, life threatening illness 
or injury, severe physical attack, witnessing a death or serious injury and loss of a close 
relative or friend. Information about these adversities was provided in the life history 
interview conducted in wave 3 and the questions asked are presented in Appendix 1. A 
variable was constructed to indicate exposure to zero, one, two, or three or more 
adversities. This was assigned a value if information was provided about at least 10 of the 14 
adversities, and the value was scaled up if information about some items was missing. 
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2.2.2.4 Hypothesised confounder: Functional limitations 
Functional limitations are measured by combining two sets of questions used to ascertain 
whether respondents need help with activities of daily living or ADLs (dressing, walking 
across a room, bathing, eating, getting in and out of bed and using the toilet), and with 
independent activities of daily living or IADLs (using a map, preparing a hot meal, shopping 
for groceries, making a phone call, taking medications, doing housework and managing 
money).  
2.2.2.5 Hypothesised confounder: Medication use 
A time-invariant variable was constructed to indicate between waves 0 and 6 use of 
medications likely to affect inflammation and/or depressive symptoms. Medications 
included were those used to treat conditions of the Central Nervous System, coronary heart 
disease and diabetes, pain killers, non-steroidal anti-inflammatory drugs, corticosteroids, 
hormone replacement therapy and oral contraceptives, as these are the medications that 
have been included in similar studies (Gimeno et al. 2009, Matthews et al. 2010). Detailed 
information collected in wave 0 and the wave 6 nurse interview was combined with less 
detailed information collected during main interviews in waves 2 to 6. Further details are 
given in Appendix 20. 
2.2.3 Hypothesised mediators  
Hypothesised mediators are psychological stress, social withdrawal, pain, health behaviours, 
obesity and other metabolic biomarkers. 
2.2.3.1 Hypothesised mediators: Psychosocial factors that contribute to psychological stress 
Because it appears that chronic as opposed to acute psychological stress is an important 
predictor of negative health outcomes (Cohen et al. 2012, Miller et al. 2014), each indicator 
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of stress was measured using mean measures over two consecutive waves, if this 
information was available. 
Psychological stress involves psychological responses to exposures that are likely to be 
stressful. Measures were constructed that captured both perceived psychological stress and 
exposures that are likely to be stressful.  
Measures that primarily capture psychological experiences are financial strain, subjective 
social status, perceived low control and high demands at home and/or at work, 
effort:reward imbalance at work, perceived job insecurity, distressing relationships, 
community stress, loneliness and perceived strain. Measures that mainly encompass 
stressful exposures are financial limitations, being financially worse off than one’s 
neighbours and friends, getting a partner since the previous wave, losing a partner since the 
previous wave, and caring for a partner, parent or parent-in-law.  
The distinction between measures that capture mainly stressful exposures and psychological 
stress experiences is illustrated by measures of financial limitations and strain. Financial 
strain is based on a rating of how well the respondent felt that they were getting along 
financially, with responses ranging from “managing very well” to “severe financial 
difficulties”. Financial limitations are based on whether the respondent reported that having 
too little money had prevented them from doing any of a list of specific activities, such as 
having family and friends round for a drink or meal, and replacing or repairing broken 
electrical goods. This is closer to an objective measure of financial limitations that 
respondents were exposed to than the more subjective measure of perceived financial 
strain. Information about the questions used to elicit information and how items were 
combined is included in Appendix 20. 
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Subjective social status, “an individual’s perception of his or her position within the social 
hierarchy” (Haught et al. 2015:357), was included because it has implications for health 
(Sapolsky 1982, Singh-Manoux et al. 2003) and has been found to predict health outcomes 
after adjustment for objective social status (Bradshaw et al. 2017, Han 2014). Two types of 
measure were used, the first being slightly more subjective than the second. The more 
subjective rating was based on respondents’ assessments of where they should be 
positioned on a ladder that represents where people stand in society, with “those who have 
the most money, most education and best jobs” at the top and the “worst off” at the 
bottom. The other type used respondents’ ratings of how well off financially they were 
compared against their friends and neighbours.   
Respondents were also asked about levels of control and demands at home. Mean values 
were calculated to measure self-efficacy and demands. 
Work stress was estimated using two measures; effort reward imbalance, and low control at 
work. Effort reward imbalance is a measure derived from a model of psychosocial conditions 
at work and occupational stress (Siegrist et al. 2004). Low control is a measure of 
occupational stress derived from an alternative model that combines low control, high 
demands and low social support (Karasek & Theorell 1990). These two measures have been 
used to measure work stress in ELSA (Dragano et al. 2011, Lunau et al. 2013). 
Job insecurity was indicated by responses to the item, “My job security is poor”. 
Relationship distress was measured using items adapted from an instrument developed to 
measure marital satisfaction (Schuster et al. 1990). It consists of three items that measure 
positive interactions, and three that measure negative interactions. Positive and negative 
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interactions are sometimes measured separately, but here they are combined because all 
six items have been found to load onto one factor (Whisman & Ubelacker 2009). As other 
authors have done using this measure in ELSA, negative items were reverse scored and then 
all items summed to give a single value (Whisman & Ubelacker 2009, Whisman et al. 2010). 
The measure of community stress was developed using cognitive piloting techniques, and its 
validity was tested in a larger study (Stafford et al. 2003). Bell et al. (2014) used the same 
measure in ELSA, referring to it as a measure of subjective neighbourhood disorder. It 
consists of nine pairs of opposing statements, and respondents are asked to rate how 
closely they agree with each. For example, “Most people in this area can be trusted”, and, 
“Most people in this area can’t be trusted”. Following the process used by Bell and 
colleagues (2014), negative items were reverse coded, values summed and scores grouped 
into quintiles.  
Loneliness was measured using a three-item version of the Revised UCLA (University of 
California, Los Angeles) loneliness scale (Hughes et al. 2004), used previously to measure 
loneliness in ELSA (Shankar et al. 2011). 
Perceived strain was measured using one question from the 12 item General Health 
Questionnaire. Although the item is not designed to be used independently, it asks directly 
about perceived chronic strain. The wording is: 
“We should like to know how your health has been in general over the past few weeks. Have 
you recently… 
                   … felt constantly under strain?  
“Not at all, No more than usual, Rather more than usual, Much more than usual” 
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Respondents were asked in every wave whether they lived with a partner, and this 
information was used to identify respondents whose partnership status had changed since 
the previous wave. 
A caring role was indicated if respondents reported caring for their spouse, parent or 
parent-in-law during the previous week, regardless of whether they lived in the same 
household. 
The measure for social withdrawal combined information provided about social 
engagement (reading the paper, using the internet or a mobile, hobbies, holidays and day 
trips), memberships of organisations, and activities such as going to the cinema or theatre 
and eating out. 
Because of results presented below, an index of psychological stress and social withdrawal 
was constructed that summed perceived financial strain, low subjective social status, low 
control in general and social withdrawal. Social withdrawal was included in the index as a 
behavioural correlate of psychological stress, although an additional index was created that 
excluded it for sensitivity analyses. For both indices, each variable was weighted equally and 
summed. To maximise the number of participants included in the analyses, this index was 
assigned a value when information was available for any of the component variables, using 
mean values in place of the missing values.  
2.2.3.2 Hypothesised mediator: Pain 
Level of pain was measured using information from two questions. The first asked, “Are you 
often troubled by pain?” The second, which was only addressed to those reporting pain, 
asked whether most of the time the pain was mild, moderate, or severe. Two additional 
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measures of pain indicated whether the respondent reported pain in their back or 
elsewhere, that is, in their hips, knees, feet or mouth. 
2.2.3.3 Hypothesised mediators: Health behaviours 
Health behaviours are physical activity, current smoking status and drinking alcohol.  
Physical activity was measured using questions in which respondents rated how frequently 
they engaged in activities that involve vigorous, moderate and mild levels of activity. From 
this information, respondents’ activity levels were classified as high, moderate, low and 
sedentary. Appendix 20 provides more details. 
2.2.3.4 Hypothesised mediator: Obesity and metabolic biomarkers 
Height, weight, and waist circumference were measured during nurse interviews. Mean 
values of BMI and waist circumference in waves 2 and 4 were used to create estimates for 
wave 3, and data from waves 4 and 6 were used to create estimates for wave 5. Obesity is 
indicated by BMI of 30 or above (NHS 2017). A substantial increase in risk of metabolic 
complications by waist circumference of 88cms or more for women and 102cms or more for 
men (WHO 2000, Davillas & Benzeval 2016). 
Waist circumference and BMI are highly correlated and so one measure was used in the 
main analyses. The measure chosen was waist circumference because this measure appears 
to be more sensitive to socio-economic inequalities (Davillas & Benzeval 2016, Chen & 
Tunstall-Pedoe 2005) and is a more direct measure of abdominal adiposity, which is 
associated with inflammation (Castanon et al. 2014). However, BMI is more often used in 
relation to inflammation and depressive symptoms (Penninx et al. 2013, Chocano-Bedoya et 
al. 2014, Copland et al. 2012) and was used in sensitivity analyses.  
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Metabolic biomarkers were HDL cholesterol, triglycerides and glycosylated haemoglobin, 
each measured from the blood samples, blood pressure and obesity. As mentioned above, 
the blood samples were analysed at the Royal Victoria Infirmary in Newcastle-upon-Tyne. 
Cholesterol, HDL, and triglycerides were analysed using the Olympus AU during waves 2 and 
4, and the Roche Modular system during wave 6. Glycosylated haemoglobin was analysed 
using the TOSOH G7 during waves 2 and 4, and the GOSOH G8 during wave 6. Values of 
glycosylated haemoglobin are provided as percentages in waves 2 and 4, and as 
concentrations in wave 6. Values in the earlier waves were converted to concentrations 
using a “master equation” provided by the National Glycohemoglobin Standardization 
Program NGSP (2017): 
Concentration (mmol/mol) = (Percentage * 2.152) / 0.09148 
Nurses measured systolic and diastolic blood pressures three times using an automated 
machine, and mean values were calculated. Appendix 20 describes the procedure. 
2.2.4 Moderators 
Gender was measured with a binary variable indicating male or female. Age was measured 
at each wave and a variable created to indicate respondents aged 70 and over. 
Respondents with longstanding illnesses and limiting longstanding illnesses were identified 
from answers to two questions:  
“Do you have any long-standing illness, disability or infirmity? By long-standing I 
mean anything that has troubled you over a period of time, or that is likely to affect 
you over a period of time” 
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“Does this/do these illness/es or diability/ies limit your acitivities in any way?” 
Histories of asthma and RA were reported in each wave of data collection, and all available 
information was used. Current asthma was also measured, as asthma can have long periods 
of remission. This was indicated if respondents reported attacks of wheezing or whistling in 
the previous 12 months, and that their breathing was normal between attacks. This 
information was only available in waves 1 to 5. The items used are presented in Appendix 
20. 
3. Analyses 
Summary statistics were calculated for variables in each wave and using data pooled across 
waves. Using the pooled data, summary statistics were calculated for the whole sample and 
for 4 sub-samples; (1) the sub-sample used to address RQ1, (2) respondents excluded from 
the sub-sample used to address RQ1, (3) respondents included in random effects (RE) 
models used to address RQ2, and (4) respondents excluded from RE models used to address 
RQ2. Logistic regression analyses with REs were used to estimate differences between 
distributions of variables in sub-samples (1) and (2), and (3) and (4). 
Summary statistics were also calculated for the number of months between main and nurse 
interviews in waves 2, 4, and 6. 
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RQ1. What are the prospective relationships between inflammation and depressive 
symptoms? 
a. Does inflammation at time t-1 predict depressive symptoms at time t? 
b. Do depressive symptoms at time t-1 predict inflammation at time t? 
Associations between standardised measures of depressive symptoms and logged CRP were 
estimated using three waves of data (2, 4 and 6) and RE models.  
To address RQ1a, depressive symptoms at time t was regressed onto Ln(CRP) at time t-1 
(two waves earlier), with adjustment for depressive symptoms at time t-1 (model 1). To 
address RQ1b, Ln(CRP) at time t was regressed onto depressive symptoms at time t-1 with 
adjustment for Ln(CRP) at time t-1 (model 2). 
𝑀𝑜𝑑𝑒𝑙 1:   𝐷𝑖𝑡 = 𝛼 + 𝛽1𝐼𝑖𝑡−1 + 𝛽2𝐷𝑖𝑡−1 + 𝛽3𝐺𝑖 + 𝛽4𝐴𝑖𝑡 + 𝛽5𝐴
2
𝑖𝑡 + 𝛽6𝑄𝑖 + 𝛽7𝑊𝑖 + 𝛽8𝑀𝑖
+ 𝛽9𝐿𝐼𝑖𝑡−1 + 𝑈𝑖 + 𝜀𝑖𝑡  
 
𝑀𝑜𝑑𝑒𝑙 2:   𝐼𝑖𝑡 = 𝛼 + 𝛽1𝐷𝑖𝑡−1 + 𝛽2𝐼𝑖𝑡−1 + 𝛽3𝐺𝑖 + 𝛽4𝐴𝑖𝑡 + 𝛽5𝐴
2
𝑖𝑡 + 𝛽6𝑄𝑖 + 𝛽7𝑊𝑖 + 𝛽8𝑀𝑖
+ 𝛽9𝐿𝐼𝑖𝑡−1 + 𝑈𝑖 + 𝜀𝑖𝑡  
 
I=Ln(CRP), D=depressive symptoms, G=gender, A=age, Q=Level 2 qualifications in wave 2, W=total 
wealth in wave 2, M=use of medications that could affect depressive symptoms and inflammation 
between waves 0 and 6, LI=longstanding illness. 
 
The outcome at the previous time-point (lag dependent variable) was included because (1) 
earlier measures of depressive symptoms and CRP predict later measures of depressive 
symptoms and CRP, respectively, referred to as auto-correlations, and (2) if depressive 
symptoms and CRP were correlated previously, then earlier CRP is likely to predict 
subsequent depressive symptoms simply because of its correlation with depressive 
symptoms earlier. Including in the model the lag dependent variable means that we can 
interpret any prospective associations as net of cross-sectional associations at the earlier 
time-point. 
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All models were adjusted for gender, age and age squared at time t, use of medications that 
affect inflammation and/or depressive symptoms at time t, longstanding illness at time t-1, 
qualifications below Level 2 in 2004, and low accumulated wealth in 2004.  
These controls were included because they have been used in previous studies. Childhood 
SEP was not included because it is highly correlated with the other SEP variables and has 
more missing values (Table 4.6). Age squared has not been included in previous studies, but 
was used here because age combined with age squared predicts log(CRP) and depressive 
symptoms more accurately than age alone. See Appendix 21.  
In order to examine moderation by gender, age group and health status (RQ3), the same 
models were estimated for respondents of each gender, age group and health status. In 
addition, models estimated using the whole sample and including interaction terms with 
each moderator; models 3-8. In models that examine moderation by RA or asthma, 
longstanding illness was replaced by a variable indicating longstanding illness excluding the 
specific condition, which took a no value if the specific condition was reported.  
Moderation by gender 
 
𝑀𝑜𝑑𝑒𝑙 3:   𝐷𝑖𝑡 = 𝛼 + 𝛽1𝐼𝑖𝑡−1 + 𝛽2𝐷𝑖𝑡−1 + 𝛽3𝐺𝑖 + 𝛽4𝐼𝑖𝑡−1 ∗ 𝐺𝑖 + 𝛽5𝐴𝑖𝑡 + 𝛽6𝐴
2
𝑖𝑡 + 𝛽7𝑄𝑖
+ 𝛽8𝑊𝑖 + 𝛽9𝑀𝑖 + 𝛽10𝐿𝐼𝑖𝑡−1 + 𝑈𝑖 + 𝜀𝑖𝑡 
 
𝑀𝑜𝑑𝑒𝑙 4:   𝐼𝑖𝑡 = 𝛼 + 𝛽1𝐷𝑖𝑡−1 + 𝛽2𝐼𝑖𝑡−1 + 𝛽3𝐺𝑖 + 𝛽4𝐷𝑖𝑡−1 ∗ 𝐺𝑖 + 𝛽5𝐴𝑖𝑡 + 𝛽6𝐴
2
𝑖𝑡 + 𝛽7𝑄𝑖
+ 𝛽8𝑊𝑖 + 𝛽9𝑀𝑖 + 𝛽10𝐿𝐼𝑖𝑡−1 + 𝑈𝑖 + 𝜀𝑖𝑡 
 
 
Moderation by age 
 
𝑀𝑜𝑑𝑒𝑙 5:   𝐷𝑖𝑡 = 𝛼 + 𝛽1𝐼𝑖𝑡−1 + 𝛽2𝐷𝑖𝑡−1 + 𝛽3𝐴70𝑖 + 𝛽4𝐼𝑖𝑡−1 ∗ 𝐴70𝑖 + 𝛽5𝐺𝑖 + 𝛽6𝐴𝑖 + 𝛽7𝑄𝑖
+ 𝛽8𝑊𝑖 + 𝛽9𝑀𝑖 + 𝛽10𝐿𝐼𝑖𝑡−1 + 𝑈𝑖 + 𝜀𝑖𝑡 
 
𝑀𝑜𝑑𝑒𝑙 6:   𝐼𝑖𝑡 = 𝛼 + 𝛽1𝐷𝑖𝑡−1 + 𝛽2𝐷𝑖𝑡−1 + 𝛽3𝐴70𝑖 + 𝛽4𝐷𝑖𝑡−1 ∗ 𝐴70𝑖 + 𝛽5𝐺𝑖 + 𝛽6𝐴𝑖 + 𝛽7𝑄𝑖
+ 𝛽8𝑊𝑖 + 𝛽9𝑀𝑖 + 𝛽10𝐿𝐼𝑖𝑡−1 + 𝑈𝑖 + 𝜀𝑖𝑡  
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Moderation by health status 
 
𝑀𝑜𝑑𝑒𝑙 7:   𝐷𝑖𝑡 = 𝛼 + 𝛽1𝐼𝑖𝑡−1 + 𝛽2𝐷𝑖𝑡−1 + 𝛽3𝐻𝑖 + 𝛽4𝐼𝑖𝑡−1 ∗ 𝐻𝑖 + 𝛽5𝐺𝑖 + 𝛽6𝐴𝑖 + 𝛽7𝐴
2
𝑖
+ 𝛽8𝑄𝑖 + 𝛽9𝑊𝑖 + 𝛽10𝑀𝑖𝑡−1 + 𝑈𝑖 + 𝜀𝑖𝑡 
 
𝑀𝑜𝑑𝑒𝑙 8:   𝐼𝑖𝑡 = 𝛼 + 𝛽1𝐷𝑖𝑡−1 + 𝛽2𝐼𝑖𝑡−1 + 𝛽3𝐻𝑖 + 𝛽4𝐷𝑖𝑡−1 ∗ 𝐻𝑖 + 𝛽5𝐺𝑖 + 𝛽6𝐴𝑖 + 𝛽7𝐴
2
𝑖
+ 𝛽8𝑄𝑖 + 𝛽9𝑊𝑖 + 𝛽10𝑀𝑖𝑡−1 + 𝑈𝑖 + 𝜀𝑖𝑡 
 
I=Ln(CRP), D=depressive symptoms, G=gender, A=age, A70=age 70 or over, Q=Level 2 qualifications in 
wave 2, W=total wealth in wave 2, M=use of medications that could affect depressive symptoms and 
inflammation, LI=longstanding illness, H=health status (longstanding illness, asthma, RA). 
 
 
Sensitivity analyses 
Linear regression models assume that the outcome is distributed normally. However, the 
distribution of depressive symptoms is not normal, with the highest frequency of 
respondents reporting no depressive symptoms. Other studies have used raw scores of the 
CESD measure in ELSA for analyses that assume normality (Daly 2013, Hamer et al. 2009, 
Rafnsson et al. 2017) and I do the same. However, sensitivity analyses were conducted using 
a measure of depressive symptoms in three categories with ordered probit models.  
RQ2. Are prospective associations between inflammation and depressive symptoms 
confounded or mediated by other factors? 
Salient confounders and mediators, referred to as explanatory variables, were selected in 
two stages. In the first stage, associations were estimated between each explanatory 
variable and (1) depressive symptoms and (2) Ln(CRP) (models 9 and 10). The second stage 
was used for all variable found to be associated with both depressive symptoms and 
Ln(CRP). This compared the extent of attenuation (or magnification) by each variable by 
examining differences in the inflammation-depressive symptoms association when it is 
estimated using a baseline model (model 11) and in models that include each explanatory 
variable in turn (model 12).  
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RE models were used, and every model was adjusted for gender, age, and age squared. 
Gender was treated as time-invariant, and age and age squared as time varying. Measures 
of Ln(CRP) and depressive symptoms were standardised. 
Associations between hypothesised explanatory variables and the two outcomes 
 
𝑀𝑜𝑑𝑒𝑙 9:   𝐷𝑖𝑡 = 𝛼 + 𝛽1𝑉𝑖𝑡 + 𝛽2𝐺𝑖 + 𝛽3𝐴𝑖𝑡 + 𝛽4𝐴
2
𝑖𝑡 + 𝑈𝑖 + 𝜀𝑖𝑡 
 
𝑀𝑜𝑑𝑒𝑙 10:   𝐼𝑖𝑡 = 𝛼 + 𝛽1𝑉𝑖𝑡 + 𝛽2𝐺𝑖 + 𝛽3𝐴𝑖𝑡 + 𝛽4𝐴
2
𝑖𝑡 + 𝑈𝑖 + 𝜀𝑖𝑡 
 
Attenuation of the inflammation-depressive symptoms association 
 
𝑀𝑜𝑑𝑒𝑙 11:   𝐼𝑖𝑡 = 𝛼 + 𝛽1𝐷𝑖𝑡 + 𝛽2𝐺𝑖 + 𝛽3𝐴𝑖𝑡 + 𝛽4𝐴
2
𝑖𝑡 + 𝑈𝑖 + 𝜀𝑖𝑡  
 
𝑀𝑜𝑑𝑒𝑙 12:   𝐼𝑖𝑡 = 𝛼 + 𝛽1𝐷𝑖𝑡 + 𝛽2𝑉𝑖𝑡 + 𝛽3𝐺𝑖 + 𝛽4𝐴𝑖𝑡 + 𝛽5𝐴
2
𝑖𝑡 + 𝑈𝑖 + 𝜀𝑖𝑡  
 
V=hypothesised explanatory variable, I=Ln(CRP), D=depressive symptoms, A=age, G=gender. 
 
Variables were selected as salient confounders or mediators if they predicted both Ln(CRP) 
and depressive symptoms, and attenuated the baseline association between Ln(CRP) and 
depressive symptoms so that it changed the magnitude of the association by more than 
15%. 
To simplify the structural equation model (SEM) described below, the same tests were used 
to select a single measure of SEP. In addition, an index of psychological stress and social 
withdrawal was constructed that summed salient psychosocial factors hypothesised to be 
associated with sickness behaviours. 
Pairwise correlations were estimated between all variables included in the SEM to check 
whether any variables were highly correlated. 
SEMs were estimated to examine temporal relationships between inflammation, depressive 
symptoms, and the most salient confounders and mediators. The specification is set out in 
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Figure 4.2. It represents a simplified version of reality, due to limitations in the measures 
available, the number of observations and processing power. This is why more hypothesised 
confounders and mediators are not included, and why auto-correlations in inflammation 
and depressive symptoms are not estimated between waves 2 and 6. 
The final SEM was built in stages so that changes in relationships could be observed as 
additional factors were included. 
Multiple likelihood with missing values (MLMV) was the estimation method used. It assumes 
joint normality of all variables in the model, and so age squared was not included. The 
assumption is violated, and this affects the accuracy of results. However, MLMV has the 
advantage that it uses all available information, whilst other estimation methods include 
only respondents for whom complete information is available. In illustration, if a respondent 
has complete information for all variables except for CRP in wave 2, other methods will drop 
them altogether, whereas the MLMV method includes this respondent in estimations of 
every part of the model that does not include CRP in wave 2. 
The specification was fitted using MLMV for the whole sample, men, women, respondents 
with at least one longstanding illness, RA, and asthma. 
Sensitivity analyses 
The SEM used in the main analyses was built in stages to test whether associations found in 
the final model were evident in simpler specifications. 
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The final specification was estimated for the whole sample using the asymptotic distribution 
free (ADF) estimation method, as this method makes no assumptions about the 
distributions of variables.  
The SEM model was estimated for the whole sample using MLMV but excluding 
respondents whose nurse interviews occurred more than two months before or after the 
main interview. This provides a stronger test for concurrent associations between 
inflammation and depressive symptoms. 
The index of psychological stress and social withdrawal summed low self-efficacy, subjective 
social status, financial strain and social withdrawal. Sensitivity analyses were conducted 
using three alternative indices. 
Subjective social status is included in the index in the main analyses because it has 
implications for health (Sapolsky 1982, Singh-Manoux et al. 2003) and has been found to 
predict health outcomes after adjustment for objective social status (Bradshaw et al. 2017, 
Han 2014). However, it is not clear exactly what scores on the variable used mean. 
Assessments of social status have been found to depend upon whether respondents 
compare themselves against global or local referents (Haught et al. 2015) and we do not 
know which type of referent respondents used when reporting social status. For this reason, 
sensitivity analyses used an alternative index that excludes subjective social status. 
The measure of psychological stress-and-withdrawal includes financial strain, which is likely 
to be correlated with SEP. Although the SEMs include SEP, sensitivity analyses were 
conducted using an alternative index that excludes financial strain. 
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The index includes social withdrawal and measures of psychological stress. Additional 
sensitivity analyses excluded social withdrawal from this index to better test the importance 
of psychological stress as a mediator. 
Alternative measures of pain were also used in sensitivity analyses used to select mediators 
for the SEM, and in the SEM specification. It is possible that relationships between pain and 
both inflammation and depressive symptoms differ depending upon the site of the pain. For 
example, Zis et al. (2017) identify primary pain syndrome. This is typically experienced as 
lower back pain and has no known cause, and it is possible that it is more closely associated 
with depressive symptoms than pain in other parts of the body. 
SEMs were also estimated using alternative measures of obesity as obesity can be measured 
using waist circumference and BMI, and because relationships between weight and 
inflammation could be continuous rather than threshold effects of obesity.  
Using sub-samples of respondents with a history of asthma and with current asthma, 
alternative SEM specifications that excluded pain were estimated. This is because pain is not 
a common symptom of asthma. 
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Figure 4.2: SEM specification  
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Notes: The model also includes correlations between error terms for the hypothesised explanatory factors in wave 3, and autocorrelations between each measure 
in waves 3 and 5. Oval shapes represent error terms for Ln(CRP) and depressive symptoms. 
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4. Results 
RQ1. What are the prospective relationships between inflammation and depressive 
symptoms? 
a. Does inflammation at time t-1 predict depressive symptoms at time t? 
b. Do depressive symptoms at time t-1 predict inflammation at time t? 
Summary statistics for the variables used to address RQ1 are presented in Tables 4.2 and 
4.3.  
Table 4.2 presents summary statistics for variables in each wave, and shows that for most 
variables, values are comparable across waves.  
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Table 4.2: Summary statistics for variables in each wave 
 Wave 2 or time-invariant Wave 4 Wave 6 
Variables used to address all RQs M/% SD/ N Min Max N M/% SD/ N Min Max N M/% SD/ N Min Max N 
Depressive symptoms 1.578 1.961 0 8 9215 1.431 1.944 0 8 10518 1.362 1.914 0 8 9905 
CRP 2.497 2.139 0.2 9.9 5434 2.418 2.131 0.2 9.9 5990 2.123 1.923 0.1 9.8 5781 
Ln(CRP) 0.532 0.930 -1.609 2.293 5434 0.479 0.956 -1.61 2.29 5990 0.363 0.919 -2.30 2.28 5781 
Standardised DS 0.000 1.000 -0.804 3.275 9215 0.000 1.000 -0.74 3.38 10518 0.000 1.000 -0.71 3.47 9905 
Standardised Ln(CRP) 0.000 1.000 -2.302 1.893 5434 0.000 1.000 -2.18 1.90 5990 0.000 1.000 -2.90 2.09 5781 
Depressive symptoms change w2-w4 -0.107 1.891 -8 8 6402           
Depressive symptoms change w4-w6 -0.010 1.828 -7 8 8166           
Depressive symptoms changew2-w6 -0.106 1.974 -8 8 5386           
CRP change w2-w4 0.067 1.932 -9.2 9.3 3044           
CRP change w4-w6 -0.303 1.876 -8.9 9.3 3746           
CRP change w2-w6 -0.243 2.014 -9.5 9.4 2566           
Female 55.4% 15891 0 1 28688           
Age 65.7 10.5 17 90 9432 65.1 10.2 24 90 11050 66.5 10.2 28 90 10601 
Age in 2004 63.5 12.7 17 96 26356           
Low wealth in 2004 2.037 0.824 1 3 17845           
                
Variables used to address RQ1                
Below L2 qualification in 2004 42.7% 6933 0 1 16245           
Medication use 86.4% 7001 0 1 8105 86.8% 8012 0 1 9228 81.7% 7312 0 1 10597 
Longstanding illness 56.5% 5323 0 1 9426 54.2% 5984 0 1 11041 54.6% 5780 0 1 10594 
Aged 70 and over 35.3% 9988 0 1 28296 23.8% 7890 0 1 33150 36.0% 11456 0 1 31822 
Ever had RA 3.8% 323 0 1 8532 4.1% 411 0 1 10054 6.8% 666 0 1 9732 
Ever had asthma 15.4% 1445 0 1 9385 15.7% 1720 0 1 10986 13.8% 1458 0 1 10541 
Active asthma 6.7% 628 0 1 9418 6.1% 673 0 1 11034     0 
                
Variables used to address RQ2                
Limiting longstanding illness by w2 0.835 0.896 0 2 15942 0.732 0.869 0 2 10266 0.630 0.837 0 2 9739 
RA by wave 6 12.4% 1289 0 1 10355           
Asthma by wave 6 29.1% 3483 0 1 11984           
Active asthma by wave 6 20.8% 2234 0 1 10735           
                
 Wave 3 Wave 5      
 Mean SD Min Max N Mean SD Min Max N      
High risk waist circumference 0.533 0.480 0 1 10918 0.541 0.474 0 1 10136      
Physical inactivity 1.008 0.906 0 3 9766 1.034 0.925 0 3 10264      
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Pain 0.718 1.023 0 3 9527 0.755 1.032 0 3 9722      
Functional limitations 0.833 1.982 0 13 9767 0.842 2.011 0 13 10266      
Psychological stress index 0.513 0.097 0.216 0.921 8204 0.504 0.098 0.216 0.972 8980      
Low control 3.074 0.849 1 6 8170 2.992 0.866 1 6 8915      
Low subjective social status 40.76 16.75 0 95 7919 40.85 16.79 0 95 8645      
Financial strain 1.997 0.893 1 4 9084 1.968 0.895 1 4 9538      
Work stress 0.352 0.509 0 4 7880 0.299 0.488 0 4 8606      
Relationship distress extended family 0.437 0.199 0 1 8012 0.449 0.196 0 1 8795      
Relationship distress friends 0.397 0.147 0 1 8081 0.397 0.152 0 1 8845      
Social withdrawal 2.242 0.612 1 3 8124 2.139 0.595 1 3 8897      
Age, below Level 2 qualifications and low wealth, each in 2004, were coded using all available information, so timing is not exact; where information is unavailable in wave 2 (2004), 
information is used from wave 1, then from waves 3,4,5 and 6, in that order. Limiting longstanding illness takes zero for no longstanding illness, one for longstanding illness that is not limiting, 
and two for limiting longstanding illness. Loneliness, low control, low subjective social status, financial strain and social withdrawal were weighted equally and summed for the psychological 
stress index. M is mean and applies to continuous variables. % applies to binary variables and is th % of respondents for whom the variable has a yes value. N is the number of respondents 
with a non-missing value for the variable. 
 
Table 4.3: Summary statistics of variables pooled across waves for the whole sample and for the sub-sample used to address RQ1 
 (1) Whole sample (2) Excluded from RQ1 (3) Included in RQ1 Differences (2)vs(3) 
Variable 
Mean 
%=y 
SD 
N=y Min Max N 
Mean 
%=y 
SD 
N=y N 
Mean 
%=y 
SD 
N=y N OR p-value 
CRP 2,4,6 2.344 2.072 0.1 9.9 17205 2.178 1.984 3335 2.383 2.091 13870 6.415 0.000 
Ln(CRP) 2,4,6 0.457 0.938 -2.303 2.293 17205 0.374 0.942 3335 0.476 0.936 13870 3.129 0.000 
Depressive symptoms 2,4,6 1.453 1.941 0 8 29638 1.557 2.017 15768 1.335 1.845 13870 0.915 0.000 
Female (time invariant) 55.4% 47679 0 1 86064 55.6% 40140 72194 54.3% 7531 13870 0.899 0.037 
Age 2,4,6 65.8 10.3 17 90 31083 65.2 11.2 17213 66.4 9.1 13870 1.017 0.000 
Below L2 quals 2004 (time invariant) 42.7% 20810 0 1 48735 45.3% 15794 34865 36.1% 5007 13870 0.512 0.000 
Low wealth in 2004 (time invariant) 0.679 0.275 0.333 1 53535 0.696 0.274 39665 0.630 0.269 13870 0.210 0.000 
Age 70 or above 2,4,6 34.6% 10755 0 1 31083 34.5% 5938 17213 34.9% 4841 13870 0.998 0.975 
Longstanding illness 12,34,56 55.1% 20373 0 1 36974 55.6% 12846 23104 54.3% 7531 13870 0.927 0.102 
Medication use (time invariant) 90.3% 45984 0 1 50904 93.1% 34479 37034 82.8% 11484 13870 0.151 0.000 
Summary statistics for each variable refer to measures pooled over three occasions, indicated by wave numbers to the right of the variable description. Measures are based on information 
provided in the wave when inflammation and depressive symptoms are measured (waves 2, 4 and 6), and if available, information provided in the previous wave (1, 3 and 5). When 
information is available in both waves, the mean value is used. ORs are odds ratios that respondents are included in analyses for RQ1 if they have high values for the variable. Bold font 
indicates variables with distributions that differ between the two sub-samples. %=Yand N=y  apply to binary variables and are the percentages and numbers, respectively, of observations for 
which the variable takes a yes value. N is the number of observations for which the variable has a non-missing value. 
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For both CRP and depressive symptoms, the between and within individual variation is of a 
similar magnitude. For example, variation in depressive symptoms between individuals in 
wave 2 is 3.846, as this is the square of the standard deviation (1.9612). This is of a similar 
magnitude to the variation in depressive symptoms within individuals between waves 2 and 
4; 3.576 (1.8912). Similarly, the variation in CRP between individuals is 4.575 (2.1392), which 
is of a similar magnitude to the average difference in CRP within individuals between waves 
2 and 4, of 3.733 (1.9322). This means that associations should be identifiable (that is, 
identified if they exist) equally easily within individuals over time and between individuals 
regardless of time. 
Average numbers of depressive symptoms, CRP levels, and proportions with at least one 
longstanding illness reduce slightly between waves 2 and 6, possibly because healthier 
respondents are less likely to drop out of the study (Bridges et al. 2015). However, lifetime 
prevalence of RA increases over time, as respondents are given more opportunities to 
report it.  
Table 4.3 provides summary statistics for variables used to address RQ1, pooled across 
waves. In the sample used to address RQ1, mean levels of CRP were 2.4mg/l, and the mean 
number of depressive symptoms was 1.3 out of 8. Just over half (54%) were women, the 
mean age was 66, and about one third (35%) did not have Level 2 qualifications in 2004. A 
high proportion (83%) reported using medications that could affect inflammation and/or 
depressive symptoms, and just over half (51%) had at least one chronic illness. 
Compared against those who did not provide complete information and were therefore 
excluded from the analyses used to address RQ1, the sample used had slightly lower levels 
of depressive symptoms, and medication use. They were better educated, wealthier, and 
slightly older. Men were over-represented. CRP levels were slightly higher. 
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After adjustment for gender, age, age squared, education, wealth, medication use and 
longstanding illness, each SD increase in Ln(CRP) predicted a 0.030SD increase in depressive 
symptoms four years later (95% confidence interval 95%ci=0.010-0.050, p=0.004, n=7,829). 
That is, each 0.919mg/L CRP was associated with an increase of 0.05 depressive symptoms, 
or each mg/L increase in CRP predicted 0.06 depressive symptoms. The association between 
depressive symptoms and Ln(CRP) four years later was not statistically significant (β=0.004, 
95%ci=-0.019-0.028, p=0.708, n=5,869). 
Tables 4.4 and 4.5 present results by gender, age group and health status. They provide no 
evidence that prospective associations differ by any of these factors. After adjustment for 
medications, education, wealth, and if applicable, age, age squared, gender and 
longstanding illness, CRP predicts depressive symptoms four years later among all groups, 
although associations do not reach statistical significance among men and those with no 
longstanding illness.  
There is no evidence that depressive symptoms predict CRP four years later among any sub-
sample and no evidence of interaction effects. 
Table 4.4 shows that after adjustment for the lagged dependent variables, inflammation, 
SEP, age, medication use and longstanding illness, women have higher levels of depressive 
symptoms than men, but Table 4.5 provides no evidence that after equivalent adjustments, 
there are gender differences in relation to Ln(CRP).  After the same adjustments, older age 
category, longstanding illness, RA, and asthma are each associated with depressive 
symptoms, and longstanding illness and asthma are each associated with Ln(CRP). 
Sensitivity analyses 
When depressive symptoms were measured in three categories and ordered probit models, 
the results were almost identical. See Appendix 22.
Chapter 4: Inflammation and depressive symptoms             208 
 
 
 
Table 4.4:   Adjusted associations between inflammation and depressive symptoms four years later for whole sample and by gender, age 
category and health status. 
 Whole sample Men Women 
Outcome is depressive symptoms at t beta 95% CI p_val N beta 95%CI p_val N beta 95%CI p_val N 
Ln(CRP)(t-1) 0.026 -0.003-0.056 0.081 7829 0.026 -0.001-0.052 0.055 3596 0.032 0.003-0.062 0.033 4233 
Gender 0.141 0.099-0.183 0.000 
           Gender*Ln(CRP)(t-1) 0.006 -0.033-0.046 0.763 
                           
 Whole sample Aged under 70 Aged 70 plus 
 beta 95%CI p_val N beta 95%CI p_val N beta 95%CI p_val N 
Ln(CRP)(t-1) 0.029 0.005-0.052 0.016 7830 0.030 0.007-0.053 0.012 5485 0.051 0.012-0.089 0.011 2345 
70 plus(t-1) 0.081 0.036-0.125 0.000            
70 plus(t-1)*Ln(CRP)(t-1) 0.022 -0.021-0.066 0.318            
                
 Whole sample No longstanding illness With longstanding illness 
Outcome is depressive symptoms at t beta 95%CI p_val N beta 95%CI p_val N beta 95%CI p_val N 
Ln(CRP)(t-1) 0.015 -0.013-0.043 0.306 7829 0.021 -0.004-0.046 0.103 3685 0.033 0.004-0.063 0.028 4144 
Longstanding illness(t-1) 0.178 0.138-0.217 0.000 
           Longstanding illness(t-1)*Ln(CRP)(t-1) 0.028 -0.009-0.066 0.139 
                      15 random effects models using linear 
regressions and depressive symptoms as 
a continuous variable. Betas refer to 
increases in depressive symptoms 
associated with each unit increase in 
Ln(CRP) and other variables in the 
model. Models adjusted for depressive 
symptoms at time t-1, age, age squared 
at time t, gender, medication at time t, 
qualifications below Level 2 in 2004, 
wealth in 2004. First two sets of models 
are also adjusted for longstanding illness 
at time t-1. Model with age 70+ does not 
include additional adjustment for age, 
and the specifications for sub-samples 
aged below 70 and 70+ adjust for age 
but not age-squared. Ln(CRP) and 
depressive symptoms are standardized. 
Bold font indicates p-values below 0.05. 
 
 Whole sample With RA 
Outcome is depressive symptoms at t beta 95%CI p_val N beta 95%CI p_val N 
Ln(CRP)(t-1) 0.030 0.008-0.051 0.006 6962 -0.013 -0.149-0.124 0.857 165 
RA(t-1) 0.194 0.054-0.333 0.006 
      RA(t-1)*Ln(CRP)(t-1) -0.031 -0.161-0.099 0.639 
                 
 Whole sample With history of asthma 
Outcome is depressive symptoms at t beta 95%CI p_val N beta 95%CI p_val N 
Ln(CRP)(t-1) 0.020 -0.002-0.042 0.069 7788 0.046 -0.013-0.104 0.125 1200 
Asthma(t-1) 0.221 0.159-0.283 0.000 
      Asthma(t-1)*Ln(CRP)(t-1) 0.038 -0.016-0.092 0.168 
                 
 Whole sample With active asthma 
Outcome is depressive symptoms at t beta 95%CI p_val N beta 95%CI p_val N 
Ln(CRP)(t-1) 0.030 0.009-0.051 0.005 7825 0.021 -0.074-0.116 0.664 472 
Active asthma(t-1) 0.277 0.194-0.360 0.000 
      Active asthma(t-1)*Ln(CRP)(t-1) 0.006 -0.075-0.087 0.889 
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Table 4.5: Adjusted associations between depressive symptoms and Ln(CRP) four years later for the whole sample and by gender, age category 
and health status. 
 Whole sample Men Women 
Outcome is Ln(CRP) at time t beta 95%CI p_val N beta 95%CI p_val N beta 95%CI p_val N 
Depr(t-1) 0.001 -0.038-0.040 0.956 5869 0.003 -0.038-0.044 0.876 2659 0.005 -0.023-0.033 0.719 3210 
Gender 0.046 0.000-0.093 0.050            
Gender*Depr(t-1) 0.005 -0.043-0.053 0.835            
                
 Whole sample Aged below 70 Aged 70+ 
Outcome is Ln(CRP) at time t beta 95%CI p_val N beta 95%CI p_val N beta Ci1 Ci2 p_val N 
Depr(t-1) 0.005 -0.021-0.032 0.686  0.004 -0.023-0.031 0.776 4265 0.023 -0.022 0.067 0.320 1605 
70+(t-1) 0.029 -0.020-0.078 0.245            
70+(t-1)*Depr(t-1) 0.014 -0.034-0.063 0.565            
                
 Whole sample No longstanding illness With longstanding illness 
Outcome is Ln(CRP) at time t beta 95%CI p_val N beta 95%CI p_val N beta 95%CI p_val N 
Depr(t-1) 0.022 -0.016-0.060 0.255 5870 0.023 -0.015-0.060 0.238 2828 -0.008 -0.037-0.022 0.605 3041 
Longstanding illness(t-1) 0.045 0.001-0.088 0.043            
Longstanding illness(t-1)*Depr(t-1) -0.027 -0.073-0.019 0.251            
           15 random effects models, with Ln(CRP) at 
time t as the outcome. Beta values refer to 
the increases in Ln(CRP) associated with 
each unit increase in depressive symptoms 
and the other variables specified. All 
models are adjusted for Ln(CRP) at time t-1, 
age and age squared at time t, gender, 
medication for inflammation or depression 
at time t, qualifications below Level 2 in 
2004, and wealth in 2004. The first two sets 
of models are also adjusted for 
longstanding illness at time t-1. The model 
that includes the indicator of age 70+ does 
not include additional adjustment for age, 
and the specifications for sub-samples 
above and below 70 adjust for age but not 
age squared. Measures of Ln(CRP) and 
depressive symptoms are standardised.  
 Whole sample With RA 
Outcome is Ln(CRP) at time t beta 95%CI p_val N beta 95%CI p_val N 
Depr(t-1) 0.006 -0.019-0.032 0.632 5240 -0.062 -0.218-0.093 0.432 114 
RA(t-1) 0.076 -0.079-0.231 0.339       
RA(t-1)*Depr(t-1) -0.054 -0.200-0.092 0.467       
           
 Whole sample With history of asthma 
Outcome is Ln(CRP) at time t beta 95%CI p_val N beta 95%CI p_val N 
Depr(t-1) 0.001 -0.025-0.027 0.961 5837 0.003 -0.050-0.056 0.908 870 
Asthma(t-1) 0.103 0.037-0.169 0.002       
Asthma(t-1)Depr(t-1) 0.016 -0.039-0.070 0.572       
           
 Whole sample With active asthma 
Outcome is Ln(CRP) at time t beta 95%CI p_val N beta 95%CI p_val N 
Depr(t-1) -0.002 -0.026-0.022 0.847 5866 0.063 -0.017-0.143 0.121 346 
Active asthma(t-1) 0.111 0.022-0.200 0.014       
Active asthma(t-1)*Depr(t-1) 0.073 -0.001-0.147 0.053 
      
Bold font indicates associations with p-values below 0.05.
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RQ2. Are prospective associations between inflammation and depressive symptoms 
confounded or mediated by other factors? 
Table 4.6 presents summary statistics for variables used to address RQ2, pooled across 
waves. In the sample used in the analyses (3), mean plasma CRP was 2.3mg/l, and the mean 
number of depressive symptoms was 1.1 out of 8. 55% were women, the mean age was 65, 
and almost one third had no GCSE equivalents in 2004.  
Just over half had a longstanding illness, a quarter had a limiting longstanding illness and 
over three-quarters were using medications that could affect depressive symptoms or 
inflammation, or both. Mean waist circumference was 95cms, which indicates risk of 
metabolic complications for white Europeans, as cutpoints are 94cms for men and 80cms 
for women (Albert et al. 2006. Mean blood pressure was 133/75, which is slightly higher 
than the clinically healthy range (Blood Pressure Association 2017). Mean plasma level of 
glycosylated haemoglobin is 39mmol/mol , which is below the reference range (48-
59mmol/mol, GP Notebook 2017a), probably because respondents fasted before the blood 
samples were taken. Mean plasma triglycerides were 1.6mmol/l and high density lipid (HDL) 
cholesterol was 1.6mmol/L, which are within clinical ranges (GP Notebook 2017b, 2017c). 
Low levels of pain and functional limitations were reported. Almost one in 10 smoked, and 
almost one fifth drank frequently. 
Most respondents had children, other family and friends, and about three-quarters lived 
with partners. Very low proportions (less than 2%) had lost or acquired a partner between 
waves. On average, relationships with other family and friends were more stressful than 
relationships with partners or children. Just under one third were in paid work, and 2.3% 
reported job insecurity. About one fifth reported feeling worse off than their neighbours 
and a similar proportion reported feeling worse off than their friends. Mean subjective 
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social status was over 50 out of 100, at 61. Almost a quarter of the sample reported financial 
limitations and just under one tenth cared for a partner or parent.  
The sub-sample used to address RQ2 is likely to be less representative of adults aged 50 and 
over living in England than the sample of ELSA respondents from which it is drawn. The sub-
sample consists of respondents who provided complete information about depressive 
symptoms, CRP and hypothesised confounders and mediators.  
Compared against respondents who were excluded from the analyses conducted to address 
RQ2, the sample used had fewer depressive symptoms, reported more advantaged 
backgrounds, were better qualified and had more wealth. They were also healthier. Fewer 
reported longstanding illness, limiting longstanding illness and medication use and fewer 
had high waist circumference. Plasma levels of glycosylated haemoglobin and triglycerides 
were lower, HDL cholesterol levels were higher and their blood pressures were higher. They 
reported less pain and fewer functional limitations. A lower proportion smoked and they 
were more physically active. 
The sample used reported lower levels of loneliness, social withdrawal, community stress, 
work stress, perceived financial strain and financial strain and higher levels of self-efficacy 
and subjective social status. Those in paid employment are under-represented and higher 
proportions had a partner, child, and friends. Those used in the analyses reported slightly 
higher levels of distress in their relationships with partners, possibly because a higher 
proportion had lived with partners. They reported fewer childhood adversities and were 
more conscientious and extravert and less neurotic. 
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Table 4.6: Summary statistics of variables pooled across waves for the whole sample and for the sub-sample used to address RQ2  
 (1) Whole sample (2) Excluded from RQ2 (3) Included in RQ2 Diff. (2)vs.(3) 
 M/% SD/ N Min Max N M/% SD/ N N M/ % SD/ N N OR p-val 
CRP 2.344 2.072 0.100 9.900 17205 2.382 2.083 10437 2.285 2.054 6768 0.976 0.187 
Ln(CRP) 0.457 0.938 -2.303 2.293 17205 0.478 0.933 10437 0.424 0.944 6768 0.924 0.061 
Depressive symptoms 1.453 1.941 0 8 29638 1.547 1.999 22870 1.136 1.692 6768 0.859 0.000 
Hypothesised moderators              
Female 55.4% 47673 0 1 86064 55.5% 43970 79296 0.547 3703 6768 0.934 0.271 
Age 65.8 10.3 17 90 31083 65.7 10.8 24315 66.0 8.472 6768 1.002 0.384 
Longstanding illness 12,34,56 55.1% 20387 0 1 36974 56.2% 16977 30206 50.4% 3409 6768 0.705 0.000 
Limiting longstanding illness 12,34,56 35.2% 13008 0 1 36974 37.1% 11194 30206 26.8% 1813 6768 0.445 0.000 
Hypothesised confounders              
Main carer's occupation at age 14 2.087 1.111 1 5 39960 2.099 1.119 34789 2.002 1.049 5171 0.852 0.000 
Below L2 qualifications in 2004 42.7% 0.495 0 1 48735 44.5% 0.497 41967 0.315 0.464 6768 0.338 0.000 
Low accumulated wealth in 2004 0.679 0.275 0.333 1.000 53535 0.691 0.275 46767 0.597 0.261 6768 0.091 0.000 
Agreeable 0.878 0.120 0.25 1.00 26601 0.878 0.121 19833 0.877 0.116 6768 0.861 0.595 
Conscientious 0.822 0.125 0.25 1.00 26529 0.821 0.127 19761 0.828 0.117 6768 2.109 0.006 
Neurotic 0.526 0.149 0.25 1.00 26547 0.531 0.151 19779 0.513 0.144 6768 0.257 0.000 
Open 0.719 0.140 0.25 1.00 26472 0.719 0.142 19704 0.720 0.134 6768 1.120 0.639 
Extravert 0.787 0.140 0.25 1.00 26565 0.785 0.142 19797 0.792 0.136 6768 1.753 0.020 
Childhood adversity 0.995 1.048 0 3 19566 1.008 1.051 13914 0.964 1.041 5652 0.931 0.047 
No. physical limitations 12,34,56 0.222 0.360 0 1 36867 0.241 0.373 30099 0.136 0.276 6768 0.254 0.000 
Medication use 2,4,6 90.3% 45984 0 1 50904 92.2% 40686 44136 78.3% 5298 6768 0.085 0.000 
Hypothesised mediators              
Perceived strain 1,3,3 0.477 0.183 0.25 1.00 27090 0.479 0.185 20322 0.472 0.178 6768 0.898 0.470 
Perceived loneliness 2,34,56 0.280 0.100 0.2 0.6 29998 0.284 0.103 23230 0.267 0.090 6768 0.098 0.000 
Social withdrawal 2.201 0.578 1 3 33786 2.242 0.579 27018 2.034 0.544 6768 0.393 0.000 
Lives with partner 2,4,6 73.6% 19359 0 1 26290 72.9% 14229 19522 75.8% 5130 6768 1.250 0.001 
Acquired partner since last wave 0.6% 135 0 1 21170 0.7% 94 14402 0.6% 41 6768 0.849 0.571 
Lost partner since last wave 2.1% 450 0 1 21170 2.2% 323 14402 1.9% 127 6768 0.828 0.234 
Has children 2,4,6 86.5% 22795 0 1 26346 85.9% 16824 19583 88.3% 5971 6763 1.436 0.000 
Has other family 2,4,6 92.8% 24521 0 1 26424 92.6% 18236 19690 93.3% 6285 6734 1.135 0.208 
Has friends 2,4,6 94.6% 24996 0 1 26418 94.2% 18533 19684 96.0% 6463 6734 1.603 0.000 
Stressy partner relationship 12,34,56 0.295 0.205 0 1 32893 0.293 0.209 26125 0.304 0.191 6768 1.417 0.011 
Distressing child relationship 12,34,56 0.360 0.185 0 1 32881 0.359 0.189 26113 0.362 0.170 6768 1.145 0.382 
Distressing other family relationship 0.443 0.187 0 1 32621 0.443 0.192 25853 0.444 0.166 6768 1.171 0.255 
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12,34,56 
Distressing friend relationship 
12,34,56 0.400 0.141 0 1 32710 0.400 0.146 25942 0.402 0.121 6768 1.177 0.370 
Community stress 1,3,3 0.383 0.144 0.143 1.000 26944 0.388 0.148 20176 0.369 0.133 6768 0.350 0.000 
Low control generally 12,34,56 0.498 0.135 0.167 1.000 32976 0.503 0.138 26208 0.481 0.124 6768 0.215 0.000 
High demands generally 12,34,56 0.520 0.156 0.167 1.000 32897 0.523 0.158 26129 0.508 0.148 6768 0.424 0.000 
In paid employment 2,4,6 35.1% 9173 0 1 26144 35.9% 6974 19433 32.8% 2199 6711 0.847 0.003 
Effort:reward at work 2,34,56 0.082 0.123 0 1 29345 0.084 0.125 22577 0.078 0.116 6768 0.627 0.033 
Low control at work 2,34,56 0.183 0.255 0 1 29628 0.186 0.258 22860 0.174 0.244 6768 0.807 0.040 
Job security 2,34,56 0.025 0.142 0 1 32770 0.025 0.144 26002 0.023 0.133 6768 1.012 0.942 
Worse off than neighbours 2,34,56 0.186 5606 0 1 30189 0.187 4387 23421 0.180 1220 6768 0.931 0.284 
Worse off than friends 2,34,56 0.213 6481 0 1 30371 0.216 5103 23603 0.203 1377 6768 0.928 0.235 
Subjective social status 12,34,56 0.581 0.162 0.05 1.00 32335 0.574 0.165 25567 0.605 0.148 6768 5.419 0.000 
Can't buy things 2,34,56 29.3% 9589 0 1 32782 30.5% 7942 26014 24.3% 1647 6768 0.644 0.000 
Perceived financial strain 12,34,56 0.509 0.210 0.25 1.00 35422 0.520 0.213 28654 0.463 0.190 6768 0.161 0.000 
Carer partner/parent/in-law 12,34,56 7.9% 2931 0 1 36996 7.8% 2360 30228 8.4% 570 6768 1.113 0.284 
Pain 12,34,56 0.252 0.318 0 1 35768 0.262 0.326 29000 0.212 0.278 6768 0.499 0.000 
Pain in back 12,34,56 19.5% 6942 0 1 35595 20.1% 5791 28827 17.0% 1150 6768 0.746 0.000 
Pain in limbs 12,34,56 24.6% 8852 0 1 35934 25.1% 7330 29166 22.5% 1522 6768 0.849 0.013 
Current smoker 12,34,56 17.0% 5820 0 1 34197 18.4% 5043 27429 11.5% 777 6768 0.453 0.000 
Drinks daily 12,34,56 18.8% 6314 0 1 33556 18.6% 4993 26788 19.5% 1321 6768 1.118 0.118 
Physically inactive 12,34,56 0.349 0.287 0 1 36805 0.369 0.295 30037 0.260 0.224 6768 0.132 0.000 
High waist circumference 2,4,6 53.4% 12643 0 1 23691 54.3% 9182 16923 51.1% 3461 6768 0.837 0.002 
Glycosylated haemoglobin 2,4,6 39.887 8.131 11.456 137 18230 40.160 8.368 11462 39.425 7.692 6768 0.983 0.000 
Triglycerides 2,4,6 1.686 1.050 0.30 25 18468 1.711 1.095 11700 1.641 0.966 6768 0.917 0.008 
HDL cholesterol 2,4,6 1.580 0.435 0.4 4.7 18456 1.570 0.436 11688 1.598 0.431 6768 1.301 0.003 
Diastolic blood pressure 2,4,6 74.272 10.983 34 128 22108 74.128 11.168 15340 74.599 10.546 6768 1.007 0.008 
Systolic blood pressure 2,4,6 133.2 18.1 74 259 22108 133.3 18.4 15340 133.1 17.3 6768 1.000 0.853 
Summary statistics for each variable refer to its measurement on three occasions. Waves in which each variable was measured are indicated to the right of the 
variable name. Measures are based on information provided in the wave when inflammation and depressive symptoms are measured (waves 2, 4 and 6), and if 
available, information provided in the previous wave (1, 3 and 5). When information is available in both waves, the mean value is used. When information is 
available in just one wave, information from this wave is used. ORs are odds ratios that respondents are included in analyses for RQ2 if they have high values for 
the variable. Bold font indicates variables with distributions that differ between the two sub-samples. M indicates mean and applies to continuous variables. % 
applies to binary variables and is the percentage of observations with a yes value for the variable. N is the number of observations for which the variable has a 
non-missing value.
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Table 4.7 presents evidence used to identify the most salient confounders or mediators of 
the association between CRP and depressive symptoms. The first two sets of columns give 
statistics for estimated associations between each hypothesised confounder/mediator and 
depressive symptoms, and Ln(CRP). The final set of columns present results of comparisons 
between baseline associations of Ln(CRP) and depressive symptoms and attenuated 
associations, as each hypothesised confounder or mediator is added to the model. All 
models are adjusted for gender, age and age squared. 
Variables that confound or mediate the association between Ln(CRP) and depressive 
symptoms, i.e. that predict both outcomes, are longstanding illness, limiting longstanding 
illness, main carer’s occupation at age 14, below Level 2 qualifications in 2004, accumulated 
wealth in 2004, agreeableness, conscientiousness, childhood adversity, functional 
limitations, medication use, community stress, self-efficacy, subjective social status, 
financial limitations, social withdrawal, pain, smoking, frequency of drinking, physical 
inactivity, obesity, glycosylated haemoglobin, triglycerides and HDL cholesterol. 
Variables selected as particularly salient reduced the magnitude of the unadjusted 
association between Ln(CRP) and depressive symptoms by at least 15%; longstanding illness, 
limiting longstanding illness, childhood SES, qualifications, low accumulated wealth, 
functional limitations, medication use, community stress, low control or self-efficacy, 
subjective social status and perceived financial strain, social withdrawal, pain, physical 
inactivity, obesity, triglycerides and HDL cholesterol.
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Table 4.7: Associations between each hypothesised explanatory variable and (1) Ln(CRP), (2) depressive symptoms, and estimated associations 
between Ln(CRP) and depressive symptoms as each hypothesised explanatory variable is added to the baseline model. All models are adjusted 
for gender and age and estimated for the whole sample 
 Estimated associations between each hypothesised explanatory variable and: Ln(CRP)-depressive symptoms associations  
as each variable added to the baseline model  Depressive symptoms Ln(CRP) 
Hypothesised explanatory variable β 95%CI p-val N β 95%CI p-val N % base β 95%CI p-val N 
None = baseline model           100.0 0.084 0.039-0.130 0.000 6768 
                 
Hypothesised confounders                 
Longstanding illness 12,34,56 0.639 0.543-0.734 0.000 6768 0.134 0.084-0.184 0.000 6768 72.2 0.061 0.016-0.106 0.008 6768 
Limiting longstanding illness 12,34,56 1.053 0.948-1.158 0.000 6768 0.191 0.135-0.248 0.000 6768 50.7 0.043 -0.001-0.087 0.058 6768 
Main carer's occupation at age 14 0.096 0.044-0.148 0.000 5171 0.058 0.027-0.089 0.000 5171 79.8 0.067 0.017-0.118 0.009 5171 
Below L2 qualifications in 2004 0.372 0.264-0.480 0.000 6768 0.275 0.214-0.337 0.000 6768 80.4 0.068 0.022-0.114 0.004 6768 
Low accumulated wealth in 2004 0.997 0.812-1.182 0.000 6768 0.572 0.465-0.678 0.000 6768 62.0 0.052 0.007-0.098 0.024 6768 
Agreeable -0.577 -1.009- -0.145 0.009 6768 0.545 0.297-0.794 0.000 6768 104.7 0.088 0.043-0.134 0.000 6768 
Conscientious -2.005 -2.423- -1.588 0.000 6768 -0.459 -0.701- -0.216 0.000 6768 89.0 0.075 0.030-0.120 0.001 6768 
Neurotic 3.533 3.210-3.856 0.000 6768 -0.106 -0.303-0.092 0.295 6768       
Open -1.671 -2.035- -1.307 0.000 6768 -0.124 -0.336-0.087 0.250 6768       
Extravert -2.601 -2.955- -2.247 0.000 6768 -0.114 -0.324-0.095 0.285 6768       
Childhood adversity 0.189 0.138-0.240 0.000 5652 0.068 0.037-0.098 0.000 5652 97.8 0.083 0.034-0.131 0.001 5652 
No. functional limitations 12,34,56 1.823 1.673-1.972 0.000 6768 0.317 0.235-0.399 0.000 6768 36.1 0.030 -0.013-0.074 0.172 6768 
Medication use waves 0-6 0.543 0.422-0.664 0.000 6768 0.310 0.239-0.380 0.000 6768 74.2 0.063 0.017-0.108 0.007 6768 
                 
Hypothesised mediators                 
Perceived strain 1,3,3 2.222 1.990-2.454 0.000 6768 0.068 -0.055-0.191 0.281 6768       
Loneliness 2,34,56 8.265 7.836-8.694 0.000 6768 0.234 -0.019-0.487 0.070 6768       
Acquired partner since last wave -0.715 -0.826--0.603 0.000 6768 -0.034 -0.096-0.027 0.278 6768       
Lost partner since last wave -0.457 -0.919-0.005 0.053 6768 -0.054 -0.278-0.170 0.637 6768       
Distressing partner relationship 12,34,56 3.311 2.892-3.730 0.000 6768 0.180 -0.048-0.408 0.122 6768       
Distressing child relationship 12,34,56 2.859 2.462-3.256 0.000 6763 0.078 -0.137-0.293 0.475 6763       
Distressing other family rel. 12,34,56 1.399 1.106-1.691 0.000 6734 0.028 -0.124-0.180 0.721 6734       
Distressing friend relationship 12,34,56 1.693 1.289-2.096 0.000 6734 0.087 -0.123-0.296 0.418 6734       
Community stress 1,3,3 2.287 1.963-2.612 0.000 6768 0.371 0.196-0.547 0.000 6768 80.6 0.068 0.023-0.113 0.003 6768 
Low control generally 12,34,56 3.132 2.803-3.462 0.000 6768 0.240 0.066-0.414 0.007 6768 82.2 0.069 0.025-0.113 0.002 6768 
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High demands generally 12,34,56 1.729 1.440-2.019 0.000 6768 0.040 -0.112-0.193 0.605 6768       
Work effort:reward imbalance 2,34,56 1.910 1.215-2.606 0.000 6711 0.053 -0.301-0.407 0.771 6711       
Low work control 2,34,56 0.351 -0.026-0.727 0.068 6711 -0.065 -0.253-0.123 0.497 6711       
Job insecurity 2,34,56 0.273 -0.018-0.564 0.066 6711 -0.049 -0.194-0.096 0.506 6711       
Worse off than people nearby 2,34,56 0.498 0.387-0.609 0.000 6768 0.054 -0.003-0.111 0.062 6768       
Worse off than friends 2,34,56 0.536 0.432-0.641 0.000 6768 0.018 -0.036-0.071 0.520 6768       
Subjective social status 12,34,56 -2.516 -2.806--2.226 0.000 6768 -0.478 -0.636--0.320 0.000 6768 60.9 0.051 0.007-0.096 0.024 6768 
Can't buy things 2,34,56 0.744 0.640-0.849 0.000 6768 0.063 0.009-0.118 0.023 6768 85.9 0.072 0.028-0.117 0.001 6768 
Perceived financial strain 12,34,56 1.657 1.438-1.877 0.000 6768 0.362 0.245-0.479 0.000 6768 65.9 0.056 0.011-0.100 0.015 6768 
Cares for partner or parent 0.272 0.099-0.444 0.002 6768 -0.048 -0.134-0.039 0.279 6768       
Social withdrawal 0.553 0.471-0.635 0.000 6768 0.170 0.125-0.214 0.000 6768 64.1 0.054 0.009-0.099 0.019 6768 
Pain 12,34,56 1.582 1.433-1.730 0.000 6768 0.329 0.248-0.409 0.000 6768 38.3 0.032 -0.012-0.076 0.151 6768 
Back pain 12,34,56 0.878 0.753-1.003 0.000 6768 0.169 0.104-0.234 0.000 6768 74.3 0.063 0.018-0.108 0.006 6768 
Pain hips, knees, feet or mouth 12,34,56 0.816 0.701-0.931 0.000 6768 0.256 0.196-0.316 0.000 6768 58.7 0.050 0.005-0.095 0.031 6768 
Currently smokes 12,34,56 0.490 0.343-0.636 0.000 6768 0.247 0.164-0.330 0.000 6768 86.2 0.073 0.027-0.118 0.002 6768 
Drinks at least daily 12,34,56 -0.170 -0.292- -0.048 0.006 6768 -0.072 -0.137--0.008 0.028 6768 97.6 0.082 0.037-0.128 0.000 6768 
Physical inactivity 12,34,56 1.401 1.215- -1.587 0.000 6768 0.493 0.396-0.590 0.000 6768 46.0 0.039 -0.006-0.084 0.092 6768 
High waist circumference 2,4,6 0.152 0.065-0.239 0.001 6768 0.483 0.439-0.527 0.000 6768 80.1 0.068 0.020-0.115 0.005 6768 
Glycosylated hb (mmol/mol) 2,4,6 0.010 0.004-0.015 0.001 6768 0.010 0.007-0.013 0.000 6768 92.7 0.078 0.033-0.124 0.001 6768 
Triglycerides (mmol/l) 2,4,6 0.089 0.046-0.132 0.000 6768 0.149 0.127-0.171 0.000 6768 83.2 0.070 0.024-0.116 0.003 6768 
HDL cholestrol 2,4,6 -0.315 -0.426- -0.205 0.000 6768 -0.486 -0.544- -0.427 0.000 6768 71.3 0.060 0.014-0.107 0.011 6768 
Diastolic blood pressure (mmHg) 2,4,6 0.001 -0.003-0.005 0.737 6768 0.008 0.006-0.010 0.000 6768       
Systolic blood pressure (mmHg) 2,4,6 0.002 -0.001-0.004 0.153 6768 0.005 0.003-0.006 0.000 6768       
Each row presents results from three RE models, each using three waves of data and adjusted for age, age squared and gender. Models are estimated for the 
sample of respondents with complete information for all variables in the table, with the exception of childhood SES and childhood adversity, as numbers reporting 
these variables are lower than for the other variables.  Models for stressful relationships with partner, children, other family members and friends adjust for 
having a partner, children, other family and friends, respectively. Models for effort:reward imbalance, control at work and job insecurity adjust for being in paid 
work during the previous month. The first set of columns present estimated associations of each hypothesised explanatory variable with depressive symptoms, 
and the second set with Ln(CRP). Beta values in these columns refer to increases in depressive symptoms and Ln(CRP), respectively, associated with unit increases 
in each hypothesized explanatory variable. The third set presents estimated associations between Ln(CRP) and depressive symptoms for a baseline model (top 
row), adjusted only for gender, age, and age squared, and models in which one explanatory variable is added. All models are estimated using the same sample 
with complete information for all variables, except for childhood SES and childhood adversity. Beta values represent increases in depressive symptoms for each 
unit increase in Ln(CRP). Measures use information from two consecutive waves, if available, as indicated by wave numbers to the right of each variable 
description. High waist circumference is over 88 cms for women and over 102 cms for men. Bold font indicates variables that attenuate the unadjusted 
association by at least 15%.
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In order to simplify SEM models, some variables were excluded because they overlapped 
conceptually or were highly correlated. Longstanding illness and functional limitations were 
excluded because they overlap with limiting longstanding illness. HDL cholesterol and 
triglycerides were excluded because these, like waist circumference, are biomarkers of 
metabolic dysregulation (Lacey et al. 2016, McMunn et al. 2016) and it was simpler to use 
just one marker. Waist circumference was selected over HDL cholesterol and triglycerides 
because it of more direct interest to policy makers in public health.  
Community stress was excluded because it was only measured in waves 1 and 3. An index of 
psychological stress-and-withdrawal was created that combined low control or self-efficacy, 
subjective social status, perceived financial strain and social withdrawal. The index 
represented the psychosocial manifestations of sickness behaviours. 
Results presented in Appendix 22 Table A22.3 indicate that selected variables have pairwise 
correlation coefficients below 0.4 with the exception of age and limiting longstanding illness 
(r=0.42) and stress in waves 3 and 5 and limiting longstanding illness (r=0.46, r=0.44, 
respectively). 
Selected variables were included in an SEM model using the MLMV estimation method. 
Results are presented in Figure 4.3 and Table 4.8.  
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Figure 4.3: SEM results for the whole sample  
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The SEM model uses MVML method of estimation, with 11,986 observations. All lines indicate associations with p-values <0.05. Unbroken lines indicate positive 
associations and dashed lines indicate negative associations. All measures in waves 3 and 5 are auto-correlated. Error terms for all mediators at wave 3 are 
positively correlated except for psychological stress and obesity, which are not correlated. 
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Table 4.8: Magnitudes of prospective associations between Ln(CRP) and depressive symptoms for the whole sample 
 Associations between baseline Ln(CRP) and depressive symptoms four years later 
 Waves 2,3,4 Waves 4,5,6 
Mediator Ln(CRP)-Med Med-DS Pathway Ln(CRP)-Med Med-DS Pathway 
None   0.041   NS 
Stress&withdrawal 0.024 0.937 0.022 0.004 0.571 0.002 
Obesity 0.157 NS --- 0.020 NS --- 
Physical inactivity 0.072 0.190 0.014 0.035 0.214 0.007 
Pain 0.056 0.389 0.022 0.034 0.168 0.006 
       
 Associations between depressive symptoms and Ln(CRP) four years later 
 Waves 2,3,4 Waves 4,5,6 
Mediator Ln(CRP)-Med Med-DS Pathway Ln(CRP)-Med Med-DS Pathway 
None   NS   NS 
Stress&withdrawal 0.039 NS --- 0.015 NS --- 
Obesity 0.020 0.214 0.004 NS 0.069 --- 
Physical inactivity 0.069 NS --- 0.043 0.094 0.004 
Pain 0.097 0.088  0.052 NS --- 
These are results of SEM models using the MLMV method with 11,986 observations. NS is not statistically significant. Prospective associations between Ln(CRP) 
and depressive symptoms were measured on two occasions. On the first occasion, Ln(CRP) was measured in wave 2 (2004), mediators in wave 3 (2006), and 
depressive symptoms in wave 4 (2008). On the second occasion, Ln(CRP) was measured in wave 4 (2008), mediators in wave 5 (2010), and depressive symptoms 
in wave 6 (2012). There is adjustment for gender, age, accumulated wealth, limiting longstanding illness and medication use. Pathway magnitudes are calculated 
by multiplying the two associations with the mediator. Because each mediator has values between zero and one and the other variables are standardised, sizes 
are comparable. High waist measure indicates >=88cms for women and >=102cms for men. 
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Mean delays between measurements of depressive symptoms (in the main interviews) and 
CRP (in nurse interviews) are set out in Table 4.9. During the same wave, measures of 
depressive symptoms were mostly made one to two months before measures of CRP. SEM 
results provide no evidence of direct effects of Ln(CRP) on depressive symptoms during the 
same wave. Neither is there evidence of this in sensitivity analyses that include only 
respondents whose nurse and main interviews were one month or less apart (Appendix 22).  
Table 4.9: Delays between main and nurse interviews 
 Number of months between main and nurse interview 
 Mean S.D. Min Max Mode Median Inter-quartile range 
Wave 2 1.25 1.23 -3 11 1 0-1 >0-<2 
Wave 4 1.83 1.89 0 13 1 0-1 >0-<2 
Wave 6 1.01 0.87 -6 7 1 0-1 >0-<1 
Most nurse interviews took place after main interviews. Information is only available about year and 
month of interviews, to protect the anonymity of respondents. 
 
 
There are autocorrelations between waves 3 and 5 for each hypothesised mediator, and 
their error terms in wave 3 are all positively correlated. 
Ln(CRP) in wave 2 has a direct effect on depressive symptoms in wave 4, but this is not 
repeated between waves 4 and 6, after fuller adjustment for history of CRP and the 
hypothesised mediators. 
Associations between Ln(CRP) and depressive symptoms four years later are mediated by 
physical inactivity, pain and stress-and-withdrawal. Magnitudes of associations are small. 
For example, after adjustment for gender, age, wealth, limiting longstanding illness, 
medication use and earlier measures of CRP, depressive symptoms and all hypothesised 
mediators, physical inactivity in wave 5 mediates an association in which each SD increase in 
Ln(CRP) in wave 4 is associated with an increase in depressive symptoms in wave 6 (4 years 
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later) by 0.7%SD. This is equivalent to an association between 1mg/L CRP in wave 4 and an 
increase in depressive symptoms in wave 6 of 0.06. Prospective associations mediated by 
pain and stress-and-withdrawal are even smaller; 0.6% and 0.2%, respectively. Mediated 
associations between Ln(CRP) in wave 2 and depressive symptoms in wave 4 are of much 
greater magnitudes, but do not include adjustment for earlier levels of each mediator. 
There is no evidence of direct effects of depressive symptoms on CRP four years later and 
very weak evidence of a small association mediated by physical inactivity, in which each SD 
increase in depressive symptoms is associated with an increase in Ln(CRP) by 0.4%SD.  
Obesity predicts and is predicted by inflammation. One SD increase in Ln(CRP) in wave 4 is 
associated with a 2.4% increase in risk of very high waist circumference two years later. 
Having a very high waist circumference in wave 5 is associated with an increase in Ln(CRP) 
two years later by 6.9%SD, which is equivalent to 1.14mg/L. These associations are net of all 
confounding variables and earlier measures of CRP, depressive symptoms, waist 
circumference, physical inactivity, pain and stress. 
As expected, there is evidence of autocorrelations between time-points for depressive 
symptoms and Ln(CRP). Co-variances of error terms in waves 4 and 6 are negative. 
Age predicted Ln(CRP) and was negatively associated with depressive symptoms. Female 
gender, low wealth, limiting longstanding illness and medication use are each positively 
associated with both outcomes. 
Results of sensitivity analyses are consistent with these results. See Appendix 22 Figures 
A22.1 and A22.2. 
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Building the final SEM from simpler specifications indicates that most associations and 
mediated associations are found regardless of the complexity of the specification.  
The ADF estimation method was used with a much smaller sample; 1,762 as opposed to 
11,986 using MLMV estimation. This method makes no assumptions about the distributions 
of variables, but only includes respondents who provided complete information. The ADF 
method produced some negative correlations, probably due to difficulties fitting the 
specification to the data with small numbers, but otherwise the results are remarkably 
consistent with those produced when the MOMV method is used. 
Excluding respondents whose main and nurse interviews were more than two months apart 
made no difference to the results.  
SEM models that used alternative measures of psychological stress that excluded, one at a 
time, social withdrawal, subjective social status and financial strain, and that used an 
alternative measure of pain that excludes back pain produced identical results.  
When BMI of 30 of above was used to measure obesity instead of high waist circumference, 
results were similar. However, relationships between depressive symptoms and subsequent 
continuous measures of both waist circumference and BMI were negative and statistically 
significant. 
RQ3. Moderation by gender, age and health status 
Results presented in Figure 4.4 and Table 4.10 suggest that these results do not differ 
substantially by gender or between those with and without at least one longstanding illness. 
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However, effect sizes are slightly larger for women than men, and among respondents with 
at least one longstanding illness compared with the whole sample. 
For the sub-sample of respondents with RA, none of the prospective associations between 
inflammation and depressive symptoms, direct or mediated, are statistically significant. This 
is probably because few respondents reported RA (N=1,058) and the model is complex. 
Although numbers are also small for those with a history of asthma (n=2,935), prospective 
associations between inflammation and depressive symptoms are mediated by stress-and-
withdrawal and inactivity. 
Results of analyses using the sub-samples with asthma history and current asthma that 
exclude pain as a hypothesised mediator are similar. See Appendix 22. 
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Figure 4.4: SEM results for sub-samples 
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Respondents with a history of asthma (n=2,935)    Respondents with currently active asthma (n=1,949)  
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 Table 4.10: Direct and mediated prospective associations between Ln(CRP) and depressive symptoms for each sub-sample 
  Associations between baseline Ln(CRP) and depressive symptoms four years later 
Mediators 
Whole sample Men Women Chronic illness RA History of asthma Current asthma 
2,3,4 4,5,6 2,3,4 4,5,6 2,3,4 4,5,6 2,3,4 4,5,6 2,3,4 4,5,6 2,3,4 4,5,6 2,3,4 4,5,6 
None  0.054 --- --- --- 0.061 --- 0.067 --- --- --- 0.090 --- 0.105 --- 
Stress 0.104 0.002 0.006 --- 0.016 0.003 0.012 0.003 --- --- 0.015 0.006 0.043 --- 
Obesity --- --- --- --- --- --- --- --- --- --- --- --- --- --- 
Inactivity 0.016 0.008 0.020 0.005 0.013 0.010 0.016 0.010 --- --- 0.017 0.003 --- 0.004 
Pain 0.022 0.006 0.009 0.004 0.032 0.005 0.021 0.005 --- --- 0.040 --- 0.042 --- 
              
 Waves: Associations between baseline depressive symptoms and Ln(CRP) four years later 
Mediators 2,3,4 4,5,6 2,3,4 4,5,6 2,3,4 4,5,6 2,3,4 4,5,6 2,3,4 4,5,6 2,3,4 4,5,6 2,3,4 4,5,6 
None  --- --- --- --- --- --- --- --- --- --- --- --- --- --- 
Stress --- --- 0.020 --- --- --- --- --- --- --- --- --- --- --- 
Obesity 0.004 --- 0.004 --- --- --- 0.009 --- --- --- --- --- --- --- 
Inactivity --- 0.004 --- --- --- --- --- 0.004 --- --- --- --- 0.006 --- 
Pain 0.008 --- --- --- --- --- 0.010 --- --- --- --- -0.007 --- --- 
Observations 11,986 5,325 6,661 10,625 1,058 2,935 1,949 
Pathways are calculated by multiplying estimated associations between each mediator and (1) depressive symptoms, (2) Ln(CRP). If both associations are 
statistically significant (p<0.05), a value is given. Otherwise, the cell is filled with a blank. Measures of depressive symptoms and Ln(CRP) are standardised. One 
negative correlation is italicised.
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5. Discussion 
This section discusses finding, strengths and weaknesses, summarises conclusions and 
presents ideas about policy implications and directions for future research. 
5.1 Discussion of findings 
5.1.1 Relationship between inflammation and depressive symptoms four years later 
This study adds confidence to a small body of epidemiological evidence that chronic low-
grade inflammation predicts depressive symptoms. It provides an important contribution 
because depressive symptoms and inflammation were measured on three occasions and RE 
models were used so that prospective associations were estimated net of pre-existing 
levels. 
Inflammation predicted depressive symptoms four years later, after adjustment for gender, 
age, education, wealth, longstanding illness and medication use. The magnitude of the 
association is small; each SD increase in baseline Ln(CRP) predicted an increase in depressive 
symptoms by 3.3%SD (95%ci=1.4%-5.2%, p=0.001, n=8,549). This is consistent with 
epidemiological evidence of prospective associations of small magnitudes between CRP and 
depressive symptoms after adjustment for similar covariates (Valkanova et al. 2013, Au et 
al. 2015, Das 2016).  
The chapter provides new evidence about factors that mediate associations between 
inflammation and depressive symptoms. Using an exploratory approach, a wide range of 
factors were considered as mediators and those that were found to attenuate associations 
between inflammation and depressive symptoms were selected. SEMs with three measures 
of CRP and depressive symptoms at four year intervals included as hypothesised mediators 
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obesity, physical inactivity, pain and psychological stress-and-withdrawal. Physical inactivity, 
pain and an index of psychological stress-and-withdrawal mediated associations between 
inflammation and depressive symptoms four years later. The associations were robust to 
adjustment for hypothesised confounders (gender, age, SEP, limiting longstanding illness 
and medication use) and to a range of sensitivity analyses.  
There were no direct effects of CRP on depressive symptoms, either concurrently or over 
four years. Obesity did not mediate associations between inflammation and depressive 
symptoms.  
These are new findings and should be tested in other datasets. 
This study did not set out to test the inflammatory theory of depression. To do so would 
require information about chronic inflammation and subsequent measures of depressive 
symptoms repeated at short intervals. Nevertheless, the evidence is relevant. At first sight, 
the results are inconsistent with the theory because there is no evidence of direct effects of 
CRP on depressive symptoms, either after four years, or during the same wave. But this may 
reflect the times between measurements of CRP and depressive symptoms. As mentioned in 
the introduction, laboratory evidence uses measures of inflammation and depressive 
symptoms a few minutes or hours later (Smith 1991, Miller et al. 2009), which is obviously 
very different from measuring depressive symptoms after a gap of four years. Although the 
SEM also estimated associations between CRP and depressive symptoms during the same 
wave of data collection, depressive symptoms were measured in the main interviews, and 
blood samples from which CRP was assayed were taken during the nurse interviews, most of 
which took place about a month after the main interview. Therefore, while the lack of 
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evidence for direct associations between CRP and depressive symptoms does not support 
the inflammatory theory of depression, neither does it indicate that the theory is incorrect. 
However, the results, (which I emphasise are new and need to be tested in other datasets), 
are consistent with the hypothesis that chronic low-grade inflammation is associated with 
sickness behaviours that over time contribute to the development of depressive symptoms 
(Dantzer & O’Connor 2008, Miller & Raison 2016, Dantzer & Kelly 2007). CRP predicts 
psychological stress-and-withdrawal two years later. Social withdrawal is a sickness 
behaviour, which is associated with isolation and depression (Dantzer et al. 2008). 
Social withdrawal and other sickness behaviours (increased arousal and anxiety and 
negative mood) probably affect how individuals respond to events and circumstances such 
that they are appraised as stressful. This explanation is consistent with evidence that 
cytokines affect the regulation of the HPA axis (Makhija & Karunkaran 2013, Capuron & 
Miller 2011), affecting physiological and psychological responses to stressors. Jiang et al. 
(2104) describe three biological mechanisms through which they suggest inflammation leads 
to depressive symptoms, and one of these involves activation of the HPA axis. 
The importance of psychological stress as a mediator is indicated by findings that the 
psychosocial measures that most effectively attenuated the inflammation-depressive 
symptoms association are measures of perceived psychological stress as opposed to 
potentially stressful events and circumstances. Perceived stress reflects both stressful 
exposures and their psychological appraisal. Variables that most effectively attenuated the 
CRP-depressive symptoms association were subjective social status, self-efficacy and 
financial strain. In contrast, the role of caring, which is an exposure that is likely to be 
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stressful and which has been described as a stressor (Miller et al. 2014, Pearlin et al. 1997) 
did not attenuate the association.  
More specifically, a single item rating of perceived financial strain attenuated the CRP-
depressive symptoms association more effectively than a relatively objective measure of 
financial limitations based on the number of activities that respondents reported being 
unable to participate in because of financial limitations. Similarly, subjective social status, 
measured using a rating ladder, attenuated the association more effectively than more 
objective measures of status based on assessments of whether respondents were better off 
than specific groups; friends, neighbours and work colleagues. 
Thus, although no evidence is provided that inflammation has immediate and direct effects 
on depressive symptoms, sickness behaviours associated with inflammation may contribute 
to social withdrawal and also to the appraisal of circumstances and events as stressful. Over 
time, both of these outcomes are likely to contribute to the development of depressive 
symptoms. It is also possible that sickness behaviours associated with chronic inflammation 
also affect perceptions of pain and motivation to participate in physical activities.  
The finding that pain mediates associations between CRP and depressive symptoms is new 
but not unexpected. It is consistent with evidence of associations between pain and both 
inflammation and depressive symptoms, as set out by Kiecolt-Glaser and colleagues (2015). 
It is possible that perceptions of pain are increased by heightened arousal that is associated 
with inflammation. Pain is unpleasant and disabling, and if chronic it could contribute to the 
development of depressive symptoms. 
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Physical inactivity also mediated the association between CRP and depressive symptoms, 
independent of obesity. This is consistent with evidence of correlations between physical 
inactivity and inflammation (Gleeson et al. 2011), and with the hypothesis that fatigue 
induced by inflammation reduces motivation to engage in physical activity. Other studies 
report that physical inactivity is associated with depressive symptoms (Mammen & Faulkner 
2013, Pereira et al. 2014). In addition, a study using ELSA waves 1 and 2 reports prospective 
associations between recurrent depressive symptoms and elevated CRP that was mediated 
by physical inactivity and obesity, after mutual adjustment Hamer et al. (2009). 
9.1.2.1 5.1.2 Relationship between depressive symptoms and inflammation four 
years later  
After adjusting for gender, age, education, wealth, longstanding illness and medication use, 
this study found is no evidence that depressive symptoms predicted CRP either concurrently 
or four years later. This is consistent with evidence from some large-scale epidemiological 
studies (Das 2016, Au et al. 2015, Gimeno et al. 2009). Other studies report prospective 
associations, but it appears that it is cumulative episodes of depression as opposed to single 
measures of depressive symptoms that predict inflammation (Copeland et al. 2012, Duivis et 
al. 2011, Hamer et al. 2009). 
More detailed evidence from the SEM suggests that a small association is mediated by low 
physical activity. This finding should be tested in other datasets, possibly including 
cumulative episodes of depression.  
In the context of the other variables included in the SEMs, there was little evidence that 
psychological stress-and-withdrawal predicted inflammation. Sensitivity analyses that 
excluded social withdrawal found no evidence that psychological stress predicted 
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inflammation either. This was not expected, as other studies provide evidence that chronic 
psychological stress predicts CRP levels (Johnson et al. 2013, Hansel et al. 2013, Berk et al. 
2013). However, the relationships between psychological stress and inflammation are 
complex, since psychological stress has been found to predict both suppression of immune 
function (Chida & Mao 2009, Kiecolt-Glaser et al. 1995) and uncontrolled pro-inflammatory 
behaviours (Miller et al. 2002, Chrousos et al. 1996).  
9.1.2.2 5.1.3 Variables that attenuated the CRP-depressive symptoms 
association: Consistency with existing evidence 
After adjustment for gender and age, each of the following variables attenuated the cross-
sectional association between CRP and depressive symptoms, rendering it non-significant; 
accumulated wealth, limiting longstanding illness, obesity, pain, physical inactivity, 
functional limitations, loneliness, self-efficacy, subjective social status, financial strain and 
social withdrawal.  
Valkanova’s critical review and meta-analysis of prospective associations between 
inflammation and subsequent depressive symptoms report associations of small magnitude 
that are robust to adjustment for a wide range of factors (Valkanova et al. 2013). On the 
face of it, this is inconsistent with our findings that the same prospective association is fully 
attenuated by individual variables. However, samples and analysis models differ between 
studies and this could explain apparent inconsistencies. 
For example, Gimeno et al. (2009) tested attenuation of the prospective association 
between CRP and depressive symptoms and report no attenuation by SEP, health-related 
behaviours, biological factors, health conditions or medication use. Our study finds no or 
marginal evidence of full attenuation by metabolic factors, longstanding illness or 
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medication use. SEP was measured differently in this study; Gimeno and colleagues used 
occupational position, and this study uses accumulated wealth. In addition, this study does 
not measure health behaviours together, but rather physical inactivity. Gimeno’s measure 
included physical inactivity combined with smoking and heavy drinking, which together 
attenuated to a very small degree the prospective association between CRP and depressive 
symptoms.  
Another example is a study by Matthews et al. (2010), who report associations between CRP 
and depressive symptoms that are robust to adjustment for ethnicity, education, hormone 
therapy and menopausal status, smoking, health conditions, anti-depressant use, physical 
activity, BMI and waist circumference. The set of covariates differs from those included in 
my models, and so does the sample, as Matthews used a sample of Caucasian and African-
American women with mean age of 42. Further, their study had more power because 
although the sample size was smaller (3,302 women), data were used from 7 sweeps of data 
collection. 
The most comparable study to this one uses two waves of ELSA to examine prospective 
associations between CRP and depressive symptoms (Au et al. 2015). In line with the 
findings presented here, they report prospective associations between CRP and subsequent 
depression that are robust to adjustment for gender, age, education, marital status, 
employment status and smoking, but not to metabolic factors that included BMI. Unlike the 
results presented here, Au and colleagues do not find that physical inactivity fully attenuates 
the CRP-depressive symptoms association. However, their measure is not the same as mine 
and is combined with smoking. 
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In addition to the factors that fully attenuated the association, others partly attenuated it. 
These included low qualifications, which, as expected, were associated with higher levels of 
depressive symptoms and inflammation. Plasma levels of triglycerides and total:HDL 
cholesterol also predicted both outcomes, which is consistent with existing evidence 
(Tamakoshi et al. 2003, Au et al. 2013, Penninx et al. 2013). Medication use predicted 
depressive symptoms and CRP, and partially attenuated the association between them, in 
line with findings reported by Gimeno et al. (2009). 
Consistent with existing evidence, smoking was associated with both depressive symptoms 
and CRP, and attenuated the association between them (Mathew et al. 2017, Berk et al. 
2013, Calder et al. 2013, O’Connor et al. 2009, Copeland et al. 2012, Hamer et al. 2009).  
Frequent alcohol consumption was associated with fewer depressive symptoms and lower 
CRP, and slightly attenuated the CRP-depressive symptoms association. This is consistent 
with findings from another study using ELSA data (Hamer et al. 2009). The measure used by 
this study and Hamer’s is a binary indicator of daily or almost daily alcohol consumption. 
Studies using more detailed measures of alcohol consumption report that abstinence and 
heavy drinking predict higher, not lower, levels of depression and inflammation (O’Connor 
et al. 2009).  
Several of the stress measures partly attenuated the association between CRP and 
depressive symptoms; namely, perceived strain, stressful relationships with partner, 
children, and friends, high perceived demands, feeling worse off than one’s friends, and 
financial limitations. Measures of stress that did not attenuate the association were caring 
role and getting or losing a partner, which are exposures rather than experiences of stress. 
Community stress and work stress did not attenuate the association either, but numbers 
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were limited for these variables as community stress was measured in waves 1 and 3 only, 
and a minority of respondents were in paid work. 
As expected, childhood adversity predicted both outcomes and partly attenuated the 
association. Other studies provide evidence that childhood adversity predicts depressive 
symptoms (Nelson et al. 2017, Li et al. 2016) and chronic low-grade inflammation (Fagundes 
et al. 2013, Hansel et al. 2010 , Taylor et al. 2006). A small-scale study of adult cancer 
patients reports that childhood adversity explained a prospective association between CRP 
and depressive symptoms (Archer et al. 2012).  
A conscientious personality predicted lower levels of depressive symptoms and 
inflammation, partly attenuating the association between them. This is consistent with 
other evidence that conscientiousness is associated with positive health behaviours (Bogg & 
Roberts 2004) and positive health (Goodwin & Friedman 2006, Friedman 2008). The other 
dimensions of personality did not attenuate the association, although they were all 
associated with depressive symptoms.  
9.1.2.3 5.1.4 Moderation by gender, age category and health status 
I find no evidence of moderation by gender. The magnitude of associations between CRP 
and depressive symptoms four years later was slightly greater among women than men, but 
the difference was far from being statistically significant. This lends little support to the 
hypothesis that the association is stronger among women (Derry et al. 2015). But neither 
does it support the hypothesis that associations are stronger among men, suggested by 
some pre-existing evidence (Howren et al. 2009, Gimeno et al. 2009, Das 2016, Luukinen 
2010, Vetter et al. 2013), although none of these studies formally tested for gender 
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differences. It is possible that no gender difference was apparent in this study because most 
of the women included were post-menopausal. 
There was also no evidence that associations between inflammation and depressive 
symptoms differed between respondents aged 70 and over and those under 70. 
Inflammation predicted depressive symptoms for both age groups, and depressive 
symptoms predicted inflammation for neither. Stewart et al. (2009) found no evidence of a 
prospective association between inflammation and depressive symptoms in a relatively 
small sample with mean age of 61, and note that the association was reported using a 
sample of similar size but with respondents who were substantially older and reported poor 
health (Van den Biggelaar et al. 2007). The analyses presented here adjust for health status 
and medications, which probably differ between age categories. Nevertheless, the similarity 
of findings between the two age categories does not support the suggestion that biological 
processes differ among older populations (Alexopoulos & Morimoto 2011).  
Although the difference was not quite statistically significant, associations between Ln(CRP) 
and subsequent depressive symptoms were greater for those with at least one longstanding 
illness. This is consistent with the argument presented in the introduction by Stewart et al. 
(2009) that among healthy populations, there is insufficient variation in inflammation and 
depressive symptoms to detect an association unless large samples are used. In our sample, 
the variances of depressive symptoms and CRP among those without a limiting longstanding 
illness were 2.1 and 3.5, respectively, compared against the higher values of 4.7 and 4.8 
among those with at least one limiting longstanding illness. This would make it easier to 
detect existing associations. 
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The same factors mediated prospective associations between CRP and depressive symptoms 
for those with longstanding illness and the whole sample.  
I thought that associations between CRP and depressive symptoms might be relatively 
strong among respondents with RA and asthma. However, there is no evidence of 
differences for respondents with histories of each condition. For respondents with RA, there 
was no evidence of mediated or direct associations between CRP and depressive symptoms, 
possibly because the sample size was small. However, among those with asthma, physical 
inactivity and stress-and-withdrawal each mediated the association between inflammation 
and depressive symptoms. Pain did not. This is not surprising, as pain is not a symptom of 
asthma. In fact, the results were unchanged when pain was excluded from the specification. 
Additional findings about obesity, inflammation and depressive symptoms are discussed in 
Appendix 23. 
5.2 Strengths and limitations 
The evidence presented here draws on a very rich large-scale longitudinal dataset. ELSA 
includes comprehensive information encompassing biological, psychosocial and socio-
economic factors, collected from adults aged 50 and over, who have been tracked since 
2000. This chapter uses information collected during six waves, including biomarkers of 
inflammation collected on three occasions. Large sample sizes, measures on multiple 
occasions and the use of sophisticated statistical techniques means that analyses have been 
conducted using over 7,500 observations. Consequently, it has been possible to model 
several hypotheses simultaneously that explain prospective associations between 
depressive symptoms and inflammation. This provides new evidence about prospective 
associations between CRP and depressive symptoms and the factors that mediate them. 
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Furthermore, it has been possible to examine how these prospective associations differ by 
gender, age and health status. 
Values in the dataset indicate its representativeness and validity. For example, in the 
sample, mean CRP  is 2.3mg/L. Guidelines produced by the World Health Organisation 
suggest that baseline CRP over 3mg/l indicates increased vulnerability to a range of health 
conditions (Whicher 1998). Consequently, the mean level in the sample is quite high, 
probably reflecting its age, and the high proportion (55%) with longstanding illness. Other 
studies using samples of a similar age find similar levels of CRP (Stewart et al. 2009, Das 
2016, Pasco et al. 2010, Baune et al. 2012). 
Similarly, levels of depressive symptoms reported here are consistent with those reported in 
other studies that use the same measure in ELSA (Hamer et al. 2009, Daly 2013). About one 
in fourteen respondents reported active asthma, which is equivalent to rates reported 
among adults by Asthma UK (2013). In wave 2, 3.8% reported a history of RA, which is 
higher than national estimates (Widdifield et al. 2014), but very similar to the rate reported 
in a sample of adults of this age living in the US (Stewart et al. 2009). 
The study also has limitations, one of which is that it is based on a sample of adults aged 50 
and over living in England who are almost entirely white, and the results may not apply to 
other populations. Another limitation is selection into and attrition from the ELSA samples, 
which reduces sample size and can introduce bias. Reduced sample size decreases power, 
reducing the chances of detecting associations that exist in the population. Bias affects the 
accuracy of results in ways that are less predictable, and so is of more concern for the 
interpretation of findings.  
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Tables 4.3 and 4.6 present distributions of variables in the whole and analysis samples. 
These indicate that compared against the whole sample, respondents included in the 
analyses were better off economically, had higher qualifications, and better health, and 
reported healthier lifestyles, more social support, and lower levels of childhood adversity 
and adult psychosocial challenges.  
Additional information about sample biases resulting from attrition is available from ELSA 
documentation (Scholes et al. 2008, Scholes et al. 2009, Cheshire et al. 2012, Bridges et al. 
2015). This indicates that respondents who provided usable blood samples tended to live 
outside London and the North West of England, to be white, aged below 75, have 
qualifications at Level 2 or above, have higher status occupations, own their home, live 
alone or in households of at least four people, be divorced, widowed, or separated, retired, 
with no limiting longstanding illness, in good self-rated health, with vision and hearing, to be 
non-smokers and take regular exercise. 
The biases in the samples used are likely to result in under rather than over estimations of 
associations between inflammation and depressive symptoms. Thus, the results presented 
here are conservative, and we can have all the more confidence in them. 
This is for several reasons. First, those who live their lives in socio-economically advantaged 
positions tend to have better health. Therefore, sample bias excludes those who are 
disadvantaged and who have poor health outcomes, which serves to reduce the variation in 
inflammation and depressive symptoms. This makes it more difficult to identify existing 
associations between inflammation and depressive symptoms than it would be using a more 
representative sample. Further, results reported in this chapter indicate that accumulated 
wealth, level of qualifications, having at least one limiting longstanding illness, self-rated 
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health, physical activity, and smoking status each partially explain the magnitude and 
consistency of associations between inflammation and depressive symptoms. Reducing the 
variation in each of these variables due to sampling bias may make it more difficult to 
identify raw associations between inflammation and depressive symptoms that exist in the 
wider population. It will also make it more difficult to identify that each of these variables 
explains associations between CRP and depressive symptoms. 
CRP was used to measure inflammation, but many other biomarkers could be used, possibly 
generating different results. Baune et al. (2012) examined associations between baseline 
levels of a variety of biomarkers of inflammation and subsequent depressive outcomes, and 
found relatively weak evidence of associations for CRP. In their review, Valkanova et al. 
(2103) suggest alternative biomarkers to CRP that may be more relevant to pathways linking 
inflammation to subsequent depressive symptoms. Ideally, a combination of biomarkers 
should be used to measure inflammation (Calder et al. 2013, Zhou et al. 2010).  
Childhood adversity was measured using retrospective information, and biases due to 
sample selection, incomplete reporting, and measurement error are likely to differ between 
the retrospective and contemporaneous data. For example, cognitive function (more 
specifically, delayed recall) appears to be associated with accuracy of recall (Brown 2013), 
but it may not be associated with the reporting of contemporaneous information. In 
addition, this measure was available for relatively few respondents. 
Numerous associations were tested and some may be statistically significant by chance. 
Evidence about factors that confound, mediate and moderate associations between 
inflammation and depressive symptoms is new, and while this is a strength of the study, the 
findings should be tested using other datasets 
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Low numbers meant that only a selection of hypothesised explanatory variables was 
included.  
The selection of variables as salient attenuators of the association between inflammation 
and depressive symptoms depends on the accuracy and comprehensiveness with which 
they are measured. Other measures in different datasets might find evidence for a different 
group of mediators.  
The SEMs were complex, and some negative auto-correlations within depressive symptoms 
and inflammation were almost certainly artefacts resulting from difficulties in fitting the 
data to the specifications. The research questions asked and the complex SEMs used to 
address them are new. Results are tentative. Nevertheless, a strength of this study is that 
the scope of the dataset made it possible to estimate even simplified SEMs. The findings 
should be tested in other datasets, but indicate that further research is needed about 
factors that mediate associations between chronic inflammation and depressive symptoms. 
5.3 Conclusions, policy implications, and future research 
This study provides an important contribution to a growing body of evidence indicating that 
chronic low-grade inflammation predicts depressive symptoms. It is particularly valuable 
because inflammation and depressive symptoms were measured on three occasions, which 
is one occasion more than in most studies to date. This is important because depressive 
symptoms and inflammation change over time together, and adjustment for earlier history 
lends more confidence to findings about the direction of prospective associations. 
Prospective associations of very small magnitude were found between CRP and depressive 
symptoms four years later, after adjustment for gender, age, education, wealth, chronic 
Chapter 4: Inflammation and depressive symptoms             241 
 
 
 
illness and medication use. Although effect sizes are small, they apply to a large population 
of community-dwelling adults aged 50 and over in England.  
There is no evidence that depressive symptoms predict subsequent inflammation. It is 
possible that repeated episodes of depression predict inflammation but this hypothesis was 
not tested. 
Prospective associations did not differ by gender, age group or health status. Gender 
differences have been indicated in previous studies and lack of such an indication in this 
study may reflect the predominance of women who were post-menopausal. Evidence about 
differences by age and health status is new. There is an indication that associations are 
stronger for those aged 70 and over and for those reporting at least one longstanding 
illness. 
New evidence is provided about the factors that mediate prospective associations between 
chronic inflammation and depressive symptoms. Few studies, if any, provide such 
comprehensive evidence about mediated effects and further research using other datasets 
is needed to explore the roles of other potential mediators and to test the reliability of 
these findings.  
In particular, the evidence presented here indicates that it will be fruitful to examine the 
how sickness behaviours affect outcomes that over prolonged periods may lead to further 
difficulties, such as the development of depressive symptoms. These outcomes include 
social participation and withdrawal, appraisal of potentially stressful exposures, 
engagement in physical activities and experiences of pain. 
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If replicated, the findings provide useful and specific information for policy makers and 
practitioners in public health who wish to address the negative consequences of chronic 
inflammation. As there is no evidence that inflammation directly affects depressive 
symptoms, antidepressant medication is not indicated in the first instance. Instead, for 
those at risk of chronic inflammation, interventions should focus on addressing pain, 
promoting physical activity and social participation, and helping individuals to cope more 
effectively with stressful events and circumstances. Doctors typically identify chronic 
inflammation and pain and prescribe appropriate pharmaceuticals. Policies should be 
developed that encourage doctors also to emphasise to patients with chronic inflammation 
the importance of physical activity, social participation and to explore whether they feel 
stressed. They should be encouraged to make referrals for support in relation to physical 
activity, social participation and experiences of stress. 
Many additional questions remain that have not been addressed here. For example, to what 
extent do these results apply to ethnic groups that are not white Caucasian? What would 
the results be if other biomarkers of inflammation were used? Does the duration of 
inflammation matter for the subsequent development of depressive symptoms? If 
persistent depressive symptoms predict inflammation, is this association mediated by health 
behaviours? What are the relationships between inflammation and depressive symptoms 
among those with medically unexplained symptoms? 
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Chapter 5: Discussion 
The thesis provides new evidence that illustrates the importance of relationships between 
psychological factors and immune dysregulation in a life-course context. Chapters 2 and 3 
provide comprehensive evidence, much of it new, about social adversities that predict 
onsets of asthma and RA during adulthood, suggesting the importance of psychosocial 
pathways in the development of these immune-mediated conditions. The role of 
psychosocial pathways is exemplified by a new finding that depressive symptoms partially 
mediated associations between childhood adversity and the development of asthma 
decades later. Evidence of a small but consistent positive association between depressive 
symptoms and asthma onset shortly afterwards is new and intriguing, and partly motivated 
the choice of RQs addressed in Chapter 4. This chapter provides valuable evidence that 
among white adults in mid and late life, chronic inflammation predicts depressive symptoms 
four years later, and new evidence suggests that the association is mediated by 
psychological and behavioural factors associated with sickness behaviours.  
This chapter discusses the strengths and limitations of the research and then summarises 
the main conclusions. Each conclusion is discussed in the context of existing evidence 
together with its implications for policy makers, practitioners and researchers. 
1. Strengths and limitations 
A strength of the thesis is that it draws on theory and evidence from multiple disciplines; 
Sociology, Psychology and Psychoneuroimmunology, the last being a hybrid of Neurology, 
Endocrinology and Immunology (Ader 2000). Biological evidence informed the choice of 
research questions and interpretations of findings. 
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The research questions addressed involve relationships between multiple factors over the 
life-course, and the research was only possible because of the availability of high quality 
datasets, excellent software and a wide range of simple and sophisticated statistical 
techniques. The NCDS and ELSA each contain comprehensive information collected using 
well validated instruments, and track large samples with repeated waves of data collection 
over many years. Large sample sizes and the use of multiple imputation meant that it was 
possible to examine rare outcomes; adult onset asthma and RA.  
ELSA includes nurse interviews, and biomarkers of inflammation have been collected on 
three occasions. Combined with the extensive economic, social, psychological and 
behavioural information available, this meant that it was possible to examine prospective 
relationships between chronic inflammation and symptoms of depression and provide 
evidence about the socio-economic, behavioural and biological factors that confound and 
mediate the associations found. 
The NCDS has some advantages over ELSA. It tracks the sample from birth, and so provides 
life-course data collected contemporaneously, although there is still some recall because 
sweeps of data collection are up to 10 years apart. ELSA collects data every two years, but 
most respondents joined the sample when they were aged 50 or over. Information about 
their lives before participation in the study was collected but it is retrospective and this 
limits its scope and quality. For example, psychological factors and health behaviours other 
than smoking are not measured, and sensitivity analyses reported in Chapter 3 indicated 
that recall of the ages when adversities were experienced was inaccurate. 
Both the NCDS and ELSA are based on samples of predominantly white individuals. Findings 
could be different for other ethnic groups. In addition, the studies are subject to sample bias 
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because individuals who participate differ from those who do not. Sample bias may be 
amplified in ELSA, as core participants of ELSA are drawn from waves of HSE, which uses a 
sample designed to be representative of adults in England. Based on the ELSA sample, 
chapter 3 uses the sub-sample of respondents who participated in LIFE, and chapter 4 uses 
the sub-samples of respondents who participated in the nurse interviews, both drawn from 
the ELSA sample, which is itself a sample of the HSE.  
Attrition bias develops over time, as participants with certain characteristics are more likely 
to drop out of the sample than others. Attrition rates are lower in the NCDS than in ELSA; 
61.5% of the observed NCDS sample participated at age 42, and 49.8% of ELSA wave 1 
respondents participated in wave 6. However, ELSA included refreshment samples in waves 
3, 4 and 6, which addresses attrition bias. 
Multiple imputation, which is used in chapters 2 and 3, addresses biases resulting from 
missing values and attrition but it does not address sample bias. 
Incidence rates of asthma in chapter 2 and of RA in chapter 3 are very close to those 
reported in other studies (Simpson & Shiekh 2012, Widdefield et al. 2014). This lends 
confidence to the generalisability of findings. Further, most findings are about relationships 
between variables, which may not be much affected by sample and attrition biases. In fact, 
biases may serve to reduce evidence of relationships between adversity and poor health, in 
which case the evidence would err on the side of conservatism. This is because individuals 
who participate in surveys and follow-up surveys tend to be more socio-economically 
advantaged and healthier than non-participants (Ward et al. 2009, Atherton et al. 2007). 
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Another limitation of the evidence is that multiple relationships are tested and the 
conventional level of probability of 5% is used as a shorthand indicator of statistical 
significance. On average, 5% of the correlations estimated would be statistically significant if 
there were no relationships in the population from which the sample was drawn. Most of 
the relationships were tested because there were theoretical grounds for expecting them to 
exist, and many have been tested in other datasets. Nevertheless, some reported findings 
are new and could be specific to the dataset used. It is therefore necessary to test their 
reliability and validity using other datasets. 
2. Main conclusions and implications for policy, practice and 
research 
Five headline new findings, six research recommendations and three policy 
recommendations are summarised in Box 1. 
2.1 Psychosocial factors predict onsets of asthma and RA 
The thesis provides new evidence about the psychosocial factors that contribute to onsets 
of asthma and RA.  
The importance of psychosocial factors was tested using a conceptual framework that 
classifies the pathways that lead to health inequalities as material, psychosocial (involving 
psychological responses to social exposures) and behavioural (Benzeval et al. 2014). Findings 
that social adversities (family and relationship-related adversities and traumatic events) 
predict onsets of asthma and RA after adjustment for material and occupation-related 
adversities is consistent with the involvement of psychosocial pathways, and adjustment for 
behavioural factors further isolates pathways involving psychological factors. 
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Box 1: Headline findings and recommendations for research and policy 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Headline new findings 
1. After adjustment for material adversities and behavioural factors, social adversities 
(relationship-related and traumatic) predict onsets of asthma during mid-adulthood 
and RA. This is consistent with the hypothesis that psychosocial pathways contribute to 
the development of these immune-mediated conditions. 
2. Chronic but not acute adversities predict RA onset. This is consistent with biological 
evidence about the effects of psychological stress on the immune system. 
3. Depressive symptoms mediate associations between childhood adversity and onset of 
asthma decades later, indicating that psychosocial pathways are involved in the 
development of asthma during adulthood. 
4. Depressive symptoms shortly before mid-adulthood are a salient predictor of asthma 
onset soon afterwards. 
5. Prospective associations between low-grade chronic inflammation and depressive 
symptoms years later are mediated by behavioural and psychological factors associated 
with sickness behaviours. 
 
Research recommendations 
1. Additional evidence is needed about how psychological stress contributes to immune 
dysregulation and other health outcomes. While relevant information has been 
collected in earlier sweeps of longitudinal surveys, it would be useful to devise and 
include in future surveys additional measures of stress, such as hair cortisol as a marker 
of physiological stress and measures of global and chronic psychological stress. 
2. It may be fruitful to examine the different health impacts of chronic and acute 
adversities. 
3. Further evidence is needed to test whether depressive symptoms or other 
psychological factors mediate associations between childhood adversities and health 
outcomes such as asthma onset. 
4. The association between depressive symptoms and asthma onset soon afterwards is an 
intriguing finding and should be tested in other datasets. Depressive symptoms and 
other psychological factors may be proximal predictors of the onsets of asthma and of 
other immune-mediated conditions also. 
5. More evidence is needed about the factors that mediate prospective associations 
between chronic inflammation and depressive symptoms using measures on multiple 
occasions. Likely mediators include sickness behaviours and the psychological, 
behavioural and biological outcomes associated with them. 
6. Prospective associations may depend upon the chronicity of baseline inflammation or 
depressive symptoms. More evidence is needed to test this hypothesis. 
 
Policy recommendations 
1. Include in the training of practitioners in health and social care information about the 
importance of helping people to cope effectively with both traumatic events and 
ongoing situations that are likely to be stressful. These might include caring for a sick 
relative, living with a family member who is addicted to alcohol or other drugs, or 
relationship difficulties. 
2. Provide training to health practitioners about the social and psychological predictors 
and consequences of immune-mediated diseases such as asthma and RA. This may 
facilitate early diagnosis and treatment, and inform management of these conditions. 
3. Include inflammatory theories of depression in the training of health professionals. 
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After adjustment for material and occupation-related adversities, social adversities 
predicted onsets of both asthma and RA. Associations with RA onset were not mediated by 
smoking behaviour. The approach used to provide evidence about psychosocial pathways  
that lead to onsets of these conditions is new and so is the evidence. It is consistent with the 
hypothesis that psychological and physiological stress responses contribute to the 
development of asthma and RA. 
New evidence was provided about the relative importance of chronic and acute social 
adversities for RA onset; chronic but not acute adversities predicted onset. The findings is 
consistent with theories of allostatic load (McEwen & Seeman 1999) and biological evidence 
and theory about impacts of stress on the immune system (Miller et al. 2014, Cohen et al. 
2012). 
Information about the types of adversity that predict onsets of asthma and RA is relevant for 
policy makers because it indicates the need to develop interventions that minimise the risk 
of exposure to these adversities and mitigate their impacts. For example, chronic family 
adversities predicted onsets of both asthma and RA after adjustment for material 
adversities and traumatic events. Family adversities included caring for a parent, partner or 
sick child, partnership breakdown and living with a partner or child addicted to a substance. 
The findings add weight to other arguments that carers should be offered practical support 
including opportunities for respite care. Interventions should be funded that help couples in 
difficulty and substance users who live with family members. Further, this evidence 
indicates that practitioners who work to support vulnerable individuals living in families 
communicate well not only with the individual, but also with every member of the family so 
that they all feel supported. Other evidence indicates that circumstances and events are 
perceived as more stressful if they feel out of one’s control (Fairbank & Hough 1979, Averill 
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1973, Fusilier & Ganster 1989, Glass & Singer 1972), are unpredictable (Glass & Singer 1972) 
and not normative (Pearlin 2010). Practitioners have experience, knowledge and skills that 
mean that they do not feel that the situation is out of their control, unpredictable or not 
normative. If they communicate well with the families of their clients, they may be able to 
help them to deal more positively with these situations. This type of communication and 
support may be useful also for individuals who have faced traumatic events. 
Evidence that depressive symptoms partly mediate associations between childhood 
adversity and asthma onset is a direct indication of the importance of psychosocial 
pathways in the development of asthma. However, it is not necessarily the case that 
depressive symptoms are the most salient psychological mediator of the association; they 
are the variable that was measured in the study and they may be associated with more 
salient mediators, such as psychological stress. Chronic psychological stress appears to 
predict both depressive symptoms (Kiecolt-Glaser et al. 2015) and asthma onset (Wright et 
al. 2005). 
If psychological symptoms affect immune function, this begs questions about whether 
psychological interventions could be used to prevent or treat asthma, and about whether 
this might apply to other immune-mediated conditions. It also highlights the importance of 
developing policies that (1) minimise exposures to adversities that are likely to be stressful 
and distressing and (2) help people to cope effectively with them so that experiences of 
psychological stress and distress are minimised.  
Chapters 2 and 3 provide evidence about additional factors that predict onsets of asthma 
and RA after adjustment for life-course adversity. For the first time, so far as I am aware, 
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contributions of psychological, behavioural and biological factors are assessed net of a 
comprehensive set of social and material adversities.  
One of the factors that predicts asthma onset, after adjustment for life-course adversity and 
other carefully chosen factors, is depressive symptoms shortly before onset. The association 
is small in magnitude but consistent. Few studies have examined prospective associations 
between depression and asthma onset, although those that do report evidence of them 
(Jonas et al. 1999, Loerbroks et al. 2010, Scott et al. 2008). Chapter 2 adds to these findings 
by providing new evidence that depressive symptoms are particularly salient shortly before 
asthma onset. 
An explanation is that diagnosed asthma is preceded by chronic low-grade inflammation, 
which leads to the development of both depressive symptoms (Smith 1991, Miller & Raison 
2016, Hughes & Kumari 2017) and asthma. It raises questions about how inflammation leads 
to the development of depressive symptoms in the context of asthma onset and more 
generally, which are addressed in Chapter 4. 
2.2 Additional evidence about adversities as predictors of asthma and RA onsets 
during adulthood 
Life-course adversities summarise the environmental exposures that might contribute to 
negative health outcomes and, specifically, to onsets of asthma and RA. The adversities 
measured are neither exhaustive nor perfectly measured and consequently under-estimate 
total adversity. Whilst it is widely accepted that asthma and RA develop through 
interactions between genetic and environmental factors, the evidence presented in 
chapters 2 and 3 nevertheless illustrates the very substantial contribution made by 
environmental exposures to the development of each condition. These findings are 
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consistent with evidence provided by a handful of studies that examine the importance of 
adversities as predictors of asthma and RA, although the evidence presented here provides 
an important contribution because it includes a more comprehensive range of adversities 
measured over the life-course. 
Findings that life-course adversities contribute substantially to the development of asthma 
and RA suggest that adversities may play an important role in the development of other 
immune-mediated conditions. They also indicate that prevalence rates of asthma and RA 
(and possibly other immune-mediated conditions) might be reduced by policy interventions 
as well as by prescription of pharmaceutical medicines. Understanding the environmental 
contributions to these conditions should therefore be a priority for public health.  
Few studies provide evidence about gender differences in relationships between adversity 
and onsets of asthma and RA, and so the evidence provided in Chapters 2 and 3 constitutes 
an important contribution. Two large-scale studies report no evidence of gender differences 
in relationships between adversity and adult onset asthma (Lietzen et al. 2011, Rod et al. 
2012) and chapter 2 similarly finds no gender differences. In relation to RA onset, existing 
evidence is even more sparse; just one study finds no statistically significant differences by 
gender (Wesley et al. 2014). Results presented in chapter 3 are not statistically significant 
either but suggest that risk of RA onset from mid-adulthood onwards is predicted more 
strongly by childhood adversity for women than men, and by adversity during adulthood for 
men than women. This implies that any gender differences are likely to be complex but not 
great in magnitude, and suggests that public health should be concerned with these 
relationships for men and women. 
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Only one study provides evidence about whether associations between life-course adversity 
and risk of adult onset asthma differ by atopic history (Lietzen et al. 2011). Chapter 2 reports 
findings consistent with Lietzen’s that these associations are the same regardless of whether 
respondents report a history of hay fever or eczema. This evidence is relevant to 
understanding about why hay fever predicts asthma onset. There are numerous asthma 
phenotypes (Halder et al. 2008) and it is possible that hay fever predicts asthma onset 
because it reflects a biological vulnerability to atopic conditions that is a feature of some but 
not all asthma phenotypes. Development of asthma phenotypes not predicted by hay fever 
might therefore be more sensitive to environmental factors, measured by adversity. 
However, results presented in chapter 2 do not support this hypothesis but rather suggest 
that life-course adversities are equally important for asthma onset regardless of previous 
atopic history. 
Differences in relationships between adversity and asthma onset by childhood 
temperament have not been investigated before and the evidence presented here is new. 
The hypothesis was that internalising temperament affects psychological and behavioural 
responses to adversities in ways that lead to asthma onset. If the hypothesis were true, if 
would imply that adversities predict asthma onset more among those with an internalising 
temperament during childhood. However, no evidence of differences was found between 
those with and without an internalising temperament and so the evidence did not support 
this hypothesis. 
The ways in which adversities combine over the life-course to predict onsets of asthma and 
RA have not previously been examined. The thesis compares life-course models and 
concludes that adversities experienced during different life stages combine cumulatively to 
predict asthma onset. There is an indication that this cumulative model applies also to RA 
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onset, but the quality of the retrospective data used means that no conclusions can be 
drawn. The cumulative model is consistent with theories of allostatic load, which is 
conceptualised as a marker of physiological wear and tear that accumulates over the life-
course (McEwen & Stellar 1993). It indicates that policies designed to minimise the risk of 
adverse exposures and mitigate their impacts should be developed for populations during 
all life stages. 
After adjustment for social adversities, material adversities also predicted onsets of both 
asthma and RA. No other studies have examined the contributions of material adversities to 
onsets of asthma and RA during adulthood. However, financial hardship is an approximate 
marker of SEP, and a handful of studies have examined relationships between these 
diseases and SEP (Verstappen 2017, Basagna et al. 2004, Simpson & Sheikh 2010). 
Differences between studies in terms of samples, measures and methods used complicate 
comparisons. Nevertheless, the associations presented in the thesis between material 
adversities and disease onsets, after adjustment for social adversities and gender, are 
equivalent to or slightly smaller than positive associations with low SES reported in other 
studies (Simpson & Shiekh 2010, Ekerljung et al. 2010, Bergstrom et al. 2011, Bergstrom et 
al. 2013). 
2.3 Additional evidence about behavioural and biological predictors of asthma and 
RA onsets during adulthood 
Factors that predicted onset of asthma during mid-adulthood after adjustment for life-
course adversity were depressive symptoms (as mentioned above), female gender, history 
of eczema and/or hay fever and internalising temperament during childhood. RA onset is 
predicted by life-course adversity, female gender, low educational qualifications and 
number of years smoking. This evidence is important because better understanding about 
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the predictors of each disease could facilitate their early diagnosis and treatment, which is 
associated with better prognoses. In particular, progression of RA can cause irreversible 
damage, which may be prevented if it is diagnosed and treated quickly. 
Findings that asthma onset during adulthood is predicted by female gender and a history or 
other atopic conditions are consistent with evidence from numerous studies. However, 
evidence that adult onset asthma is predicted by depressive symptoms shortly before onset 
is new. 
Evidence about the predictors of RA is consistent with existing evidence but is nevertheless 
valuable because it contributes to confidence in its reliability and validity. The gender 
difference in RA is well established (patient.co.uk 2016). Fewer studies report that RA onset 
is more common among individuals with lower levels of education (Bergstrom et al. 2013, 
Voigt et al. 1994) and those with a history of smoking (Tobon et al. 2010, Lahiri et al. 2012).  
2.4 Prospective associations between chronic inflammation and depressive 
symptoms 
Chapter 4 provides an important contribution to epidemiological evidence about 
prospective relationships between chronic low-grade inflammation and depressive 
symptoms. It finds no evidence that depressive symptoms predict chronic low-grade 
inflammation four years later, which is consistent with existing evidence (Copeland et al. 
2012, Duivis et al. 2011, Hamer et al. 2009, Das 2016, Au et al. 2015, Gimeno et al. 2009). 
However, there is evidence of a small prospective relationship between chronic 
inflammation and depressive symptoms four years later. This finding is consistent with most 
other studies (Valkanova et al. 2013) and with the inflammatory theory of depression (Smith 
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1991, Miller & Raison 2016, Hughes & Kumari 2017). While the magnitude of the association 
is small, it affects large numbers. It may be fruitful to investigate the nature of this 
relationship further, for example by examining whether prolonged inflammation matters 
more than shorter periods for depressive symptoms. 
New evidence is provided relating to differences in these prospective associations by 
gender, age category and health status. No differences are statistically significant. In relation 
to prospective associations between chronic inflammation and depressive symptoms 
subsequently, effect sizes are slightly greater among those aged 70 and over and among 
those with at least one longstanding illness. There is no indication that these prospective 
associations differ by gender of between groups with and without asthma and RA.  
It would be interesting to examine these relationships differ between people with and 
without heart disease and ME/CFS. Heart disease is characterised by both inflammation and 
depressive symptoms. Symptoms of ME/CFS resemble severe forms of the sickness 
behaviours (fatigue, malaise, and lack of motivation) that are typical of both chronic 
inflammation and depression, so there is high co-morbidity between ME/CFS and 
depression, and the condition is exacerbated by stress (Wessely et al. 1998). 
2.5 Prospective associations between chronic inflammation and depressive 
symptoms are mediated by social withdrawal, psychological stress, pain and physical 
inactivity 
A new finding is that the association between chronic low-grade inflammation and 
depressive symptoms four years later is fully explained by psychological stress and social 
withdrawal, physical inactivity and pain. The association was not mediated by obesity and 
findings relating to obesity are discussed in Appendix 23.  
Chapter 5: Discussion             256 
 
 
 
Few studies have tested mediation, possibly because inflammation, depressive symptoms 
and hypothesised mediators are auto-correlated over time and so it is difficult to assess the 
directionality of associations without multiple measures. Fortunately, repeated measures at 
three different time points made this possible. 
As explained in Chapter 4, mediation by these factors is consistent with existing evidence of 
associations between physical activity, pain, psychological stress and social withdrawal and 
(1) chronic inflammation and (2) depressive symptoms.  
A plausible explanation for the results is that sickness behaviours contribute to each factor. 
Social withdrawal has been described as a sickness behaviour (Miller & Raison 2016, Dantzer 
& Kelly 2007) and this, combined with fatigue (another sickness behaviour) could reduce 
motivation to engage in physical activity. Heightened arousal may increase sensitivity to 
pain. Heightened arousal and anxiety, negative mood and social withdrawal, which are 
sickness behaviours associated with inflammation, may affect how adversities are 
appraised, increasing the likelihood that they are perceived (and reported) as stressful. 
Consistent with this explanation is physiological evidence that indicates the involvement of 
pro-inflammatory cytokines in behaviours of the hypothalamic pituitary adrenal (HPA) axis, 
which is central to the stress response (Makhija & Karunkaram 2013, Capuron & Miller 2011, 
Jiang et al. 2014). 
Physical inactivity, pain, social withdrawal and psychological stress could contribute over 
time to the development of depressive symptoms. 
An important caveat is that the factors identified as particularly salient mediators may not 
be salient in other datasets, as salience depends upon the accuracy and comprehensiveness 
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of measurement, as well as sample characteristics. However, they suggest that behavioural 
and psychological factors associated with sickness behaviours mediate prospective 
associations between chronic inflammation and depressive symptoms. This hypothesis 
should be tested in other datasets. If the findings presented here are replicated, they have 
important implications. 
Health practitioners working with people likely to have chronic inflammation, for example 
people with immune-mediated diseases or heart disease, should be aware (and probably 
are already) that these people are likely to feel down and have increased depressive 
symptoms. This is not a necessary consequence of inflammation and so anti-depressants 
should not be used in the first instance. Rather, practitioners should treat consider treating 
inflammation and its causes, pain if patients are experiencing it, encourage social 
participation and physical activity unless this is contra-indicated by their condition, and do 
what they can to help patients cope with psychological stress. Simply knowing that feeling 
stressed can be a biological consequence of inflammation may help patients as it provides 
understanding that could contribute to feeling more in control. Policy makers could 
promote training about the inflammatory theory of depression, and also the more 
immediate outcomes of chronic inflammation. These findings suggest the importance of 
funding existing interventions that promote social participation and physical activity and 
provide support for those likely to feel stressed, as it appears that social withdrawal, 
physical inactivity and experiences of chronic stress may contribute to the development of 
depressive symptoms. 
2.6 Psychological factors and immune dysregulation in a life-course context 
The thesis includes three empirical projects that examine relationships between 
psychological factors and immune dysregulation. Immune dysregulation is measured using 
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an allergic disease (asthma), and autoimmune disease (RA) and chronic low-grade 
inflammation. These measures represent various types of immune dysregulation. Taken 
together, the results are consistent with a model illustrated in Figure 5.1. 
Figure 5.1: Model representing hypothesised relationships between psychological factors 
and immune dysregulation within a life-course context 
 
 
 
 
 
 
 
 
 
 
In the model, adversities lead to an increased risk of psychological stress, which impacts on 
immune function and increases the risk of immune dysregulation. Acute and chronic 
inflammatory responses, which are forms of immune dysregulation, are associated with 
sickness behaviours, and these contribute to psychological stress. Sickness behaviours also 
contribute to a heightened sensitivity to pain, physical inactivity and social withdrawal, and 
these, together with psychological stress contribute to the development of depressive 
symptoms and other mental health difficulties. These psychiatric symptoms may lead to 
additional adversities and to their negative appraisals. They may also affect motivation to 
participate in social and physical activities. 
 
Immune dysregulation Psychological stress Adversity 
Depressive symptoms and 
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Social withdrawal 
Pain 
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The model illustrates numerous vicious cycles in which immune dysregulation and negative 
outcomes reinforce one another. The evidence presented in the thesis is consistent with the 
model, but more evidence is needed to test it. If further research indicates that this model is 
a valid representation, policy makers must consider ways of breaking these vicious cycles. 
Epidemiological evidence about psychological stress as a predictor of immune dysregulation 
is scarce, and research about the psychological correlates of chronic inflammation has 
mostly focussed on depressive symptoms and depression. This focus is probably because 
depression is recognised by clinicians as a medically important health outcome and well 
validated instruments exist to measure it based on depressive symptoms. These instruments 
focus on psychological symptoms, although depression and depressive symptoms 
unequivocally have a biological basis. Stress similarly has both biological and psychological 
manifestations and causes. Like depression, stress is a construct, but it does not have 
anything like the same clinical importance as depression, and its measurement is less 
developed.  
Biological stress is measured by concentrations of cortisol excreted in saliva, urine and hair, 
but methods of measurement and their interpretations are still developing (Miller et al. 
2016, Abell et al. 2016). Perceived psychological stress is measured in various contexts; 
relationship stress (Locke-Wallace 1959, Schuster et al. 1990), work stress (Siegrist 1996, 
Karasek et al. 1998), loneliness (Hughes et al. 2004) and community stress (Stafford et al. 
2003). However, these experiences have cumulative effects and it would be useful to 
develop ways of combining existing measures to create indices of overall or global perceived 
psychological stress that are used across studies.  
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Findings presented in chapters 2 and 3 indicate that when other measures of psychological 
stress are unavailable, social adversities may provide useful proxy measures. Social 
adversities can affect health through material, behavioural and psychological pathways, but 
availability of large datasets with comprehensive information means that it is possible to 
adjust for factors that could affect health through pathways not involving stress. Evidence 
about relationships between adversities and health outcomes has the unrelated advantage 
of direct policy relevance. 
It would also be valuable to continue developing well-validated measures of psychological 
and biological stress that are included in surveys. These measures can be used to investigate 
relationships between adversities, psychological stress, biological stress and immune 
dysregulation and other health outcomes. 
Evidence about these relationships will contribute to understanding how the social becomes 
biological (Blane et al. 2013). The immune system developed early in the evolution of 
vertebrates and is closely integrated with all other physiological systems (Deng et al. 2013). 
Evidence exists about the physiological mechanisms through which psychological stress 
affects immune function (Wright 2005) and there is growing evidence about the 
physiological mechanisms that link chronic inflammation with psychological outcomes that 
are likely to affect appraisals of exposures as stressful (Byrne et al. 2016, Miller & Raison 
2016). Evidence from the Social Sciences and Social Epidemiology is relatively sparse but, 
including the evidence from this PhD, it further highlights the importance of psychological 
stress for immune dysregulation. The development of high quality measures for both 
biological and psychological manifestations of stress that are included in surveys would 
provide the opportunity to investigate relationships likely to be central to understanding 
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about the psychosocial pathways through which socio-economic factors get under the skin 
(Bartley 2012) and inequalities in health develop over the life-course. 
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Oral presentations at peer reviewed conferences 
March 2018 (London) 60 years of our lives: A scientific conference celebrating the National 
Child Development Study at 60, “Psychosocial predictors of asthma onset during mid-
adulthood: Evidence from the NCDS”. 
September 2016 (York) Annual Scientific Meeting of the Society for Social Medicine, “How 
do adversities predict onset of rheumatoid arthritis? Evidence from the English Longitudinal 
Study of Ageing”. 
September 2016 (Winchester) Annual conference of the British Society of Population 
Studies, “The importance of material hardship and psychosocial factors for onset of 
rheumatoid arthritis”. 
October 2015 (Dublin) Conference of the Society of Life Course and Longitudinal Studies, 
“Does adversity predict onset of rheumatoid arthritis? Evidence from the English 
Longitudinal Study of Ageing”. 
September 2014 (Oxford) Annual Scientific Meeting of the Society for Social Medicine, 
“Does exposure to stressors predict onset of asthma during mid-adulthood? Evidence from 
the British 1958 birth cohort”. 
October 2014 (Lausanne) Conference of the Society of Life Course and Longitudinal Studies, 
“Do internalising type behaviours during childhood predict onset of asthma during mid-
adulthood? Evidence from the British 1958 birth cohort”. 
July 2014 (Oxford) Conference of the National Centre for research methods. Poster. “Stress, 
temperament, and onset of asthma in adulthood.” 
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Published conference abstracts 
 
Hammond, C. (2016) ’How do adversities predict onset of rheumatoid arthritis? Evidence 
from the English Longitudinal Study of Ageing’, Journal of Epidemiology and Community 
Health, 70: Supplement:A21. 
Hammond, C. (2014) ‘Does exposure to stressors predict onset of asthma during mid-
adulthood? Evidence from the British 1958 birth cohort’, Journal of Epidemiology and 
Community Health, 68, Supplement:A29. 
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Appendix 1: Evidence of associations between adversities and negative health outcomes. 
Table A1.1:   Evidence that adversities used in Chapter 2 predict negative health outcomes 
Adversity Health outcome Reference  Brief description 
During childhood    
Cumulative adversity 
  
Disrupted development of the brain, nervous, and immune 
systems; alcoholism; depression; eating disorders; heart 
disease; cancer  
Middlebrooks & 
Audage 2008 
Summary of evidence, published by the Centers for 
Disease Control and Prevention (CDC). 
Development during childhood and adult functioning of 
nervous, endocrine, and immune systems; in adulthood type 
2 diabetes and cardiovascular disease. 
Danese & 
McEwen 2012 
Review. 
Ischaemic heart disease, cancer, chronic lung disease, skeletal 
problems, liver disease, sexually transmitted diseases, 
depression, suicide attempts, poor self-rated health, obesity, 
smoking, alcoholism, drug abuse; at least fifty sexual partners, 
physical inactivity. 
Felitti et al. 1998 Following a routine medical examination, adults 
provided retrospective information about childhood 
exposures to adversities in the Adverse Child 
Experiences (ACE) Study, n=9,508. 
Early mortality up to age 50. Kelly-Irving et al. 
2013a 
NCDS, n=15,221. 
Cancer by age 50 for women, evidence of a trend for men. Kelly-Irving et al. 
2013b 
NCDS, n=6,138. 
Adult onset arthritis Von Korff et al. 
2009 
World Mental Health Survey, a cross-sectional study 
with retrospective information about childhood 
adversity, n=18,309. 
Hospital admissions for asthma among adults Wainwright et 
al. 2007 
Longitudinal study of English residents, retrospective 
data about childhood adversities, n=20,854. 
Lifetime asthma prevalence Scott et al. 2008 World Mental Health Survey, n=18,303. 
 Time spent in care Poor preventive health care whilst in care, in terms of annual 
health assessments, immunisations, and dental checks. 
Department of 
Health 2001. 
Report of national statistics using data from 42,200 
children who had been looked after continuously for 
1yr+ in 2000 
 In adulthood, lower self rated health; depression; smoking; 
less exercise amongst younger cohort only 
Jackson et al. 
2002 
Longitudinal prospective data from the NCDS and 
1970 British Cohort Study. N depends on outcome 
but 728 and 722 cohort members spent time in care 
in the NCDS and BCS70, respectively. 
 Depression in adulthood Hobcraft 1998. NCDS, n=18,558. 
 Early parental loss  Parental death associated with depression among women, Maier & Current health data with retrospective data about 
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parental divorce associated with physical health problems 
among men. 
Lachman 2000 early parental loss from adults aged 30-60 in MIDUS, 
n=2,988. 
  Parental death is associated with adult onset asthma.  Scott et al. 2008 World Mental Health Survey, a cross-sectional study 
with retrospective information about parental 
death, n=18,303. 
 Neglect  Dysregulation of the stress response, measured using cortisol, 
at age 45 among women but not men. 
Power et al. 
2012 
NCDS, n=4,777. 
 Parental mental 
illness 
Adult onset asthma. Scott et al. 2008 World Mental Health Survey, n=18,303. 
 Financial adversity Low birthweight, death, disability, illness and psychological ill 
health during infancy and childhood. 
Spencer 2008 Summary of evidence. 
  Lung function at age 44-46, measured using fev1. Bartley et al. 
2011 
NCDS, n=6,287. 
  After adjustment for demographics, no associations with 
number of serious health conditions, illness symptoms, 
functional impairment, self-rated health, or depressive 
symptoms in old age. 
Kahn & Pearlin 
2006 
Retrospective information about financial hardship 
collected from US residents aged 65+, n=1,167. 
 Residential 
mobility  
 
Reduced continuity of health care and emotional and 
behavioural problems during childhood, early use of illegal 
drug use, depression during adolescence, teenage pregnancy. 
Jelleyman & 
Spencer 2008 
Review.  
 Use of illegal drugs at ages 18 and 36; psychological distress, 
suicidal ideation, and smoking at age 18 but not at 36. 
Brown et al. 
2012 
Longitudinal study in Scotland, n=850. 
 Among boys, more behavioural problems and health risk 
behaviours, measured using smoking, drinking, marijuana use 
and sexual behaviours. 
 
Duncan 2013 Evaluations of the US Gautreaux program, which 
moved thousands of families out of socio-
economically deprived areas. 
During adulthood   
Material     
 Income Graded relationship with mortality risk. Sorlie et al. 1995 Income data for adults aged 25+ in the US, tracked 
using national mortality statistics, the Death Indices, 
n=530,000. 
 Perceived financial 
strain 
Number of serious conditions; depressive symptoms; poor 
self-rated health; illness symptoms; poor physical functioning 
Kahn & Pearlin 
2006 
Retrospective information about financial hardship 
collected from US residents aged 65+, n=1,167. 
 Homelessness Poor physical and mental health, drug and alcohol 
dependency. 
Griffiths 2002 Literature review. 
Occupation-related   
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 Unemployment 
 
Mortality. Associations particularly strong among men and for 
periods of unemployment during early-middle stage of 
careers 
Roelfs et al. 
2011 
Review and meta-analysis 
 Poor psychological health; poor physical health; suicide  Wanberg 2012 Review  
 Involuntary job loss 
during mid-life 
Depressive symptoms among men but not women  Wahrendorf et 
al. 2013 
Depressive symptoms measured 
contemporaneously using a longitudinal European 
survey (SHARE) which includes retrospective 
employment histories, n=4,822. 
 Occupational stress 
 
Incident coronary heart disease Kuper & 
Marmot 2003 
Longitudinal study of civil servants working in 
London, n=10,308. 
 Smoking, alcohol consumption, obesity, physical inactivity Kouvonen et al. 
2006 
Cross sectional study of public sector employees in 
Finland, n=36,127. 
Relationship-related    
 Divorce and 
separation 
 
Temporary increase in psychological distress Booth & Amato 
1991 
Eight year longitudinal study of married persons 
living in the US , n=2,033 
 Poor mental health measured using GHQ, especially soon 
after separations 
Willitts et al. 
2004 
The British Household Panel Study (BHPS) aged 
under 65, n=4,430. 
 Death of partner Increased mortality risk especially among men and younger 
survivors 
Stroebe et al. 
2007 
Review. 
 Relationship 
difficulties with 
partner 
 
Mortality; morbidity; poor self rated health; dysregulation of 
the cardiovascular, immunological and endocrine systems 
Loving & 
Slatcher 2013 
Review. 
 High allostatic load Seeman et al. 
2004 
Longitudinal study of Taiwanese residents aged 54-
90, n=950. 
 Overcrowded 
housing 
Depression; psychological symptoms; accidental and violent 
deaths, including suicide 
Page 2002 Summary of evidence. 
Loss of child    
 Death of child Early mortality, especially among women Stroebe et al. 
2007 
Review. 
NCDS is National Child Development Study, a prospective study of all babies born March 3-9 1958 in mainland Britain, followed up on multiple occasions. 
World Mental Health Survey is a cross sectional study of adults living in countries that include Colombia, Mexico, United States, Belgium, France, Germany, Italy, Netherlands, Spain, 
Ukraine, Lebanon, Nigeria, Japan, and China. 
MIDUS is the Midlife Development in the US Survey, a nationally representative survey of adults living in the US aged 25+ conducted in 1995-1996 and followed up between 2002 
and 2006. 
SHARE is the Survey of Health and Retirement in Europe, a longitudinal study of adults aged 50+ living in 19 European countries. It includes LIFESHARE, a survey of retrospective 
information that includes employment histories. 
BHPS is the British Household Panel Survey, a stratified general population sample that has been followed up every two years. 
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Appendix 2: Measurement of quality of relationship with 
partner 
The quality of cohort members’ relationships with their current partner was assessed at age 
33 using the Locke-Wallace Marital Adjustment Test. Locke & Wallace (1959) report that this 
test has good reliability and validity. A binary variable was created to indicate relationship 
quality likely to cause distress using a cut point of 100, which is the score generally used to 
identify distressed persons (Crane et al. 2000). The items are listed below. 
How happy is your relationship, all things considered?  
1 (extremely happy) to 7 (extremely unhappy) 
 
Most people have disagreements with their partner. Please show how much you and your partner 
agree or disagree about the things listed below: 
1. Handling family finances 
2. How to spend your time 
3. Showing affection for each other 
4. Liking the same friends 
5. Having sex together 
6. Behaving generally in the right and decent way towards other people 
7. Sharing household tasks 
8. Outlook on life 
9. Relationships with parents or parents-in-law 
10. Deciding if or when to have children 
11. How children should be brought up 
When disagreements arise between you and your partner how do they usually end?  
a) You give in 
b) your partner gives in 
c) agreement by mutual give and take 
d) you both agree to differ 
e) varies/depends/don’t know 
Do you and your partner share any outside interests? 
a) Yes, we share all our outside interests 
b) Yes, we share some outside interests 
c) Yes, we share a few outside interests 
d) No, we don’t share any outside interests 
In leisure time do you usually prefer to be out and about or stay at home? 
a) I prefer to be out and about 
b) I prefer to stay at home 
In leisure time does your partner usually prefer to be out and about or stay at home? 
a) My partner prefers to be out and about 
b) My partner prefer to stay at home 
Do you ever wish you had not married (or lived as a couple)? 
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a) Yes, frequently 
b) Yes, occasionally 
c) Only rarely 
d) No, never 
If you had to live your life over again, which of these do you think you would do? 
a) Marry (or live as a couple with) the same person 
b) Marry (or life as a couple with) a different person 
c) Not marry (or live as a couple) at all 
d) Don’t know 
Do you share your problems with your partner? 
a) Yes, I share all of them 
b) Yes, I share most of them 
c) Yes, I share some of them 
d) No, I share none or hardly any of them
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Appendix 3: Factor analyses of responses to items of Rutter scale 
Factor analyses were conducted using maximum likelihood estimation, and specifying three factors that might be correlated. The factor loadings 
after rotation are presented in Table A3.1. 
Table A3.1:   Factor loadings on items of Rutter parent scale  
 7 11 16 1. Wording at 7 and 11: “Has difficulty 
settling to anything for more than a 
few moments”. Wording at 16: 
“Cannot settle to anything for more 
than a few moments” 
2. Wording at 7 and 11: “Prefers to do 
things on his/her own rather than with 
others. Wording at 16: “Tends to do 
things on own – rather solitary” 
3. Asked at age 7 and 11 only. 
4. Wording at 7 and 11: “Destroys own 
or others belongings (tears or breaks)”. 
Wording at 16: “Often destroys own or 
other’s property” 
5.   Wording at 16: “Often appears 
miserable, unhappy, tearful or 
distressed” 
6.   Wording at age 16 is, “Squirmy, 
fidgety child” 
7.   Wording at 16: “Often worried, 
worries about many things” 
 
Wording of items Ext Int Rst Ext Int Rst Ext Int Rst 
Difficulty settling to anything
1
 -0.03 -0.05 0.65 -0.01 -0.04 0.61 0.14 0.01 0.48 
Prefers to do things on his/her own
2
 0.08 0.18 -0.03 0.09 0.15 -0.08 -0.02 0.34 -0.02 
Is bullied by other children
3
 0.07 0.29 0.09 0.1 0.23 0.1    
Destroys own or others belongings
4
 0.26 -0.11 0.25 0.28 -0.07 0.16 0.42 -0.08 0.08 
Is miserable or tearful
5
 0.31 0.28 0.01 0.37 0.23 0.01 0.27 0.39 -0.03 
Is squirmy or fidgety
6
 0.07 0.03 0.55 0.03 -0.01 0.61 -0.03 -0.01 0.71 
Worries about many things
7
 -0.05 0.73 -0.03 -0.02 0.77 -0.04 -0.06 0.59 0.01 
Is irritable, quick to fly off handle 0.5 0.12 0.04 0.56 0.1 0.00 0.50 0.21 0.06 
Sucks thumb or finger during day
8
 -0.02 0.06 0.05 0 0.04 0.09 0.05 0.08 0.03 
Is upset by new situation
9
 -0.04 0.5 -0.02 -0.04 0.49 0.03 -0.09 0.49 0.01 
Has twitches, mannerisms or tics of the face
10
 -0.01 0.1 0.18 -0.01 0.07 0.18 0.04 0.1 0.14 
Fights with other children
11
 0.53 -0.16 -0.02 0.51 -0.15 -0.01 0.62 0.03 -0.08 
Bites nails
12
 0.04 0.06 0.11 0.05 0.02 0.14 0.07 0.06 0.14 
Is disobedient at home
13
 0.63 -0.05 0 0.57 -0.07 0.03 0.06 -0.06 0.06 
Often tells lies
14
       0.56 -0.06 0.05 
Bullies other children
14
       0.57 -0.04 -0.10 
Very restless. Has difficulty staying seated for long
14
 -0.04 -0.01 0.73 
Not much liked by other children
14
  0.25 0.13 0.00 
Fussy or over-particular
14
  -0.01 0.33 -0.03 
Has the study child had attacks of migraine or recurrent sick headaches in the past 12 months?
14
 0 0.2 0.01 
8.   Wording at 16: “Frequently sucks thumb or fingers”.   
9.   Wording at 7 and 11: “Is upset by new situations, by things happening for the first time”. Wording at 16: “Tends to be fearful or afraid of new things or new situations” 
10. Wording at 7 and 11: “Has twitches or mannerisms of the face, eyes or body” Wording at 16: “Has twitches, mannerisms or tics of the face or body” 
11. Wording at 16: “Frequently fights or is extremely quarrelsome with other children”                                                                
12. Wording at 16: “Frequently bites nails or fingers”                                                                 Ext=externalising, int=internalising, rst=restlessness. 
13. Wording at 16: “Is often disobedient”                                                                                      Factor analyses using maximum likelihood estimation conducted allowing three factors, 
14. Asked at age 16 only.                                                                                                                                                                    followed by rotations allowing correlations between factors.  
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Appendix 4: The Malaise Inventory 
Respondents ticked yes or no boxes for each item, as instructed: 
“These questions are concerned with how you are feeling generally. Please answer them by 
ticking either the ‘Yes’ or ‘No’ box for each one. It is important that you try to answer ALL 
the questions.” 
1. Do you often have back-ache? 
2. Do you feel tired most of the time? 
3. Do you often feel miserable or depressed? 
4. Do you often have bad head-aches? 
5. Do you often get worried about things? 
6. Do you usually have great difficulty in falling or staying asleep? 
7. Do you usually wake unnecessarily early in the morning? 
8. Do you wear yourself out worrying about your health? 
9. Do you often get into a violent rage? 
10. Do people often annoy and irritate you? 
11. Have you at times had a twitching of the face, head or shoulders? 
12. Do you often suddenly become scared for no good reason? 
13. Are you scared to be alone when there are no friends near you? 
14. Are you easily upset or irritated? 
15. Are you frightened of going out alone or of meeting people? 
16. Are you constantly keyed up and jittery? 
17. Do you suffer from indigestion? 
18. Do you suffer from an upset stomach? 
19. Is your appetite poor? 
20. Does every little thing get on your nerves and wear you out? 
21. Does your heart often race like mad? 
22. Do you often have bad pains in your eyes? 
23. Are you troubled with rheumatism or fibrosis? 
24. Have you ever had a nervous breakdown? 
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Appendix 5: How multiple imputed datasets were created 
Missing values were imputed in 20 datasets using stata version 15. No assumptions were 
made about patterns of missingness and therefore an imputation strategy was used that is 
referred to as the chained approach (Van Buuren 2007). The whole sample was used, except 
for three cohort members with missing values for gender. 
Variables for which missing values were imputed were all those used in the analyses, 
referred to as variables of interest, and auxiliary variables. Criteria used to select auxiliary 
variables were that they should have few missing values and correlate with both values and 
missingness of each variable of interest. In order to select auxiliary variables, correlations 
were estimated between each proposed auxiliary variable and values and missingness for all 
variables of interest. Scores were devised to summarise the results as follows: evidence of 
associations with missingness and values for adult onset asthma were scored three, for total 
adversity at each life stage were scored two, and with other variables of interest were 
scored one. Results are presented in Table A5.1.  
Auxiliary variables chosen were the number of sweeps in which cohort members 
participated up to age 55; at birth, occupational class of the cohort member’s father or 
grandfather, maternal marital status, maternal age below 22, pain relief, foetal distress; 
during childhood, levels of maladjustment reported by parents and teachers. 
Continuous measures were imputed using predictive mean matching, which does not 
assume that values of the outcome variable are normally distributed. Values were taken 
from respondents predicted to have a similar value, and a pool of 10 values was used from 
which one was sampled (Morris et al. 2014). 
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Table A5.1:   Numbers of observations and evidence of correlations with missingness and values of variable of interest 
   P-values for associations between proposed auxiliary variable and: Number of other variables 
of interest
2
 with p-
values<0.05 for values and 
missingness 
Proposed auxiliary variable Score
1 
Obs. Asthma onset Childhood 
adversity 
Transition 
adversity 
Early adulthood 
adversity 
   Value Miss Value Miss Value Miss Value Miss 
Number of sweeps cm participated in
3 
18 18557 0.727 0.000 0.000 0.000 0.000 0.000 0.000 0.000 12 
Participated in sweep 1 8 18557 0.268 0.000 0.011 0.000 0.312 0.000 0.000 0.000 4 
Participated in sweep 3 5 18557 0.716 0.000 0.000 0.000 0.701 0.000 0.196 0.000 3 
            
White British, Irish, other white 14 14501 0.342 0.000 0.000 0.000 0.015 0.000 0.007 0.000 8 
            
Occupational class father/maternal grandfather 15 17170 0.213 0.000 0.000 0.000 0.000 0.000 0.000 0.000 9 
Mother left school after minimum leaving age 10 17352 0.253 0.000 0.000 0.158 0.000 0.000 0.000 0.011 6 
            
Mother under 18 at birth 6 17400 0.188 0.009 0.000 0.000 0.001 0.017 0.696 0.188 2 
Both parents under 18 at birth 0 16729   0.417 0.823 0.699   0.234 0.998 0.805 0 
Mother under 20 at birth 14 17400 0.877 0.000 0.000 0.000 0.000 0.000 0.000 0.011 8 
Mother under 22 at birth 14 17400 0.396 0.000 0.000 0.000 0.000 0.000 0.000 0.003 8 
Mother 40+ at birth 0 17400 0.498 0.477 0.739 0.000 0.274 0.015 0.772 0.854 0 
            
Firstborn 6 14269 0.838 0.140 0.000 0.179 0.000 0.027 0.001 0.219 4 
                     
Mother not married at birth 13 17404 0.834 0.000 0.000 0.000 0.000 0.000 0.003 0.000 7 
Worked >40hrs/wk 32+ wks pregnancy 3 16169 0.129 0.757 0.000 0.200 0.823 0.203 0.320 0.798 3 
Any difficulty
4
 during pregnancy 11 17405 0.193 0.042 0.043 0.009 0.783 0.411 0.515 0.032 11 
            
Born before 30 weeks 4 15571   0.000 0.586 0.000 0.001 0.000 0.263 0.000 2 
Born before 31 weeks 5 15571   0.000 0.799 0.000 0.001 0.000 0.114 0.000 3 
Born before 32 weeks 7 15571   0.000 0.568 0.000 0.000 0.000 0.015 0.000 3 
Born before 33 weeks 7 15571 0.811 0.000 0.245 0.000 0.000 0.000 0.007 0.000 3 
Born before 34 weeks 6 15571 0.623 0.000 0.105 0.000 0.000 0.000 0.106 0.000 4 
Born before 35 weeks 6 15571 0.739 0.000 0.005 0.000 0.002 0.000 0.124 0.000 2 
Born before 36 weeks 7 15571 0.244 0.000 0.000 0.000 0.000 0.000 0.398 0.000 3 
Born before 37 weeks 10 15571 0.973 0.000 0.000 0.000 0.000 0.000 0.027 0.000 4 
            
Pain relief during birth 16 17371 0.259 0.002 0.000 0.000 0.016 0.000 0.002 0.000 10 
Foetal distress during birth 13 17407 0.342 0.561 0.001 0.000 0.011 0.208 0.000 0.006 9 
Any complication during delivery 12 17408 0.842 0.175 0.044 0.000 0.114 0.000 0.005 0.000 8 
C-section elective delivery 3 17408 0.516 0.822 0.003 0.000 0.394 0.546 0.154 0.007 1 
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Number of family difficulties at age 7
5 
19 14210 0.143 0.000 0.000 0.000 0.000 0.000 0.000 0.000 13 
One/both parents have chronic physical illness by 16 6 14654 0.092 0.170 0.000 0.000 0.025 0.194 0.000 0.553 4 
Shared loo/bathroom/cooking facilities/hot water at 7 16 14550 0.079 0.000 0.000 0.369 0.000 0.000 0.000 0.000 12 
>2persons/room
6
 at 7 12 13951 0.507 0.000 0.000 0.002 0.000 0.015 0.000 0.000 6 
            
Maternal separation >1 month at 7 14 14226 0.348 0.000 0.000 0.000 0.000 0.000 0.000 0.000 8 
Maternal separation >6 months at 7 14 14226 0.096 0.000 0.000 0.000 0.001 0.000 0.000 0.001 8 
Maternal separation >1 year at 7 13 14226 0.421 0.000 0.000 0.000 0.003 0.000 0.004 0.001 7 
Maternal separation >2 years at 7 12 14226 0.482 0.002 0.000 0.000 0.021 0.001 0.024 0.007 6 
Maternal separation >1m between 6-24m 11 13945 0.862 0.000 0.000 0.048 0.042 0.006 0.368 0.026 7 
Maternal separation >6m between 6-24m 5 14028 0.289 0.006 0.000 0.004 0.026 0.003 0.217 0.607 1 
Maternal separation >1yr between 6-24m 5 14038 0.179 0.061 0.000 0.004 0.004 0.007 0.623 0.263 1 
            
% children in school from manual background at 7 17 10956 0.576 0.000 0.000 0.000 0.000 0.000 0.000 0.000 11 
% children in class from manual background at 7 7 7439 0.116 0.028 0.000 0.013 0.000 0.000 0.000 0.463 3 
            
Poor vision, hearing or speech at 7 13 13992 0.035 0.002 0.000 0.219 0.001 0.011 0.030 0.000 10 
Limiting longstanding illness at 7 2 14596 0.888 0.000 0.000 0.777 0.299 0.813 0.211 0.055 2 
Disabling condition/handicap age 7 3 14551 0.834 0.000 0.000 0.334 0.349 0.366 0.012 0.043 1 
            
Had immunisations by 7 10 14264 0.261 0.000 0.000 0.972 0.000 0.013 0.000 0.023 6 
Number common childhood diseases by 7 4 14580 0.554 0.188 0.000 0.705 0.990 0.086 0.903 0.041 4 
History of infections
7
   1 14477 0.226 0.000 0.001 0.062 0.817 0.300 0.359 0.178 1 
            
Cognitive ability at age 7 21 14406 0.005 0.000 0.000 0.000 0.000 0.000 0.000 0.000 12 
Teacher rates child below average at 7
8 
21 14946 0.043 0.000 0.000 0.000 0.000 0.000 0.000 0.000 12 
            
BMI at age 7 1 13295 0.172 0.008 0.107 0.000 0.512 0.455 0.921 0.161 1 
BMI at age 11 4 12498 0.704 0.544 0.000 0.020 0.581 0.854 0.237 0.402 2 
BMI at age 16 2 11040 0.561 0.642 0.040 0.275 0.032 0.353 0.155 0.119 2 
            
Smokes at least 10 per week at 16 14 11969 0.571 0.000 0.000 0.000 0.000 0.000 0.000 0.006 8 
Smokes at all at age 16 14 11969 0.621 0.000 0.000 0.000 0.000 0.000 0.000 0.006 8 
            
Lifetime prevalence of asthma at 33
9 
15 12667     0.000 0.000 0.000 0.000 0.000 0.000 9 
            
Maladaption score parent Rutter scale at 7 9 13650 0.078 0.000 0.000 0.000 0.000 0.136 0.000 0.013 5 
Maladaption score from BSAG
10
 at 7 18 14926 0.136 0.000 0.000 0.000 0.000 0.000 0.000 0.000 12 
Maladaption score parent Rutter at 11 15 12408 0.005 0.000 0.000 0.000 0.000 0.001 0.000 0.022 6 
Maladaption score from BSAG
10
 at 11 21 14156 0.001 0.000 0.000 0.000 0.000 0.000 0.000 0.000 12 
Maladjustment score parent Rutter at 16 17 10982 0.006 0.000 0.000 0.000 0.000 0.000 0.000 0.000 8 
Maladaption score teacher Rutter at 16 20 11610 0.001 0.000 0.000 0.001 0.000 0.000 0.000 0.000 11 
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Mean maladaption parent Rutter score 7,11,16
10,11 
16 16297 0.037 0.218 0.000 0.000 0.000 0.000 0.000 0.000 10 
Mean maladaption teacher BSAG/Rutter 7,11,16
10,11 
21 16843 0.004 0.000 0.000 0.001 0.000 0.000 0.000 0.000 12 
            
Parent reports cm sensitive/highly strung at 7 4 14392 0.010 0.000 0.000 0.081 0.704 0.848 0.683 0.023 1 
Parent's assessment of child’s activity at 7 4 14585 0.640 0.007 0.000 0.000 0.000 0.338 0.000 0.064 2 
            
BSAG
10
 unforthcomingness score age 7 7 14928 0.420 0.000 0.000 0.554 0.000 0.000 0.000 0.000 3 
BSAG
10
 withdrawel score age 7 7 14927 0.622 0.000 0.000 0.257 0.000 0.000 0.000 0.000 3 
BSAG
10
 depression score age 7 17 14927 0.155 0.000 0.000 0.024 0.000 0.000 0.000 0.000 11 
BSAG
10
 anxiety score age 7 9 14929 0.967 0.000 0.000 0.035 0.001 0.088 0.049 0.010 5 
BSAG
10
 hostility twds adults score age 7 17 14927 0.264 0.000 0.000 0.001 0.000 0.000 0.000 0.000 11 
BSAG
10
 writing off adults and their standards 7 14 14927 0.362 0.000 0.000 0.118 0.000 0.000 0.000 0.000 10 
BSAG
10
 anxiety for acceptance by children 7 10 14927 0.267 0.000 0.000 0.025 0.000 0.054 0.001 0.000 6 
BSAG
10
 hostility towards children score age 7 14 14927 0.845 0.000 0.000 0.001 0.000 0.000 0.000 0.000 8 
BSAG
10
 restlessness score age 7 15 14926 0.189 0.000 0.000 0.001 0.000 0.000 0.000 0.000 9 
                     
BSAG
10
 unforthcomingness score age 11 12 14156 0.958 0.000 0.000 0.509 0.000 0.002 0.000 0.000 8 
BSAG
10
 withdrawel score age 11 11 14157 0.020 0.000 0.000 0.130 0.000 0.000 0.000 0.000 4 
BSAG
10
 depression score age 11 19 14158 0.005 0.000 0.000 0.000 0.000 0.000 0.000 0.000 10 
BSAG
10
 anxiety score age 11 15 14158 0.275 0.000 0.000 0.042 0.000 0.000 0.000 0.001 9 
BSAG
10
 hostility twds adults score age 11 21 14158 0.000 0.000 0.000 0.003 0.000 0.000 0.000 0.000 12 
BSAG
10
 writing off adults and their standards 11 13 14158 0.011 0.000 0.000 0.371 0.000 0.000 0.000 0.000 6 
BSAG
10
 anxiety for acceptance by children 11 14 14158 0.849 0.000 0.000 0.034 0.000 0.000 0.000 0.000 8 
BSAG
10
 hostility towards children score age 11 22 14158 0.004 0.000 0.000 0.000 0.000 0.000 0.000 0.000 13 
BSAG
10
 restlessness score age 11 15 14158 0.485 0.000 0.000 0.190 0.000 0.000 0.000 0.000 11 
            
Cautious-impulsive score age 16 15 12304 0.051 0.000 0.000 0.003 0.000 0.000 0.000 0.003 9 
Moody-even tempered score age 16 16 12355 0.077 0.000 0.000 0.000 0.000 0.000 0.000 0.000 10 
Timid-aggressive score age 16 10 12331 0.001 0.009 0.000 0.020 0.000 0.004 0.000 0.087 3 
Flexible-rigid score age 16 11 12285 0.081 0.000 0.000 0.691 0.000 0.000 0.000 0.000 7 
Sociable-withdrawn score age 16 8 12377 0.081 0.000 0.000 0.585 0.000 0.000 0.000 0.000 4 
Lazy-hard working score age 16 18 12352 0.433 0.000 0.000 0.005 0.000 0.000 0.000 0.000 12 
            
Extraversion score age 50 1 8549 0.439 0.002 0.125 0.776 0.492 0.738 0.733 0.388 1 
Agreeableness score age 50 3 8524 0.599 0.765 0.168 0.211 0.484 0.300 0.000 0.882 3 
Conscientiousness score age 50 4 8415 0.000 0.001 0.001 0.231 0.000 0.663 0.000 0.090 1 
Emotional stability score age 50 7 8531 0.000 0.001 0.000 0.069 0.000 0.872 0.000 0.026 2 
Intellect score age 50 0 8449 0.866 0.034 0.000 0.504 0.675 0.000 0.000 0.181 0 
            
Variables in bold font are those selected as auxiliary variables.  
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1. Summary score is calculated by assigning scores for correlations with both missingness and values for asthma onset (scores 3), for total adversity during each life stage 
(scores 2), all other variables of interest (score 1).   
2. Other variables of interest are smoking during pregnancy, low birth weight, breastfeeding, number of older siblings, history of eczema or hay fever up to age 33, 
pneumonia by age 7, urban industrialised residence at age 23, and at ages 23 and 33 smoking, obesity, and psychological distress (malaise score).   
3. If cohort member participated in fewer than three sweeps, they are assigned a value of three. 
4. High blood pressure, low haemoglobin, or other difficulty during pregnancy. 
5. Reported by health visitor.  
6. Excluding bathroom, skullery, and kitchen.     
7. Three or more throat/ear infections in last 12m or ever pneumonia/urine infection by 7. 
8. Rated below average ability in all areas; oral, awareness, creativity, and numbers.  
9. Prevalence of asthma or wheezy bronchitis up to age 23 and onset of asthma between 24 and 33. 
10.  Bristol Social Adjustment Guide.       
11.  Scaled up for those with missing values in up to two of the three sweeps. 
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Appendix 6: Correlations between adversities 
Results in Tables A6.1, A6.2 and A6.3 are from separate logistic bi-variate logistic 
regressions. Results in Table A6.4 are from separate linear regressions. 
Table A6.1:   ORs for one adversity contingent upon another during childhood 
 Parental loss Time in care Neglect at 
7/11 
Parental 
mental illness 
Mobility  
Spent time in care 8.47     
Neglect at 7 / 11 2.61 5.69    
Parental mental illness 3.88 5.33 3.67   
Mobility 3.57 3.01 1.46 1.86  
Free school meals
 
10.58 5.84 5.72 3.66 2.72 
All p-values 0.001 or below. Odds ratios are from bi-variate logistic regressions with adversities at the 
heads of columns as outcomes N=14,109 
 
Table A6.2:   ORs for adversity in one domain contingent upon adversity in another during 
youth 
 Material Occupation-related Relationship-related 
Occupation-related 3.37   
Relationship-related 6.99 1.71  
Child loss 5.97 1.51 4.19 
All p-values below 0.001, except for between child loss and occupation-related (p=0.006). Odds ratios 
are from bi-variate logistic regressions with adversities at the heads of columns as outcomes. 
N=14,109. 
 
Table A6.3:   ORs for adversity in one domain contingent upon adversity in another during 
early adulthood 
 Material Occupation-
related 
Relationship-
related 
Child loss 
Occupation-related 1.77    
Relationship-related 3.58 1.48   
Child loss 1.69 0.96 1.27  
Trauma 3.70 1.69 3.31 1.42 
All p-values below 0.001, except for between child loss and occupation-related (p=0.525) and 
between child loss and trauma (p=0.024). Odds ratios are from bi-variate logistic regressions with 
adversities at the heads of columns as outcome. N=14,109. 
 
 
Table A6.4:   Coefficients for levels of adversity at one life stage contingent upon level of 
exposure in another 
 Youth Early adulthood 
Childhood 0.36 0.27 
Youth  0.87 
All p-values below 0.001. Coefficients ratios are from bi-variate linear regressions with adversities at 
the heads of columns as outcomes. N=14,109. 
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Appendix 7: Analyses using the observed sample. 
These analyses used indices of adversity that were constructed for cohort members who 
provided complete or partial information about adversity. For cohort members who 
provided partial information, indices of adversity during each life stage were constructed so 
as to capture as much variation in exposure as possible. In order to do this, I adopted the 
following principles. 
1. Con-current information was used to measure each adversity. Retrospective 
information was only used when this information was missing. 
2. For coding each adversity, a no value was coded only if complete information was 
available. 
3. For coding each adversity, a yes value was coded if this was indicated from the 
information available, even if this was incomplete. 
4. Total childhood adversity was measured for all cohort members with information 
about three or more of the six adversities. For cohort members with information 
about one or two childhood adversities, total childhood adversity was measured 
only if they reported at least one adversity. 
5. Total adversity during youth and early adulthood was only coded for cohort 
members who participated in the relevant sweep, i.e. at ages 23 and 33, 
respectively. They were assigned values of zero if cohort members provided 
information in all domains, but were assigned positive values if adversity was 
reported in at least one domain. 
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6. Values of total adversity that included missing information were not scaled up. This 
is a conservative approach because cohort members for whom data are missing 
tend to be those who are more disadvantaged and so would be more likely to score 
highly on the measure had fuller information been available for them. Not scaling 
the variable up for missing values is therefore likely to reduce the variation in 
adversity, which would make estimates of associations less likely to be statistically 
significant. 
Using the original dataset, most findings are equivalent to those using multiple imputed 
datasets. The only notable difference is that the life-course model of adversity that is most 
parsimonious and accurate includes adversities during childhood and transition but not 
during early adulthood. 
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Appendix 8: Sensitivity analyses using a measure of 
asthma onset that disregards symptoms up to age 7 
These sensitivity analyses are based on a measure of asthma onset during mid-adulthood 
(34-42) that includes those who did not report a history of asthma between ages 7 and 33. 
For 1,452 cohort members, a history of asthma or wheezy bronchitis was reported at age 7 
but not subsequently. These cohort members are excluded from the main analyses but 
included in the sensitivity analyses reported here.  
Missing values were imputed in 20 datasets and information from 18,554 participants was 
used in the sensitivity analyses.  Numbers reporting asthma onset during mid-adulthood in 
the original and multiple imputed datasets are presented in Table A8.1.  
Table A8.1:   Summary statistics for asthma onset during mid-adulthood, including 
respondents with asthma symptoms up to age 7 
 NCDS sample Multiply imputed datasets 
 Obs %=yes No.=yes %=yes 95% CI 
Men and women 7885 3.9% 308 4.5% 3.2%-5.7% 
Men 3809 2.8% 107 3.3% 2.1%-4.6% 
Women 4076 4.9% 200 5.7% 4.2%-7.1% 
Gender diff. p=0.000 p=0.000 
18,544 respondents in the multiply imputed datasets. 
 
In the original sample, proportions reporting asthma onset during mid-adulthood ignoring 
asthma symptoms up to age 7 are slightly higher than in the main analyses (3.9% compared 
to 3.7% for men and women together), but gender differences are very similar. After 
multiple imputation, proportions reporting asthma onset are almost identical regardless of 
whether respondents with asthma symptoms up to age 7 are included. The similarity in 
rates of asthma onset when respondents are included who reported asthma symptoms 
before age 7 lends confidence to the validity of imputed values in both these and the main 
analyses.
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3. RQ1. Do life course adversities predict asthma onset during mid-
adulthood? 
Table A8.2 presents results of logistic regressions of asthma onset during mid-adulthood on 
life course adversity, including respondents who reported asthma symptoms up to age 7. 
The results are very similar to those presented in the main text. There are positive graded 
associations between adversities during each life stage and asthma onset during mid-
adulthood but magnitudes of these associations are slightly smaller than those reported in 
the main text. This suggests that adversities predict asthma onset during mid-adulthood 
more strongly for respondents who have no history of asthma symptoms compared to 
respondents who had symptoms of asthma during early life.  
There is no evidence that associations differ by gender, atopic history or temperament. 
These results are the same as those reported in the main text. 
Because the results are so similar, no further sensitivity analyses using this measure of 
asthma onset. 
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Table A8.2:   Odds ratios for asthma onset 34-42 predicted by life course adversity, including respondents with asthma symptoms up to age 7 
 Set of dummies Continuous measure Indicator of two or more adversities 
  OR 95%CI p-val OR 95%CI p-val  OR 95%CI p-val 
Life course (0-33) 
            Female 
 
1.781 1.412-2.246 0.000 1.788 1.419-2.254 0.000 
 
1.784 1.414-2.250 0.000 
Adversities 0 
  
 
 
1.181 1.103-1.265 0.000 <2 Reference   
 
1 1.033 0.664-1.609 0.885 
    
2+ 1.607 1.199-2.155 0.002 
 
2 1.121 0.725-1.733 0.609 
         
 
3 1.328 0.809-2.179 0.265 
         
 
4 1.336 0.813-2.179 0.256 
         
 
5 1.815 1.105-2.980 0.020 
         
 
6 2.051 1.161-3.624 0.016 
         7-15 3.061 1.744-5.372 0.000 
         Wald test  
 
F=6.686, p=0.000 
          F-statistic 
 
F=8.650 
  
F=22.620 F=15.994 
  Test of linearity   
  
P=0.674     
   Childhood (0-16) 
            Female 
 
1.795 1.429-2.255 0.000 1.787 1.419-2.250 0.000  1.776 1.406-2.243 0.000 
Adversities 0     1.209 1.076-1.359 0.003 <2 Reference   
 
1 1.092 0.806-1.481 0.571     2+ 1.565 1.175-2.084 0.004 
 
2 1.397 0.982-1.987 0.067          
 
3 1.442 0.966-2.153 0.079          
 
4 1.986 1.249-3.156 0.005          
 
5-6 2.903 1.357-6.214 0.010          
Wald test  
 
F=4.274, p=0.001           
F-statistic 
 
F=6.816   F=13.830    F=14.420   
Test of linearity     P=0.731        
Transition to adulthood (17-23)            
Female 
 
1.694 1.339-2.143 0.000 1.699 1.343-2.149 0.000  1.711 1.354-2.162 0.000 
Adveristies 0     1.399 1.231-1.589 0.000 <2 Reference   
 
1 1.309 0.996-1.721 0.057     2+ 1.946 1.482-2.555 0.000 
 
2 1.833 1.346-2.494 0.000          
 
3-4 2.895 1.864-4.495 0.000          
Wald test  
 
F=11.353, p=0.000           
F-statistic 
 
F=14.267   F=25.284    F=23.119   
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Test of linearity     P=0.759        
Early adulthood (24-33)            
Female 
 
1.822 1.448-2.292 0.000 1.831 1.455-2.304 0.000  1.810 1.438-2.277 0.000 
Adversities 0     1.352 1.170-1.562 0.000 <2 Reference   
 
1 1.240 0.987-1.558 0.065     2+ 1.694 1.246-2.302 0.002 
 
2 1.521 1.037-2.230 0.037          
3-4 2.730 1.817-4.101 0.000          
Wald test  
 
F=9.583, p=0.000           
F-statistic 
 
F=12.565   F=18.883    F=15.504   
Test of linearity     P=0.258        
               Results of 12 models with no other co-variates. Within life stage, models were estimated for each measure of adversity using 20 datasets with imputed values, N=15,548. 
Appendix 9 Chapter 2: Sensitivity analyses using alternative measure of childhood adversity 344 
 
 
 
Appendix 9: Sensitivity analyses using an index of childhood 
adversity that excludes residential moves 
In these sensitivity analyses, an index of childhood adversity is used that sums exposures to early 
parental loss, time in care, neglect, parental mental illness and free school meals. It differs from the 
measure used in the main analyses because it excludes residential moves. Summary statistics for this 
measure in the original and multiple imputed datasets are presented in Table A9.1 
Table A9.1:   Summary statistics for childhood adversity among cohort members without asthma 
before 33 
 Observed sample Twenty imputed datasets 
  Men & women Men & women Men Women 
Adversity Obs Mean/
%=Y 
SD 
/N=Y 
Mean 
/%=Y 95%CI 
Mean 
/%=Y 95%CI 
Mean/
%=Y 95%CI 
Total 7941 0.555 0.866 0.914 0.888-0.941 0.935 0.900-0.970 0.892 0.859-0.926 
0 7941 64.0 5082 49.5 48.2-50.7 48.8 47.2-50.4 50.2 48.5-51.9 
1 7941 21.5 1707 21.7 20.7-22.7 21.8 20.5-23.1 21.6 20.0-23.2 
2 7941 10.4 826 16.8 15.8-17.7 16.5 15.2-17.8 17.1 15.7-18.5 
3-5 7941 4.1 326 12.1 11.2-12.9 12.9 11.9-14.0 11.2 10.1-12.3 
The imputed datasets include 14,109 respondents 
Compared with the index of childhood adversity that includes residential moves, this index has a 
lower mean value and a higher proportion of respondents reporting no childhood adversities. This is 
not surprising as high residential mobility was the most common childhood adversity, reported by 
almost half (47.2%) of the cohort members. As with the measure that includes high residential 
mobility, values of the index presented here are higher in the multiple imputed datasets than in the 
original dataset. This suggests that compared with cohort members who provided complete 
information, those who did not had experienced relatively high levels of childhood adversity, 
regardless of whether the index included or excluded high residential mobility. There was no 
evidence of gender differences in either index of childhood adversity. Although not reported in the 
table, logit regressions of female gender on childhood adversity provided no evidence of 
associations; p=0.401 for the original sample, p=0.188 for the multiple imputed samples. 
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4. RQ1. Do life course adversities predict asthma onset during mid-
adulthood? 
Table A9.2 presents results of logistic regressions of asthma onset during mid-adulthood on 
childhood adversity using the index that excludes residential moves. The results are almost identical 
to those presented in the main text. Because results are so similar, no further sensitivity analyses 
using this index of childhood adversity were conducted. 
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Table A9.2:   Odds ratios for asthma onset between 34 and 42 predicted by life course adversity, using index of childhood adversity that excludes 
residential moves 
 Set of dummies Continuous measure Indicator of two or more adversities 
  OR 95%CI p-val OR 95%CI p-val  OR 95%CI p-val 
Childhood (0-16)              
Female 
 
1.764 1.330 2.340 0.000 1.755 1.324 2.326 0.000  1.743 1.313 2.312 0.000 
Adversities 0     1.297 1.106 1.522 0.003 <2   
 
1 1.184 0.881 1.593 0.266     2+ 1.665 1.168 2.373 0.008 
 
2 1.324 0.895 1.959 0.167           
 
3 2.392 1.497 3.823 0.001           
 
4 1.000              
 
5-6 1.000              
Wald test  
 
F=7.110, p=0.002            
F-statistic 
 
F=8.759   F=11.547 F=10.348 
Test of linearity     P=0.177       
Results of 12 models with no other covariates. Within life stage, models were estimated for each measure of adversity using 20 datasets with imputed values, N=14,109.
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Appendix 10:   Additional information about data and 
measures 
5. The dataset 
The sample consists of core members and their cohabiting partners. Original core members 
were interviewed in HSE in 1998, 1999, or 2001 and in ELSA wave 1. They were all aged 50 
or over at the time of wave 1 data collection. Refreshment samples of new core members 
were added in waves 3, 4, 6 and 7 to maintain numbers and the age distribution as the 
original core members aged. Participants of HSE between 2001 and 2004 who were aged 50-
53 at the time of wave 3 data collection were included in wave 3. In wave 4, participants of 
HSE 2006 who were aged 50-74 at the time of wave 4 data collection were interviewed. In 
wave 6, the refreshment sample included respondents from HSE 2009-2011 aged 50-55, and 
in wave 7, it included respondents from HSE 2011 who were aged 50-53. Members of the 
refreshment samples for waves 6 and 7 are included in imputation models but not in the 
main analyses, as they did not participate in the life history interview in 2006, referred to as 
LIFE. Core members exit from ELSA when they die, move away from mainland Britain, or do 
not participate for any other reason.  
6. Onset of RA 
Questions used to code RA onset are presented in Table A10.1. 
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Table A10.1: Questions used to code onset of RA 
Wave Question 
1 Has a doctor ever told you that you have (or have had) any of the conditions on this card? 
PROBE : What others? CODE ALL THAT APPLY 
Chronic lung disease such as chronic bronchitis or emphysema 
     Asthma 
     Arthritis (including osteoarthritis , or rheumatism) 
     Osteoporosis, sometimes called thin or brittle bones 
     Cancer or a malignant tumour (excluding minor skin cancers) 
     Parkinson's disease 
     Any emotional, nervous or psychiatric problems 
     Alzheimer’s disease 
     Dementia, organic brain syndrome, senility or any other serious memory impairment 
     None of these 
 
Which type or types of arthritis do you have: (READ OUT EACH IN TURN AND CODE ALL THAT 
APPLY) 
     osteoarthritis? 
     rheumatoid arthritis? 
     some other kind of arthritis? 
 
Approximately how old were you when you were first told by a doctor that you had arthritis? 
2-7 Our records show that when we last interviewed  you on [^date of last 
interview] you said that you had had (or had been told by a doctor you had had ) 
arthritis. 
     Yes 
     No 
  
Reason why respondent disputes having had arthritis3. 
     Never had  
     No longer has 
     Did not have previously, but has now 
 
Apart from what you have already told us, and thinking about what has 
happened since we last saw you on [^date of last interview] has a doctor told 
you that you have any of the conditions on this card4 
PROBE - 'What others?'···Code all that apply. 
     Chronic lung disease such as chronic bronchitis or emphysema 
     Asthma 
     Arthritis (including osteoarthritis , or rheumatism) 
     Osteoporosis, sometimes called thin or brittle bones 
     Cancer or a malignant tumour (excluding minor skin cancers) 
     Parkinson's disease 
     Any emotional, nervous or psychiatric problems 
     Alzheimer's disease 
     Dementia, senility or another serious memory impairment 
     None of these 
 
Which type or types of arthritis [^do you / does [^name]] have... 
code all that apply. 
     Osteoarthritis? 
     Rheumatoid arthritis? 
     Some other kind of arthritis? 
 
Approximately how old were you when you were first told by a doctor that you 
had arthritis? 
 
When in the last two years were you first told by a doctor that you had arthritis? 
                                                          
3
 In wave 7, choice of answers is: Never diagnosed, No longer has, Did not have previously, but has now, 
Misdiagnosed. 
4 In wave 7, conditions also include Malignant blood disorder, e.g. leukaemia, Multiple Sclerosis or Motor 
Neurone Disease. 
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Seven hundred and eighty-three respondents were coded as reporting RA with a valid age of 
onset. This was a sub-group of the 2,467 respondents who, in at least one wave, reported a 
history of RA. 1,684 of these 2,467 were coded as missing for RA onset because they 
provided inconsistent information about RA onset or incomplete information about age of 
onset. Of these respondents, 55 reported a history of RA but subsequently disputed that 
they had ever had the condition, and never re-confirmed the diagnosis. 1,094 respondents 
reported a history of RA and subsequently reported a history of a different type of arthritis 
with no confirmatory report of a history of RA. 186 respondents reported multiple types of 
arthritis the first time that arthritis was reported, and as this is the time when information 
about age of onset is used, it was impossible to identify which type of arthritis the age given 
referred to. The remaining 349 respondents gave no information about age of onset. 
7. Adverse exposures 
Questions from the face-to-face interview and self-completion questionnaire that were used 
to measure adversities during childhood and adulthood are presented in Tables A10.2 and 
A10.3, respectively. 
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Table A10.2: Questions used to measure childhood adversities 
Adversity Questions Mode 
Poor amenities and/or crowding at 
age 10 & living in UK 
We would like to find out more about where you lived when you were ten years old. Earlier you told me that when you were ten you lived at (a 
residence in recorded country for residence living in at 10
th
 year of life). 
How many bedrooms did your household occupy in this residence? If asked: Include only bedrooms. Do not count bathrooms, kitchens, living 
rooms, dining rooms or any rooms your household sublet. 
Including yourself, how many people lived in your household at this residence when you were 10? 
Did this accommodation have any of the features on this card when you were aged 10? 
      Fixed bath 
      Cold running water supply 
      Hot running water supply 
      Inside toilet 
      Central heating 
      All of these 
      None of these 
In what year did you start living in your (first / next) residence that you lived in for six months or more? 
Was this residence (which you started living at in (year when started living in residence)) in the UK? 
In what year did you stop living in this residence (which you started living at in (year when stopped living in residence))? 
IV 
Severe financial hardship Have you ever experienced severe financial hardship? 
If so, how old were you when it first happened? 
SC 
Parental unemployment 6m+ When you were aged under 16, were either of your parents unemployed for more than 6 months when they wanted to be working? SC 
Early parental loss Now I would like to ask you a few questions about your parents. 
Did your parents permanently separate or divorce before you were 16? By parents, I mean your natural or adoptive parents? 
      Yes 
      No 
      Spontaneous only: One or both parents died before respondent was 16 (coded as yes) 
      Spontaneous only: parents never lived together during respondent’s lifetime (coded as yes) 
      Spontaneous only: Never lived with parents / Don’t know (coded as yes) 
IV 
Separation from mother for 6m+ Were you separated from your mother for 6 months or longer before you were 16? IV 
Parents argue often by 16 When you were aged under 16, did your parents argue or fight very often? SC 
Parent abused substances/ mental 
health difficulties 
When you were aged under 16, did your parents drink excessively, take drugs or have mental health problems? SC 
Physically abused by parent When you were under 16, were you physically abused by your parents? SC 
Sexually assaulted Have you ever been a victim of sexual assault (including rape or harassment)? SC 
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If so, How old were you when it first happened? 
Had life threatening illness or injury Have you ever had a life-threatening illness or accident? 
If so, How old were you when it first happened? 
SC 
Severe physical attack Have you ever been a victim of serious physical attack or assault? 
If so, How old were you when it first happened? 
SC 
Witness death or serious injury Have you ever witnessed the serious injury or death of someone in war or military action? 
If so, How old were you when it first happened? 
Other than in war or military action, have you ever witnessed an accident or violent act in which someone was killed or seriously wounded? 
If so, How old were you when it first happened? 
SC 
Lost close relative or friend Have you ever lost a very close friend or relative in a war or military service? 
If so, How old were you when it first happened? 
Have you ever had a very close friend or relative who died or was at risk of death due to illness or serious accident? 
If so, How old were you when it first happened? 
SC 
Major natural disaster Have you ever experienced a major fire, flood, earthquake or other natural disaster?  
If so, How old were you when it first happened? 
SC 
 IV indicates fact to fact interview, SC indicates self-completion questionnaire. 
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Table A10.3:   Questions used to measure adversities during adulthood 
Adversity Questions Mode 
Severe financial hardship Have you ever experienced severe financial hardship? 
If so, How old were you when it first happened? 
SC 
Unemployed and searching for 
work 
We would like to find out about the paid work that you have done. I’m going to ask you about each job you have had that lasted for 6 months or 
more. If you have done a series of short-term jobs for different employers that were essentially the same role then please count these as one job. 
Age left full time education (derived variable stored in the data archive). 
Have you ever done any paid work which lasted for a period of 6 months or more? If yes: 
Did you start your first paid job which lasted for 6 months or more straight after you left full-time education or was there more than a 3-month 
gap? 
Which of these describes the situation(s) you were in straight after you left continuous full-time education (before you started your first job?) 
Code all that apply. 
      Unemployed and searching for a job 
      Unemployed but not searching for a job 
      Short term job (i.e. less than 6 months) 
      Sick or disabled 
      Looking after home or family 
      Looking after a sick or disabled relative or friend 
      Retired 
      Education / Training 
      Voluntary work 
      Other – SPECIFY 
In what year did you start your (first / next) paid job which lasted for 6 months or more? 
In what year did you stop doing that job? 
Did you start your next job straight after leaving this job or was there more than a 3-month gap? 
Which of these describes the situation(s) you were in during the time before you started your next job? Code all that apply. 
      Same list as above. 
Which of these describes the situation(s) you were in during the time after you left your last job? Code all that apply. 
      Same list as above. 
Have you ever done any paid work which lasted for a period of 6 months or more? If no: 
Which of these describes the situation(s) you were in straight after you left continuous full-time education (before you started your first job?) 
Code all that apply. 
      Same list as above. 
Has your situation changed since then? 
In what year did your situation change? 
Which of these describes the situation you changed to? Code all that apply. 
IV 
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Involuntary job loss Have you ever left a job because the company you were working for went out of business or the site closed down?  
If so, which job did you leave because the company you were working for went out of business or the site closed down?  
 
Carer as main occupation The same occupational history questions as those used to code unemployment. IV 
Provided long term care for 
relative or friend 
Have you ever provided long-term care to a disabled or impaired friend or relative or friend? 
If so, How old were you when it first happened? 
SC 
Partner or child addicted to a 
substance 
Have you ever had a husband, wife, partner or child who has been addicted to drugs or alcohol? 
If so, How old were you when it first happened? 
SC 
Breakdown of cohabiting 
relationship 
Including same sex partnerships, have you ever lived together with someone (else) as a couple or have you ever been married? 
Are you still living with “”? If not, why is this? 
      Relationship breakdown (including divorce) – ONLY THIS ANSWER IS ASSIGNED A YES VALUE 
      Widowed / partner died 
      Partner moved into nursing or care home 
      Other reason 
In what year did you stop living with “”? 
IV 
Moving house In what year did you stop living in this residence (which you started living at in “”)? 
Ask respondent to estimate the year they stopped living in this residence. If cannot estimate, ask for decade and enter the mid year of this decade 
– i.e. if 1940s enter 1945. 
IV 
Death of cohabiting partner Including same sex partnerships, have you ever lived together with someone (else) as a couple or have you ever been married? 
Are you still living with “”? If not, why is this? 
      Relationship breakdown (including divorce) 
      Widowed / partner died – ONLY THIS ANSWER IS ASSIGNED A YES VALUE 
      Partner moved into nursing or care home 
      Other reason 
In what year did “” die? 
IV 
Death of child Based on information collected in previous waves 
Our records show that when we last interviewed you, you had a child called “”, whose date of birth was “”. Are these details correct? 
Is this child still alive? 
Did “” live with you for most of his/her childhood? 
When did “” die? 
New information about biological children 
Have you ever given birth to a(nother) baby – even one who only lived for a short time? 
Have you ever fathered a(nother) baby – even one who only lived for a short time? 
Is “” still alive? 
When did “” die? 
New information about adopted children 
(Apart from the adopted child you have already told me about), have you adopted any (other) children as your own? 
Is “” still alive? 
IV 
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When did “” die? 
Did “” live with you for most of his/her childhood? 
Stillbirth, miscarriage or abortion 
(female only) 
Have you ever had a child that was not born alive? Include miscarriages, abortions or stillbirths. Please do not include any children mentioned 
already. 
In what year did this (your first such, your next such) pregnancy end? 
IV 
Death or near death of relative or 
close friend in peace time 
Have you ever had a very close friend or relative who died or was at risk of death due to illness or serious accident? 
If so, How old were you when it first happened? 
SC 
Death of relative or close friend in 
war time 
Have you ever lost a very close friend or relative in a war or military service? 
If so, How old were you when it first happened? 
SC 
Victim of sexual assault Have you ever been a victim of sexual assault (including rape or harassment)? 
If so, How old were you when it first happened? 
SC 
Victim of serious physical attack Have you ever been a victim of serious physical attack or assault? 
If so, How old were you when it first happened? 
SC 
Life threatening illness or accident Have you ever had a life-threatening illness or accident? 
If so, How old were you when it first happened? 
SC 
Active combat Have you ever fired a weapon in combat or been fired upon? 
If so, How old were you when it first happened? 
SC 
Witnessed serious injury or death Have you ever witnessed the serious injury or death of someone in war or military action? 
If so, How old were you when it first happened? 
Other than in war or military action, have you ever witnessed an accident or violent act in which someone was killed or seriously wounded? 
If so, How old were you when it first happened? 
SC 
Natural disaster Have you ever experienced a major fire, flood, earthquake or other natural disaster?  
If so, How old were you when it first happened? 
SC 
Note: IV indicates fact to fact interview, SC indicates self-completion questionnaire. 
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Information about life events was collected in the self-completion questionnaire using pairs 
of questions; the first asked whether the event had ever occurred, and the second, which 
was only asked if the event was reported, asked for the year when it first happened. 
Indicators of life events reported (for the first time) during each life stage were created as 
follows. If respondents reported that they had never experienced the event, the variable is 
assigned zero for all life stages. If they reported the event, the variable is given a value of 
one for the life stage in which it was first experienced, and a zero for earlier life stages, if 
applicable. For subsequent life stages, no information is available about the event, and so 
the value assigned for each subsequent life stage is equal to the proportion of respondents 
who reported the same exposure for the first time during that life stage. For example, 510 
respondents reported experiencing severe financial hardship for the first time during 
transition (ages 16-29). These respondents are assigned a value of one for the variable 
indicating severe financial hardship during transition, and zero for financial hardship during 
childhood. For the variable indicating financial hardship during early adulthood, they are all 
assigned a value of 0.018; this is the proportion of respondents who reported severe 
financial hardship for the first time during early adulthood. 
Theories of stress proliferation (Pearlin et al. 1997) and cumulative disadvantage (Dannefer 
2003) predict that adversities are more likely to occur among respondents who have already 
been exposed. Therefore, assigning values to respondents who have already been exposed 
that are mean values for those who have not already been exposed is likely to 
underestimate true values. Since adversities during each life stage are uncommon, 
assignment of underestimated values is associated with underestimated variance. This 
would result in conservative estimates of associations, which means that we can have more 
confidence in the robustness of any associations found. 
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Poor housing amenities and/or overcrowding during childhood is coded using retrospective 
information about housing conditions at age 10. The variable indicates both provision of 
shelter, which is a basic human need, and economic status. The latter depends on context. 
Consequently, this variable is coded as missing for respondents living outside the UK at age 
10; for those living in the UK, the criteria for a yes value change over time. The criteria are 
designed to reflect relative level of amenities, with similar proportions of each cohort 
assigned a yes value (reflecting poor amenities) for this variable. See Table A10.4. 
Table A10.4: Criteria for poor housing amenities/overcrowding at age 10 for UK residents 
Born Criteria 
1907-1919 No fixed bath, no hot running water, no inside toilet and more than two people to each bedroom 
1920-1929 No fixed bath, no hot running water, no inside toilet and more than two people to each bedroom 
1930-1939 None/one of fixed bath, hot running water, inside toilet and > two people to each bedroom 
1940-1949 Up to two of fixed bath, hot running water, inside toilet and > two people to each bedroom 
1950-1959 More than two people to each bedroom 
1960-1969 More than two people to each bedroom 
1970-1979 More than two people to each bedroom 
1980-1989 More than two people to each bedroom 
 
 
For child death, children included are respondents’ biological children, and non-biological 
children who spent most of their childhood with the respondent. In LIFE, information is 
collected about children in three stages: (1) confirmation or correction of information 
provided in previous waves of data collection, (2) additional information about respondents’ 
biological children who hadn’t been mentioned previously, (3) additional information about 
respondents’ adopted children who hadn’t been mentioned previously. Respondents 
reported for each child their year of birth, whether they were still living, and their year of 
death. This information is used to calculate the age of the respondent in the year that their 
child died. More than one age is calculated for respondents reported losing more than one 
child. 
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Variables indicating house moves take three values; no or few moves, a moderate number 
of moves, and many moves. Because moving is more frequent during some life stages than 
others, the distributions of the number of moves reported during each life stage were 
divided into terciles, with approximately one third of respondents falling into each tercile. 
Numbers of moves associated with each tercile are reported in Table A10.5. For indices of 
adversity, a binary indicator of many moves is used. 
Table A10.5: Moving house 
Life stage No or few moves Moderate moves Lots of moves 
Youth (ages 16-30) 0-4 5,6 7-13 
Early adulthood (ages 31-44) 0-2 3 4-9 
Mid-adulthood (ages 45-59) 0-1 2 3-7 
Youth and early adulthood (ages16-44) 0-4 5-7 8-18 
Youth to mid-adulthood (ages 16-59) 0-5 6-8 9-19 
 
I considered using additional information to code material adversity, but decided that the 
information available was insufficient. HMRC records from 1948 have been linked to the 
records of ELSA respondents (Bozio et al. 2010). National Insurance contributions are 
included in these records. Since these are means tested, I considered using non-payment of 
National Insurance as an indicator of financial hardship. However, reflecting an apparently 
regressive rule, National Insurance contributions are not paid by some wealthy members of 
society as well as the poorer ones, as all those who are not working do not contribute, 
regardless of income and assets. I therefore decided that this indicator of material adversity 
was not sufficiently precise. 
I also considered using information about low pay. During the LIFE face to face interview, 
respondents provided retrospective information about pay. 4,865 respondents gave 
information about gross pay and 2,385 gave information about net pay. This information 
could be used in conjunction with national records of mean income levels year on year to 
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identify those whose pay fell below a poverty line. However, as information about outgoings 
is very limited, net pay would have to be used, and this information is available for relatively 
few respondents. Moreover, there are gaps in the information due not only to missing 
information but also to questionnaire design; respondents were asked about pay only when 
they started employment in a new job. Further, recall of pay may not be accurate. 
Other authors have measured material adversity during childhood using similar information 
to that used in this paper. For example, Tampubolon (2015) used housing amenities and 
self-reported financial hardship during childhood as indicators of “childhood material lack”. 
8. Resources 
Variables that I thought might buffer impacts of adversity on the development of RA were 
parenting, cultural capital during childhood, and education. Tests were conducted to 
estimate whether interactions of each variable with adversity predicted risk of RA onset. 
Parent-child relationships were assessed retrospectively using a reduced form of the 
Parental Bonding Instrument (PBI, Parker et al. 1979) that was administered in the self-
completion questionnaire. The PBI has two scales for each parent, one measuring care and 
the other over-protection, which are currently used (Karukivi et al. 2014, Enokido et al. 
2014). The shortened version has good psychometric properties (Todd et al. 1994). It has 
seven items relating to each parent, listed in Table A10.6. 
Table A10.6: Items used to measure parent-child relationships  
Item  Care Overprotective 
Mother let me do the things I like doing*  X 
Mother appeared to understand my problems and worries X  
Mother liked me to make my own decisions*  X 
Mother seemed emotionally cold to me* X  
Mother made me feel I was not wanted* X  
Mother tried to make me dependent on her/him  X 
Mother was overprotective of me   X 
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1=”very unlike” 2=”moderately unlike” 3=”moderately like” 4=”very like” 
* Reverse coded. The same questions are asked about the respondent’s father 
Using the approach suggested by Parker et al. (2014), scores for care and over-
protectiveness were calculated by summing item values for each scale, separately for 
maternal and paternal parenting. Four variables were created for each respondent.  
I experimented with other measures of parenting, based on these scores. The first assigned 
respondents to one of four groups depending upon whether their scores on each dimension 
of parenting fell above or below cut points. Parker et al. (2014) describe the four groups and 
suggest scores for cut points, which were used. The four groups are optimal parenting (high 
care, low overprotection), affectionate constraint (high care and high overprotection), 
neglectful parenting (low care, low overprotection) and affectionless control (low care, high 
overprotection). Respondents were assigned a value for two variables, one relating to 
maternal and the other relating to paternal parenting. 
Second, a classification of parenting was created in which respondents were assigned to one 
of the four groups on the basis of the closest-to-optimal parenting that they received, 
regardless of which parent provided this parenting and whether one or both parents 
parented in this way. This created a single variable that measured quality of parenting. This 
approach assumes that positive experiences of parenting from either parent figure buffer 
the impacts of adversity, an argument put forward by Shonkoff et al. 2012. 
Continuous and binary measures were created for each measure of parenting. 
Cultural capital during childhood was indicated by whether or not respondents reported 
having enough books to fill two shelves in their home when they were aged 10. Education 
was measured using their highest qualification at the time of the LIFE interview.  
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Variables measuring parenting, cultural capital during childhood, and education are derived 
from the original dataset using the sub-sample with complete data about RA onset and each 
variable. Summary statistics are presented in Table A10.7. 
Table A10.7:   Summary statistics of possible resources 
  Binary  Continuous 
Variable Obs %=yes No.=yes No.=no Mean S.D. Min Max 
Maternal caring 4,915 88.5% 4340 4,915 9.93 1.85 3 12 
Maternal overprotection 4,915 28.3% 1391 4,915 7.67 1.96 4 16 
Fathering caring 4,915 85.8% 4217 4,915 9.56 1.88 3 12 
Fathering overprotection 4,915 25.8% 1268 4,915 7.54 1.88 4 16 
Maternal optimal 4,915 68.3% 3357      
Mat. affectionate constraint 4,915 20.4% 1003      
Maternal neglectful 4,915 3.5% 172      
Maternal affectionless control 4,915 7.9% 388      
Fathering optimal 4,915 68.6% 3372      
Fath. affectionate constraint 4,915 17.2% 845      
Fathering neglectful 4,915 5.8% 285      
Fathering affectionless control 4,915 8.4% 413      
Best parenting available         
Optimal  4,915 80.2% 3942      
Affectionate constraint 4,915 14.8% 727      
Neglectful 4,915 2.2% 108      
Affectionless control 4,915 2.8% 138      
Cultural capital in childhood         
At least 2 shelves books at 10 6,449 18.6% 1,199      
Education         
Highest qualification in 2006    6,233 2.47 1.89 0 5 
No qualifications or Level 1 6,233 31.8% 1,982      
Level 4 or above 6,233 37.9% 2,362      
Interactions between each variable and total level of adversity 
Maternal caring (linear measures)   3,336 8.30 9.65 0 36 
Maternal overprotection    3,336 6.70 8.28 0 42 
Fathering caring    3,336 7.90 9.18 0 36 
Fathering overprotection    3,336 6.63 8.20 0 48 
Maternal caring (binary measures)   3,336 0.73 0.94 0 3 
Maternal overprotection    3,336 0.27 0.70 0 3 
Fathering caring    3,336 0.69 0.92 0 3 
Fathering overprotection    3,336 0.24 0.67 0 3 
Maternal optimal    3,336 0.54 0.86 0 3 
Mat. affectionate constraint    3,336 0.19 0.58 0 3 
Maternal neglectful    3,336 0.05 0.32 0 3 
Maternal affectionless control    3,336 0.08 0.43 0 3 
Fathering optimal    3,336 0.54 0.86 0 3 
Fath. affectionate constraint    3,336 0.15 0.51 0 3 
Fathering neglectful    3,336 0.07 0.40 0 3 
Fathering affectionless control    3,336 0.09 0.46 0 3 
Best parenting available       0  
Optimal     3,336 0.67 0.93 0 3 
Affectionate constraint    3,336 0.14 0.51 0 3 
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Neglectful    3,336 0.02 0.24 0 3 
Affectionless control    3,336 0.03 0.25 0 3 
Cultural capital during 
childhood 
        
At least 2 shelves books at 10    3,639 0.15 0.53 0 3 
Education and life course adversity up to age 44      
Highest qualification in 2006    3,323 4.04 5.35 0 25 
No qualifications or Level 1    3,323 0.43 0.96 0 5 
Level 4 or above    3,323 0.64 1.16 0 5 
Education and life course adversity up to age 59      
Highest qualification in 2006    3,286 4.74 5.93 0 25 
No qualifications or Level 1    3,286 0.49 1.07 0 5 
Level 4 or above    3,286 0.75 1.30 0 5 
Sample is LIFE with information about RA onset. Parenting & cultural capital interacted with childhood adversity.  
 
The importance of each variable as a resource was assessed using models that include as 
predictors of RA onset total life course adversity, one hypothesised resource, and the 
interaction term that combines adversity and the resource. The variable is considered a 
resource if the interaction term is negative and statistically significant at the 95% level of 
confidence. This is a strict test, as I wished to include in models only those variables that 
affected associations between adversities and RA onset.  
Parenting models include gender. This is because ratings of parenting may differ by gender. 
Some studies report that compared with men, women rate their parents as more caring 
(Mackinnon et al. 1989, Cubis et al. 1989), and that both genders rate fathers as more 
overprotective than mothers (Brewin et al. 1992, Richman et al. 1990). Furthermore, the 
impacts of parenting on later life outcomes may differ by the offspring’s gender (Pearce et 
al. 1995, Richman et al. 1990). The results are presented in Table A10.8. 
The high number of statistical tests (108 in total) means that one should be cautious about 
interpreting low p-values as evidence of associations in the wider population. There is no 
evidence that cultural capital or education confers protection against impacts of adversity 
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on the risk of RA onset, and so they are not included as resources in the models of changing 
RA risk with age.  
There is weak evidence that maternal overprotection is associated with a lower risk of 
developing RA from ages 45 and 60 (for the binary measure HR=0.702, 95%CI 0.536-0.920, 
p=0.010; HR=0.688, 95%CI 0.486-0.974, p=0.035, respectively) and that in the context of 
high levels of adversity, maternal overprotection is associated with a higher hazard of 
developing the condition from age 60 (increase in HR with each additional adversity=1.149, 
95%CI 1.008-1.310, p=0.038). There is no evidence of an interaction effect when the binary 
measure of maternal overprotection is used, and coupled with the high number of tests, I 
did not consider this sufficient evidence to include parenting as a resource in the models.  
Table A10.8: Hazard ratios for RA onset contingent upon hypothesised resources and their 
interactions with adversity 
  
RA onset from 45 RA onset from 60 
  
HR 95% ci p-val HR 95% ci p-val 
          Model 1: Care and overprotection from each parent (binary measures) 
    
 
Female 1.141 0.759-1.714 0.526 1.156 0.679-1.967 0.594 
 
Maternal care 0.758 0.155-3.702 0.732 0.693 0.103-4.683 0.707 
 
Maternal overprotection 0.332 0.111-0.991 0.048 0.253 0.056-1.154 0.076 
 
Paternal care 1.527 0.359-6.493 0.566 0.941 0.177-4.998 0.943 
 
Paternal overprotection 1.901 0.771-4.690 0.163 1.347 0.384-4.720 0.642 
 
Adversity 1.160 0.587-2.294 0.669 0.881 0.540-1.437 0.611 
 
Adv*maternal care 1.076 0.615-1.883 0.797 1.264 0.625-2.557 0.515 
 
Adv*mat. overprotection 1.201 0.798-1.807 0.379 1.313 0.765-2.255 0.324 
 
Adv*paternal care 1.012 0.588-1.741 0.966 1.102 0.575-2.111 0.770 
 
Adv*pat. overprotection 0.830 0.575-1.198 0.320 0.882 0.531-1.464 0.627 
 
N 3363 
   
2619 
   
          Model 2: Care and overprotection for each parent (linear measures) 
    
 
Female 1.122 0.743-1.693 0.584 1.125 0.657-1.924 0.668 
 
Maternal care 0.825 0.630-1.081 0.163 0.840 0.597-1.182 0.317 
 
Maternal overprotection 0.702 0.536-0.920 0.010 0.688 0.486-0.975 0.035 
 
Paternal care 1.077 0.820-1.416 0.592 1.168 0.827-1.650 0.377 
 
Paternal overprotection 1.290 0.990-1.680 0.059 1.186 0.840-1.676 0.332 
 
Adversity 0.674 0.117-3.882 0.659 0.880 0.506-1.530 0.650 
 
Adv*maternal care 1.061 0.954-1.180 0.276 1.060 0.934-1.204 0.369 
 
Adv*mat. overprotection 1.092 0.979-1.219 0.116 1.149 1.008-1.310 0.038 
 
Adv*paternal care 1.002 0.897-1.119 0.972 0.961 0.845-1.093 0.545 
 
Adv*pat. overprotection 0.915 0.818-1.024 0.123 0.883 0.768-1.017 0.084 
 
N 3363 
   
2619 
   
          Model 3: Closest-to-optimal parenting from either parent 
     
 
Female 1.150 0.779-1.696 0.482 1.078 0.650-1.787 0.771 
 
Optimal reference 
  
reference 
  
 
Affectionate constraint 0.506 0.152-1.683 0.267 0.324 0.057-1.831 0.202 
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Neglect 0.000 0.000 1.000 0.000 0.000 1.000 
 
Affectionless control 2.017 0.209-19.424 0.544 0.817 0.020-33.003 0.915 
 
Adversity 1.237 1.070-1.430 0.004 1.161 0.971-1.389 0.102 
 
Adv*optimal reference 
  
reference 
  
 
Adv*affection constraint 1.106 0.707-1.730 0.658 1.260 0.674-2.358 0.469 
 
Adv*neglect 0.812 0.000 1.000 0.869 0.000 1.000 
 
Adv*affectionless control 0.540 0.166-1.760 0.307 0.833 0.174-3.984 0.819 
 
N 3604 
   
2825 
   
          Model 4: Four types of parenting from each parent (binary measures) 
    
 
Female 1.140 0.759-1.713 0.529 1.115 0.658-1.891 0.685 
 
Maternal: optimal reference 
      
 
Affectionate constraint 0.321 0.096-1.077 0.066 0.155 0.023-1.053 0.057 
 
Neglect 0.910 0.057-14.661 0.947 0.000 0.000-0.000 
 
 
Affectionless control 0.555 0.092-3.341 0.521 0.744 0.084-6.563 0.790 
 
Paternal: optimal reference 
      
 
Affectionate constraint 1.663 0.623-4.438 0.310 1.144 0.266-4.925 0.857 
 
Neglect 0.176 0.005-5.942 0.333 0.772 0.020-29.916 0.890 
 
Affectionless control 1.758 0.402-7.681 0.453 1.708 0.278-10.489 0.563 
 
Adversity 1.269 1.071-1.505 0.006 1.181 0.965-1.445 0.107 
 
Maternal adv*optimal reference 
      
 
Adv*affection constraint 1.169 0.738-1.851 0.505 1.450 0.753-2.791 0.267 
 
Adv*neglect 0.916 0.352-2.383 0.857 0.259 0.259-0.259 
 
 
Adv*affectionless control 1.104 0.580-2.101 0.763 0.994 0.404-2.446 0.989 
 
Paternal adv*optimal reference 
      
 
Adv*affection constraint 0.843 0.563-1.265 0.410 0.864 0.464-1.608 0.644 
 
Adv*neglect 1.334 0.452-3.934 0.602 0.763 0.163-3.568 0.731 
 
Adv*affectionless control 0.778 0.428-1.414 0.411 0.883 0.420-1.857 0.742 
 
N 3363 
   
2619 
   
          Model 5: Cultural capital during childhood 
      
 
Books 0.697 0.272-1.782 0.451 0.772 0.219-2.724 0.688 
 
Adversity 1.242 1.078-1.430 0.003 1.175 0.986-1.400 0.071 
 
Adv*books 0.992 0.666-1.479 0.969 0.935 0.553-1.580 0.802 
 
N 3668 
   
2876 
   
          Model 6: Highest qualification in 2006 (linear measure) 
     
 
Highest qualification 0.945 0.789-1.132 0.542 0.922 0.721-1.178 0.515 
 
Adversity 1.370 1.120-1.676 0.002 1.205 0.932-1.558 0.154 
 
Adv*highest qualification 0.972 0.902-1.046 0.444 1.006 0.916-1.104 0.902 
 
N 3396 
   
2632 
   
          Model 7: Highest qualification in 2006 Level 4 or above 
      Level 4 or above 1.271 0.638-2.533 0.496 1.444 0.574-3.636 0.435 
 
Adversity 1.267 1.054-1.523 0.012 1.257 0.990-1.598 0.061 
 
Adv*Level 4 or above 1.044 0.786-1.386 0.768 0.929 0.647-1.333 0.690 
 
N 3396 
   
2632 
   
          Model 8: Highest qualification in 2006 below Level 1 
      
 
Below Level 1 0.795 0.375-1.686 0.550 0.745 0.265-2.094 0.577 
 
Adversity 1.332 1.131-1.569 0.001 1.204 0.972-1.491 0.089 
 
Adv*below Level 1 0.891 0.649-1.222 0.473 1.035 0.700-1.530 0.864 
 
N 3396 
   
2632 
   
          These are results from 16 models, 8 for RA with onset from 45 and 8 for RA with onset from 60. Adversity is total 
exposure up to age 44 for RA with onset from 45, and up to age 59 for RA with onset from 60. Analyses are run 
on sub-samples with complete information about all variables in each model. Optimal parenting is high care, low 
overprotection. Neglect is low care and low overprotection. Affectionless control is low care, high 
overprotection. Affectionate control is high care and high overprotection. 
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9. Factors to condition upon 
Model specification is improved by including factors that are associated with both adversity 
and RA onset (Greenland et al. 1999). Based on evidence summarised in the introduction, 
factors thought to predict RA onset were measured and correlations tested between each 
and RA onset.  Once the variables that predicted RA onset had been identified, additional 
tests were conducted to test whether these variables were also associated with adversity. 
Variables considered were qualifications in 2006 and measures relating to sex hormones. 
LIFE includes comprehensive fertility histories as well as information about use of hormonal 
contraceptives, ages of menarche and menopause, and removal of ovaries and 
hysterectomies. Summary statistics of the variables coded are presented in Table A10.9. 
These are drawn from the original dataset, excluding respondents who did not participate in 
LIFE or for whom information is missing about RA status or age of onset. 
Table A10.9:   Summary statistics for female sex hormone variables 
Variable Obs 
%=yes 
/Mean 
No.=yes 
/S.D. Min Max 
Any live births 3,707 85.8% 3181 0 1 
Any pregnancies lasting at least 8 months 3,707 85.9% 3184 0 1 
Menarche by age 12 3,707 37.6% 1394 0 1 
Menarche after age 14 3,707 18.5% 684 0 1 
Last period after age 52 3,707 20.7% 769 0 1 
Years between menarche and menopause 2,883 36.56 4.71 23 50 
Oral contraception/injection/implant by 59 3,562 48.2% 1718 0 1 
HRT use by age 59 2,856 18.8% 538 0 1 
Hysterectomy by 44 3,693 11.5% 423 0 1 
Hysterectomy by 59 3,693 20.5% 756 0 1 
Removal of ovaries by 44 3,681 3.6% 134 0 1 
Removal of ovaries by 59 3,681 8.9% 328 0 1 
Hysterectomy or removal of ovaries by 44 3,685 11.9% 437 0 1 
Hysterectomy or removal of ovaries by 59 3,689 21.1% 780 0 1 
Based on the female respondents who participated in LIFE and provided sufficient information to code age of RA 
onset 
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Cox regression models were estimated of RA onset contingent upon measures of education 
and each sex hormone variable in separate bi-variate regressions. The proportional hazards 
assumption was also tested for each variable. 
The results, which are presented in Table A10.10, provide no evidence of associations 
between any sex hormone related variable and RA onset. Consequently, we do not 
condition the analyses on these sex hormone variables.  
Table A10.10:   Hazard ratios and p-values from PH tests for RA onset contingent upon 
female sex hormones and education in 2006 
 
RA onset from 45 RA onset from 60 
 
HR 95% c.i. p-val 
PH 
test 
p-val HR 95% c.i. p-val 
PH 
test 
p-val 
Any live births 1.437 0.809-2.552 0.216 0.162 1.617 0.742-3.524 0.227 0.067 
Any pregnancies
1 
1.414 0.796-2.511 0.237 0.170 1.584 0.727-3.451 0.247 0.070 
Menarche by age 12 0.977 0.693-1.378 0.895 0.831 0.891 0.564-1.408 0.622 0.646 
Menarche after age 14 1.327 0.885-1.992 0.171 0.927 1.223 0.719-2.080 0.458 0.302 
Last period after age 52 0.803 0.514-1.253 0.333 0.611 0.846 0.480-1.492 0.564 0.735 
Menarche-menopause (years) 1.021 0.980-1.063 0.317 0.332 1.040 0.988-1.095 0.133 0.365 
Oral contraception
2
 by 44 0.229 0.023-2.273 0.208 0.146      
Oral contraception
2
 by 59      0.802 0.343-1.877 0.611 0.608 
HRT use by age 59 1.710 0.907-3.223 0.097 0.582 0.729 0.093-5.691 0.763 0.827 
Hysterectomy by 44 1.188 0.712-1.981 0.509 0.666 1.084 0.539-2.177 0.822 0.741 
Hysterectomy by 59 1.113 0.734-1.686 0.615 0.980 0.950 0.538-1.676 0.858 0.117 
Removal of ovaries by 44 1.056 0.431-2.584 0.905 0.663 1.101 0.346-3.501 0.870 0.779 
Removal of ovaries by 59 1.103 0.608-2.001 0.747 0.691 0.802 0.323-1.991 0.635 0.158 
Hysterectomy
3
 by 44 1.235 0.750-2.036 0.407 0.547 1.064 0.529-2.139 0.863 0.774 
Hysterectomy
3
 by 59 1.125 0.746-1.696 0.575 0.845 0.921 0.522-1.626 0.778 0.114 
Highest qualification in 2006 0.878 0.813-0.950 0.001 0.658 0.881 0.795-0.975 0.014 0.181 
Below Level 1 in 2006 1.479 1.110-1.969 0.007 0.817 1.544 1.066-2.236 0.021 0.091 
Level 4 or above in 2006 0.623 0.446-0.872 0.006 0.476 0.674 0.435-1.044 0.078 0.439 
These are results of 34 bi-variate Cox regression analyses of each variable on RA onset. 17 regressions were 
estimated for RA onset from ages 45 and 60. PH tests were conducted separately for each variable, so that 34 
tests were conducted. P-values below 0.05 for the PH tests suggest that the PH assumption may be violated. 
1. Pregnancy lasting at least eight months 
2. Oral contraception or injection or implant 
3. Hysterectomy or removal of ovaries 
 
In contrast, associations were found between education in 2006 and RA onset. Additional 
analyses were therefore conducted to test for associations between education and 
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adversity. Associations were tested with the various indices of adversity used to address 
different research questions. This was necessary because in the interests of parsimony, 
analyses should condition on education only when it is associated with both RA onset and 
the measure of adversity used. Results presented in Table A10.11 using the continuous 
measure of education indicate that education at the time of the LIFE interview is not 
associated with childhood adversity, is positively associated with adversity during transition 
and early adulthood, and is negatively associated with adversity during mid-adulthood. 
To inform the decision about which measure of education to use in the analyses, bi-variate 
associations with adversity were estimated using different measures of education (Table 
A10.11). There is no theoretical reason to choose one measure of education over another. 
The continuous measure of education usefully summarises all available information but its 
distribution is far from normal (Figure A10.1), so a binary indicator of Level 2 qualifications 
and above is used. 
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Table A10.11:   Evidence of associations between education at time of LIFE interview and both adversity and RA onset 
Highest qualification at time 
of LIFE interview 
Indices of adversity 
Birth to 44 Birth to 59 Childhood (birth to 16) 
Beta 95% ci p-value Beta 95% ci p-value Beta 95% ci p-value 
Linear measure              0.042 0.012-0.073 0.006 0.019 -0.013-0.052 0.242 -0.004 -0.020-0.013 0.667 
Dummies 
            
 
No qualifications Reference 
           
 
Level 1 -0.006 -0.292-0.280 0.968 -0.005 -0.305-0.295 0.973 0.044 -0.114-0.201 0.587 
 
Level 2 0.013 -0.155-0.182 0.877 -0.086 -0.266-0.094 0.350 -0.019 -0.110-0.073 0.690 
 
Level 3 0.359 0.131-0.586 0.002 0.271 0.025-0.516 0.031 -0.066 -0.190-0.058 0.295 
 
HE but below L4 0.025 -0.153-0.204 0.781 0.002 -0.188-0.192 0.985 -0.044 -0.141-0.053 0.375 
 
Level 4 and above 0.241 0.075-0.407 0.005 0.089 -0.088-0.266 0.325 0.003 -0.087-0.094 0.942 
Binary measures 
            
 
No qualifications -0.123 -0.254-0.008 0.066 -0.033 -0.172-0.107 0.647 0.019 -0.052-0.091 0.593 
 
Level 1 and below -0.133 -0.258--0.008 0.037 -0.036 -0.169-0.096 0.593 0.030 -0.038-0.098 0.381 
 
Level 2 and below -0.179 -0.295--0.064 0.002 -0.123 -0.246-0.000 0.050 0.022 -0.040-0.085 0.486 
 
Level 3 and below -0.092 -0.210-0.026 0.127 -0.044 -0.170-0.082 0.494 0.005 -0.059-0.069 0.881 
 
Below Level 4 -0.193 -0.332--0.054 0.007 -0.084 -0.232-0.065 0.270 -0.023 -0.098-0.053 0.554 
 
Highest qualification at time 
of LIFE interview 
Indices of adversity 
Youth (17-29) Early adulthood (30-44) Mid-adulthood (45-59) 
Beta 95% ci p-value Beta 95% ci p-value Beta 95% ci p-value 
Linear measure 0.031 0.018-0.044 0.000 0.018 0.005-0.030 0.005 -0.021 -0.033--0.009 0.001 
Dummies 
            
 
No qualifications 
            
 
Level 1 -0.053 -0.175-0.069 0.392 -0.024 -0.140-0.091 0.681 -0.066 -0.178-0.045 0.243 
 
Level 2 0.009 -0.063-0.081 0.805 0.087 0.019-0.155 0.012 -0.043 -0.110-0.024 0.212 
 
Level 3 0.224 0.127-0.321 0.000 0.171 0.079-0.263 0.000 0.029 -0.062-0.121 0.532 
 
HE but below L4 0.071 -0.005-0.148 0.067 0.057 -0.016-0.129 0.124 -0.062 -0.133-0.009 0.088 
 
Level 4 and above 0.152 0.080-0.224 0.000 0.088 0.020-0.157 0.012 -0.131 -0.198--0.063 0.000 
Binary measures 
            
 
No qualifications -0.086 -0.141--0.030 0.002 -0.083 -0.135--0.030 0.002 0.065 0.014-0.117 0.013 
 
Level 1 and below -0.104 -0.157--0.051 0.000 -0.094 -0.144--0.044 0.000 0.055 0.006-0.104 0.028 
 
Level 2 and below -0.137 -0.187--0.087 0.000 -0.060 -0.108--0.013 0.013 0.053 0.006-0.100 0.026 
 
Level 3 and below -0.086 -0.137--0.034 0.001 -0.023 -0.072-0.026 0.355 0.083 0.035-0.131 0.001 
 
Below Level 4 -0.113 -0.175--0.052 0.000 -0.036 -0.095-0.023 0.227 0.105 0.047-0.163 0.000 
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Figure A10.1: Highest level of 
qualification at time of LIFE interview 
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Highest qualification at time of LIFE interview
Highest qualification at time 
of LIFE interview 
RA onset from 45 RA onset from 59 
HR 95% ci p-value HR 95% ci p-value 
Linear measure 0.878 0.813-0.950 0.001 0.881 0.795-0.975 0.014 
Dummies 
        
 
No qualifications 
        
 
Level 1 0.901 0.493-1.649 0.736 0.893 0.427-1.869 0.764 
 
Level 2 0.854 0.581-1.254 0.420 0.768 0.457-1.292 0.320 
 
Level 3 0.648 0.353-1.188 0.161 0.501 0.201-1.251 0.139 
 
HE but below L4 0.658 0.420-1.029 0.066 0.683 0.387-1.206 0.189 
 
Level 4 and above 0.482 0.295-0.788 0.004 0.507 0.265-0.968 0.040 
Binary measures 
        
 
No qualifications 1.453 1.089-1.937 0.011 1.503 1.042-2.166 0.029 
 
Level 1 and below 1.479 1.110-1.969 0.007 1.544 1.066-2.236 0.021 
 
Level 2 and below 1.622 1.188-2.214 0.002 1.601 1.060-2.419 0.025 
 
Level 3 and below 1.604 1.147-2.243 0.006 1.483 0.957-2.296 0.078 
 
Below Level 4 1.781 1.119-2.833 0.015 1.669 0.896-3.111 0.107 
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10. Smoking 
The questions used to measure smoking history are presented in Table A10.12. They elicit 
information about the years in which the respondent started and ended smoking and the 
total duration of smoking. 
Table A10.12: Questions used to measure smoking history 
Question Answers provided 
Have you ever smoked cigarettes? Yes / No 
In what year did you first smoke daily? Open answer 
How old do you think you were when you 
first smoked daily? (Asked if cannot provide 
year) 
11 years or less / 12 to 15 years / 16 to 29 years / 30 to 39 years 
/ 40 to 49 years / 50 to 59 years / 60 to 69 years / 70 to 79 years 
/ 80 years or over  
Do you smoke cigarettes at all nowadays? Yes / No 
In what year did you last smoke a cigarette? Open answer 
How old do you think you were when you 
last smoked? (Asked if cannot provide year) 
11 years or less / 12 to 15 years / 16 to 29 years / 30 to 39 years 
/ 40 to 49 years / 50 to 59 years / 60 to 69 years / 70 to 79 years 
/ 80 years or over  
For approximately how many years 
regularly? 
Less than 5 years / 5 to 9 years / 10 to 14 years / 15 to 19 years / 
20 years or more 
 
 
Some respondents reported smoking regularly for fewer years than the number of years 
between their reports of when they started and stopped smoking. Presumably, these 
respondents stopped smoking and then took it up again over this period. In order to create 
variables that measure years of smoking during pre-specified life stages, I assume that for 
these respondents, the rate of smoking is the same across time.  
I exclude smoking before age 16 because it will not help to answer RQ5. RQ5 asks whether 
any associations found between childhood adversity and RA onset are mediated by smoking.  
Smoking is measured during transition, early and mid-adulthood. Three variables are 
created for each life stage and for combinations of life stages, one measuring the total 
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number of years smoked, the second indicating whether the respondent smoked at all, and 
the third indicating smoking every year during the life stage. Summary statistics are 
presented in Table A10.13. 
Table A10.13:   Summary statistics of smoking variables 
Measure of smoking Obs. Mean/%=yes S.D./No.=yes 
Years smoked at least one a day 16-29 7542 5.997 6.091 
Smoked at least one year 16-29 7539 54.8% 4134 
Smoked every year 16-29 7542 22.0% 1657 
Years smoked at least one a day 16-44 7247 11.573 12.374 
Smoked at least one year 16-44 7246 55.2% 4003 
Smoked every year 16-44 7247 16.9% 1222 
Years smoked at least one a day 30-44 7460 5.621 6.861 
Smoked at least one year 30-44 7455 44.6% 3323 
Smoked every year 30-44 7460 31.0% 2310 
Years smoked at least one a day 16-59 6954 14.816 17.322 
Smoked at least one year 16-59 6954 53.7% 3736 
Smoked every year 16-59 6954 25.1% 1743 
Years smoked at least one a day 30-59 7167 8.958 12.196 
Smoked at least one year 30-59 7161 42.7% 3056 
Smoked every year 30-59 7167 15.5% 1110 
Years smoked at least one a day45-59 7505 3.502 5.846 
Smoked at least one year 45-59 7498 30.0% 2253 
Smoked every year 45-59 7505 15.4% 1158 
 
Separate Cox regressions were run of RA onset on each smoking variable. I conditioned on 
gender because both smoking behaviours and risk RA onset differ between men and 
women. The results are presented in the Table A10.14. 
Number of years smoked during each life stage was selected to measure smoking behaviour 
because this predicts RA onset as well as the other types of measure and summarises more 
information.  
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Table A10.14:   Hazard ratios of RA onset contingent upon smoking behaviours 
 
 
RA onset 45+ RA onset 60+ RA onset 45-59 
 
HR 95%CI p-val HR 95%CI p-val HR 95% CI p-val 
Years smoked 16-29 1.021 0.998-1.045 0.079 1.010 0.980-1.042 0.509 1.023 0.985-1.063 0.233 
Smoked at all 16-29 1.243 0.931-1.659 0.140 1.070 0.732-1.565 0.727 1.325 0.824-2.130 0.246 
Smoked every year 16-29 1.531 1.122-2.087 0.007 1.312 0.859-2.002 0.209 1.638 0.987-2.719 0.056 
             
Years smoked 30-44 1.023 1.003-1.044 0.023 1.019 0.993-1.046 0.158 1.013 0.979-1.049 0.452 
Smoked at all 30-44 1.398 1.052-1.857 0.021 1.359 0.938-1.970 0.105 1.176 0.728-1.901 0.507 
Smoked every year 30-44 1.379 1.034-1.839 0.029 1.323 0.911-1.921 0.141 1.112 0.668-1.852 0.683 
Years smoked 45-59 
    
1.031 1.003-1.059 0.028 1.001 0.962-1.042 0.947 
Smoked at all 45-59 
    
1.536 1.056-2.234 0.025 1.029 0.616-1.716 0.914 
Smoked every year 45-59 
    
1.490 0.993-2.236 0.054 0.909 0.465-1.776 0.780 
Years smoked 16-44 1.012 1.000-1.024 0.041 1.010 0.995-1.025 0.183 1.006 0.986-1.025 0.575 
Smoked at all 16-44 1.306 0.971-1.757 0.078 1.211 0.823-1.783 0.331 1.249 0.761-2.051 0.379 
Smoked every year 16-44 1.727 1.242-2.402 0.001 1.674 1.088-2.576 0.019 1.548 0.867-2.763 0.139 
Years smoked 16-59 
    
1.008 0.998-1.019 0.127 1.001 0.987-1.016 0.861 
Smoked at all 16-59 
    
1.124 0.757-1.669 0.563 1.154 0.693-1.923 0.582 
Smoked every year 16-59 
    
1.347 0.899-2.018 0.149 0.994 0.554-1.781 0.983 
Years smoked 30-59 
    
1.013 0.998-1.027 0.085 1.004 0.984-1.024 0.683 
Smoked at all 30-59 
    
1.263 0.862-1.851 0.230 1.070 0.647-1.768 0.792 
Smoked every year 30-59 
    
1.339 0.879-2.040 0.174 0.900 0.444-1.823 0.770 
These are results of 36 separate Cox regressions of RA onset on each measure of smoking, conditioning on gender. 
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11. Variables used in sensitivity analyses 
These variables were measured in wave 3 of data collection. 
Cognitive function was measured during the face-to-face interview with no interruptions 
and nobody present apart from the interviewer and respondent. Both memory and 
executive function were measured. 
One of the measures of memory function is a delayed recall test. In this test, a list of ten 
words was read to respondents. They were immediately asked to recall as many words as 
they could, generating a score between 0 and 10. After performing several unrelated tasks, 
they were once again asked to recall as many of the ten words as they could. The score for 
delayed recall (0-10) is used, because scores from the same test predicted accuracy of data 
recalled in another large British dataset (Brown 2013). 
Depressive symptoms were measured by summing scores of eight items of the Centre for 
Epidemiological Studies Depression scale (CESD). These items are presented in Table A10.15. 
Table A10.15:   Items used to measure depressive symptoms 
Item Response Score 
Now think about the past week and the feelings you have experienced.  
Please tell me if each of the following was true for you much of the time during the past week. 
Much of the time during the past week, you felt depressed? Yes 1 
 No 0 
Much of the time during the past week, you felt that everything you did was an effort? Yes 1 
No 0 
Much of the time during the past week, your sleep was restless? Yes 1 
 No 0 
Much of the time during the past week, you were happy? Yes 0 
 No 1 
Much of the time during the past week, you felt lonely? Yes 1 
 No 0 
Much of the time during the past week, you enjoyed life? Yes 0 
 No 1 
Much of the time during the past week, you felt sad? Yes 1 
 No 0 
Much of the time during the past week, you could not get going? Yes 1 
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 No 0 
 
 
Pain was measured using the questions presented in Table A10.16 
Table A10.16: Questions used to measure pain 
Are you often troubled with pain? Yes / No 
How bad is the pain most of the time? Is it… Mild 
 Moderate 
 Severe 
 
 
Appendix 11: Choice of model for survival analyses 
Table A11.1 presents p-values from tests of the proportional hazards assumption for 
variables used in the analyses in relation to RA onset from ages 16, 45, and 60. 
Table A11.1: P-values from tests of the proportional hazards assumption for variables 
included in the analyses 
 RA with onset from age 
 16 45 60 
Total childhood adversity (to age 16) 0.534 0.997 0.871 
Total life course adversity (0-44)  0.913 0.849 
Cumulative life course adversity (0-44)  0.869 0.852 
Total life course adversity (0-59)   0.965 
Cumulative life course adversity (0-59)   0.680 
Total years smoking 30-44  0.311 0.547 
Total years smoking 45-59   0.385 
Female  0.058 0.119 0.590 
Cohort of birth 0.149 0.112 0.285 
Level 2 qualification or higher in 2006 0.930 0.948 0.222 
Notes: These are results of tests of the proportional hazards (PH) assumption following separate Cox regressions 
of RA onset on each variable. P-value<0.05 suggests violation of the PH assumption. The sample is participants of 
LIFE who provided complete information about the predictor and RA onset. All models include one predictor and 
the hazard function, except for cohort of birth, which is estimated using five dummy variables indicating birth 
during different periods. Measures of gender and education are binary and measures of smoking and adversity 
are continuous. Total adversity indicates the total number of adversities during the life stage or stages. 
Cumulative level indicates the number of life stages in which at least one adversity was reported.  
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Appendix 12: How multiple imputed datasets were created 
Missing values were imputed in 20 datasets using Stata version 14 (StataCorp. 2015). No 
assumptions were made about patterns of missingness and an imputation strategy referred 
to as the chained approach (Van Buuren 2007) was used. 
The variables imputed were those used in the analyses, referred to as variables of interest, 
and auxiliary variables. Analyses used as the outcome the hazard function for RA onset, 
which is derived from time to censoring or RA onset, and whether or not RA onset occurred. 
Missing values were not imputed for these two variables because Stata 14 does not support 
survival analysis using outcome variables for which missing values have been imputed using 
multiple imputation. However, both variables were included in imputation models for the 
other variables of interest. 
Multiple imputation assumes that data are missing at random conditional upon a set of 
conditioning, or auxiliary, variables (Goldstein 2009). Imputation models included as many 
auxiliary variables as possible, as this is recommended by Rubin (1996), and has been found 
to increase efficiency and reduce bias (Collins et al. 2001). Auxiliary variables were selected 
from a larger group, referred to as auxiliary candidates, which were chosen because they 
had below 10% missing values and were thought to be associated with the values and 
missingness of the variables of interest. The initial selection of auxiliary candidates was 
informed by existing evidence about determinants of (1) variables of interest and (2) 
participation in ELSA (Hancock et al. 2016).   
In order to select auxiliary variables from auxiliary candidates, correlations were estimated 
with values and missingness for each variable of interest, and a scoring system was devised 
to summarise the results.  
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Some auxiliary candidates were conceptually similar, likely to be highly correlated and to 
have similar relationships with variables of interest. An example is home ownership status 
and socio-economic status, both measured in wave 3. As this could cause problems with 
convergence, just one was selected as an auxiliary variable, based on the scoring system 
described above.  
Auxiliary variables chosen were number of sweeps in which the respondent had 
participated, being a core or core partner sample member, having had a wave 3 interview 
concurrent with the partner’s interview, participant in HSE 2003, living with a partner, 
depression score using the Centre for Epidemiological Studies Depression (CESD) scale in 
wave 3, memory score from cognitive function test in wave 3, limiting longstanding illness in 
wave 3, poor or very poor self-rated health in wave 3, self-rated dental health in wave 3, car 
owner in wave 3, home owner in wave 3, ever pregnant in wave 3, last period after the age 
of 52, having had a hysterectomy or removal of ovaries by age 44, and use of hormonal 
contraception by age 59. 
Multiple imputation using all chosen auxiliary variables failed to converge. In order to 
achieve convergence, specific variables were omitted from each imputation model. A 
strategy was devised to guide decisions about the order in which variables were omitted. 
The first variables omitted were auxiliary variables that had weakest correlations with values 
and missingness for the imputed variable. Second, variables of interest were omitted for 
which there was least evidence for associations with values and missingness of the imputed 
variable. Finally, highly correlated variables were omitted, as these variables were likely to 
cause problems with convergence. 
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Although the main analyses are conducted using imputed datasets that include only 
participants in the LIFE interview who provided full information about RA onset, multiple 
imputation used all available data, regardless of participation in LIFE. The only respondents 
excluded from imputation models were those for whom information was missing about RA 
onset, gender, or date of birth. 
Table A12.1 presents summary statistics for variables of interest using the original dataset 
with missing values and the multiple datasets with missing values imputed. 
Using the multiple datasets with imputed values for missing data, estimated mean values of 
adversity are generally higher than those reported by respondents who provided complete 
information. Differences are particularly striking when adversities are summed over longer 
periods of time, e.g. from birth to age 59. This suggests that respondents who did not 
provide complete information about adversity tended to have experienced more adversities 
over their lives than those who provided complete information. The exception is that 
respondents who provided complete information tended to report at least one adversity 
during more life stages.  
Compared against estimates using the imputed datasets, respondents who provided 
complete information tended to smoke during more years between the ages of 30 and 44, 
and for fewer years between 45 and 59. 
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Table A12.1:  Summary statistics using the original and twenty imputed datasets     
   Original sample Multiple samples  
Variable Type Values Obs 
Mean 
%=ye
s 
SD 
N=ye
s 
(n=6,624) 
Mean 95%ci 
         
         
Childhood adversity terciles 0 3580 45.9 1643 43.9 41.9 45.9 
  
1 3580 29.9 1069 29.6 27.9 31.4 
  
2+ 3580 24.2 868 26.4 24.9 28.0 
         
 
binary 
 
3580 54.1 1937 56.1 54.1 58.1 
         
 
dummies 0 3580 45.9 1643 43.9 41.9 45.9 
  
1 3580 29.9 1069 29.6 27.9 31.4 
  
2 3580 14.3 513 15.1 13.9 16.3 
  
3+ 3580 9.9 355 11.4 10.2 12.5 
         
Adversity 0-44 terciles 0-1 3428 43.3 1485 36.4 35.0 37.8 
  
2-3 3428 37.8 1297 37.5 36.1 38.9 
  
4+ 3428 18.8 646 26.1 24.8 27.5 
         
 
continuous 0-6+ 3428 2.050 1.624 2.398 2.345 2.452 
         
 
dummies 0 3428 18.6 637 15.1 14.1 16.1 
  
1 3428 24.7 848 21.3 20.1 22.4 
  
2 3428 21.6 742 20.4 19.2 21.6 
  
3 3428 16.2 555 17.1 15.8 18.4 
  
4 3428 9.7 332 11.6 10.7 12.5 
  
5 3428 5.3 180 7.2 6.4 8.0 
  
6+ 3428 3.9 134 7.4 6.4 8.3 
         
Adversity 0-59 terciles 0-1 3214 34.5 1108 27.3 26.0 28.6 
  
2-3 3214 38.0 1220 36.2 34.8 37.5 
  
4+ 3214 27.6 886 36.6 35.2 37.9 
         
 
continuous 0-7+ 3214 2.503 1.825 2.966 2.909 3.022 
         
 
dummies 0 3214 13.2 425 9.9 9.1 10.8 
  
1 3214 21.3 683 17.3 16.3 18.4 
  
2 3214 20.4 656 18.6 17.5 19.8 
  
3 3214 17.5 564 17.5 16.5 18.6 
  
4 3214 13.4 431 14.2 13.1 15.2 
  
5 3214 6.7 215 9.1 8.3 9.9 
  
6 3214 3.8 121 5.9 5.2 6.7 
  
7+ 3214 3.7 119 7.4 6.5 8.2 
         Cumulative adversity 0-44       
 
dummies 0 4998 12.7 637 15.1 14.1 16.1 
  
1 4998 32.7 1636 34.4 33.0 35.9 
  
2 4998 35.2 1761 34.0 32.7 35.3 
  
3 4998 19.3 964 16.4 15.3 17.6 
         
 
continuous 0-3 4998 1.611 0.937 1.518 1.489 1.547 
         Cumulative adversity 0-59       
 
dummies 0 4640 9.2 425 9.9 9.1 10.8 
  
1 4640 25.4 1178 26.7 25.5 27.9 
 
2 4640 33.9 1573 33.4 32.1 34.8 
  
3 4640 22.9 1062 22.5 21.3 23.6 
  
4 4640 8.7 402 7.5 6.6 8.3 
         
 
continuous 0-4 4640 1.965 1.093 1.908 1.878 1.939 
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Youth adversity binary 
 
5145 50.1 2579 51.0 49.7 52.2 
         
 
dummies 0 5145 49.9 2566 49.0 47.8 50.3 
  
1 5145 29.3 1506 29.2 28.0 30.5 
  
2 5145 13.0 667 13.1 12.1 14.0 
  
3+ 5145 7.9 406 8.7 7.9 9.4 
         
Early adulthood adversity        
 
binary 
 
4999 43.4 2170 44.8 43.4 46.1 
         
 
dummies 0 4999 56.6 2829 55.2 53.9 56.6 
  
1 4999 26.3 1313 26.4 25.2 27.6 
  
2 4999 11.2 561 11.7 10.8 12.6 
  
3+ 4999 5.9 296 6.6 5.9 7.4 
         
Mid-adulthood adversity        
 
binary 
 
4644 38.3 1778 39.0 37.7 40.4 
         
 
dummies 0 4644 61.7 2866 61.0 59.6 62.3 
  
1 4644 24.7 1147 24.8 23.6 26.0 
  
2 4644 8.9 413 9.1 8.3 10.0 
  
3+ 4644 4.7 218 5.1 4.5 5.7 
         
Adversities from histories during:        
childhood binary 
 
4971 43.6 2168 44.3 43.0 45.6 
youth binary 
 
6540 36.9 2414 36.9 35.7 38.0 
early adulthood binary 
 
6540 38.0 2483 38.0 36.8 39.1 
mid-adulthood binary 
 
6540 30.3 1980 30.3 29.2 31.4 
         
Material adversity during:        
childhood binary 
 
4178 16.7 699 18.3 16.8 19.8 
youth binary 
 
5435 11.4 619 12.6 11.7 13.5 
0-29 binary 
 
4161 19.5 812 27.8 26.5 29.1 
0-44 binary 
 
4161 22.1 918 33.1 31.7 34.4 
0-59 binary 
 
4161 25.0 1040 37.5 36.2 38.9 
         
childhood dummies 0 4178 83.3 3479 81.7 80.2 83.2 
  
1 4178 14.9 622 16.1 14.7 17.4 
  
2+ 4178 1.8 77 2.2 1.8 2.7 
         youth dummies 0 5435 88.6 4816 87.4 86.5 88.3
  
1 5435 9.8 534 10.6 9.7 11.4 
  
2+ 5435 1.6 85 2.0 1.6 2.5 
         
0-29 dummies 0 4161 80.5 3349 72.2 70.9 73.5 
  
1 4161 16.5 688 21.6 20.3 22.9 
  
2+ 4161 3.0 124 6.1 5.2 7.0 
         
0-44 dummies 0 4161 77.9 3243 66.9 65.6 68.3 
  
1 4161 17.6 733 23.5 22.3 24.8 
  
2+ 4161 4.4 185 9.5 8.5 10.5 
         
0-59 dummies 0 4161 75.0 3121 62.5 61.1 63.8 
  
1 4161 18.3 762 24.3 23.1 25.6 
  
2 4161 4.6 193 8.1 7.2 9.0 
  
3+ 4161 2.0 85 5.1 4.4 5.8 
         
         Social adversity during:  
childhood continuous 0-3+ 4568 0.715 0.799 0.750 0.728 0.772 
youth continuous 0-3+ 5211 0.548 0.702 0.571 0.553 0.589 
0-29 continuous 0-3+ 4499 1.256 1.093 1.320 1.290 1.350 
0-44 continuous   0,1-2,3-5,6+ 4368 1.089 0.787 1.149 1.128 1.170 
0-59 continuous          0,1-2,3+ 4368 1.234 0.714 1.245 1.227 1.264 
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         childhood dummies 0 4568 50.3 2296 48.2 46.8 49.6
  
1 4568 28.0 1280 28.6 27.4 29.8 
  
2 4568 13.3 609 14.3 13.4 15.2 
  
3 4568 5.5 249 5.8 5.2 6.4 
  
4+ 4568 2.9 134 3.1 2.6 3.6 
         
youth dummies 0 5211 57.4 2990 56.1 54.8 57.4 
  
1 5211 30.4 1584 30.7 29.5 31.9 
  
2 5211 10.3 538 11.0 10.2 11.8 
  
3+ 5211 1.9 99 2.2 1.8 2.6 
         
0-29 dummies 0 4499 31.6 1423 29.3 28.1 30.4 
  
1 4499 29.8 1340 29.8 28.6 31.0 
  
2 4499 20.0 899 20.6 19.5 21.7 
  
3 4499 10.2 457 11.0 10.1 11.9 
  
4 4499 5.1 230 5.6 4.9 6.2 
  
5+ 4499 3.3 150 3.8 3.3 4.3 
         
0-44 dummies 0 4368 23.2 1013 20.7 19.6 21.8 
  
1 4368 26.4 1154 25.7 24.6 26.8 
  
2 4368 22.0 959 22.1 21.0 23.3 
  
3 4368 12.9 563 14.1 13.2 15.1 
  
4 4368 7.7 337 8.6 7.8 9.4 
  
5 4368 4.1 181 4.7 4.1 5.3 
  
6+ 4368 3.7 161 4.1 3.5 4.7 
         
0-59 dummies 0 4059 17.8 723 15.1 14.2 16.1 
  
1 4059 25.0 1016 23.4 22.3 24.5 
  
2 4059 21.8 885 21.8 20.6 23.0 
  
3 4059 15.3 620 16.1 15.1 17.1 
  
4 4059 9.0 366 10.2 9.4 11.0 
  
5 4059 5.2 213 6.3 5.6 7.0 
  
6 4059 2.7 109 3.4 2.9 3.9 
  
7+ 4059 3.1 127 3.6 3.1 4.2 
         Family adversity during: 
childhood binary 0-2+ 5364 35.8 1922 36.2 34.9 37.5 
youth binary 0,1+ 5427 31.5 1709 32.2 31.1 33.4 
0-29 continuous 
0,1-
2,3+ 5288 0.633 0.643 0.648 0.631 0.665 
0-44 continuous 
0,1-
2,3+ 5137 0.829 0.701 0.861 0.844 0.879 
0-59 continuous 
0.1-
3,4+ 4773 0.824 0.612 0.867 0.851 0.884 
         childhood dummies 0 5364 64.2 3442 63.8 62.5 65.1
  
1 5364 23.1 1240 23.1 22.1 24.2 
  
2 5364 9.0 484 9.2 8.4 10.0 
  
3 5364 2.6 137 2.7 2.2 3.1 
  
4+ 5364 1.1 61 1.2 0.9 1.5 
         
youth dummies 0 5427 68.5 3718 67.8 66.6 68.9 
  
1 5427 23.7 1286 23.9 22.8 24.9 
  
2+ 5427 7.8 423 8.4 7.7 9.1 
         
0-29 dummies 0 5288 45.7 2419 44.9 43.5 46.2 
  
1 5288 30.2 1595 30.1 28.8 31.3 
  
2 5288 15.0 794 15.4 14.4 16.3 
  
3 5288 5.9 313 6.2 5.6 6.8 
  
4+ 5288 3.2 167 3.5 3.0 4.0 
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0-44 dummies 0 5137 34.6 1775 32.9 31.7 34.1 
  
1 5137 29.3 1505 29.0 27.7 30.2 
  
2 5137 18.6 958 19.1 18.1 20.2 
  
3 5137 9.7 497 10.3 9.5 11.1 
  
4 5137 5.0 257 5.5 4.9 6.1 
  
5+ 5137 2.8 145 3.2 2.8 3.7 
         
0-59 dummies 0 4773 29.0 1385 26.6 25.5 27.7 
  
1 4773 27.6 1319 27.2 26.0 28.3 
  
2 4773 21.0 1001 20.9 19.9 22.0 
  
3 4773 10.9 521 11.9 11.0 12.8 
  
4 4773 6.1 292 7.1 6.4 7.8 
  
5 4773 2.8 133 3.4 2.9 3.9 
  
6+ 4773 2.6 122 2.9 2.4 3.3 
         Traumatic adversity during: 
childhood continuous 0-2+ 4662 0.326 0.564 0.338 0.318 0.357 
youth binary 0,1+ 5294 17.7 938 18.6 17.5 19.8 
0-29 binary 0,1+ 4654 39.6 1842 41.0 39.3 42.6 
0-44 binary 0,1+ 4654 43.4 2019 44.8 43.2 46.4 
0-59 binary 0,1+ 4654 48.1 2237 49.5 47.9 51.0 
                  
childhood dummies 0 4662 72.4 3373 71.6 70.2 73.1 
  
1 4662 22.7 1060 23.0 21.7 24.2 
  
2+ 4662 4.9 229 5.4 4.6 6.2 
         
youth dummies 0 5294 82.3 4356 81.4 80.2 82.5 
  
1+ 5294 17.7 938 18.6 17.5 19.8 
         
0-29 dummies 0 4654 60.4 2812 59.0 57.4 60.7 
  
1 4654 30.0 1396 30.7 29.3 32.1 
  
2+ 4654 9.6 446 10.3 9.3 11.3 
         
0-44 dummies 0 4654 56.6 2635 55.2 53.6 56.8 
  
1 4654 31.3 1457 32.0 30.7 33.4 
  
2+ 4654 12.1 562 12.8 11.7 13.9 
         
0-59 dummies 0 4654 51.9 2417 50.5 49.0 52.1 
  
1 4654 33.9 1580 34.4 33.0 35.8 
  
2 4654 11.5 535 12.2 11.2 13.1 
  
3+ 4654 2.6 122 2.9 2.4 3.4 
                  
Chronic adversity during:        
youth binary 0,1+ 5422 13.1 711 14.0 13.1 14.9 
16-44 binary 0,1+ 5422 28.0 1516 29.2 28.0 30.5 
16-59 binary 0,1+ 5422 39.2 2127 40.5 39.2 41.8 
         youth dummies 0 5422 86.9 4711 86.0 85.1 86.9
  
1 5422 12.1 658 12.7 11.7 13.6 
  
2+ 5422 1.0 53 1.3 1.0 1.7 
         
16-44 dummies 0 5422 72.0 3906 70.8 69.5 72.0 
  
1 5422 21.8 1180 22.4 21.2 23.5 
  
2+ 5422 6.2 336 6.8 6.1 7.5 
         
16-59 dummies 0 5422 60.8 3295 59.5 58.2 60.8 
  
1 5422 28.5 1544 28.8 27.6 30.0 
  
2 5422 8.2 445 8.7 7.9 9.4 
  
3+ 5422 2.5 138 3.1 2.6 3.6 
         Acute adversity during: 
youth binary 
 
5356 11.2 602 11.9 11.0 12.8 
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16-44 binary 
 
5356 15.1 809 16.0 15.1 17.0 
16-59 binary 
 
5356 18.0 962 19.2 18.1 20.3 
         youth dummies 0 5356 88.8 4754 88.1 87.2 89.0
  
1 5356 9.9 528 10.1 9.2 10.9 
  
2+ 5356 1.4 74 1.8 1.4 2.2 
         
16-44 dummies 0 5356 84.9 4547 84.0 83.0 84.9 
  
1 5356 13.0 695 13.3 12.3 14.2 
  
2+ 5356 2.1 114 2.8 2.2 3.3 
         
16-59 dummies 0 5356 82.0 4394 80.8 79.7 81.9 
  
1 5356 15.3 820 15.7 14.6 16.7 
  
2+ 5356 2.7 142 3.6 2.9 4.2 
         
         
Female gender binary 
 
6624 54.7 3626 54.7 53.5 55.9 
Level 2+ in 2006 binary 
 
6109 68.4 4179 67.7 66.5 68.9 
         
         Born by 1920 binary 
 
6624 3.7 247 3.7 3.3 4.2
Born 1921-1930 binary 
 
6624 12.9 854 12.9 12.1 13.7 
Born 1931-1940 binary 
 
6624 23.8 1579 23.8 22.8 24.9 
Born 1941-1950 binary 
 
6624 34.7 2297 34.7 33.5 35.8 
Born 1951 or after binary 
 
6624 24.9 1647 24.9 23.8 25.9 
                  
Years smoked 30-44 continuous 
 
6272 5.553 6.843 5.372 5.208 5.537 
Years smoked 45-59 continuous 
 
6337 3.383 5.758 3.602 3.459 3.745 
         
The original sample includes all participants in LIFE who provided information about RA status, 
gender, and date of birth. 
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Appendix 13: Descriptive statistics 
Table A13.1 presents lifetime prevalence and incidence rates of RA for the unweighted and 
weighted samples that participated in the LIFE interview, and that participated in at least 
one sweep of ELSA regardless of participation in LIFE. Numbers in the weighted samples are 
smaller than in the unweighted samples because weights are available only for those who 
participated in LIFE, or in the first seven waves of ELSA. The results suggest that adults with 
RA were more likely than those without RA to participate in ELSA, but less likely to 
participate in the LIFE interview.  
Table A13.1: Lifetime prevalence and incidence rates of RA in weighted and unweighted 
samples 
  Number of 
respondents 
Lifetime prevalence Incidence per 100 per year 
   95% confidence 
interval 
 95% confidence 
interval 
LIFE Unweighted 6,626 3.92% 3.46%-4.39% 0.054 0.047-0.060 
 Weighted 5,889 4.37% 3.80%-4.92% 0.058 0.051-0.067 
ELSA Unweighted 16,118 4.72% 4.39%-5.04% 0.068 0.063-0.073 
 Weighted 3,303 3.90% 3.17%-4.63% 0.051 0.042-0.062 
RA onset before age 16 is classified as juvenile, not rheumatoid, arthritis. 
 
In the main text, Figure 3.3 presents the hazard function for RA onset adjusted for birth 
cohort for the LIFE sample. Figure A13.1 presents the equivalent hazard function using the 
whole ELSA sample.  
Figure A13.1 shows that up to age 80, the baseline hazard function for the total ELSA sample 
is very similar to that for the respondents who participated in LIFE (Figure 3.3). Only 16 of 
the respondents who participated in the LIFE interview reported RA onset after age 80, and 
so the smoothed hazard function ends at about age 80 for this sub-sample. Amongst the 
total ELSA sample, 31 respondents reported RA onset after age 80, and the curve changes 
direction with a second peak of relatively high incidence at just over the age of 90. The 
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increased risk of RA onset in very late life may reflect attrition from the sample due to death 
as well as an increased likelihood of developing a chronic illness amongst those who remain.  
Figure A13.1: Hazard function for RA onset adjusted for birth cohort using the whole ELSA 
sample 
 
This figure uses a base of 16,118 respondents who participated in at least one sweep of ELSA, of 
whom 760 reported RA onset. 
 
Figure A13.2 presents the equivalent hazard function using the weighted LIFE sample, which 
is also very similar to Figure 3.3. 
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Figure A13.2:   Hazard function for RA onset adjusted for birth cohort using weighted 
sample of LIFE participants  
 
 
 
Figures A13.3, A13.4, and A13.5 present hazard functions for RA onset using the weighted 
LIFE sample for each birth cohort, for men and women, and for respondents with different 
socio-economic backgrounds, respectively.  
The results are similar to those using the unweighted LIFE sample. As for Figure3. 4, which 
used the unweighted LIFE sample, Figure A13.3 illustrates that RA onset was diagnosed 
earlier in the life course for younger cohorts. In the weighted sample, mean age of RA onset 
is 49 for those born after 1950, 54 for those born between 1941 and 1950, 63 for those born 
between 1931 and 1940, 68 for those born between 1921 and 1930, and 77 for those born 
before 1921.  
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Figure A13.3: Hazard functions for RA onset for each birth cohort using weighted sample 
of LIFE participants 
 
 
 
 
As with the unweighted sample, Figure A13.4 suggests a gender difference in RA onset that 
turns out not to be statistically significant. The hazard ratio for RA onset of women 
compared against men is 1.048, 95%CI=0.806-1.363, p=0.727. Figure A13.5 suggests a small 
difference between those growing up with a main carer whose main occupation was routine 
or manual, but the difference is statistically significant; HR=1.652, 95%CI=1.228-2.223, 
p=0.001. 
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Figure A13.4:   Hazard functions for RA o Hazard functions for RA onset for men and 
women adjusted for birth cohort, using weighted sample of LIFE participants 
 
 
 
Figure A13.5:   Hazard functions for RA onset by socio-economic background, 
adjusted for birth cohort and using weighted sample of LIFE participants 
 
Note: Socio-economic background is measured by whether the respondent reported that their father had a 
manual or routine occupation when they were 14 years old.
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Figures A13.6 and A13.7 present hazard functions with confidence intervals for men and women, 
and respondents growing up with a main carer whose occupation was routine/manual or not. There 
is no adjustment for birth cohort, as Stata does not support inclusion of confidence intervals for 
adjusted hazard functions. The unadjusted hazard ratios for RA onset by gender and socioeconomic 
background are 1.079, 95%CI=0.845-1.378, p=0.542 and 1.684, 95%CI=1.280-2.216, p=0.000, 
respectively. 
Figure A13.6: Unadjusted hazard functions with confidence intervals for men and women who 
participated in LIFE 
Hazard functions with confidence intervals are striped for women and blank for men. 
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Figure A13.7: Unadjusted hazard functions with confidence intervals by socio-economic 
background for LIFE participants 
 
Hazard functions with confidence intervals are striped for those whose main carer during childhood had a 
routine or manual occupation and blank for those whose was not. 
 
For all groups, confidence intervals increase with age, probably because a higher proportion 
of respondents have been censored. 
Figure A13.6 shows that up to about age 50, more women than men develop RA, but 
thereafter, the confidence intervals for women and men overlap substantially. Figure A13.7 
shows a more consistent relationship between those who grew up in more and less socio-
economically advantaged families, with those from more disadvantages families developing 
the condition sooner and more frequently. Although the confidence intervals for the two 
groups overlap a little for most of the life course, it is only late in life – at about age 65 – that 
the confidence intervals between the two groups overlap substantially. RA risk increases 
amongst those from socio-economically advantaged backgrounds after age 80, but there are 
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no observations from the disadvantaged group at this age, possibly reflecting the socio-
economic gradient in life expectancy (Office for National Statistics 2015). 
Table A13.2 presents summary statistics for all variables used in the analyses, including 
those used in the appendices, for men and women using the imputed datasets. Means are 
estimated and have confidence intervals, and gender differences are indicated when these 
confidence intervals do not overlap.  
Table A13.2:   Summary statistics for men and women separately 
   Men (n=2,998) Women (n=3,626) 
Variable Type 
 
Mean/% 95%CI Mean 95%CI 
         
         
Childhood adversity terciles 0 44.3 41.6-46.9 43.7 41.2-46.2 
  
1 29.7 27.5-31.9 29.5 27.4-31.7 
  
2+ 26.0 23.9-28.2 26.8 24.7-28.8 
       
 
binary 
 
55.7 53.1-58.4 56.3 53.8-58.8 
       
 
dummies 0 44.3 41.6-46.9 43.7 41.2-46.2 
  
1 29.7 27.5-31.9 29.5 27.4-31.7 
  
2 15.4 13.7-17.2 14.8 13.3-16.4 
  
3+ 10.6 9.1-12.1 12.0 10.3-13.6 
         Adversity 0-44 terciles 0-1 37.4 35.4-39.4 35.5 33.7-37.3 
  
2-3 37.0 35.0-39.0 37.9 36.0-39.8 
  
4+ 25.6 23.6-27.6 26.6 24.8-28.4 
         
 
continuous 0-6+ 2.362 2.285-2.440 2.428 2.360-2.496 
         
 
dummies 0 15.5 13.9-17.1 14.8 13.5-16.1 
  
1 21.9 20.3-23.5 20.7 19.2-22.3 
  
2 20.1 18.3-21.9 20.7 19.0-22.3 
  
3 16.9 15.1-18.8 17.2 15.7-18.8 
  
4 11.6 10.2-13.0 11.6 10.3-13.0 
  
5 7.1 6.0-8.3 7.2 6.1-8.2 
  
6+ 6.9 5.6-8.2 7.8 6.6-9.0 
         Adversity 0-59 terciles 0-1 27.7 25.9-29.5 26.9 25.2-28.6 
  
2-3 35.7 33.7-37.7 36.5 34.7-38.3 
  
4+ 36.6 34.5-38.7 36.5 34.7-38.4 
         
 
continuous 0-7+ 2.940 2.852-3.027 2.987 2.912-3.061 
         
 
dummies 0 10.2 9.0-11.4 9.7 8.6-10.8 
  
1 17.5 16.0-19.0 17.2 15.7-18.7 
  
2 18.8 17.0-20.7 18.5 17.0-19.9 
  
3 16.9 15.2-18.6 18.1 16.6-19.5 
  
4 14.4 13.0-15.8 14.0 12.4-15.5 
  
5 9.3 8.0-10.7 8.9 7.7-10.0 
  
6 6.0 4.9-7.1 5.9 4.8-6.9 
  
7+ 6.8 5.7-8.0 7.8 6.7-9.0 
         Cumulative adversity 0-44 dummies 0 15.5 13.9-17.1 14.8 13.5-16.1 
  
1 35.1 33.1-37.2 33.9 32.0-35.8 
  
2 33.8 31.9-35.7 34.3 32.4-36.1 
  
3 15.6 13.9-17.3 17.1 15.5-18.7 
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continuous 0-3 1.495 1.453-1.537 1.537 1.499-1.575 
         Cumulative adversity 0-59 dummies 0 10.2 9.0-11.4 9.7 8.6-10.8 
  
1 26.9 25.2-28.7 26.5 24.8-28.2 
 
2 33.8 31.9-35.7 33.1 31.1-35.0 
  
3 22.0 20.3-23.7 22.9 21.2-24.5 
  
4 7.0 5.9-8.2 7.8 6.6-9.0 
         
 
continuous 0-4 1.887 1.841-1.934 1.925 1.883-1.967 
         
Youth adversity binary 
 
50.7 48.6-52.7 51.2 49.5-52.9 
         
 
dummies 0 49.3 47.3-51.4 48.8 47.1-50.5 
  
1 28.7 26.8-30.6 29.7 28.0-31.3 
  
2 13.5 12.1-14.8 12.8 11.5-14.0 
  
3+ 8.5 7.4-9.5 8.8 7.8-9.8 
         
Early adulthood adversity binary 
 
43.1 41.0-45.1 46.1 44.3-48.0 
         
 
dummies 0 56.9 54.9-59.0 53.9 52.0-55.7 
  
1 25.3 23.5-27.1 27.4 25.8-29.0 
  
2 11.2 10.0-12.4 12.1 10.8-13.3 
  
3+ 6.6 5.5-7.7 6.7 5.7-7.7 
         Mid-adulthood adversity binary 
 
39.3 37.0-41.5 38.8 37.1-40.6 
         
 
dummies 0 60.7 58.5-63.0 61.2 59.4-62.9 
  
1 24.5 22.7-26.3 25.0 23.5-26.6 
  
2 9.2 8.0-10.4 9.1 8.0-10.1 
  
3+ 5.5 4.5-6.6 4.7 3.9-5.5 
         Histories childhood binary 
 
42.9 41.0-44.8 45.4 43.6-47.2 
Histories youth binary 
 
30.4 28.8-32.1 42.2 40.6-43.8 
Histories early adulthood binary 
 
36.4 34.7-38.2 39.2 37.6-40.8 
Histories mid-adulthood binary 
 
30.4 28.8-32.1 30.2 28.7-31.8 
         
Material adversity childhood binary 
 
17.7 15.8-19.7 18.8 16.9-20.6 
Material adversity youth binary 
 
12.7 11.4-14.1 12.5 11.3-13.7 
Material adversity 0-29 binary 
 
27.2 25.3-29.2 28.2 26.5-29.9 
Material adversity 0-44 binary 
 
33.4 31.4-35.4 32.8 31.0-34.5 
Material adversity 0-59 binary 
 
39.0 37.0-40.9 36.3 34.6-38.1 
         Material adversity childhood dummies 0 82.3 80.3-84.2 81.2 79.4-83.1 
  
1 15.8 14.0-17.6 16.3 14.6-18.0 
  
2+ 1.9 1.3-2.6 2.5 1.9-3.2 
         Material adversity youth dummies 0 87.3 85.9-88.6 87.5 86.3-88.7 
  
1 10.6 9.4-11.8 10.5 9.3-11.7 
  
2+ 2.1 1.5-2.7 2.0 1.5-2.5 
         
Material adversity 0-29 dummies 0 72.8 70.8-74.7 71.8 70.1-73.5 
  
1 21.4 19.6-23.2 21.8 20.1-23.6 
  
2+ 5.8 4.7-7.0 6.4 5.3-7.5 
         
Material adversity 0-44 dummies 0 66.6 64.6-68.6 67.2 65.5-69.0 
  
1 23.6 21.8-25.4 23.5 21.8-25.2 
  
2+ 9.8 8.4-11.2 9.3 8.0-10.6 
         
Material adversity 0-59 dummies 0 61.0 59.1-63.0 63.7 61.9-65.4 
  
1 24.3 22.5-26.0 24.4 22.6-26.1 
  
2 8.6 7.4-9.9 7.7 6.5-8.8 
  
3+ 6.1 4.9-7.2 4.3 3.4-5.1 
         
         Social adv. childhood continuous 0-3+ 0.758 0.725-0.791 0.743 0.713-0.773 
Social adversity youth continuous 0-3+ 0.529 0.502-0.555 0.606 0.581-0.631 
Social adversity 0-29 continuous 0-3+ 1.293 1.250-1.337 1.342 1.303-1.381 
Social adversity 0-44 cont.       0,1-2,3-5,6+ 1.110 1.080-1.139 1.181 1.153-1.210 
Social adversity 0-59 Cont.              0,1-2,3+ 1.209 1.182-1.235 1.276 1.250-1.301 
         Social adv. childhood dummies 0 47.6 45.6-49.7 48.7 46.8-50.6 
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1 28.9 27.2-30.6 28.3 26.6-30.0 
  
2 15.3 13.9-16.8 13.4 12.2-14.7 
  
3 5.6 4.6-6.5 6.0 5.1-6.8 
  
4+ 2.5 1.8-3.2 3.6 2.9-4.2 
         
Social adversity youth dummies 0 57.6 55.6-59.5 54.9 53.1-56.6 
  
1 32.0 30.1-33.9 29.7 28.1-31.3 
  
2 8.7 7.6-9.8 12.9 11.7-14.0 
  
3+ 1.7 1.2-2.2 2.6 2.0-3.2 
         
Social adversity 0-29 dummies 0 29.7 27.9-31.5 28.9 27.3-30.5 
  
1 30.1 28.2-32.0 29.5 28.0-31.1 
  
2 21.4 19.7-23.0 20.0 18.6-21.4 
  
3 10.8 9.4-12.1 11.1 10.0-12.3 
  
4 5.0 4.0-5.9 6.1 5.2-6.9 
  
5+ 3.1 2.4-3.8 4.3 3.6-5.1 
         
Social adversity 0-44 dummies 0 21.6 20.0-23.3 20.0 18.5-21.4 
  
1 26.6 24.8-28.3 24.9 23.5-26.4 
  
2 22.4 20.8-24.1 21.8 20.3-23.4 
  
3 14.0 12.6-15.4 14.2 13.0-15.5 
  
4 7.9 6.8-9.0 9.2 8.1-10.2 
  
5 4.2 3.4-5.0 5.1 4.25.9 
  
6+ 3.2 2.5-4.0 4.8 4.0-5.6 
         
Social adversity 0-59 dummies 0 16.1 14.7-17.6 14.3 13.0-15.6 
  
1 24.4 22.7-26.2 22.5 21.1-24.0 
  
2 22.5 20.7-24.3 21.2 19.7-22.8 
  
3 15.7 14.2-17.2 16.5 15.2-17.8 
  
4 10.1 8.8-11.3 10.4 9.2-11.5 
  
5 5.3 4.4-6.3 7.1 6.1-8.0 
  
6 3.0 2.2-3.7 3.8 3.0-4.5 
  
7+ 2.9 2.2-3.6 4.2 3.4-5.0 
         Family adversity childhood binary 0-2+ 35.2 33.2-37.2 37.0 35.3-38.8 
Family adversity youth binary                    0,1+ 23.5 21.9-25.0 39.5 37.8-41.2 
Family adversity 0-29 continuous   0,1-2,3+ 0.557 0.532-0.582 0.724 0.701-0.747 
Family adversity 0-44 continuous   0,1-2,3+ 0.758 0.731-0.785 0.947 0.923-0.971 
Family adversity 0-59 Continuous   0,1-3,4+ 0.771 0.747-0.795 0.947 0.926-0.968 
         Family adversity childhood dummies 0 64.8 62.8-66.8 63.0 61.2-64.7 
  
1 23.2 21.6-24.9 23.1 21.6-24.6 
  
2 8.7 7.6-9.7 9.7 8.6-10.8 
  
3 2.4 1.7-3.0 2.9 2.3-3.5 
  
4+ 0.9 0.5-1.3 1.4 1.0-1.8 
         
Family adversity youth dummies 0 76.5 75.0-78.1 60.5 58.8-62.2 
  
1 19.0 17.6-20.5 27.9 26.3-29.4 
  
2+ 4.5 3.7-5.2 11.6 10.5-12.7 
         
Family adversity 0-29 dummies 0 51.5 49.5-53.4 39.4 37.7-41.1 
  
1 27.8 26.0-29.6 31.9 30.2-33.5 
  
2 13.4 12.1-14.8 17.0 15.7-18.3 
  
3 4.9 4.1-5.8 7.3 6.4-8.2 
  
4+ 2.3 1.7-2.9 4.5 3.7-5.2 
         
Family adversity 0-44 dummies 0 39.0 37.1-40.8 27.8 26.3-29.4 
  
1 28.8 26.9-30.6 29.2 27.5-30.8 
  
2 17.5 16.0-19.0 20.5 19.1-21.9 
  
3 8.5 7.3-9.7 11.8 10.7-12.9 
  
4 4.2 3.4-5.0 6.5 5.6-7.4 
  
5+ 2.0 1.4-2.6 4.2 3.5-4.9 
         
Family adversity 0-59 dummies 0 32.9 31.1-34.7 21.4 20.0-22.8 
  
1 27.5 25.7-29.3 26.9 25.3-28.4 
  
2 19.7 18.2-21.3 21.9 20.4-23.4 
  
3 9.8 8.6-11.1 13.7 12.4-14.9 
  
4 5.7 4.8-6.7 8.2 7.3-9.2 
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5 2.4 1.8-3.0 4.2 3.4-5.1 
  
6+ 1.9 1.4-2.4 3.7 3.0-4.3 
         Traumatic adv. childhood continuous 0-2+ 0.360 0.333-0.387 0.319 0.296-0.343 
Traumatic adversity youth binary 0,1+ 26.6 24.8-28.5 12.1 10.8-13.3 
Traumatic adversity 0-29 binary 0,1+ 48.2 46.0-50.3 35.0 33.0-37.0 
Traumatic adversity 0-44 binary 0,1+ 52.0 49.9-54.2 38.9 36.9-40.8 
Traumatic adversity 0-59 binary 0,1+ 57.5 55.4-59.6 42.8 40.8-44.8 
         
Traumatic adv. childhood dummies 0 69.8 67.8-71.8 73.2 71.3-75.0 
  
1 24.4 22.7-26.2 21.8 20.1-23.5 
  
2+ 5.8 4.7-6.9 5.1 4.2-6.0 
         
Traumatic adversity youth dummies 0 73.4 71.5-75.2 87.9 86.7-89.2 
  
1+ 26.6 24.8-28.5 12.1 10.8-13.3 
         
Traumatic adversity 0-29 dummies 0 51.8 49.7-54.0 65.0 63.0-67.0 
  
1 35.2 33.2-37.1 27.0 25.2-28.7 
  
2+ 13.0 11.4-14.6 8.1 7.0-9.2 
         
Traumatic adversity 0-44 dummies 0 48.0 45.8-50.1 61.1 59.2-63.1 
  
1 36.1 34.1-38.1 28.7 27.0-30.4 
  
2+ 15.9 14.2-17.7 10.2 8.9-11.4 
         
Traumatic adversity 0-59 dummies 0 42.5 40.4-44.6 57.2 55.2-59.2 
  
1 38.5 36.4-40.6 31.0 29.3-32.8 
  
2 15.3 13.7-16.9 9.5 8.4-10.7 
  
3+ 3.7 2.9-4.5 2.3 1.7-2.8 
         
         Chronic adversity youth binary 0,1+ 10.5 9.2-11.8 16.8 15.5-18.1 
Chronic adversity 16-44 binary 0,1+ 25.0 23.2-26.8 32.7 31.1-34.3 
Chronic adversity 16-59 binary 0,1+ 34.9 33.0-36.8 45.2 43.4-46.9 
         Chronic adversity youth dummies 0 89.5 88.2-90.8 83.2 81.9-84.5 
  
1 10.0 8.7-11.3 14.8 13.5-16.1 
  
2+ 0.5 0.2-0.9 2.0 1.4-2.5 
         
Chronic adversity 16-44 dummies 0 75.0 73.2-76.8 67.3 65.7-68.9 
  
1 20.4 18.7-22.1 24.0 22.5-25.5 
  
2+ 4.6 3.7-5.5 8.7 7.6-9.7 
         
Chronic adversity 16-59 dummies 0 65.1 63.2-67.0 54.8 53.1-56.6 
  
1 26.3 24.6-28.1 30.8 29.1-32.4 
  
2 6.7 5.7-7.6 10.3 9.2-11.4 
  
3+ 1.9 1.2-2.5 4.1 3.4-4.9 
         Acute adversity youth binary 
 
16.0 14.5-17.5 8.5 7.5-9.5 
Acute adversity 16-44 binary 
 
20.7 19.1-22.3 12.2 11.1-13.3 
Acute adversity 16-59 binary 
 
24.6 22.8-26.4 14.8 13.5-16.1 
         Acute adversity youth dummies 0 84.0 82.5-85.5 91.5 90.5-92.5 
  
1 13.7 12.3-15.1 7.1 6.2-8.0 
  
2+ 2.3 1.6-2.9 1.4 0.9-1.9 
         
Acute adversity 16-44 dummies 0 79.3 77.7-80.9 87.8 86.7-88.9 
  
1 17.2 15.7-18.8 10.0 8.9-11.0 
  
2+ 3.4 2.6-4.3 2.2 1.6-2.8 
         
Acute adversity 16-59 dummies 0 75.4 73.6-77.2 85.2 83.9-86.5 
  
1 20.1 18.4-21.7 12.0 10.8-13.2 
  
2+ 4.5 3.6-5.5 2.8 2.0-3.5 
                  
Level 2+ quals in 2006 binary 
 
70.5 68.8-72.2 65.3 63.7-67.0 
         
         Born by 1920 binary 
 
3.0 2.4-3.6 4.4 3.7-5.0 
Born 1921-1930 binary 
 
13.3 12.1-14.6 12.5 11.4-13.6 
Born 1931-1940 binary 
 
25.3 23.8-26.9 22.6 21.3-24.0 
Born 1941-1950 binary 
 
36.9 35.2-38.7 32.8 31.3-34.3 
Born 1951 or after binary 
 
21.4 20.0-22.9 27.7 26.2-29.1 
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Years smoked 30-44 continuous 
 
6.223 5.973-6.474 4.669 4.452-4.885 
Years smoked 45-59 continuous 
 
3.956 3.735-4.177 3.309 3.120-3.498 
         
The sample is all participants of LIFE who provided information about RA onset, date of birth, and 
gender. Missing values on all variables have been imputed. Bold font indicates gender differences 
that are statistically significant at p<0.05. 
 
 
Table A13.3 presents summary statistics for each adversity reported during each life stage 
using the original dataset. 
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Table A13.3: Summary statistics for exposures to each adversity, using the original dataset 
Adversity Obs %=yes N=yes 
Childhood (up to 15)    
 
poor amenities and/or crowding at age 10 & living in UK 6,370 12.5% 796 
 
severe financial hardship  4,611 3.0% 139 
 
parental unemployment 6m+  5,450 5.6% 305 
 
early parental loss  6,754 12.1% 819 
 
separation from mother for 6m+  6,745 14.0% 947 
 
parents argue often  5,525 19.8% 1092 
 
parent drank, drugs, mental health  5,589 6.3% 350 
 
parent physically abused respondent  5,601 3.5% 194 
 
sexually assaulted  5,600 3.7% 208 
 
major natural disaster 5,560 3.2% 176 
 
had life threatening illness or injury 5,463 7.6% 415 
 
severe physical attack 5,554 1.3% 72 
 
witness death or serious injury 5,453 3.4% 188 
 
lost close relative or friend  5,097 14.7% 749 
     Youth (16-29) 
   
 
first experienced severe financial hardship 5,577 7.6% 424 
 
any period of unemployment searching for work  6,755 4.3% 291 
 
job loss resulting from company closing  6,718 5.8% 391 
 
stillbirth, miscarriage or abortion  6,740 9.1% 610 
 
first provided long-term care for relative or friend  5,565 2.0% 111 
 
main occupation carer of first time cared  5,570 2.8% 155 
 
first had partner or child addicted  5,612 1.8% 102 
 
breakdown of cohabiting partnership  6,758 10.4% 706 
 
house moves  6,732 47.3% 3184 
 
death of cohabiting partner  6,758 0.5% 35 
 
death of child when respondent  6,759 2.0% 135 
 
stillbirth, miscarriage or abortion  6,740 9.1% 610 
 
first death of close friend/relative not in war 5,525 16.9% 934 
 
first death or risk of death of close friend/relative in war   5,581 5.0% 278 
 
death of close friend or relative  5,494 21.0% 1154 
 
first victim of sexual assault  5,600 1.7% 94 
 
first victim of serious physical attack  5,597 2.1% 118 
 
first life threatening illness or accident  5,580 3.7% 209 
 
first fired weapon or been fired upon  5,619 4.3% 244 
 
first witnessed serious injury or death not in war  5,571 6.3% 349 
 
first witnessed serious injury or death in war  5,604 3.9% 219 
 
witnessed serious injury or death  5,557 9.6% 533 
 
first experienced natural disaster  5,589 3.1% 173 
  
   
Early adulthood (30-44)    
 
first experienced severe financial hardship  5,577 3.2% 179 
 
any period of unemployment searching for work  6,755 4.9% 330 
 
job loss resulting from company closing  6,718 7.5% 505 
 
stillbirth, miscarriage or abortion  6,740 5.3% 358 
 
first provided long-term care for relative or friend  5,565 4.4% 243 
 
main occupation carer of first time cared  5,583 5.7% 321 
 
first had partner or child addicted  5,612 1.1% 63 
 
breakdown of cohabiting partnership  6,758 15.0% 1016 
 
house moves  6,732 49.9% 3360 
 
death of cohabiting partner  6,758 1.7% 117 
 
death of child when respondent  6,759 1.6% 107 
 
stillbirth, miscarriage or abortion  6,740 5.3% 358 
 
first death of close friend/relative not in war 5,525 12.1% 667 
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first death or risk of death of close friend/relative in war   5,581 0.3% 18 
 
death of close friend or relative  5,481 12.5% 684 
 
first victim of sexual assault  5,600 0.2% 13 
 
first victim of serious physical attack  5,597 1.0% 55 
 
first life threatening illness or accident  5,580 2.7% 151 
 
first fired weapon or been fired upon  5,619 0.2% 10 
 
first witnessed serious injury or death not in war  5,571 2.0% 110 
 
first witnessed serious injury or death in war  5,604 0.2% 13 
 
witnessed serious injury or death  5,551 2.1% 117 
 
first experienced natural disaster  5,589 1.6% 89 
     Mid-adulthood (45-59) 
   
 
first experienced severe financial hardship  5,577 2.2% 124 
 
any period of unemployment searching for work  6,755 5.7% 386 
 
job loss resulting from company closing  6,718 9.1% 611 
 
stillbirth, miscarriage or abortion  6,740 0.2% 15 
 
first provided long-term care for relative or friend  5,565 9.0% 501 
 
main occupation carer of first time cared  5,595 11.3% 631 
 
first had partner or child addicted  5,612 0.9% 48 
 
breakdown of cohabiting partnership  6,758 7.2% 487 
 
house moves  6,732 47.7% 3210 
 
death of cohabiting partner  6,758 5.6% 380 
 
death of child when respondent  6,759 1.3% 87 
 
stillbirth, miscarriage or abortion  6,740 0.2% 15 
 
first death of close friend/relative not in war 5,525 12.7% 699 
 
first death or risk of death of close friend/relative in war   5,581 0.2% 10 
 
death of close friend or relative  5,486 12.9% 708 
 
first victim of sexual assault  5,600 0.1% 4 
 
first victim of serious physical attack  5,597 0.7% 39 
 
first life threatening illness or accident  5,580 5.0% 279 
 
first fired weapon or been fired upon  5,619 0.0% 1 
 
first witnessed serious injury or death not in war  5,571 1.2% 67 
 
first witnessed serious injury or death in war  5,604 0.1% 3 
 
witnessed serious injury or death  5,551 1.3% 70 
 
first experienced natural disaster  5,589 1.6% 90 
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Appendix 14: Do adversities predict RA onset? Additional results. 
Table A14.1 presents results of models of RA onset on single adversities with mutual adjustment, 
using the observed sample. They indicate that childhood housing amenities and crowding are an 
important predictor of RA onset. 
Table A14.1:   Associations between RA onset and single adversities during each life stage with 
mutual adjustment 
 RA onset from 45 (n=3,256) RA onset from 60 (n=2,586) 
Childhood adversity HR 95%ci p-val HR 95%ci p-val 
Poor housing amenities/crowding 1.924 1.167-3.175 0.010 2.707 1.457-5.027 0.002 
Financial hardship 0.636 0.147-2.745 0.544 0.590 0.077-4.521 0.612 
Parental unemployment 6m+ 0.700 0.249-1.965 0.498 0.969 0.296-3.170 0.958 
Parental loss 0.833 0.384-1.807 0.644 1.070 0.397-2.882 0.893 
Maternal separation 6m+ 0.718 0.347-1.487 0.372 0.754 0.306-1.861 0.540 
Parents often argue 1.280 0.734-2.231 0.385 1.430 0.684-2.987 0.341 
Par. substance abuse/mental illness 1.987 0.933-4.231 0.075 0.703 0.161-3.059 0.638 
Physical abuse by parent 2.071 0.706-6.072 0.185 2.312 0.523-10.214 0.269 
Sexual assault 0.459 0.063-3.354 0.443     
Major natural disaster 1.094 0.341-3.512 0.880 1.215 0.288-5.119 0.791 
Life threatening illness/injury 0.905 0.394-2.083 0.815 1.352 0.533-3.427 0.526 
Physical attack 1.448 0.194-10.779 0.718     
Witness death/serious injury 1.801 0.713-4.549 0.214 1.182 0.277-5.040 0.822 
Loss of close relative/friend 1.274 0.732-2.219 0.391 1.294 0.622-2.693 0.490 
         
 RA onset from age 45 (n=3,239) RA onset from 60 (n=2,570) 
Transition adversity HR 95%ci  p-val HR 95%ci  p-val 
Financial hardship         
Unemployment, searching for work 1.606 0.581-4.441 0.361 0.785 0.105-5.845 0.813 
Involuntary job loss 1.691 0.775-3.691 0.187 1.349 0.415-4.392 0.619 
Caring role 3.932 0.851-18.174 0.080     
House moves 0.638 0.440-0.924 0.017 0.422 0.233-0.766 0.005 
Death of partner 1.715 0.223-13.202 0.604 2.786 0.313-24.780 0.358 
Death of child 1.694 0.527-5.445 0.376 2.907 0.878-9.625 0.081 
Stillbirth, miscarriage, abortion 1.699 0.837-3.451 0.142 1.710 0.636-4.598 0.288 
Partnership breakdown 1.329 0.563-3.138 0.516 4.020 1.637-9.871 0.002 
Partner or child addicted         
Sexual assault         
Physical attack 0.621 0.079-4.857 0.650     
Life threatening illness/injury 2.204 0.996-4.875 0.051 3.733 1.543-9.028 0.003 
Witness death/serious injury 1.033 0.492-2.172 0.931 0.945 0.359-2.486 0.908 
Major natural disaster 1.784 0.710-4.482 0.218 1.953 0.566-6.742 0.290 
Active combat 1.316 0.525-3.298 0.558 0.756 0.203-2.814 0.676 
         
 RA onset from age 45 (n=3,319) RA onset from age 60 (n=2,571) 
Early adulthood adversity HR 95%ci p-val HR 95%ci p-val 
Financial hardship         
Unemployment, searching for work 1.129 0.400-3.186 0.818 1.081 0.244-4.781 0.918 
Involuntary job loss 1.062 0.478-2.356 0.883 1.481 0.569-3.858 0.421 
Caring role 0.704 0.218-2.269 0.556 0.000 0.000-0.000  
House moves 0.778 0.569-1.063 0.115 0.775 0.515-1.167 0.222 
Death of partner 1.183 0.288-4.862 0.816 0.000 0.000-0.000  
Death of child 0.748 0.104-5.401 0.773 0.000 0.000-0.000  
Stillbirth, miscarriage, abortion 0.991 0.353-2.779 0.986 0.871 0.204-3.716 0.852 
Partnership breakdown 1.053 0.534-2.074 0.882 1.350 0.565-3.226 0.500 
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Partner or child addicted         
Sexual assault         
Physical attack 1.294 0.173-9.683 0.802     
Life threatening illness/injury 0.453 0.063-3.263 0.432 0.926 0.126-6.777 0.940 
Witness death/serious injury 1.537 0.374-6.325 0.551 1.533 0.208-11.332 0.675 
Major natural disaster         
Active combat         
         
     RA onset from age 60 (n=2,743) 
Mid-adulthood adversity     HR 95%ci p-val 
Financial hardship         
Unemployment, searching for work     0.427 0.057-3.171 0.405 
Involuntary job loss     0.740 0.265-2.068 0.566 
Caring role     0.802 0.286-2.251 0.676 
House moves     1.121 0.758-1.657 0.566 
Death of partner     1.420 0.550-3.669 0.469 
Death of child     1.214 0.166-8.857 0.848 
Stillbirth, miscarriage, abortion         
Partnership breakdown     1.005 0.299-3.376 0.993 
Partner or child addicted         
Sexual assault         
Physical attack         
Life threatening illness/injury     0.456 0.062-3.339 0.440 
Witness death/serious injury         
Major natural disaster         
Active combat         
These are results from seven models. Each model includes mutual adjustment for each adversity, total 
adversity within each life stage for which single adversities are not included, birth cohort, gender and Level 2+ 
qualifications at the time of LIFE. Childhood is up to age 15, youth is 16-29, early adulthood is 30-44, mid-
adulthood is 45-59. 
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Appendix 15: How do adversities over the life course 
combine to predict RA onset? Additional results. 
12. Does the life stage during which one is exposed matter? What is 
the relative importance for RA onset of adversities during childhood, 
youth, early and mid-adulthood? 
It is possible that findings, reported in the main text, about the salience for RA onset of 
childhood and youth adversity reflect reporting bias in questions that ask about the first 
time that events were experienced. I therefore conducted sensitivity analyses using indices 
that exclude adversities reported using this type of question. These constitute about half the 
childhood and adult adversities reported; 7 out of 14, and 8 out of 15, respectively. I 
expected the reduced index to capture adversity less comprehensively, resulting in greater 
measurement error and weaker evidence for associations, regardless of any bias resulting 
from using the “first time” questions. Bias would be indicated if the pattern of results, that is 
the relative importance for RA onset of childhood and transition adversity reported in the 
main analyses, were not evident when the reduced index was used. 
The results are presented in Table A15.1. As predicted, the evidence for associations 
between RA onset and youth adversity is slightly weaker, although the results for childhood 
adversity are almost identical. The pattern of findings is very similar to that presented in the 
main text; adversities during childhood and youth appear particularly salient for RA onset.  
Table A15.1: Associations between adversity during each life stage and RA onset, 
excluding adversities reported using questions about first experiences 
Adversity 
during each life 
stage 
RA onset from age 45 (n=6,560) RA onset from age 60 (n=5,525) 
HR 95%CI p-value HR 95%CI p-value 
Childhood 1.375 1.035-1.827 0.028 1.326 0.914-1.922 0.137 
Youth 1.500 1.138-1.977 0.004 1.775 1.252-2.515 0.001 
Early adulthood 1.097 0.828-1.453 0.518 0.978 0.678-1.409 0.904 
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Mid-adulthood 
    
1.170 0.820-1.671 0.387 
These are results from two models, each adjusted for birth cohort, gender, and level of education at the time of 
LIFE. HR is hazard ratio, and 95%CI is 95% confidence interval. Childhood is ages 0-15, youth 16-29, early 
adulthood 30-44, and mid-adulthood 45-59. The measures for adversity during each life stage are indicators of 
exposure to one or more adversity. 
 
Additional sensitivity analyses were conducted using a smaller dataset that excluded 
respondents who, in wave 3, reported moderate or severe pain or depression, or who 
performed poorly on a memory recall task. Details are given in Appendix 18. Using this 
sample to test for the salience of adversity during any particular life stage provided different 
results, presented in Tables A18.4 and A18.5. Because results of analyses examining the 
salience of adversity during particular life stages were unreliable, no further tests to 
examine life course patterns of adversity as predictors of RA onset were conducted.   
To examine gender differences in the main sample, Cox regression analyses were estimated 
for RA onset on the number of life stages during which at least one adversity was reported 
for men and women separately. The results are presented in Table A15.2. They provide no 
evidence of gender differences in the relationship between cumulative life course adversity 
and RA onset. 
Table A15.2: Cumulative life course adversity and RA onset among men and women 
RA onset from 45 
  Men (n=2,975) Women (n=3,585) 
Measure  HR 95%CI p-value HR 95%CI p-value 
Dummies 0 
         1 2.630 0.896-7.724 0.078 1.416 0.622-3.220 0.407 
 2 3.937 1.387-11.175 0.010 1.961 0.860-4.470 0.109 
 3 3.294 1.091-9.945 0.035 2.275 0.931-5.559 0.071 
Wald test 
   
0.050 
   
0.201 
 
   
Linear 
 
1.372 1.079-1.745 0.010 1.311 1.030-1.668 0.028 
 
         
RA onset from 60 
 
 
Men (n=2,593) Women (n=2,932) 
Measure 
Value
s HR 95%CI p-value HR 95%CI p-value 
Dummies 0 
         1 3.087 0.427-22.339 0.264 1.912 0.507-7.209 0.339 
 2 6.666 1.052-42.224 0.044 2.193 0.648-7.419 0.207 
 3 6.389 0.964-42.346 0.055 2.841 0.828-9.748 0.097 
 4 5.608 0.692-45.425 0.106 2.854 0.552-14.768 0.211 
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Wald test 
   
0.116 
   
0.606 
 
   
Linear 
 
1.375 1.086-1.741 0.008 1.250 0.974-1.604 0.080 
Results from four models, each adjusted for birth cohort and education. HR is hazard ratio, 95%CI 95% 
confidence interval. 
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Appendix 16: Do material, psychosocial and behavioural 
factors independently predict RA onset? Additional 
results. 
13. Do material and social adversities independently predict RA 
onset? 
To examine whether relationships between adversity and RA onset are graded, associations 
were estimated using sets of dummies. Results are presented in Table A16.1. They suggest 
that relationships between RA onset and material adversities are likely to be threshold 
effects of one or more material adversities, and that that relationships with social 
adversities are likely to be graded. 
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Table A16.1: HRs for RA onset contingent upon material and social adversities using sets 
of dummies 
Childhood  
RA onset from age 16 
(n=6,623) 
RA onset from age 45 
(n=6,560) 
RA onset from age 60 
(n=5,525) 
Type of adversity HR 95%CI p-val HR 95%CI p-val HR 95%CI p-val 
            
Material 0 Reference 
         
  
1 1.376 0.961-1.971 0.081 1.332 0.906-1.958 0.145 1.519 0.944-2.446 0.085
 
2+ 0.907 0.304-2.705 0.860 0.959 0.327-2.817 0.940 1.272 0.407-3.974 0.679 
 
   
Social 0 Reference  
      
  
1 1.181 0.860-1.624 0.304 1.194 0.845-1.687 0.316 1.238 0.821-1.867 0.308
  
2 1.365 0.927-2.009 0.115 1.446 0.955-2.189 0.081 1.262 0.734-2.170 0.399 
  
3 1.351 0.767-2.378 0.297 1.368 0.741-2.527 0.317 1.060 0.450-2.498 0.894 
 
4+ 1.660 0.823-3.348 0.157 1.682 0.789-3.584 0.178 0.987 0.250-3.890 0.985 
 
      RA onset from age 45     
Birth to 44    (n=6,560)     
Type of adversity   HR 95%CI p-val    
             
Material 
0 
    
Reference 
      1 
    
1.242 0.862-1.790 0.245 
    
 
2+ 
    
1.278 0.762-2.145 0.353 
    
               Social 0 
            
  
1 
    
1.647 1.029-2.636 0.038
    
  
2 
    
1.483 0.913-2.410 0.111 
    
  
3 
    
1.993 1.176-3.376 0.010 
    
  
4 
    
2.191 1.224-3.923 0.008 
    
  
5 
    
1.167 0.398-3.421 0.778 
    
 
6+ 
    
2.892 1.380-6.060 0.005 
                   
          RA onset from age 60 
Birth to 59         (n=5,525)  
Type of adversity        HR 95%CI p-val 
 
             
Material 0 
            
 
1 
        
1.471 0.958-2.260 0.078
 
2 
        
1.412 0.608-3.275 0.422 
3+ 
        
1.882 0.750-4.723 0.178 
        
Social 0 
            
  
1 
       
2.319 1.075-5.001 0.032
  
2 
       
 2.492 1.170-5.305 0.018 
  
3 
       
 2.894 1.275-6.570 0.011 
  
4 
       
 2.550 1.037-6.270 0.041 
  
5 
       
 1.974 0.615-6.331 0.253 
  
6 
       
 0.099   
 
 
7+ 
       
 3.255 0.994-10.662 0.051
These are results from ten models estimated using twenty samples with imputed values of 
respondents who participated in LIFE. Each model includes a set of dummies for one type of adversity 
and a single continuous measure for the other type of adversity, so that there is mutual adjustment 
for material and social adversity. Models are also adjusted for birth cohort, gender and qualifications 
at Level 2 or above in 2006 and total adversity during the life stages in which material and social 
adversities are not included. Childhood is 0-15. Bold font indicates associations that are statistically 
significant at p<0.05. 
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14. Are any associations found explained by health behaviours? 
Table A16.2 presents results of models of RA onset on material and social adversities with 
and without smoking. 
Table A16.2: HRs for RA onset contingent upon material and social adversities with 
adjustment for smoking 
 RA onset from age 45 (n=6,560) RA onset from age 60 (n=5,525) 
 
HR 95%CI p-value HR 95%CI p-value 
        
Material adversity birth to 29 1.284 0.925-1.781 0.135 1.540 1.021-2.323 0.039 
Social adversity birth to 29 1.229 1.077-1.402 0.002 1.194 1.005-1.418 0.043 
         Material adversity birth to 29 1.275 0.919-1.770 0.146 1.531 1.014-2.311 0.043 
Social adversity birth to 29 1.224 1.073-1.397 0.003 1.187 0.999-1.411 0.052 
Smoking during early adulthood 1.012 0.993-1.032 0.225 0.980 0.929-1.034 0.454 
Smoking during mid- adulthood 
    
1.055 0.999-1.114 0.056 
These are HRs for four models, each adjusted for birth cohort, gender and education. Smoking is the 
number of years smoked. Early adulthood is 30-44, mid-adulthood is 45-59. HRs for material 
adversities refer to one or more adversity as opposed to none. HRs for social adversities refer to each 
additional adversity, up to a maximum of three or more. Bold font indicates associations that are 
statistically significant at p<0.05. 
 
 
Additional models estimated associations between smoking and RA onset with adjustment 
only for gender. These found evidence of correlations between smoking and RA onset. For 
example, the HR for each additional year of smoking between ages 16 and 44 for RA onset 
from age 45 is 1.01 (95%CI=1.00-1.02, p=0.041) and for each additional year of smoking 
between 45 and 59 for RA onset from age 60 is 1.03 (95%CI=1.00-1.06, p=0.028). 
15. How do the answers to these questions vary by gender? 
Table A16.3 presents results of models of RA onset on material and social adversities for 
men and women separately.  
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Table A16.3: HRs for RA onset contingent upon material and social adversities for men and 
women  
Men 
Adversity 
RA onset from age 16 (n=2,997) RA onset from age 45 (n=2,975) RA onset from age 60 (n=2,593) 
HR 95%CI p-val HR 95%CI p-val HR 95%CI p-val 
             
Childhood         
Material 1.529 0.927-2.520 0.096 1.559 0.924-2.630 0.096 1.887 1.015-3.507 0.045 
Social 1.135 0.883-1.460 0.321 1.156 0.884-1.511 0.289 1.242 0.890-1.734 0.202 
             Birth to 44       
Material 
    
1.589 1.018-2.480 0.041 1.865 1.067-3.258 0.029 
Social 
    
1.355 1.025-1.790 0.033 1.442 1.001-2.077 0.049 
             Birth to 59    
Material 
        
1.912 1.123-3.255 0.017 
Social 
        
1.549 1.025-2.341 0.038 
             
Women 
Adversity 
RA onset from age 16 (n=3,626) RA onset from age 45 (n=3,585) RA onset from age 60 (n=2,932) 
HR 95%CI p-val HR 95%CI p-val HR 95%CI p-val 
            
Childhood           
Material 1.166 0.699-1.945 0.556 1.081 0.617-1.895 0.785 1.153 0.590-2.253 0.678 
Social 1.220 0.969-1.535 0.090 1.254 0.971-1.619 0.083 0.981 0.699-1.376 0.910 
            Birth to 44 
Material 
    
0.995 0.626-1.580 0.982 1.114 0.617-2.010 0.721 
Social 
    
1.389 1.084-1.780 0.009 1.195 0.857-1.667 0.293 
             Birth to 59 
Material 
        
1.153 0.669-1.988 0.607 
Social 
        
1.207 0.832-1.753 0.322 
These are results from six models for men and six models for women, all with adjustment for birth 
cohort and qualifications of Level 2+ at time of LIFE, and with mutual adjustment for material and 
social adversities. Models that include childhood material and social adversities adjusts also for total 
adversity between 16 until RA onset is measured, and the model that includes material and social 
adversities to age 44 as predictors of RA onset from age 60 includes adjustment for total adversity 
between 45 and 59. Material adversity is measured using an indicator of one or more adversity. Social 
adversities are measured using continuous variables with the following values: childhood 0,1,2,3+; 
birth to 44 0,1-2,3-5,6+; birth to age 59 0,1-2,3+.
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When interaction terms are included in analyses using the whole sample, there is no 
evidence of gender differences. P-values for the interaction terms are presented in Table 
A16.4. 
Table A16.4:   P-values for interaction terms of gender with material and social adversities 
  RA onset from age 
P-values are from ten models, each with 
mutual adjustment for material and social 
adversities, birth cohort, Level 2 
qualifications at the time of LIFE and 
gender. For models with material and 
social adversity during childhood and 
youth, there is also adjustment for total 
adversity during subsequent life stages. 
Childhood is 0-15, youth is 16-29. 
Life stage Type 16 45 60 
     
Childhood Material 0.506 0.353 0.336 
 
Social 0.396 0.500 0.609 
     Childhood Material 
 
0.451 0.509 
 
Social 
 
0.665 0.375 
Youth Material 
 
0.837 0.453 
 
Social 
 
0.779 0.844 
     Childhood and youth Material 
 
0.257 0.263 
 
Social 
 
0.772 0.406 
     Birth to 44 Material 
 
0.282 0.217 
 
Social 
 
0.981 0.338 
     Birth to 59 Material 
  
0.290 
 
Social 
  
0.178 
 
 
 
Table A16.5 presents the HRs for RA onset contingent upon material and social adversities 
with and without smoking behaviour, for men and women separately. 
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Table A16.5:   HRs for RA onset contingent upon material and social adversities with 
adjustment for smoking for men and women 
Men 
 
RA onset from age 45 
(n=2,975) 
RA onset from age 60 
(n=2,593) 
 
HR 95%CI p-val HR 95%CI p-val 
Material adversity birth to 29 1.590 1.007-2.511 0.047 1.932 1.101-3.389 0.022 
Social adversity birth to 29 1.231 1.010-1.500 0.039 1.313 1.024-1.682 0.032 
         
Material adversity birth to 29 1.566 0.989-2.480 0.056 1.909 1.075-3.389 0.027 
Social adversity birth to 29 1.227 1.007-1.496 0.042 1.307 1.016-1.681 0.037 
Smoking 30-44 1.022 0.993-1.053 0.142 0.966 0.894-1.043 0.377 
Smoking 45-59 
   
1.084 1.004-1.171 0.039 
     Women 
 
RA onset from age 45 
(n=3,585) 
RA onset from age 45 
(n=2,932) 
 
HR 95%CI p-val HR 95%CI p-val 
Material adversity birth to 29 1.059 0.652-1.719 0.818 1.208 0.651-2.243 0.549 
Social adversity birth to 29 1.219 1.010-1.472 0.040 1.082 0.845-1.384 0.533 
         
Material adversity birth to 29 1.057 0.651-1.716 0.823 1.205 0.650-2.234 0.554 
Social adversity birth to 29 1.217 1.008-1.470 0.042 1.075 0.840-1.377 0.566 
Smoking during 30-44 1.003 0.977-1.031 0.807 1.002 0.928-1.081 0.965 
Smoking during 45-59 
    
1.019 0.941-1.104 0.646 
These are HRs for eight models, four for men and four for women. Smoking is the number of years smoked. 
Childhood is 0-15, youth is 16-29, early adulthood is 30-44, mid- adulthood is 45-59. 
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Appendix 17: Are some types of social adversity more 
salient predictors of RA onset than others? 
16. Comparison of adversities in different life domains: relationship-
related and traumatic adversities 
In order to examine whether relationships between family and traumatic adversities and RA 
onset are graded, associations were tested with sets of dummies. The results are presented 
in Table A17.1. 
The results suggest that any relationships between RA onset and family-related adversities 
during childhood and youth are likely to be threshold effects of one or more adversities, but 
during longer period (from birth to 29, 44, and 59) are likely to be graded. Any relationships 
between RA onset and traumatic adversity are likely to be threshold effects of one or more 
trauma, except in childhood, where the relationship appears graded with a maximum of two 
or more traumas.  
Consequently, continuous measures of family adversity were created for adversity from 
birth to age 29 (no adversities, one or two adversities, and three or more adversities), from 
birth to age 44 (no adversities, one or two adversities, three or more adversities), and from 
birth to age 59 (no adversities, one to three adversities, four or more adversities). During 
childhood and youth, measures of family adversity are binary indicators of one or more 
adversity. Binary indicators were created for trauma for all periods except for during 
childhood, for which the measure of trauma is continuous (zero, one, or two traumatic 
adversities).
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Table A17.1:   HRs for RA onset contingent upon relationship-related and traumatic adversities using sets of dummies 
Childhood  
RA onset from age 16 
(n=6,623) 
RA onset from age 45 
(n=6,560) 
RA onset from age 60 
(n=5,525) 
 
Type of adversity Values HR 95%CI p-value HR 95%CI p-value HR 95%CI p-value 
               
 
Relationship-related 0 
            
  
1 1.044 0.754-1.444 0.796 1.115 0.788-1.578 0.537 1.106 0.715-1.711 0.649 
  
2 1.295 0.854-1.963 0.224 1.399 0.899-2.177 0.137 0.944 0.488-1.825 0.863 
3 1.048 0.451-2.438 0.913 1.069 0.423-2.700 0.888 0.871 0.227-3.344 0.840 
  4+ 0.916 0.226-3.719 0.902 1.056 0.259-4.312 0.940 1.002 0.135-7.455 0.998 
   
            
 
Trauma 0             
  
1 1.224 0.889-1.687 0.215 1.162 0.823-1.641 0.392 1.155 0.739-1.807 0.527 
  
2+ 1.748 1.029-2.970 0.039 1.702 0.963-3.008 0.067 1.463 0.646-3.316 0.362 
               
Birth to 44      RA onset from age 45 (6,560)     
 
Type of adversity Values    HR 95%CI p-value     
               
 
Relationship-related 0 
            
 
1 
    
1.378 0.936-2.028 0.104 
     2 1.302 0.849-1.997 0.226 
  3     1.757 1.073-2.877 0.025     
  4     1.518 0.776-2.970 0.223     
  
5+ 
    
1.760 0.727-4.257 0.210 
                   
 
Trauma 0 
    
    
    
  
1 
    
1.331 0.957-1.851 0.090 
    
  
2+ 
    
1.225 0.766-1.959 0.396 
                   
Birth to age 59          RA onset from age 60 (5,525) 
 
Type of adversity Values        HR 95%CI  p-value 
 
             
Relationship-related 0 
            1 1.733 1.019-2.948 0.042 
2         1.713 0.973-3.016 0.062 
3         1.631 0.816-3.259 0.166 
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4 
        
1.973 0.876-4.446 0.101 
5 
        
0.101   1.000 
6+ 
        
1.719 0.424-6.964 0.448 
           
    
 
Trauma 0 
        
    
  
1 
        
1.235 0.801-1.904 0.339 
  
2 
        
1.074 0.557-2.069 0.831 
  
3+ 
        
0.977 0.237-4.029 0.974 
These are results from ten models. Each model includes a set of dummies for one type of adversity (relationship-related or trauma), a continuous measure for the other 
type of social adversity and a binary indicator of one or more material adversities. Models are also adjusted for birth cohort, gender, Level 2 or higher qualifications at time 
of LIFE and total adversity during the life stages in which relationship-related and traumatic adversities are not included. Childhood is 0-15. 
 
 
 
17. Comparison of chronic and acute adversities 
To examine whether relationships between chronic and acute adversities and RA onset are graded, associations were tested with sets of dummies. Results 
are presented in Table A17.2. 
Results indicate that any relationships between RA onset and both chronic and acute adversities are likely to reflect threshold effects of one or more 
adversity.  
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Table A17.2:   HRs for RA onset contingent upon chronic and acute adversities using sets of dummies 
16 to 29  RA onset from age 30 (6,613) RA onset from age 45 (6,560) RA onset from age 59 (5,525) 
 Type of adversity Values HR 95%CI p-value HR 95%CI p-value HR 95%CI p-value 
               
 
Chronic 0 Reference   Reference 
  
Reference 
  
 
1 1.548 1.048-2.287 0.028 1.695 1.114-2.580 0.014 2.429 1.462-4.036 0.001 
 2+ 1.047 0.181-6.057 0.959 1.324 0.203-8.640 0.769 2.291 0.312-16.832 0.415 
   
    
        
 
Acute 0 Reference   Reference   Reference   
 1 0.819 0.493-1.362 0.442 0.822 0.473-1.427 0.486 0.884 0.437-1.789 0.733 
  
2+ 0.686 0.165-2.858 0.605 0.765 0.181-3.231 0.715 0.730 0.103-5.175 0.753 
               
16 to 44     RA onset from age 45 (6,560) RA onset from age 59 (5,525) 
   
    
        
 
Chronic 0     Reference 
  
Reference 
  
 
1     1.484 1.062-2.073 0.021 1.649 1.076-2.527 0.022 
 2+     1.289 0.663-2.506 0.455 1.577 0.661-3.764 0.305 
   
    
    
    
 
Acute 0     Reference   Reference 
  
  
1     0.850 0.500-1.446 0.550 0.694 0.331-1.457 0.335 
  
2+     0.882 0.323-2.412 0.807 1.070 0.335-3.419 0.909 
               
16 to 59        RA onset from age 60 (5,525) 
 
 
    
        
Chronic 0     
    
Reference 
   1     1.345 0.892-2.029 0.157 
 2         1.509 0.734-3.103 0.263 
 3+         1.265 0.304-5.254 0.747 
   
    
    
    
 
Acute 0     
    
Reference   
  
1     
    
0.729 0.386-1.374 0.328 
  
2+     
    
0.897 0.283-2.839 0.853 
These are results from 12 models. Each model includes a set of dummies for one type of adversity (chronic or acute), an indicator of one or more adversities not classified 
as chronic or acute, an indicator of one or more childhood adversities, birth cohort, gender, and qualifications at Level 2 or above at the time of LIFE.  
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These results are based on small numbers and could be a quirk of the data. Whilst further 
evidence should be collected to test the reliability of these findings, it is informative to know 
how many respondents reported adversities classified as chronic and acute and also 
reported a history of RA. Table A17.3 presents this information.  As predicted, the numbers 
are small, signalling the importance of testing the reliability of these findings using other 
datasets. Nevertheless, the statistical significance of associations between RA onset and 
chronic adversities (reported in the main text) reflects a high degree of consistency. 
Table A17.3:   Numbers of respondents with one or more adversity who reported RA 
onset. 
 RA onset from age 30 RA onset from age 45 RA onset from age 60 
Adversity Number 95%CI Number 95%CI Number 95%CI 
Chronic during: 
      
 
16-29 42 30-54 38 26-49 24 15-33 
 
16-44  
 
72 58-87 42 31-53 
 
16-59  
   
53 41-64 
Acute during: 
      
 
16-29 24 13-34 21 11-30 12 5-19 
 
16-44  
 
30 18-41 16 7-24 
 
16-59  
   
19 10-28 
 
18. How do the answers to these questions vary by gender? 
Table A17.4 presents results of models of RA onset on family and traumatic adversities for 
men and women separately. They provide weak evidence of gender differences but suggest 
that, especially for RA onset from 45, traumas are relatively important for men and 
relationship-related adversities are relatively important for women.
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Table A17.4:   HRs for RA onset contingent upon relationship-related and traumatic adversities for men and women separately 
Men 
Adversity 
 
RA onset from age 16 (n=2,997) RA onset from age 45 (n=2,975) RA onset from age 60 (n=2,593) 
Life stage Type HR 95%CI p-value HR 95%CI p-value HR 95%CI p-value 
              
Childhood Relationship-related 0.986 0.655-1.483 0.944 0.996 0.637-1.558 0.987 1.161 0.677-1.991 0.587 
 
Trauma 1.248 0.888-1.755 0.202 1.239 0.868-1.768 0.238 1.325 0.868-2.021 0.192 
              Birth to 44 Relationship-related 
    
1.124 0.828-1.526 0.454 1.138 0.774-1.673 0.510 
 
Trauma 
    
1.462 0.935-2.287 0.096 1.555 0.892-2.713 0.120 
              Birth to 59 Relationship-related 
        
1.306 0.851-2.003 0.222 
 
Trauma 
        
1.581 0.898-2.785 0.113 
              
              
Women 
Adversity 
 
RA onset from age 16 (n=3,626) RA onset from age 45 (n=3,585) RA onset from age 60 (n=2,932) 
Life stage Type HR 95%CI p-value HR 95%CI p-value HR 95%CI p-value 
              
Childhood Relationship-related 1.191 0.810-1.750 0.375 1.346 0.877-2.064 0.174 0.937 0.522-1.680 0.826 
 
Trauma 1.328 0.986-1.788 0.062 1.277 0.919-1.774 0.145 1.071 0.650-1.765 0.787 
              Birth to 44 Relationship-related 
    
1.465 1.096-1.957 0.010 1.364 0.920-2.021 0.122 
 
Trauma 
    
1.184 0.784-1.788 0.422 0.896 0.495-1.620 0.715 
              Birth to 59 Relationship-related 
        
1.359 0.873-2.117 0.175 
 
Trauma 
        
0.909 0.510-1.622 0.747 
These are results from six models for men, and eight for women, all with adjustment for birth cohort, gender, and qualifications of Level 2 or above at time of 
LIFE, and with mutual adjustment for relationship-related and traumatic adversities. Models also adjust for material adversity during the period in which 
relationship-related and traumatic adversities are included, and for childhood adversity, as appropriate. Relationship-related adversity during childhood is 
measured using an indicator of one or more adversities, and during other periods using continuous variables with values for birth to age 44 of 0, 1-2, and 3+ and 
for birth to age 59 of 0,1-3,4+. Traumatic adversities are measured using indicators of one or more trauma during all periods except for childhood, when the 
variable takes values of 0,1,2+.
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Table A17.5 presents results of models of RA onset on chronic and acute adversities for men 
and women separately. 
There is some indication that HRs for RA onset from age 45 are higher and more consistent 
amongst men than women in relation to chronic adversity. However, tests with interaction 
terms of chronic adversity provide no evidence that the gender differences are statistically 
significant. The p-values for the interaction terms are 0.372 for chronic adversity between 
16 and 29, and 0.556 for chronic adversity between 16 and  44. 
Whilst there is no evidence of associations between acute adversity and RA onset for either 
men or women, HRs for women are consistently below one. No results are presented for 
associations between acute adversity and RA onset from age 60 among women because 
although 53 women reported RA onset from 60, none also reported acute adversities. 
Whilst there is no evidence that acute adversities are protective for RA onset amongst 
women, numbers are small, and the results suggest that an association might be found if a 
larger sample were used. 
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Table A17.5:   HRs for RA onset contingent upon chronic and acute adversities for men and women separately 
Men 
Adversity  RA onset from age 30 (n=2,995) RA onset from age 45 (n=2,975) RA onset from age 60 (n=2,593) 
Life stage Type HR 95%CI p-value HR 95%CI p-value HR 95%CI p-value 
  
    
        
Youth Chronic 1.936 1.106-3.389 0.021 2.041 1.102-3.779 0.023 2.378 1.116-5.068 0.025 
 
Acute 0.997 0.554-1.794 0.993 1.042 0.569-1.909 0.895 1.246 0.624-2.488 0.534 
  
    
        
Youth to 44 Chronic     2.112 1.225-3.643 0.007 1.649 0.908-2.994 0.100 
 
Acute     1.307 0.759-2.251 0.335 1.125 0.570-2.220 0.734 
  
    
        
Youth to 59 Chronic     
    
2.059 1.092-3.880 0.026 
 
Acute     
    
1.262 0.685-2.326 0.455 
  
    
        Women 
Adversity 
 
RA onset form age 30 (n=3,618) RA onset from age 45 (n=3,585) RA onset from age 60 (n=2,932) 
Life stage Type HR 95%CI p-value HR 95%CI p-value HR 95%CI p-value 
  
    
        
Youth Chronic 1.320 0.812-2.143 0.262 1.487 0.874-2.531 0.144 2.455 1.271-4.743 0.008 
 
Acute 0.524 0.196-1.397 0.196 0.481 0.148-1.569 0.225 
      
    
        
Youth to 44 Chronic     1.564 0.965-2.537 0.070 1.671 0.971-2.877 0.064 
 
Acute     0.523 0.196-1.402 0.198 
      
    
        
Youth to 59 Chronic     
    
1.442 0.790-2.631 0.233 
 
Acute     
    
    
These are results from six models for men and six for women, all adjusted for birth cohort, gender, and qualifications of Level 2 or above in 2006, and with mutual 
adjustment for chronic and acute adversities. Models also adjust adversities that were not easily classified as chronic or acute, and childhood adversity measured 
using a binary indicator of one or more adversities. Models with chronic and acute adversities during youth are also adjusted for total adversity during subsequent 
life stages, using continuous measures. Chronic adversities are main occupation as carer and/or reporting being a carer, having a partner or child who is addicted 
to alcohol or drugs, and breaking up with a cohabiting partner. Acute adversities are being a victim of sexual assault, being a victim of a serious physical attack, 
witnessing a death or serious injury, or a major natural disaster. All measures of chronic and acute adversity are indicators of one or more adversity.  
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Appendix 18: Sensitivity analyses excluding those who 
reported pain or depression, or performed poorly on a 
memory test at the time of LIFE 
Sensitivity analyses were conducted using LIFE participants except for those with incomplete 
information about RA onset, gender or date of birth, and further excluding those who in the 
Wave 3 main interview reported pain or depression or scored poorly on a memory test.  
People with RA are relatively likely to report pain and depression (Covic et al. 2012), and 
each of these has been associated with biased recall of (increased) childhood adversity 
(Raphael et al. 2001, Widom & Morris 1997). It is possible that associations found between 
life course adversity and subsequent RA onset results from recall bias due to the symptoms 
of RA, such as pain, and its comorbidity with depression. If this were the case, pain and 
depression at the time of recall would confound associations reported between life course 
adversity and RA onset and excluding groups who reported pain and depression from the 
analyses would reduce the magnitude and consistency of associations.  
Members of the NCDS who scored poorly on a memory test similar to that used in ELSA had 
particularly poor recall of childhood conditions (Brown 2013). Excluding these participants 
reduces power but is likely to increase the accuracy of measures based on recall. Reducing 
power is likely to reduce the statistical significance of any associations found; increasing 
accuracy is likely to increase it, if the associations found are not simply a coincidental effect 
of measurement error. 
One set of sensitivity analyses was conducted, excluding respondents who reported pain or 
depression or whose recall scores were low.
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Pain was measured using self-report and was classified as none, mild, moderate, or severe. 
1,524 respondents who reported moderate or severe pain were excluded.  
Depression was measured using the CESD 8-item scale with a cut point of 3 indicating 
depression. This cut point has been used before (White et al. 2017), and has been validated 
against depression diagnosed amongst older adults using standard psychiatric interviews 
(Turvey et al. 1999). 1,330 respondents who reported depression according to this criterion 
were excluded. 
The test used to assess memory function involves the interviewer reading a list of 10 words 
to the participant, who is then asked to recall as many words as he or she can remember. 
Brown (2013) used data from the 1958 British birth cohort study to compare accounts of 
living conditions during childhood (number of rooms and number of people in the 
household) collected in the 1960s with retrospective accounts of the same childhood 
conditions among the same sample when they were aged 50, in 2008. Cohort members 
whose retrospective account of childhood living conditions matched the 1960s information 
scored higher on a memory test, which, like the test used in ELSA, involved recall of 10 
words. Among those with well-matched accounts, the mean number of words recalled was 
5.58 with a standard deviation of 1.80. Among those with poorly matched accounts, the 
mean score was 4.97 with a standard deviation of 1.98. In the ELSA sample, 2,805 
respondents scored below 5, 1,654 scored below 4, and 916 scored below 3. I excluded from 
the sensitivity analyses the 1,654 respondents who scored below 4. 
Some of the respondents were excluded because they fell into more than one excluded 
group. In total, 3,173 respondents were excluded from the sensitivity analyses, leaving a 
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sample of 3,451. Of these, 102 reported RA from age 16, 85 from age 45, and 53 from age 
60. 
Summary statistics are presented in Table A18.1.  
Table A18.1: Summary statistics 
Variable Measure Values 
Mean/ 
%=yes 95% CI 
      
Childhood adversity Terciles 0 45.5 43.1-47.9 
  
1 29.5 27.5-31.5 
  
2+ 25.0 23.1-26.8 
      
 
Binary 1+ 54.5 52.1-56.9 
      Adversity 0-44 Terciles 0-1 37.7 35.8-39.6 
  
2-3 38.2 36.2-40.2 
  
4+ 24.1 22.3-26.0 
      
 
Continuous 0-6+ 2.315 2.245-2.384 
      Adversity 0-59 Terciles 0-1 28.6 26.8-30.3 
  
2-3 37.3 35.4-39.3 
  
4+ 34.1 32.3-36.0 
   
   
 
Continuous 0-7+ 2.842 2.767-2.918 
   
   
Cumulative adversity 0-44 Dummies 0 15.5 14.1-16.9 
  
1 35.3 33.4-37.3 
  
2 34.1 32.2-36.1 
  
3 15.1 13.6-16.6 
   
   
 
Continuous 0-3 1.488 1.451-1.525 
   
   
Cumulative adversity 0-59 Dummies 0 10.3 9.2-11.5 
  
1 27.6 25.9-29.2 
  
2 34.2 32.4-36.0 
  
3 22.0 20.4-23.6 
  
4 5.9 4.9-6.8 
   
   
 
Continuous 0-4 1.855 1.815-1.896 
   
   
Youth adversity Binary 1+ 50.1 48.3-51.9 
Early adulthood adversity Binary 1+ 44.2 42.3-46.1 
Mid-adulthood adversity Binary 1+ 36.8 34.9-38.6 
   
   
Material adversity during childhood Binary 1+ 14.3 12.9-15.7 
Material adversity during youth Binary 1+ 9.0 8.0-10.0 
Material adversity 0-29 Binary 1+ 17.0 15.5-18.5 
Material adversity 0-44 Binary 1+ 19.6 18.0-21.2 
Material adversity 0-59 Binary 1+ 23.1 21.4-24.8 
   
   
Social adversity during childhood Continuous 0-3+ 0.700 0.670-0.731 
Social adversity during youth Continuous 0-3+ 0.553 0.526-0.579 
Social adversity 0-29 Continuous 0-3+ 1.246 1.203-1.288 
Social adversity 0-44 Continuous 0-6+
1 
1.082 1.052-1.113 
Social adversity 0-59 Continuous 0-3+
2 
1.227 1.199-1.255 
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Relationship adversity during childhood Binary 1+ 33.5 31.8-35.2 
Relationship adversity during youth Binary 1+ 32.9 31.2-34.6 
Relationship adversity 0-29 Continuous 0-3+
2 
0.6 0.6-0.6 
Relationship adversity 0-44 Continuous 0-3+
2 
0.8 0.8-0.8 
Relationship adversity 0-59 Continuous 0-4+
3 
0.8 0.8-0.8 
   
   
Traumatic adversity during childhood Continuous 0-2+ 0.3 0.3-0.4 
Traumatic adversity during youth Binary 1+ 16.4 15.0-17.7 
Traumatic adversity 0-29 Binary 1+ 39.1 37.2-41.0 
Traumatic adversity 0-44 Binary 1+ 43.2 41.3-45.2 
Traumatic adversity 0-59 Binary 1+ 48.3 46.3-50.2 
   
   
Chronic adversity during youth Binary 1+ 13.8 12.5-15.1 
Chronic adversity 16-44 Binary 1+ 28.1 26.4-29.7 
Chronic adversity 16-59 Binary 1+ 39.3 37.5-41.1 
   
   
Acute adversity during youth Binary 1+ 11.3 10.2-12.5 
Acute adversity 16-44 Binary 1+ 15.4 14.1-16.7 
Acute adversity 16-59 Binary 1+ 18.5 17.1-20.0 
   
   
Female gender Binary 
 
53.7 52.1-55.4 
Level 2+ qualifications at time of LIFE Binary 
 
78.9 77.5-80.4 
   
   
Born by 1920 Binary 
 
1.4 1.0-1.7 
Born 1921-1930 Binary 
 
7.5 6.7-8.4 
Born 1931-1940 Binary 
 
21.6 20.2-23.0 
Born 1941-1950 Binary 
 
39.7 38.0-41.3 
Born 1951 or after Binary 
 
29.8 28.3-31.3 
      
Years smoked during early adulthood Continuous  4.8 4.5-5.0 
Years smoked during mid-adulthood Continuous  2.7 2.5-2.9 
Summary statistics refer to the 3,451 respondents in imputed datasets who participated in LIFE and provided 
information about RA onset, gender and date of birth, who did not report pain or depression and scored above 3 
on the word recall test during wave 3. One participant, who reported RA with onset before age 16, is excluded. 
Childhood is 0-15, youth 15-29, early adulthood 30-44, mid-adulthood 45-59.  
1. Social adversity between birth and 44 is a continuous variable with values of 0,1-2,3-5,6+. 
2. These variables have values of 0,1-2,3+. 
3. Relationship-related adversity from birth to age 59 has values of 0,1-3,4+.  
 
 
 
 
 
Results of Cox regression analyses used to address RQ1 are presented in Table A18.2. 
Results reflect the loss of power due to the smaller sample size, but are otherwise similar to 
those presented in the main text.
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Table A18.2:   Associations between total exposure to adversity and risk of RA onset 
Adversity RA onset from 16 
Childhood Men and women (n=3,451) Men (n=1,597) Women (n=1,854) 
Measure HR 95%CI p-val HR 95%CI p-val HR 95%CI p-val 
Terciles     0 Reference 
 
Reference 
 
Reference 
    1 2.000 1.142-3.503 0.015 1.833 0.815-4.134 0.143 2.171 0.988-4.770 0.053
 2+ 2.263 1.216-4.209 0.010 1.841 0.679-4.993 0.230 2.673 1.196-5.971 0.017 
Wald test   0.016   0.313    0.040 
 
  
           
Binary        0 Reference        
 1+ 2.126 1.261-3.582 0.005 1.852 0.845-4.057 0.124 2.411 1.186-4.901 0.015 
             RA onset from 45
Birth to 44 Men and women (n=3,420) Men (n=1,586) Women (n=1,834) 
Measure HR 95%CI p-val HR 95%CI p-val HR 95%CI p-val 
Terciles  0-1 Reference 
 
Reference 
  
Reference 
   2-3 1.844 1.020-3.331 0.043 1.685 0.761-3.728 0.198 2.045 0.813-5.146 0.128
 4-11 2.573 1.299-5.097 0.007 1.887 0.716-4.974 0.199 3.409 1.315-8.834 0.012 
Wald test   0.020        0.035 
 
 
           
Continuous 1.225 1.070-1.403 0.003 1.120 0.920-1.364 0.259 1.326 1.100-1.597 0.003 
 
 RA onset from 60 
Birth to 59 Men and women (n=2,799) Men (n=1,350) Women (n=1,449) 
Measure HR 95%CI p-val HR 95%CI p-val HR 95%CI p-val 
Terciles  0-1 Reference 
 
Reference 
  
Reference 
   2-3 1.924 0.796-4.651 0.146 2.663 0.815-8.704 0.105 1.304 0.329-5.176 0.706 
 4-12 2.441 1.049-5.683 0.038 2.017 0.587-6.928 0.265 3.055 0.917-10.175 0.069 
Wald test   0.137    0.263    0.115 
 
  
           
Continuous 1.189 1.027-1.377 0.020 1.134 0.927-1.388 0.220 1.258 1.016-1.557 0.035 
All models are adjusted for birth cohort and qualifications at Level 2 or above at time of LIFE. The model for men 
and women together is also adjusted for gender. Continuous measures have maximum values of 6 (or more) for 
adversities between birth and 44, and of 7 (or more) for adversities between birth and 59. HR is hazard ratio, 
95% ci is 95% confidence interval.  
 
Results of Cox regression models of RA onset on cumulative levels of adversity over the life 
course are presented in Table A18.3, and the results are similar to those presented in the 
main text. 
Table A18.3:   Associations between cumulative exposure to adversity and risk of RA onset  
Number of life stages 
exposed to adversity 
RA onset from age 45 
(n=3,420) 
RA onset from age 60 
(n=2,799) 
Measure Values HR 95%CI p-value HR 95%CI p-value 
Dummies 0 Reference 
  
Reference 
  
 
1 2.090 0.643-6.785 0.220 3.526 0.463-26.885 0.224 
 
2 3.288 1.140-9.483 0.028 5.111 0.718-36.408 0.103 
 
3 3.774 1.208-11.793 0.022 6.280 0.882-44.736 0.067 
 
4     6.914 0.882-44.736 0.091 
Wald test    0.061    0.355 
  
        
Continuous 
 
1.479 1.145-1.910 0.003 1.401 1.070-1.835 0.014 
Models are adjusted for birth cohort, gender, and qualifications of Level 2 or above at time of LIFE. HR is hazard 
ratio, 95% ci is 95% confidence interval.  
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Results of Cox regression models of RA onset on adversity during each life stage with mutual 
adjustment are presented in Table A18.4. The results differ from those presented in the 
main text. Using this sample, whilst adversity at each life stage is related to increased risk of 
RA onset (HRs are all over 1), only childhood adversity appears salient for RA onset later in 
life. Consequently, additional sensitivity analyses were conducted using the smaller sample 
and indices of adversities measured using the occupational, housing, fertility and 
partnership histories but excluding life events. The results, presented in Table A18.5 differ 
from those presented in Table A18.4; adversity during early adulthood is the most salient. 
The inconsistent results mean that no conclusions are drawn  about whether one life stage 
is more important than another for RA onset. 
Table A18.4:   Associations between RA onset and adversity during each life stage, with 
mutual adjustment  
Adversity during each life stage 
RA onset from age 45 (n=6,560) RA onset from age 60 (n=5,525) 
HR 95%CI p-value HR 95%CI p-value 
Childhood 2.043 1.172-3.563 0.012 2.518 1.234-5.136 0.011 
Youth 1.243 0.791-1.953 0.346 1.178 0.666-2.084 0.574 
Early adulthood 1.344 0.832-2.171 0.227 1.450 0.792-2.653 0.228 
Mid-adulthood     1.028 0.567-1.864 0.929 
These are results from two models, each adjusted for birth cohort, gender, and qualifications at Level 2 and 
above at time of LIFE. HR is hazard ratio, and 95%CI is 95% confidence interval. Childhood is 0-15, youth 16-29, 
early adulthood 30-44, mid-adulthood 45-59. Measures of adversity at each life stage indicate one or more 
adversity. 
 
Table A18.5:   Associations between adversity during each life stage and RA onset, 
excluding adversities reported using questions about first experiences 
 
Adversity during each life stage 
RA onset from age 45 (n=3,420) RA onset from age 60 (n=2,799) 
HR 95%CI p-value HR 95%CI p-value 
Childhood 1.495 0.950-2.354 0.082 1.387 0.758-2.538 0.289 
Youth 1.468 0.942-2.288 0.090 1.395 0.792-2.459 0.249 
Early adulthood 1.594 1.029-2.470 0.037 1.924 1.102-3.359 0.021 
Mid-adulthood     0.926 0.515-1.666 0.798 
These are results from two models, each adjusted for birth cohort, gender, and qualifications at Level 2 and 
above at time of LIFE. HR is hazard ratio, and 95%CI is 95% confidence interval. Childhood is 0-15, youth 16-29, 
early adulthood 30-44, mid-adulthood 45-59. Measures of adversity at each life stage indicate one or more 
adversity. 
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Table A18.6 presents results of Cox regression models of RA onset on adversities classified 
as material and social. As for the results in the main analyses, hazard ratios for each type of 
adversity are greater than one in all models. Evidence for associations with social adversities 
is weaker, probably reflecting loss of power due to the smaller sample size. In contrast, 
evidence for the importance of material adversity appears stronger. This means that 
amongst respondents excluded in these sensitivity analyses because they are likely to 
provide inaccurate information, those with a history of RA under-reported material 
adversity more than those without RA. It is possible that people with RA tend to under-
report material adversity earlier in their lives, but only if their recall is poor or if they have 
co-morbid pain or depression. 
Table A18.6: HRs for RA onset contingent upon material and social adversities 
 
Life stage and 
type of 
adversity 
RA onset from age 16 
(n=3,451) 
RA onset from age 45 
(n=3,420) 
RA onset from age 60  
(n=2,799) 
HR 95%CI p-val HR 95%CI p-val HR 95%CI p-val 
Childhood             
 
Material 1.849 1.138-3.002 0.013 1.921 1.140-3.236 0.014 2.461 1.307-4.635 0.005 
 
Social 1.247 0.966-1.608 0.090 1.309 0.993-1.724 0.056 1.184 0.829-1.691 0.352 
Birth to 44             
 Material     1.557 0.967-2.508 0.069     
 Social     1.557 1.160-2.089 0.003     
Birth to 59             
 Material         1.674 0.933-3.003 0.084 
 
Social         1.632 1.012-2.633 0.045 
These are results of five models with mutual adjustment for material and social adversities and total 
adversity during other life stages, birth cohort, gender and Level 2+ qualifications at time of LIFE. 
Material adversity is measured using an indicator of one or more adversity. Social adversities are 
measured using continuous variables with values as follows: childhood 0,1,2,3+; birth to 44 0,1-2,3-
5,6+; birth to 59 0,1-2,3+. 
 
As reported in the main analyses, there is no evidence that smoking mediates associations 
between adversity and RA onset. Results are presented in Table A18.7.  
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Table A18.7:   HRs for RA onset contingent upon material and social adversities with and 
without smoking 
 RA onset from age 45 (n=3,420) RA onset from age 60 (n=2,799) 
 
HR 95%CI p-value HR 95%CI p-value 
         
Material adversity birth to 29 1.636 0.998-2.681 0.051 2.164 1.190-3.936 0.011 
Social adversity birth to 29 1.243 1.010-1.530 0.040 1.162 0.890-1.518 0.270 
         Material adversity birth to 29 1.636 0.998-2.684 0.051 2.129 1.171-3.874 0.013 
Social adversity birth to 29 1.244 1.010-1.530 0.040 1.147 0.876-1.502 0.317 
Smoking during early adulthood 0.999 0.967-1.033 0.975 0.944 0.857-1.039 0.236 
Smoking during mid- adulthood 
    
1.095 0.992-1.208 0.071 
        
These are HRs for four models, each adjusted for birth cohort, gender and education. Smoking is the 
number of years smoked. Childhood is 0-15, youth is 16-29, early adulthood is 30-44, mid-adulthood 
is 45-59. HRs for material adversities refer to one or more adversity as opposed to none. HRs for 
social adversities refer to each additional adversity, up to a maximum of three or more. Bold font 
indicates associations that are statistically significant at p<0.05. 
 
Tables A18.8 and A18.9 present results from sensitivity analyses that compare relationships 
between RA onset and adversities of different types; family-related vs. traumatic, and 
chronic vs. acute. Findings are similar to those reported in the main text, although the 
smaller sample size means that they are not as striking. 
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Table A18.8: HRs for RA onset contingent upon relationship-related and traumatic 
adversities  
Life stage & 
type of 
adversity 
RA onset from age 16 
(n=3,451) 
RA onset from age 45 
(n=3,420) 
RA onset from age 60 
(n=2,799) 
HR 95%CI p-val HR 95%CI p-val HR 95%CI p-val 
Childhood            
Relations 1.104 0.716-1.702 0.654 1.136 0.711-1.813 0.594 0.969 0.530-1.770 0.918 
Trauma 1.360 0.987-1.875 0.060 1.396 0.985-1.980 0.061 1.331 0.852-2.081 0.209 
             
Birth to 44             
Relations     1.583 1.144-2.191 0.006     
Trauma     1.273 0.801-2.024 0.307     
             
Birth to 59             
Relations         1.659 1.007-2.733 0.047 
Trauma         1.043 0.580-1.877 0.888 
These are results from five models, each adjusted for birth cohort, gender, and Level 2+ qualifications 
at time of LIFE with mutual adjustment for relationship-related and traumatic adversities, material 
adversity during the life stage in which relationship-related and traumatic adversities are included, 
and total adversity during other life stages. Childhood relationship-related adversity is measured 
using an indicator of 1+ adversities. Family adversity during other periods is measured using 
continuous variables with values for birth-44 of 0,1-2,3+ adversities and for birth-59 of 0,1-3,4 
adversities. Traumatic adversities are measured using indicators of 1+ during all periods except 
childhood, when the variable takes values of 0,1,2+. 
 
 
 
Table A18.9:   HRs for RA onset contingent upon chronic and acute adversities  
Life 
stage & 
type 
RA onset from age 30 
(n=3,446) 
RA onset from age 45 
(n=3,420) 
RA onset from age 60 
(n=2,799) 
HR 95%CI p-val HR 95%CI p-val HR 95%CI p-val 
16-29             
Chronic 1.492 0.805-2.764 0.204 1.485 0.764-2.884 0.243 2.153 0.964-4.808 0.062 
Acute 1.070 0.543-2.108 0.845 0.928 0.441-1.953 0.843 0.962 0.371-2.494 0.937 
16 to 44            
Chronic     1.538 0.947-2.498 0.082 1.946 1.053-3.597 0.034 
Acute     0.824 0.414-1.642 0.583 0.797 0.332-1.911 0.611 
16 to 59            
Chronic         1.623 0.894-2.946 0.112 
Acute         0.686 0.299-1.570 0.372 
These are results from six models, each with mutual adjustment for chronic and acute adversities, 
and adjustment for adversities not classified as chronic or acute, childhood adversity measured using 
an indicator of one or more adversities, birth cohort, gender and qualifications of Level 2 or above at 
the time of LIFE. Chronic adversities are main occupation as carer and/or reporting being a carer, 
having a partner or child who is addicted to alcohol or drugs and breaking up with a cohabiting 
partner. Acute adversities are being a victim of sexual assault, being a victim of a serious physical 
attack, witnessing a death or serious injury, or a major natural disaster. Measures of chronic and 
acute adversity and of adversities not classified as chronic or acute are indicators of one or more 
adversity.
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Appendix 19: Sensitivity analyses using alternative multiple 
imputed datasets 
Using multiple imputation, missing values are imputed for indices of adversity rather than 
for individual adversities. Most analyses use indices of adversity and so it is appropriate to 
impute missing values for them. This was just as well since it proved impossible to impute 
missing values for individual adversities as imputation models would not converge.  
Many respondents provided information about some but not all adversities, and so, for 
many indices of exposure, partial but not complete information is available. The main 
analyses use indices of adversity that were calculated only for respondents who provided 
complete information about the relevant adversities. All other respondents were assigned 
missing values for the index, even if they had provided partial information. Values from the 
complete cases were then used to impute missing values for all other respondents, using 
the technique of multiple imputation. 
The drawback with this method is that it does not use all available information because 
some respondents provided partial information about the adversities that contribute to 
each index. In these sensitivity analyses, indices were created in the original dataset that 
included values for respondents who provided information about at least half the 
adversities measured in each index. Index values were the number of adversities reported, 
not scaled up. These were used to create multiple imputed datasets so that sensitivity 
analyses could be conducted. 
Summary statistics for the main variables used are presented in Table A19.1. 
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Compared against the summary statistics using the other multiple imputed datasets (Table 
3.7), reported levels of adversities are slightly higher. The exceptions are that levels of 
material adversity during transition and of traumatic adversities throughout the life course 
are slightly lower in these datasets.  
Table A19.1:   Summary statistics 
   Observed dataset Imputed datasets 
derived from indices 
using partial 
information    
Indices using  
complete information 
Indices using  
partial information 
Variable and measure 
Valu
es 
N Mean  
%=y 
SD / 
no.=y 
N Mean 
%=y 
SD / 
no.=y 
Mean 
%=y 95% CI 
Adversity 0-15           
 terciles 0 3580 45.9 1643 5491 42.5 2334 42.5 41.2-43.8 
 
 
1 3580 29.9 1069 5491 29.6 1624 29.5 28.2-30.7 
  
2+ 3580 24.2 868 5491 27.9 1533 28.0 26.8-29.3 
       
   
 
binary 1+ 3580 54.1 1937 5491 57.5 3157 57.5 56.2-58.8 
Adversity 0-44        
   
 
Terciles 0-1 3428 43.3 1485 5284 37.9 2000 36.2 34.9-37.4 
  
2-3 3428 37.8 1297 5284 37.5 1983 37.0 35.7-38.3 
  
4+ 3428 18.8 646 5284 24.6 1301 26.8 25.7-28.0 
    
   
   
 
Continuous 0-6+ 3428 2.050 1.624 5284 2.322 1.734 2.423 2.375-2.471 
Adversity 0-59        
    Terciles 0-1 3214 34.5 1108 5280 28.0 1480 26.4 25.3-27.6 
  
2-3 3214 38.0 1220 5280 36.8 1944 36.0 34.8-37.2 
  
4+ 3214 27.6 886 5280 35.2 1856 37.6 36.3-38.8 
    
   
   
 
Continuous 0-7+ 3214 2.503 1.825 5280 2.908 1.975 3.023 2.970-3.075 
Cumulative 0-44        
    Dummies 0 4998 12.7 637 5296 15.6 826 14.8 13.8-15.7 
 
 
1 4998 32.7 1636 5296 34.9 1849 34.3 33.0-35.5 
 
 
2 4998 35.2 1761 5296 33.9 1793 34.4 33.2-35.6 
 
 
3 4998 19.3 964 5296 15.6 828 16.5 15.5-17.5 
     
   
   
 Continuous 0-3 4998 1.611 0.937 5296 1.495 0.935 1.527 1.503-1.552 
Cumulative 0-59        
    Dummies 0 4640 9.2 425 5292 10.0 531 9.4 8.6-10.2 
 
 
1 4640 25.4 1178 5292 26.7 1411 25.9 24.8-27.0 
 
 
2 4640 33.9 1573 5292 33.6 1779 33.7 32.5-35.0 
 
 
3 4640 22.9 1062 5292 22.2 1177 23.0 21.9-24.1 
 
 
4 4640 8.7 402 5292 07.4 394 8.0 7.3-8.7 
        
   
 Continuous 0-4 4640 1.965 1.093 5292 1.904 1.086 1.942 1.914-1.970 
15-29 (binary) 1+ 5145 50.1 2579 5319 50.0 2660 50.6 49.3-51.9 
30-44 (binary) 1+ 4999 43.4 2170 5447 43.6 2373 44.6 43.3-46.0 
45-59 (binary) 1+ 4644 38.3 1778 5489 40.8 2241 41.5 40.2-42.8 
Material adversity during:       
    0-15 (binary) 1+ 4178 16.7 699 6516 17.0 1106 17.0 16.1-17.9 
 0-29 (binary) 1+ 4161 19.5 812 6481 25.2 1633 25.2 24.1-26.3 
 0-44 (binary) 1+ 4161 22.1 918 6481 29.9 1940 29.9 28.8-31.0 
 0-59 (binary) 1+ 4161 25.0 1040 6481 33.9 2195 33.9 32.7-35.0 
Social adversity during:       
    0-15 (continuous) 0-3+ 4568 0.715 0.799 5355 0.731 0.804 0.731 0.710-0.753 
 0-29 (continuous) 0-3+ 4499 1.256 1.093 5246 1.263 1.091 1.263 1.234-1.293 
 0-44 (continuous)      0-6+
1
 4368 1.089 0.787 5237 1.116 0.790 1.116 1.094-1.137 
 0-59 (continuous)      0-3+
2 
4368 1.234 0.714 5237 1.227 0.699 1.227 1.208-1.246 
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Relationship adversity during:       
    0-15 (binary) 1+ 5364 35.8 1922 6620 34.3 2269 34.3 33.1-35.4 
 0-29 (continuous)      0-3+
2 
5288 0.633 0.643 6603 0.632 0.650 0.632 0.616-0.648 
 0-44 (continuous)      0-3+
2
 5137 0.829 0.701 6597 0.851 0.711 0.851 0.834-0.868 
 0-59 (continuous)      0-4+
3 
4773 0.824 0.612 6586 0.868 0.620 0.868 0.853-0.883 
Trauma during:        
    0-15 (continuous)       0-2+ 4662 0.326 0.564 5355 0.318 0.560 0.318 0.303-0.333 
 0-29 (binary) 1+ 4654 39.6 1842 5249 37.9 1989 37.9 36.6-39.2 
 0-44 (binary) 1+ 4654 43.4 2019 5246 41.7 2187 41.7 40.4-43.0 
 0-59 (binary) 1+ 4654 48.1 2237 5246 46.5 2442 46.5 45.2-47.9 
Chronic adversity during:       
    16-29 (binary) 1+ 5422 13.1 711 5524 0.132 728 0.137 0.127-0.146 
 16-44 (binary) 1+ 5422 28.0 1516 5522 0.279 1539 0.286 0.275-0.298 
 16-59 (binary) 1+ 5422 39.2 2127 5424 0.393 2129 0.393 0.381-0.406 
Acute adversity during:        
    16-29 (binary) 1+ 5356 11.2 602 5503 0.113 620 0.113 0.104-0.121 
 16-44 (binary) 1+ 5356 15.1 809 5503 0.151 832 0.151 0.142-0.161 
 16-59 (binary) 1+ 5356 18.0 962 5503 0.180 989 0.177 0.166-0.187 
Female (binary)  6624 54.7 3626 6624 54.7 3626 54.7 53.5-55.9 
Level 2+ (binary)  6109 68.4 4179 6109 68.4 4179 67.7 66.5-68.9 
  
       
   
Born by 1920 (binary)  6624 3.7 247 6624 3.7 247 3.7 3.3-4.2 
Born 1921-30 (binary)  6624 12.9 854 6624 12.9 854 12.9 12.1-13.7 
Born 1931-40 (binary)  6624 23.8 1579 6624 23.8 1579 23.8 22.8-24.9 
Born 1941-50 (binary)  6624 34.7 2297 6624 34.7 2297 34.7 33.5-35.8 
Born 1951+ (binary)  6624 24.9 1647 6624 24.9 1647 24.9 23.8-25.9 
  
       
   
Years smoked 30-44 (cont.) 6272 5.553 6.843 6272 5.553 6.843 5.553 5.384-5.723 
Years smoked 45-59 (cont.) 6337 3.383 5.758 6337 3.383 5.758 3.383 3.242-3.525 
RA from 16 (binary)  260   260   260 
  RA from 45 (binary)  221   221   221 
  RA from 60 (binary)  137   137   137 
  Summary statistics refer to the 6,623 respondents who participated in LIFE and provided information about RA 
onset, gender and date of birth. One participant, who reported RA with onset before age 16, is excluded. 
Childhood is 0-15, youth 15-29, early adulthood 30-44, mid-adulthood 45-59.  
1. Social adversity between birth and 44 is a continuous variable with values of 0,1-2,3-5,6+. 
2. These continuous variables have values of 0,1-2,3+.  
3. Relationship-related adversity from birth to age 59 has values of0,1-3,4+.  
 
The results of Cox regression analyses used to address RQ1 are presented in Table A19.2. 
They are very similar to those presented in the main text. The only difference is that the 
magnitude of association with childhood adversity is very slightly reduced. 
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Table A19.2:   Associations between total exposure to adversity and risk of RA onset 
Adversity RA onset from 16 
0-15 Men and women (n=6,623) Men (n=2,997) Women (n=3,626) 
 HR 95%CI p-val HR 95%CI p-val HR 95%CI p-val 
Terciles  0 Reference 
 
Reference 
  
Reference 
  1 1.378 1.003-1.892 0.048 1.357 0.842-2.187 0.210 1.395 0.904-2.152 0.132 
 2+ 1.460 1.056-2.017 0.022 1.367 0.851-2.196 0.196 1.524 0.970-2.396 0.068 
Wald test   0.044    0.333    0.143 
          
Binary 1+ 1.418 1.076-1.870 0.013 1.363 0.906-2.051 0.137 1.460 0.992-2.148 0.055 
  
 RA onset from 45 
0-44 Men and women (n=6,560) Men (n=2,975) Women (n=3,585) 
Measure HR 95%CI p-val HR 95%CI p-val HR 95%CI p-val 
Terc.   0-1 Reference 
  
Reference 
  
Reference 
  2-3 1.397 0.958-2.037 0.082 1.621 0.950-2.767 0.077 1.225 0.737-2.037 0.434 
4-11 1.890 1.318-2.709 0.001 2.049 1.206-3.481 0.008 1.750 1.066-2.873 0.027 
Wald test   0.004    0.034    0.093 
          
Cont. 1.143 1.057-1.236 0.001 1.163 1.040-1.301 0.008 1.123 1.005-1.255 0.041 
  
 RA onset from 60 
  0-59 Men and women (n=5,525) Men (n=2,593) Women (n=2,932) 
Measure HR 95%CI p-val HR 95%CI p-val HR 95%CI p-val 
Terc.   0-1 Reference    
 2-3 1.607 0.962-2.686 0.070 2.939 1.220-7.080 0.016 1.064 0.550-2.058 0.853 
 4-12 1.980 1.187-3.304 0.009 3.672 1.545-8.725 0.003 1.273 0.651-2.488 0.480 
Wald test   0.030    0.012    0.747 
          
Cont. 1.121 1.025-1.227 0.012 1.196 1.060-1.350 0.004 1.048 0.917-1.199 0.489 
Models are adjusted for birth cohort and Level 2 qualifications or higher at time of LIFE. The model for men and 
women together is adjusted for gender. Continuous measures have maximum values of 6 for adversities 
between birth and age 44 and of 7 for adversities between birth and age 59. HR is hazard ratio, 95% ci is 95% 
confidence interval. 
 
Results of Cox regression models of RA onset on cumulative levels of adversity over the life 
course are presented in Table A19.3. They are very similar to those presented in the main 
text. 
Table A19.3:   Associations between cumulative exposure to adversity and risk of RA onset  
Number of life stages 
exposed to adversity RA onset from age 45 (n=3,420) RA onset from age 60 (n=2,799) 
Measure Values HR 95%CI p-val HR 95%CI p-val 
Dummies 0 Reference Reference 
 
1 1.754 0.994-3.095 0.053 2.200 0.812-5.964 0.121 
 
2 2.273 1.295-3.988 0.004 2.932 1.121-7.671 0.028 
 
3 2.473 1.349-4.535 0.003 3.679 1.374-9.854 0.010 
 
4  3.074 1.374-9.854 0.052 
Wald test  0.011 0.054 
  
   
Continuous 
 
1.301 1.116-1.516 0.001 1.275 1.084-1.501 0.003 
Models are adjusted for birth cohort, gender and Level 2 or higher qualifications at time of LIFE. HR is hazard 
ratio, 95% ci is 95% confidence interval.  
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Results of Cox regression models of RA onset on adversity during each life stage with mutual 
adjustment are presented in Table A19.4. The results are very similar to those presented in 
the main text.  
Table A19.4:   Associations between RA onset and adversity during each life stage, with 
mutual adjustment  
Adversity 
during each life 
stage 
RA onset from age 45  
(n=6,560) 
RA onset from age 60  
(n=5,525) 
HR 95%CI 
 
p-value HR 95%CI 
 
p-value 
Childhood 1.410 1.040 1.912 0.027 1.446 0.981 2.132 0.062 
Youth 1.529 1.149 2.034 0.004 1.808 1.259 2.596 0.001 
Early adulthood 1.025 0.757 1.390 0.872 0.875 0.600 1.276 0.488 
Mid-adulthood     1.176 0.814 1.701 0.388 
These are results from two models, each adjusted for birth cohort, gender and Level 2 or higher qualifications at 
time of LIFE. HR is hazard ratio, and 95%CI is 95% confidence interval. Childhood is ages 0-15, youth 16-29, early 
adulthood 30-44, mid-adulthood 45-59. Measures of adversity at each life stage are binary indicators of one or 
more adversities. 
 
 
 
 
Table A19.5 presents results of Cox regression models of RA onset on adversities classified 
as material and social. The results are very similar to those reported in the main text. 
Table A19.5:   HRs for RA onset contingent upon material and social adversities 
 
Life stage 
& type 
RA onset from age 16 (n=6,623) RA onset from age 45 (n=6,560) RA onset from age 60 (n=5,525) 
HR 95%CI  
p-
val HR 95%CI p-val HR 95%CI p-val 
0-15             
Material  1.375 1.028-1.841 0.032 1.325 0.964-1.821 0.083 1.509 1.021-2.232 0.039 
Social  1.192 1.018-1.395 0.029 1.215 1.023-1.444 0.027 1.102 0.883-1.377 0.390 
0-44             
Material      1.267 0.955-1.681 0.101 1.498 1.051-2.135 0.026 
Social     1.386 1.163-1.652 0.000 1.294 1.027-1.630 0.029 
0-59             
Material          1.626 1.151-2.297 0.006 
Social         1.281 0.983-1.669 0.067 
These are results of six models with mutual adjustment for material and social adversities and total 
adversity during other life stages, birth cohort, gender and Level 2+ qualifications at time of LIFE. 
Material adversity is measured using an indicator of one or more adversity. Social adversities are 
measured using continuous variables with values of 0,1,2,3+ between 0&15; 0,1-2,3-5,6+ between 0-
44, 0,1-2,3+ between 0&59. 
 
As reported in the main analyses, there is no evidence that smoking mediates associations 
between adversity and RA onset. Results are presented in Table A19.6.  
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Table A19.6:   HRs for RA onset contingent upon material and social adversities with 
adjustment for smoking 
 RA onset from age 45 (n=6,560) RA onset from age 60 (n=5,525) 
 
HR 95%CI p-value HR 95%CI p-value 
         
Material adversity 0-29 1.303 0.975-1.743 0.074 1.536 1.070-2.204 0.020 
Social adversity 0-29 1.261 1.107-1.436 0.000 1.217 1.032-1.436 0.020 
 
        
Material adversity 0-29 1.296 0.969-1.733 0.081 1.534 1.069-2.202 0.020 
Social adversity 0-29 1.255 1.101-1.429 0.001 1.210 1.026-1.427 0.024 
Smoking 30-44 1.013 0.993-1.033 0.204 0.982 0.932-1.035 0.506 
Smoking 45-59     1.052 0.996-1.110 0.067 
These are results for four models. Smoking is the number of years smoked. Childhood is 0-15, youth is 
16-29, early adulthood is 30-44, mid-adulthood is 45-59. 
 
 
 
Tables A19.7 and A19.8 present results from comparisons of relationships between RA onset 
and adversities of different types; family-related vs. traumatic, and chronic vs. acute. The 
results are similar to those reported in the main text. 
Table A19.7:   HRs for RA onset contingent upon relationship-related and traumatic 
adversities  
Life stage 
and type 
RA onset from age 16 (n=3,451) RA onset from age 45 (n=3,420) RA onset from age 60 (n=2,799) 
HR 95%CI p-val HR 95%CI p-val HR 95%CI p-val 
0-15          
Relations 1.106 0.857-1.426 0.438 1.205 0.915-1.587 0.184 1.071 0.752-1.525 0.703 
Trauma 1.277 1.022-1.597 0.032 1.224 0.957-1.564 0.107 1.151 0.834-1.589 0.393 
0-44             
Relations     1.290 1.062-1.567 0.010 1.220 0.948-1.569 0.122 
Trauma     1.327 0.981-1.794 0.066 1.152 0.778-1.707 0.480 
0-59             
Relations         1.218 0.914-1.623 0.178 
Trauma         1.185 0.801-1.751 0.395 
These are results from six models, each adjusted for birth cohort, gender, and Level 2+ qualifications 
at time of LIFE with mutual adjustment for relationship-related and traumatic adversities, material 
adversity during the life stage in which relationship-related and traumatic adversities are included, 
and total adversity during other life stages. Childhood relationship-related adversity is measured 
using an indicator of 1+ adversities. Family adversity during other periods is measured using 
continuous variables with values for 0-44 of 0, 1-2, 3+ adversities and for 0-59 of 0, 1-3, 4 adversities. 
Traumatic adversities are measured using indicators of 1+ during all periods except childhood, when 
the variable takes values of 0, 1, 2+. 
Appendix 19 Chapter 3: Sensitivity analyses using alternative imputed datasets      430 
 
 
Table A19.8: Hazard ratios for RA onset contingent upon chronic and acute adversities  
Life 
stage & 
type 
RA onset from age 30 
(n=6,613) 
RA onset from age 45 
(n=6,560) 
RA onset from age 60 
(n=5,525) 
HR 95%CI p-val HR 95%CI p-val HR 95%CI p-val 
16-29             
Chronic 1.661 1.123-2.457 0.011 1.773 1.174-2.677 0.006 2.674 1.630-4.384 0.000 
Acute 0.761 0.468-1.238 0.271 0.756 0.453-1.262 0.285 0.800 0.424-1.507 0.490 
16-44             
Chronic     1.561 1.139-2.140 0.006 1.814 1.220-2.697 0.003 
Acute     0.834 0.543-1.281 0.407 0.745 0.419-1.325 0.316 
16-59             
Chronic         1.371 0.940-2.001 0.102 
Acute         0.723 0.418-1.253 0.248 
These are results from six models, each with mutual adjustment for chronic and acute adversities, 
and adjustment for adversities not classified as chronic or acute, childhood adversity measured using 
an indicator of one or more adversities, birth cohort, gender and qualifications of Level 2 or above at 
the time of LIFE. Chronic adversities are main occupation as carer and/or reporting being a carer, 
having a partner or child who is addicted to alcohol or drugs and breaking up with a cohabiting 
partner. Acute adversities are being a victim of sexual assault, being a victim of a serious physical 
attack, witnessing a death or serious injury, or a major natural disaster. Measures of chronic and 
acute adversity and of adversities not classified as chronic or acute are indicators of one or more 
adversity. 
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Appendix 20: Detailed information about data and 
measures 
19. Dataset 
The ELSA sample consists of core members and their cohabiting partners. Original core 
members were participants in HSE in 1998, 1999, or 2001, and in the first wave of ELSA data 
collection between 2002 and 2003. Refreshment samples of new core members were added 
in waves 3,4, and 6 to maintain numbers and the age distribution as the original core 
members aged. Participants of HSE between 2001 and 2004 who were aged 50-53 at the 
time of data collection were included in wave 3. In wave 4, participants of HSE 2006 who 
were aged 50-74 at the time of data collection were interviewed. In wave 6, the 
refreshment sample included respondents from HSE 2009-2011 aged 50-55. 
ELSA Life history data were collected in a separate interview in wave 3, between 2006 and 
2007. Retrospective information was collected from participants who not only provided 
interviews at wave 3 but also consented to providing information about their lives so far in 
an additional interview. The exception is that participants who did not provide a wave 3 
interview were invited to participate in the life history interview if their cohabiting partner 
had agreed to provide life history data. Those whose wave 3 main interview was conducted 
late (after April 19th, 2007) were excluded. 
20. Measures 
Depressive symptoms 
The 8-item version of the Centre for Epidemiology depression scale (CESD) was 
administered in each wave of data collection during the psychosocial module of the main 
interview. The items are set out in Table A20.1.  
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Table A20.1:   Items used to measure depressive symptoms 
Item Response Score 
Now think about the past week and the feelings you have experienced.  
Please tell me if each of the following was true for you much of the time during the past week. 
Much of the time during the past week, you felt depressed? Yes 1 
 No 0 
Much of the time during the past week, you felt that everything you did was an 
effort? 
Yes 1 
No 0 
Much of the time during the past week, your sleep was restless? Yes 1 
 No 0 
Much of the time during the past week, you were happy? Yes 0 
 No 1 
Much of the time during the past week, you felt lonely? Yes 1 
 No 0 
Much of the time during the past week, you enjoyed life? Yes 0 
 No 1 
Much of the time during the past week, you felt sad? Yes 1 
 No 0 
Much of the time during the past week, you could not get going? Yes 1 
 No 0 
These items are asked in the psychosocial module of the main interview in each wave or data 
collection 
 
Hypothesised confounders and mediators 
Socio-economic factors 
All available information was used to create measures of socio-economic factors. For 
childhood SEP, information was used from the earliest wave in which it was available. The 
only exception to this was if a respondent classified their main carer’s occupation as 
unemployed or in casual work and later classified their occupation differently; in this 
situation, the latter information was used instead of the classification as unemployed or in 
casual work. If information provided in different waves differed by more than two 
categories, then a missing value was assigned to the variable. That is, if the main carer’s 
occupation was described in one wave as professional/managerial and in another as semi-
skilled or routine/manual, or if the main carer’s occupation was described in one wave as 
professional/managerial or skilled in one wave and  routine/manual in another.  
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For accumulated wealth and qualifications, information collected in wave 2 was used in the 
first instance. If the information was missing in wave 2, information was used from wave 1, 
and if this information was missing also, information was used from waves 3, 4, 5 and 6, in 
that order. Thus, although the variables are referred to as qualifications below Level 2 in 
2004 and low wealth in 2004, the date is an approximation. 
Stable psychological factors 
Stable psychological factors were measured in a self-completion questionnaire administered 
during wave 5. Items and which dimension they refer to are listed in Table A20.2. Following 
guidelines (Lachman & Weaver 1997), all scores were reverse coded except for the items 
relating to calm and careless, and the mean for each dimension was calculated. If values 
were provided for at least half the items for a dimension, that dimension was assigned a 
score based on the mean of the values provided. If more than half the items for a dimension 
had missing values, the dimension was not assigned a value. 
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Table A20.2: Items used to measure stable psychological factors and their factor loadings 
 Agreeable Open Extravert Conscientious Neurotic 
During the past 30 days, to what degree did you feel: 
 Outgoing   Y   
       
Please indicate how well each of the following describes you: 
 Helpful Y     
 Moody     Y 
 Organised    Y  
 Friendly   Y   
 Warm Y     
 Worrying     Y 
 Responsible    Y  
 Lively   Y   
 Caring Y     
 Nervous     Y 
 Creative  Y    
 Hardworking    Y  
 Imaginative  Y    
 Soft-hearted Y     
 Calm     Y 
 Intelligent  Y    
 Curious  Y    
 Active   Y   
 Careless    Y  
 Broad-minded  Y    
 Sympathetic Y     
 Talkative   Y   
 Sophisticated  Y    
 Adventurous  Y    
 Thorough    Y  
Respondents were asked to tick one of the following responses for each item: A lot / Some / A little / 
Not at all. Calm and careless are reverse coded. 
 
Childhood adversity 
The questions used to measure childhood adversities are presented in Table A20.3. Criteria 
for poor housing amenities have changed over time. Details about how these were defined 
are given in Appendix 10.  
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Table A20.3: Questions used to measure childhood adversities 
Adversity Question/s Mode 
Poor amenities 
and/or crowding at 
age 10 & living in UK 
We would like to find out more about where you lived when you were ten 
years old. Earlier you told me that when you were ten you lived at (a residence 
in recorded country for residence living in at 10
th
 year of life). 
How many bedrooms did your household occupy in this residence? If asked: 
Include only bedrooms. Do not count bathrooms, kitchens, living rooms, dining 
rooms or any rooms your household sublet. 
Including yourself, how many people lived in your household at this residence 
when you were 10? 
Did this accommodation have any of the features on this card when you were 
aged 10? 
      Fixed bath 
      Cold running water supply 
      Hot running water supply 
      Inside toilet 
      Central heating 
      All of these 
      None of these 
In what year did you start living in your (first/next) residence that you lived in 
for six months or more? 
Was this residence (which you started living at in (year when started living in 
residence)) in the UK? 
In what year did you stop living in this residence (which you started living at in 
(year when stopped living in residence))? 
IV 
Severe financial 
hardship 
Have you ever experienced severe financial hardship? 
If so, how old were you when it first happened? 
SC 
Parental 
unemployment 6m+ 
When you were aged under 16, were either of your parents unemployed for 
more than 6 months when they wanted to be working? 
SC 
Early parental loss Now I would like to ask you a few questions about your parents. 
Did your parents permanently separate or divorce before you were 16? By 
parents, I mean your natural or adoptive parents? 
      Yes 
      No 
      Spontaneous only: One or both parents died before respondent was 16 
(yes) 
      Spontaneous only: Parents never lived together during respondent’s 
lifetime                          
………………………………………………………………………………………………………(coded as 
yes) 
      Spontaneous only: Never lived with parents / Don’t know (coded as yes) 
IV 
Separation from 
mother for 6m+ 
Were you separated from your mother for 6 months or longer before you were 
16? 
IV 
Parents argued often When you were aged under 16, did your parents argue or fight very often? SC 
Parent abused 
substances/ mental 
health difficulties 
When you were aged under 16, did your parents drink excessively, take drugs 
or have mental health problems? 
SC 
Physically abused by 
parent 
When you were under 16, were you physically abused by your parents? SC 
Sexually assaulted Have you ever been a victim of sexual assault (including rape or harassment)? 
If so, How old were you when it first happened? 
SC 
Had life threatening 
illness or injury 
Have you ever had a life-threatening illness or accident? 
If so, How old were you when it first happened? 
SC 
Severe physical 
attack 
Have you ever been a victim of serious physical attack or assault? 
If so, How old were you when it first happened? 
SC 
Witness death or 
serious injury 
Have you ever witnessed the serious injury or death of someone in war or 
military action? 
If so, How old were you when it first happened? 
Other than in war or military action, have you ever witnessed an accident or 
violent act in which someone was killed or seriously wounded? 
If so, How old were you when it first happened? 
SC 
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Lost close relative or 
friend 
Have you ever lost a very close friend or relative in a war or military service? 
If so, How old were you when it first happened? 
Have you ever had a very close friend or relative who died or was at risk of 
death due to illness or serious accident? 
If so, How old were you when it first happened? 
SC 
Major natural 
disaster 
Have you ever experienced a major fire, flood, earthquake or other natural 
disaster?  
If so, How old were you when it first happened? 
SC 
All questions were asked during the life history interview in wave 3. IV indicates face to face 
interview, SC indicates self-completion questionnaire. 
 
Medication use 
Participants taking medications that might affect depressive symptoms and/or inflammation 
were identified using detailed information from wave 0 and the wave 6 nurse interview. The 
detailed information provided information about all prescribed medications and whether 
they had been taken during the previous 7 days. Each medication was coded using the 
British National Formulary classification codes set out in 1997, 1998, 2000 and 2011. For 
wave 0, the classification codes that indicated a yes value were all those beginning with 2 or 
4, 3.2, 6.1, 6.3, 6.4.1, 7.3.1, 7.3.2, 8.2, 8.3, 10.1, 11.4. The same codes were used for wave 6 
and in addition 1.5.2 and 1.5.3. This information was supplemented by information provided 
during the health module of the main interviews. The questions asked are presented in 
Table A20.4. 
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Table A20.4: Questions asked to elicit information about use of pharmaceutical 
medication 
Drugs that are likely to influence depressive symptoms Interview 
1 I have some questions about any treatment you may have had for your depression. 
Did a doctor or nurse suggest that you take medication, or see a mental health 
professional for counselling? This may include a psychiatrist, psychologist, or social 
worker for counselling or psychotherapy. 
Main 24 
   Responses: Medication, Counselling, Both medication and counselling, None. 
2 Did you start [taking medication/seeing a mental health professional/taking 
medication and seeing a mental health professional] within two weeks of being 
offered this treatment? 
Main 4 
3 Did you feel better within 6 weeks after [medication/seeing a mental health 
professional/medication and seeing a mental health professional]? 
Main 2 
Drugs that are likely to influence inflammation  
4 Are you currently taking any medication, tablets or pills for high blood pressure? Main 2-6 
5 Can I just check, are you taking any medication which prevents you from getting 
high blood pressure? 
Main 3-6 
6 Are you currently taking any tablets, pills or other medication that you swallow for 
diabetes? 
Main 2-6 
7 Are you currently taking any medication to lower cholesterol level? Main 3-6 
8 Can I just check, are you currently taking medication which prevents you from 
getting high cholesterol any more? 
Main 3-6 
9 Are you taking statins (drugs to lower cholesterol) bought over the counter from a 
pharmacist, without prescription from a doctor? Here are some examples of 
common statins, which may be bought over the counter: Atorvastatin (Lipitor), 
Fluvastatin (Lescol, Lescol XL), Pravastatin (Lipostat), Rosuvastatin (Crestor) and 
Simvastatin (Zocor) 
Nurse 6 
10 Are you currently taking medication to thin your blood like Warfarin, Asparin, Plavix, 
Ticlid or other medication to thin the blood? 
Main 2-6 
11 I would like to check whether any of the medications you are taking are on this list 
of beta-blockers. Could you show me the medications, or the repeat prescription list 
for any medications, that you have been taking over the past week?  
Main 25 
   Responses: Taking beta-blocker, Not taking beta-blocker, Taking other beta-
blocker not on the showcard. 
12 I would like to check whether any of the medications you are taking are on this list 
of ACE inhibitors or A2 receptor blockers. Could you show me the medications, or 
the repeat prescription list of any medications, that you have been taking over the 
past week? 
Main 2-6 
   Responses: Taking ACE inhibitor or A2 receptor blocker, Not taking ACE 
inhibitor or A3 receptor blocker, Taking other ACE inhibitor not on showcard 
 
Medication for depression is indicated if responses to Q1 is “medication” and to Q2 and/or Q3 is yes. 
Medication likely to influence inflammation is indicated by a positive response to any of Q4-Q12. 
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Psychosocial factors 
The questions used to measure psychosocial factors in adulthood are presented in Table 
A20.5. 
Table A20.5: Questions used to measure psychosocial factors. 
Variable Questions Wave 
Perceived strain We should like to know how your health has been in 
general over the past few weeks. Have you recently… 
                    … felt constantly under strain?  
Not at all, No more than usual, Rather more than usual, 
Much more than usual (GHQ item) 
13 
SC 
Belonging and relationships  
Loneliness 1 How often do you feel you lack companionship? 
2 How often do you feel left out? 
3 How often do you feel isolated from others? 
4 How often do you feel in tune with the people around 
you? 
5 How often do you feel lonely 
Hardly ever or never, Some of the time, Often 
W2:1-4 
W3-6: 1-5 
SC 
 
  
Got partner since last wave Do you have a husband, wife or partner with whom you 
live? 
1-6 
Lost partner since last wave SC 
 
  
Stressful relationships with: 1 How much do they really understand the way you feel 
about things? 
2 How much can you rely on them if you have a serious 
problem? 
3 How much can you open up to them if you need to talk 
about your worries? 
4 How much do they criticise you? 
5 How much do they let you down when you are counting 
on them? 
6 How much do they get on your nerves? 
A lot, some, a little, not at all 
1-6 
Partner SC 
Child 
Other family 
Friend 
 
 
 
 
  
Community stress How do you feel about your local area, that is everywhere 
within a 20 minute walk or about a mile of your home? 
Please tick one box on each line. The closer your tick is to 
a statement the more strongly you agree with it. Tick one 
box on each line (1 is closest to first statement, 7 closest 
to second statement) 
I really feel part of this area vs I feel that I don’t belong 
in this area 
Vandalism and graffiti are a 
big problem in this area 
vs There is no problem with 
vandalism and graffiti in 
this area 
I often feel lonely living in 
this area 
vs I have never felt lonely 
living in this area 
Most people in this area 
can be trusted 
vs Most people in this area 
can’t be trusted 
13 
SC 
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People would be afraid to 
walk alone in this area after 
dark 
vs People feel safe walking 
alone in this area after 
dark 
Most people in this area are 
friendly 
vs Most people in this area 
are unfriendly 
People in this area will take 
advantage of you 
vs People in this area will 
always treat you fairly 
This area is kept very clean  vs This area is always full of 
litter and rubbish 
If you were in trouble, there 
are lots of people in this 
area who would help you 
vs If you were in trouble, 
there is nobody in this 
area who would help you 
 
Occupation-related stress   
In control generally 
High demands generally 
Here are some questions about how you feel about your 
life in general. 
Please say how much you agree or disagree with the 
following statements. 
1 At home, I feel I have control over what happens in 
most situations 
2 At work, I feel I have control over what happens in most 
situations 
3 I feel that what happens in my life is often determined 
by factors beyond my control 
4 In general, I have different demands that I think are 
hard to combine 
5 In general, I have enough time to do everything 
6 Considering the things I have to do at work, I have to 
work very fast 
7 Considering the things I have to do at home, I have to 
work very fast 
Strongly agree, Moderately agree, Slightly agree, Slightly 
disagree, Moderately disagree, Strongly disagree 
1-6 
SC 
 
 
  
Work effort:reward  
Items 1-7,9,10,12 
 
Low work control 
Items 8,11 
 
Job insecurity 
Item 6 
Here are some statements people might use to describe 
their work. We would like to know how strongly you think 
these apply to the paid employment you did in the last 
month. 
1   All things considered I am satisfied with my job 
2   My job is physically demanding  
3   I receive the recognition I deserve for my work 
4   My salary is adequate 
5   My job promotion prospects are poor 
6   My job security is poor 
7   I am under constant time pressure due to a heavy 
workload 
8   I have very little freedom to decide how I do my work 
9   I have the opportunity to develop new skills 
10 I receive adequate support in difficult situations 
11 At work, I feel I have control over what happens in 
most situations 
12 Considering the things I have to do at work, I have to 
work very fast 
Strongly agree, Agree, Disagree, Strongly disagree 
2-6 
SC 
Status   
Feels worse off than: 
Neighbours 
Friends 
Compared to the financial situation of [other people living 
around here/most of your friends], would you say your 
household is:... 
2-5 
IV 
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Colleagues Much worse off, A bit worse off, About the same, A bit 
better off, Much better off? 
And how does your financial situation compare to most of 
your close work colleagues? Would you say your 
household is: 
Much worse off, A bit worse off, About the same, A bit 
better off, Much better off? 
 
 
 
   
Subjective social status Think of this ladder as representing where people stand in 
our society. At the top of the ladder are the people who 
are the best off – those who have the most money, most 
education and best jobs. At the bottom are the people 
who are the worst off – who have the least money, least 
education, and the worst jobs or no jobs. The higher up 
you are on this ladder, the closer you are to the people at 
the very top and the lower you are, the closer you are to 
the people at the very bottom. Please mark a cross on the 
rung on the ladder where you would you place yourself. 
1-6 
SC 
 
  
Financial strain   
Can’t buy some important 
things 
Does having too little money stop you from doing any of 
the following things? (Can select any number) 
Buy your first choices of food items 
Have family and friends round for a drink or meal 
Have an outfit to wear for social or family occasions 
Keep your home in a reasonable state of decoration 
Replace or repair broken electrical goods 
Pay for fares or other transport costs to get to and from 
places you want to go 
Buy presents for friends or family once a year 
Take the sorts of holidays you want 
Treat yourself from time to time 
None of these 
2-6 
IV 
   
Perceived financial strain Which of the phrases on the card best describes how 
[you/you and your 
husband/wife/partner] are getting along financially these 
days? 
Manage very well, Manage quite well, Get by alright, 
Don't manage very well, Have some financial difficulties, 
Have severe financial difficulties 
1-6 
IV 
   
Social withdrawal Engagement 
Which of these statements apply to you? Tick all that 
apply 
I read a daily newspaper 
I have a hobby or pastime 
I have taken a holiday in the UK in the last 12 months 
I have taken a holiday abroad in the last 12 months 
I have gone on a daytrip or outing in the last 12 months 
I use the internet and/or email 
I own a mobile phone 
None of these statements apply to me 
 
Participation 
1-6 
SC 
 Are you a member of any of these organisations, clubs or 
societies? Tick all that apply 
Political party, trade union or environmental groups 
Tenants groups, resident groups or Neighbourhood Watch 
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Church or other religious groups 
Charitable associations 
Education, arts or music groups or evening classes 
Social clubs 
Sports clubs, gyms, exercise classes 
Any other organisations, clubs or societies 
No, I am not a member of any organisations, clubs or 
societies 
  
Social activity 
Now some questions about your social activities. How 
often, if at all, do you do any of the following activities?  
      (Twice a month or more/About once a month/Every 
few months/About        ……..once or twice a year/Less 
than once a year/Never) 
Go to the cinema 
Eat out of the house 
Go to an art gallery or museum 
Go to the theatre, a concert or opera 
 
SC self-completion, IV main interview.  
 
Measures for loneliness, stressful relationships, and community stress are based on multiple 
items. For these measures, some items were reverse coded so that item values were 
aligned, and then the values were summed. For example, the fourth item for loneliness was 
reverse coded, and then added to the sum of the remaining items (3 for wave 2, and 4 for 
subsequent waves). Respondents with missing values for no more than half the items were 
assigned values based on the information provided, and these values were scaled up to 
match values for respondents who answered all the items.  
Low control generally was measured by taking the mean of items in Table A20.5 that 
indicate control at home (items 1, and 3 reverse coded), and then taking the mean of this 
measure with the item that indicates control at work (item 2). Respondents with missing 
values for items 1 or 3 (but not both) were included. High demands was measured by 
combining items 4-7, after reverse coding items 4,6, and 7.  
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Previous studies using ELSA data to measure work stress include measures of effort reward 
imbalance and low control at work (Dragano et al. 2011, Lunau et al. 2013). As described by 
Dragano et al (2011), items 8 and 11 were used to measure job control. These items are 
similar to items in the Job Content Questionnaire (Karasek et al. 1998). Item 8 was reverse 
coded and the mean of the two items was calculated. Again, following Dragano et al. (2011), 
the remaining 10 items were included in a factor analysis (using the maximum likelihood 
method of estimation, two factors, followed by a promax rotation that allows correlation 
between the factors). Based on the results, reward was measured using items 
1,3,4,5,6,9,and 10, with half weights assigned to items 5 and 6, to calculate a mean value. 
Effort was measured by taking the mean of items 7 and 12. Effort reward imbalance was 
calculated by dividing reward by effort.  
Item 6 (reverse coded) was used to measure job insecurity. 
Social withdrawal is calculated by assigning participants to a tercile for each of engagement, 
participation (excluding sports clubs, gyms or exercise classes) and activity, and calculating 
the mean. 
Health behaviours 
The measure of alcohol consumption was chosen because this is the only measure that is 
consistent across all waves. Respondents were asked whether they drank alcohol every day 
of the week, or almost daily, and a variable was constructed to indicate this frequency of 
drinking. 
Three questions were used to measure physical activity. Respondents were asked to rate 
how often they took part in sports of activities that involve vigorous, moderate, and mild 
Appendix 20 Chapter 4: Data and measures      443 
 
 
 
levels of activity. How this information was used to code a single variable is summarised in 
Table A20.6. The resulting variable has four values; high, moderate, low, and sedentary. 
Table A20.6: Classification of physical activity as high, moderate, or low 
  Q2 (moderate) 
Q3 (mild) Q1 (vigorous) >1/week 1/week 1-3/month Hardly ever/never 
>1/week >1/week H H H H 
 1/week H M M M 
 1-3/month H M M M 
 Hardly ever/never M M L L 
1/week >1/week H H H H 
 1/week H M M M 
 1-3/month H M L L 
 Hardly ever/never M L L L 
1-3/month >1/week H H H H 
 1/week H M M M 
 1-3/month M L L L 
 Hardly ever/never M L L S 
Hardly ever/never >1/week H H H H 
 1/week H M M M 
 1-3/month M L L L 
 Hardly ever/never M L L S 
H is high, M is moderate, L is low, S is sedentary.  
Q1 asks, “We would like to know the type and amount of physical activity involved in your daily life. 
Do you take part in sports or activities that are vigorous: more than once a week, once a week, one to 
three times a month, hardly ever, or never?”  
Q2 asks, “And do you take part in sports or activities that are moderately energetic: more than once a 
week, once a week, one to three times a month, hardly ever, or never?”  
Q3 asks, “And do you take part in sports or activities that are mildly energetic: more than once a 
week, once a week, one to three times a month, hardly ever, or never?” 
 
Metabolic biomarkers 
All respondents who were not pregnant were eligible to have their blood pressure 
measured. In waves 2, 4, and 6, nurses measured systolic and diastolic blood pressures 
three times at one-minute intervals using an Omron HEM-907 machine. The average values 
of the three measures were used. Blood pressures were taken while respondents were 
sitting, and after they had been resting for at least 5 minutes. Nurses measured the room 
temperature, and if this was outside the range of 15-20’C, they attempted to alter it by 
opening or closing doors and windows. 
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Moderators 
Questions used to measure each health status were asked during the health modules of the 
main interviews in all waves. See Table A20.7.  
Table A20.7:   Questions used to measure health status 
Variable Questions Waves 
RA, asthma Has a doctor ever told you that you have (or have had) any of the conditions on this 
card? 
PROBE : What others? CODE ALL THAT APPLY 
     Chronic lung disease such as chronic bronchitis or emphysema 
     Asthma 
     Arthritis (including osteoarthritis , or rheumatism) 
     Osteoporosis, sometimes called thin or brittle bones 
     Cancer or a malignant tumour (excluding minor skin cancers) 
     Parkinson's disease 
     Any emotional, nervous or psychiatric problems 
     Alzheimer’s disease 
     Dementia, organic brain syndrome, senility or any other serious memory 
impairment 
     None of these 
Which type or types of arthritis do you have:  
READ OUT EACH IN TURN AND CODE ALL THAT APPLY 
     Osteoarthritis? 
     Rheumatoid arthritis? 
     Some other kind of arthritis? 
Approximately how old were you when you were first told by a doctor that you had 
arthritis? 
1 
RA Our records show that when we last interviewed you on [date of last interview] you 
said that you had had (or had been told by a doctor you had had) arthritis. 
Reason why respondent disputes having had arthritis: 
     Never had  
     No longer has 
     Did not have previously, but has now 
     Misdiagnosed 
2-6 
Asthma Our records show that when we last interviewed you on [date of last interview] you 
said that you had had (or had been told by a doctor you had had) asthma. 
Reason why respondent disputes having had asthma. 
     Never had  
     No longer has 
     Did not have previously, but has now 
     Misdiagnosed 
2-6 
RA, asthma Apart from what you have already told us, and thinking about what has happened 
since we last saw you on [date of last interview] has a doctor told you that you have 
any of the conditions on this card 
PROBE - 'What others?'···CODE ALL THAT APPLY. 
     Chronic lung disease such as chronic bronchitis or emphysema 
     Asthma 
     Arthritis (including osteoarthritis , or rheumatism) 
     Osteoporosis, sometimes called thin or brittle bones 
     Cancer or a malignant tumour (excluding minor skin cancers) 
     Parkinson's disease 
     Any emotional, nervous or psychiatric problems 
     Alzheimer's disease 
     Dementia, senility or another serious memory impairment 
     None of these 
Which type or types of arthritis [do you / does [name]] have... 
2 
Appendix 20 Chapter 4: Data and measures      445 
 
 
 
CODE ALL THAT APPLY. 
     Osteoarthritis? 
     Rheumatoid arthritis? 
     Some other kind of arthritis? 
Approximately how old were you when you were first told by a doctor that you had 
arthritis? 
RA, asthma Apart from what you have already told us, and thinking about what has happened 
since we last saw you on [^date of last interview] has a doctor told you that you have 
any of the conditions on this card 
PROBE - 'What others?'···CODE ALL THAT APPLY. 
     Chronic lung disease such as chronic bronchitis or emphysema 
     Asthma 
     Arthritis (including osteoarthritis , or rheumatism) 
     Osteoporosis, sometimes called thin or brittle bones 
     Cancer or a malignant tumour (excluding minor skin cancers) 
     Parkinson's disease 
     Any emotional, nervous or psychiatric problems 
     Alzheimer's disease 
     Dementia, senility or another serious memory impairment 
     Malignant blood disorder, e.g. leukaemia or lymphoma 
     None of these 
Which type or types of arthritis [do you / does [name]] have... 
CODE ALL THAT APPLY. 
     Osteoarthritis? 
     Rheumatoid arthritis? 
     Some other kind of arthritis? 
Approximately how old were you when you were first told by a doctor that you had 
arthritis? 
3-6 
Active asthma Have you had attacks of wheezing or whistling in your chest at any 
time in the last 12 months? 
If has ever had attacks of shortness of breath with wheezing: 
Is/Was your breathing absolutely normal between attacks? 
1-5 
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Appendix 21: Additional information about analyses  
I considered including age squared in the models used to address the first three RQs 
because the relationship between age and depressive symptoms over the life course is 
known to be a function of both age and age squared (Kessler et al. 1992). Studies have 
found that prevalence of depressive symptoms decreases from childhood up to about age 
50, after which prevalence rates increase. Most respondents in ELSA are aged over 50, so it 
was not clear whether age squared should be included in specifications. Analyses using RE 
models were therefore conducted to assess whether specifications including age squared 
predict inflammation and depressive symptoms more accurately than models without age 
squared. The results are presented in Table A21.1. After including gender and age, age 
squared predicts both depressive symptoms and Ln(CRP), although effect sizes are 
negligible. The increase in R-square between the two specifications is negligible in relation 
to Ln(CRP), but substantial in relation to depressive symptoms (R2=0.018 without age2, and 
R2=0.023 with age2). Based on these considerations, I decided to include age squared in all 
specifications. 
Table A21.1: Changes in depressive symptoms and inflammation with age. 
 Model 1: Outcome is standardised Ln(CRP) Model 2: Outcome is depressive symptoms 
 
beta 95%CI p-val Rsq N beta 95%CI p-val Rsq N 
    
 
     
 
 
Model 1 
   
 
     
 
 Female 0.082 0.045-0.119 0.000 0.013 17211 0.490 0.433-0.547 0.000 0.018 29635 
Age 0.011 0.009-0.012 0.000  
 
0.007 0.004-0.009 0.000  
              
Model 2 
   
 
     
 
 Female 0.084 0.047-0.121 0.000 0.013 17211 0.464 0.407-0.521 0.000 0.023 29635 
Age 0.039 0.019-0.059 0.000  
 
-0.135 -0.160-0.109 0.000  
 Age 
squared 0.000 0.000-0.000 0.005  
 
0.001 0.001-0.001 0.000  
 These are results of random effects models. No additional variables are included. 
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Appendix 22: Additional results 
Sensitivity analyses were conducted in relation to RQ1 using an alternative measure of 
depressive symptoms with three categories; no, one and two or more depressive symptoms. 
For specifications in which depressive symptoms was the outcome, ordered probits were 
used. Using this measure, the results were very similar to those reported in the main text. 
Each SD increase in Ln(CRP) predicted an increase in depressive symptoms four years later 
(range 0-2) of 0.030 units (95%ci=0.010-0.066, p=0.008, N=7,829). There was no evidence 
that depressive symptoms predicted Ln(CRP) four years later (β=0.014, 95%ci=-0.011-0.039, 
p=0.262, N=5,869). 
Results using this three category measure of depressive symptoms by gender, health status 
and age category are presented in Tables A22.1 and A22.2. They are similar to those 
presented in the main text using a continuous measure of depressive symptoms.
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Table A22.1:   Associations between inflammation and depressive symptoms four years later by gender, age category  and health status. 
 Whole sample Men Women 
Outcome is depressive symptoms at t beta 95%CI p_val N beta 95%CI p_val N beta 95%CI p_val N 
Ln(CRP)(t-1) 0.033 -0.008-0.075 0.118 7829 0.028 -0.015-0.070 0.202 3596 0.047 0.010-0.084 0.013 4233 
Gender 0.198 0.143-0.253 0.000            
Gender*Ln(CRP)(t-1) 0.008 -0.047-0.063 0.773            
    
 Whole sample Aged under 70 Aged 70 plus 
Outcome is depressive symptoms at t beta 95%CI p_val N beta 95%CI p_val N beta 95%CI p_val N 
Ln(CRP)(t-1) 0.038 0.006-0.071 0.020 7830 0.036 0.004-0.069 0.030 5485 0.074 0.021-0.127 0.006 2345 
70 plus(t-1) 0.174 0.114-0.234 0.000            
70 plus(t-1)*Ln(CRP)(t-1) 0.030 -0.031-0.091 0.340            
    
 Whole sample No longstanding illness With longstanding illness 
Outcome is depressive symptoms at t beta 95%CI p_val N beta 95%CI p_val N beta 95%CI p_val N 
Ln(CRP)(t-1) 0.017 -0.024-0.057 0.425 7829 0.026 -0.015-0.067 0.215 3685 0.051 0.013-0.089 0.009 4144 
Longstanding illness(t-1) 0.258 0.201-0.314 0.000            
Longstanding illness(t-1)*Ln(CRP)(t-1) 0.040 -0.015-0.095 0.154 
              
 
 Whole sample With RA These are results from 15 random effects 
models using linear regressions and 
depressive symptoms as a continuous 
variable, adjusted for depressive 
symptoms at time t-1, age and age 
squared at time t, gender, medication 
for inflammation or depression at time t, 
qualifications below Level 2 in 2004 and 
wealth in 2004. The first two sets of 
models are also adjusted for 
longstanding illness at time t-1. The 
model that includes the indicator of age 
70 and over does not include additional 
adjustment for age, and the 
specifications for sub-samples aged 
below 70 and 70+ adjust for age but not  
Outcome is depressive symptoms at t beta 95%CI p_val N beta 95%CI p_val N 
Ln(CRP)(t-1) 0.038 0.008-0.068 0.014 6962 0.028 -0.170-0.226 0.782 165 
RA(t-1) 0.365 0.173-0.558 0.000       
RA(t-1)*Ln(CRP)(t-1) 0.012 -0.180-0.204 0.901       
   
 Whole sample With history of asthma 
Outcome is depressive symptoms at t beta 95%CI p_val N beta 95%CI p_val N 
Ln(CRP)(t-1) 0.028 -0.002-0.059 0.066 7788 0.063 -0.010-0.135 0.089 1200 
Asthma(t-1) 0.291 0.208-0.374 0.000       
Asthma(t-1)*Ln(CRP)(t-1) 0.041 -0.035-0.118 0.290       
   
 Whole sample With active asthma 
Outcome is depressive symptoms at t beta 95%CI p_val N beta 95%CI p_val N 
Ln(CRP)(t-1) 0.038 0.009-0.066 0.010 7825 0.040 -0.082-0.162 0.517 472 
Active asthma(t-1) 0.375 0.254-0.496 0.000       
Active asthma(t-1)*Ln(CRP)(t-1) 0.026 -0.094-0.146 0.667       
age squared. Measures of Ln(CRP) and depressive symptoms are standardised. Bold font indicates associations with p-values below 0.05. 
. 
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Table A22.2:   Associations between depressive symptoms and Ln(CRP) four years later by gender, age category and health status. 
 Whole sample Men Women 
Outcome is Ln(CRP) at time t beta 95%CI p_val N beta 95%CI p_val N beta 95%CI p_val N 
Depr(t-1) 0.017 -0.014-0.048 0.279 5869 0.006 -0.034-0.046 0.769 2659 0.020 -0.012-0.052 0.221 3210 
Gender 0.042 -0.004-0.088 0.074            
Gender*Depr(t-1) -0.006 -0.041-0.030 0.755            
    
 Whole sample Aged below 70 Aged 70+ 
Outcome is Ln(CRP) at time t beta 95%CI p_val N beta 95%CI p_val N beta 95%CI p_val N 
Depr(t-1) 0.018 -0.009-0.045 0.192 5870 0.013 -0.016-0.041 0.391 4265 0.037 -0.011-0.084 0.130 1605 
70+(t-1) 0.028 -0.021-0.077 0.258            
70+(t-1)*Depr(t-1) 0.007 -0.039-0.053 0.766            
    
 Whole sample No longstanding illness With longstanding illness 
Outcome is Ln(CRP) at time t beta 95%CI p_val N beta 95%CI p_val N beta 95%CI p_val N 
Depr(t-1) 0.025 -0.005-0.056 0.101 5869 0.033 -0.002-0.067 0.067 2828 -0.004 -0.039-0.031 0.831 3041 
Longstanding illness(t-1) 0.045 0.002-0.087 0.039            
Longstanding illness(t-1)*Depr(t-1) -0.022 -0.056-0.012 0.207            
               
 Whole sample With RA These are results from 15 random effects 
models, with Ln(CRP) at time t as the 
outcome and adjusted for Ln(CRP) at 
time t-1, age and age squared at time t, 
gender, medication for inflammation or 
depression at time t, qualifications 
below Level 2 in 2004, and wealth in 
2004. The first two sets of models are 
also adjusted for longstanding illness at 
time t-1. The model that includes the 
indicator of age 70+ does not include 
additional adjustment for age, and the 
specifications for sub-samples above and 
below 70 adjust for age but not age 
squared. Measures of Ln(CRP) and 
depressive symptoms are standardised. 
Bold font indicates associations with p-
values below 0.05. 
Outcome is Ln(CRP) at time t beta 95%CI p_val N beta 95%CI p_val N 
Depr(t-1) 0.010 -0.016-0.037 0.447 5240 -0.043 -0.217-0.132 0.630 114 
RA(t-1) 0.075 -0.080-0.230 0.345       
RA(t-1)*Depr(t-1) -0.055 -0.200-0.090 0.457       
   
 Whole sample With history of asthma 
Outcome is Ln(CRP) at time t beta 95%CI p_val N beta 95%CI p_val N 
Depr(t-1) 0.013 -0.013-0.039 0.341 5837 0.001 -0.064-0.066 0.971 870 
Asthma(t-1) 0.101 0.034-0.167 0.003       
Asthma(t-1)Depr(t-1) 0.009 -0.042-0.060 0.731       
   
 Whole sample With active asthma 
Outcome is Ln(CRP) at time t beta 95%CI p_val N beta 95%CI p_val N 
Depr(t-1) 0.010 -0.016-0.035 0.457 5866 0.063 -0.041-0.168 0.236 346 
Active asthma(t-1) 0.109 0.020-0.198 0.016       
Active asthma(t-1)*Depr(t-1) 0.067 -0.006-0.139 0.071 
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Pairwise correlations between variables used in the SEMs are presented in Table A22.3. Auto-correlations between waves are high, but otherwise 
variables are not highly correlated.  
Table A22.3:   Pairwise correlations between variables used in the SEM. 
 
Fem. Age SEP LLI Meds (crp)2 (crp)4 (crp)6 Dep2 Dep4 Dep6 Obes3 Obes5 Inact3 Inact5 Pain3 Pain5 Strss3 Strss5 
Female 1 
                  Age -0.01 1 
                 SEP 0.05 0.08 1 
                LLI 0.03 0.42 0.17 1 
               Meds 0.03 0.26 0.12 0.23 1 
              Ln(CRP)2 0.05 0.11 0.18 0.16 0.16 1 
             Ln(CRP)4 0.04 0.09 0.14 0.11 0.12 0.65 1 
            Ln(CRP)6 0.06 0.12 0.13 0.13 0.12 0.60 0.66 1 
           Depress2 0.13 0.07 0.23 0.29 0.13 0.09 0.08 0.07 1 
          Depress4 0.14 0.07 0.20 0.23 0.13 0.11 0.07 0.08 0.50 1 
         Depress6 0.13 0.08 0.18 0.20 0.13 0.11 0.08 0.09 0.44 0.50 1 
        Obesity3 0.10 0.01 0.12 0.12 0.14 0.32 0.33 0.28 0.08 0.08 0.07 1 
       Obesity5 0.11 0.05 0.12 0.13 0.17 0.32 0.34 0.33 0.09 0.08 0.07 0.90 1 
      Inactivity3 0.06 0.32 0.29 0.33 0.20 0.18 0.17 0.18 0.24 0.24 0.22 0.15 0.16 1 
     Inactivity5 0.08 0.34 0.24 0.32 0.17 0.19 0.16 0.18 0.23 0.25 0.25 0.16 0.16 0.54 1 
    Pain3 0.08 0.09 0.18 0.36 0.15 0.15 0.15 0.14 0.29 0.31 0.29 0.14 0.14 0.27 0.25 1 
   Pain5 0.11 0.09 0.18 0.32 0.16 0.12 0.14 0.13 0.27 0.28 0.27 0.16 0.15 0.24 0.27 0.50 1 
  Stress3 0.03 0.10 0.46 0.21 0.16 0.17 0.14 0.17 0.32 0.31 0.29 0.11 0.12 0.30 0.28 0.25 0.23 1 
 Stress5 0.05 0.09 0.44 0.18 0.15 0.16 0.11 0.14 0.32 0.33 0.32 0.11 0.12 0.29 0.30 0.24 0.25 0.72 1 
Age measured in 2004 (wave 2), SEP measured using low accumulated wealth in 2004, LLI is limiting longstanding illness by 2004, meds is use of medication 
between waves 0 and 6 that may affect inflammation and/or depressive symptoms. Stress is an index comprised of low self-efficacy, low subjective social status, 
financial strain and social withdrawal. Ln(CRP) and depressive symptoms are standardised and measured in waves 2,4and6. Obesity is waist circumference of 
88cms+ for women and 102cms+ for men. Inactivity refers to lack of physical exercise. Subtext numbers refer to waves of data collection, which are two years 
apart. Italicised and bold font indicate strong correlations 
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The SEM was built in stages and results are presented in Figure A22.1. Results are consistent with those of the final model, reported in Figure 4.3. 
Figure A22.1:   Building the SEM in stages (n=11,986 except in Stage 1) 
Stage 1: Inflammation and depressive symptoms (n=10,835)  Stage 2: Stage 1 + time-invariant confounders 
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  I    I
e
    I
e
    I    I
e
    I
e
 
                       
Age            Age           
                       
SEP            SEP           
                       
LLI            LLI           
                Pain    Pain   
Meds.            Meds.           
    Stress    Stress               
Female            Female           
                       
  D    De    De    D    De    De 
   
Appendix 22 Chapter 4: Results      452 
 
 
 
Stage 3: Stage 2 + one mediator  Stage 3: Stage 2 + one mediator 
                       
  I    I
e
    I
e
    I    I
e
    I
e
 
                       
Age            Age           
                Obesity    Obesity   
SEP            SEP           
    Inactivity    Inactivity               
LLI            LLI           
                       
Meds.            Meds.           
                       
Female            Female           
                       
  D    De    De    D    De    De 
                       
                       
             
      All mediators are auto-correlated over time and inter-correlated in wave 3       
                       
                       
Stage 4: Stage 2 + two mediators  Stage 4: Stage 2 + two mediators 
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Stage 5: Stage 2 + three mediators  Stage 5: Stage 2 + three mediators 
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Final specification             
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Results of additional sensitivity analyses are presented in Figure A22.2, which contains eleven illustrations. The first illustration uses the ADF 
method of estimation, which uses less available data but makes no assumptions about the distributions of variables. Mediated associations 
reported in the main analyses are no longer statistically significant when using ADF, reflecting the lack of power; the MLMV estimation uses 11,986 
observations whereas the ADF estimation uses 1,762. Smaller sample size may also result in fitting difficulties, as negative correlations are found 
between inflammation and depressive symptoms during wave 4, and between depressive symptoms and obesity.    
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Figure A22.2:   Additional robustness checks (n=11,986 except for ADF estimation) 
1. ADF estimation (n=1,762)  2. Stress/social withdrawal index excludes subjective social status 
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Inactivity correlated with (1) obesity (2) stress in wave 3  All wave 3 mediators inter-correlated except stress and obesity 
Mediators are auto-correlated over time in all models 
3. Stress/social withdrawal index excludes financial strain  4. Stress index excludes social withdrawal 
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Inactivity correlated with (1) obesity (2) stress in wave 3  All mediators inter-correlated in wave 3 
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5. Obesity measured using BMI of 30+  6. Waist measurement instead of obesity 
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Obesity auto-correlated over time  Waist auto-correlated over time 
             
7. BMI values (Kg/m
2
) instead of obesity  8. Pain in hips, knees, feet or mouth (excludes back pain) 
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and stress 
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9. Respondents with main and nurse interviews up to two months apart  10. Respondents with history of asthma, excluding pain (n=2,935) 
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N=2,638. Wave 3 mediators inter-correlated except obesity and stress  All mediators inter-correlated in wave 3 except obesity and stress 
All mediators are auto-correlated over time 
             
11. Respondents with current asthma, excluding pain (n=1,949)   
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Illustrations 2-8 include alternative measures of mediating factors. Summary statistics for 
these measures are presented in Table A22.4. Illustrations 2-4 and 8 indicate that using 
alternative measures of stress  and pain (excluding back pain) does not change the results. 
Table A22.4:   Summary statistics for alternative and additional measures in the SEMs 
 Wave 3 Wave 5 
Variable 
Mean
/%=y 
SD/ 
N=y Min Max N 
Mean
/%=y 
SD/ 
N=y Min Max N 
Stress and social withdrawal index, excluding:      
Subj. social status  0.581 0.127 0.25 1.000 6915 0.563 0.128 0.25 1.000 7235 
Financial strain 0.555 0.120 0.183 0.967 6892 0.539 0.121 0.183 0.956 7209 
Social withdrawal 0.468 0.123 0.139 0.967 6897 0.461 0.125 0.139 0.967 7204 
      
Alternative measures of obesity:      
BMI 30 plus 31.0 46.2 0 1 8507 31.5 46.5 0 1 7999 
Waist in cms 96.7 13.3 58.2 171.6 8612 96.9 13.5 58.0 155.2 8097 
BMI in Kg/m
2 
28.3 5.07 14.9 59.9 8507 28.4 5.20 15.1 66.7 7999 
      
Alternative measure of pain, excluding back pain      
Pain in limbs 24.0 42.7 0 1 7873 24.2 42.8 0 1 7791 
Based on the sample used to estimate SEMs, includes respondents who provided complete 
information about gender, age, accumulated wealth in 2004, limiting longstanding illness by wave 2 
and medication use. 
 
Illustrations 5-7 show that relationships between obesity and both depressive symptoms 
and inflammation were the same, regardless of whether obesity was measured using a 
cutpoint of high waist circumference or high BMI (30+). However, depressive symptoms in 
wave 4 predicted lower continuous values of BMI and waist circumference in wave 5. 
Additional models estimated for men and women separately (not illustrated here) found a 
positive association between depressive symptoms in wave 4 and waist circumference in 
wave 5 among men and a negative one among women.  
Illustration 9 shows that excluding respondents whose main and nurse interviews were 
more than two months apart does not affect the results. 
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Illustrations 10 and 11 present results of SEMs for respondents with asthma that exclude 
pain as a hypothesised mediator, since pain is not associated with asthma. 
Detailed results of the SEM using the MLMV method for the whole sample are presented in 
Table A22.5.   
Table A22.5:   Results of SEM for whole sample with MLMV estimation method (n=11,986) 
Model 
Coefficie
nt 
95% confidence 
interval 
p-
value 
     Outcome is Ln(CRP) in wave 2                      
    Female 0.080 0.032 0.128 0.001 
Age in 2004 0.009 0.006 0.012 0.000 
Low wealth in 2004 0.249 0.219 0.280 0.000 
Limiting longstanding illness by wave 2 0.161 0.131 0.190 0.000 
Medication by use by wave 6 0.368 0.299 0.438 0.000 
     Outcome is depressive symptoms in wave 2                       
    Female 0.240 0.200 0.280 0.000 
Age in 2004 -0.001 -0.003 0.001 0.313 
Low wealth in 2004 0.234 0.209 0.259 0.000 
Limiting longstanding illness by wave 2 0.295 0.270 0.319 0.000 
Medication by use by wave 6 0.129 0.068 0.189 0.000 
 
    
Outcome is psychological stress in wave 3                       
Ln(CRP) in wave 2 0.024 0.021 0.027 0.000 
Depressive symptoms in wave 2 0.039 0.037 0.042 0.000 
     
Outcome is obesity in wave 3     
Ln(CRP) in wave 2 0.157 0.146 0.168 0.000 
Depressive symptoms in wave 2 0.020 0.009 0.030 0.000 
 
    
Outcome is physical inactivity in wave 3     
Ln(CRP) in wave 2 0.072 0.065 0.079 0.000 
Depressive symptoms in wave 2 0.069 0.062 0.076 0.000 
 
    
Outcome is pain in wave 3                        
Ln(CRP) in wave 2 0.056 0.047 0.064 0.000 
Depressive symptoms in wave 2 0.097 0.089 0.104 0.000 
 
    
Outcome is Ln(CRP) in wave 4                          
Ln(CRP) in wave 2 0.609 0.584 0.635 0.000 
Depressive symptoms in wave 2 -0.006 -0.031 0.020 0.659 
Psychological stress in wave 3 0.092 -0.123 0.307 0.402 
Pain in wave 3 0.087 0.015 0.160 0.018 
Obesity in wave 3 0.214 0.163 0.264 0.000 
Physical inactivity in wave 3 0.016 -0.073 0.105 0.723 
 
    
Outcome is depressive symptoms in wave 4                          
Depressive symptoms in wave 2 0.413 0.392 0.434 0.000 
Ln(CRP) in wave 2 0.041 0.008 0.075 0.016 
Ln(CRP) in wave 4 -0.022 -0.057 0.012 0.204 
Psychological stress in wave 3 0.937 0.758 1.117 0.000 
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Pain in wave 3 0.389 0.330 0.448 0.000 
Obesity in wave 3 0.003 -0.041 0.047 0.878 
Physical inactivity in wave 3 0.190 0.119 0.260 0.000 
 
    
Outcome is psychological stress in wave 5                        
Psychological stress in wave 3 0.690 0.672 0.708 0.000 
Ln(CRP) in wave 4 0.004 0.002 0.006 0.001 
Depressive symptoms in wave 4 0.015 0.012 0.017 0.000 
     
Outcome is obesity in wave 5                      
Obesity in wave 3 0.876 0.866 0.887 0.000 
Ln(CRP) in wave 4 0.020 0.014 0.026 0.000 
Depressive symptoms in wave 4 0.001 -0.005 0.006 0.802 
 
    
Outcome is physical inactivity in wave 5                          
Physical inactivity in wave 3 0.518 0.496 0.540 0.000 
Ln(CRP) in wave 4 0.035 0.027 0.042 0.000 
Depressive symptoms in wave 4 0.043 0.036 0.049 0.000 
 
    
Outcome is pain in wave 5                        
Pain in wave 3 0.451 0.429 0.473 0.000 
Ln(CRP) in wave 4 0.034 0.026 0.042 0.000 
Depressive symptoms in wave 4 0.052 0.044 0.059 0.000 
 
    
Outcome is Ln(CRP) in wave 6                          
Ln(CRP) in wave 4 0.864 0.817 0.910 0.000 
Depressive symptoms in wave 4 0.006 -0.021 0.034 0.651 
Psychological stress in wave 5 0.028 -0.192 0.247 0.804 
Pain in wave 5 -0.022 -0.097 0.054 0.574 
Obesity in wave 5 0.069 0.011 0.126 0.020 
Physical inacitivity in wave 5 0.094 0.005 0.182 0.038 
 
    
Outcome is depressive symptoms in wave 6                           
Depressive symptoms in wave 4 0.755 0.705 0.805 0.000 
Ln(CRP) in wave 4 -0.007 -0.044 0.030 0.703 
Ln(CRP) in wave 6 0.013 -0.022 0.048 0.483 
Psychological stress in wave 5 0.375 0.766 0.000 0.000 
Pain in wave 5 0.106 0.230 0.000 0.000 
Obesity in wave 5 -0.085 0.009 0.118 0.110 
Physical inactivity in wave 5 0.143 0.286 0.000 0.000 
 
    
Co-variances between error terms     
Psychological stress in wave 3 * pain in wave 3 0.006 0.005 0.006 0.000 
Psychological stress in wave 3 * obesity in wave 3 0.001 0.000 0.002 0.134 
Psychological stress in wave 3 * physical inactivity in 
wave 3 0.007 0.006 0.008 0.000 
Pain in wave 3 * obesity in wave 3 0.010 0.006 0.013 0.000 
Pain in wave 3 * physical inactivity in wave 3 0.017 0.015 0.019 0.000 
Obesity in wave 3 * physical inactivity in wave 3 0.008 0.005 0.011 0.000 
Ln(CRP) in wave 4 * Ln(CRP) in wave 6 -0.207 -0.243 -0.171 0.000 
Depressive symptoms wave 4 * depressive symptoms 
wave 6 -0.289 -0.327 -0.251 0.000 
11,986 observations. Depressive symptoms and Ln(CRP) are standardised, and measures in waves 3 
and 5 are scaled to have values between zero and one. 
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Chapter 6: Appendix 23: Discussion of relationships 
between obesity, inflammation and depressive 
symptoms found using Structural Equation Models 
Results of the Structural Equation Model presented in Figure 4.3 include evidence that 
obesity, measured by high waist circumference, predicted and was predicted by chronic 
inflammation. The magnitude of the latter association is non-trivial; a large waist is 
associated with 6.2% SDs of Ln(CRP) two years later, which is equivalent to just over 1mg/L 
of CRP. It is thought that obesity is linked to chronic low-grade inflammation through 
pathways involving white adipose tissue in the abdominal region and gut microbiota 
(Capuron et al. 2017, Castanon et al. 2014, Penninx et al. 2013, Kumari & Kozyrskyj 2017).  
High waist circumference did not mediate the prospective association between CRP and 
depressive symptoms because it did not predict depressive symptoms. This finding contrasts 
with existing evidence that obesity predicts depressive symptoms (Daly 2013, Luppino et al. 
2010) and attenuates the prospective association between inflammation and depression 
(Chocano-Bedoya et al. 2014). The different results probably reflect the inclusion in this 
study of different co-variates, such as physical inactivity and pain.  
The main analyses using high waist circumference to indicate obesity and sensitivity 
analyses that used high BMI (30+) to indicate obesity each found that depressive symptoms 
in wave 2 predicted obesity two years later. This is consistent with results of a meta-analysis 
of 15 prospective studies, which reports associations between depression and onset of 
obesity (Luppino et al. 2010). However, the SEMs adjust for earlier measures of depressive 
symptoms and obesity, and after these adjustments, depressive symptoms (in wave 4) did 
not predict obesity (in wave 5).   
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Sensitivity analyses of SEM using raw values of waist circumference and BMI found that 
depressive symptoms predicted lower values two years later, even between waves 4 and 5. 
The finding resonates with recent findings that British adults who are unemployed are more 
likely than other working-age adults to be underweight (Hughes & Kumari 2017). It indicates 
the importance of examining relationships not only with obesity but also with being 
underweight. 
Together with evidence reported above about relationships between depressive symptoms 
and obesity, this suggests that relationships between depressive symptoms and subsequent 
weight change vary depending upon the individual’s initial weight. Consistent with this, 
Luppino’s meta-analysis finds no evidence of a prospective association between depressive 
symptoms and overweight (BMI=25-29.99), but reports a positive association with obesity 
(BMI>=30, Luppino et al. 2010). 
Relationships between overweight, obesity, inflammation, depressive symptoms and 
depression appear complex. Tully et al. (2015) report prospective associations between 
chronic low-grade inflammation and depressive symptoms among non-obese adults but not 
among adults who are obese. Thus, obesity may moderate rather than mediate the 
prospective relationship between chronic inflammation and depressive symptoms, although 
this possibility was not tested here. 
 
 
 
 
 
 
